[
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states treatment depends on stage/resectability and categorizes as resectable, borderline resectable, locally advanced (unresectable), or metastatic."
      },
      {
        "criterion_number": 2,
        "description": "The response should include surgery as a preferred option for resectable tumors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "For resectable disease, it lists surgery (Whipple, distal pancreatectomy, total pancreatectomy) with chemo before or after, indicating surgery is central when tumors are removable."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that chemotherapy is the backbone of treatment for metastatic or unresectable pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes systemic chemotherapy as first-line for both locally advanced (unresectable) and metastatic disease, with specific regimens, indicating chemo is the mainstay."
      },
      {
        "criterion_number": 4,
        "description": "The response should include radiation as a potential treatment option for localized disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions radiation (including SBRT and chemoradiation) in resectable/borderline settings and as consolidation for locally advanced disease."
      },
      {
        "criterion_number": 5,
        "description": "The response should include the concept of resectability.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly uses resectability categories (resectable, borderline resectable, unresectable) throughout the treatment framework."
      },
      {
        "criterion_number": 6,
        "description": "The response should specify the main chemotherapy regimens used are FOLFIRINOX or Gemcitabine + Nab-Paclitaxel.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically names modified FOLFIRINOX and gemcitabine + nab-paclitaxel as key regimens."
      },
      {
        "criterion_number": 7,
        "description": "The response should include immunotherapy and that its role is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes pembrolizumab for MSI-H/dMMR tumors, indicating immunotherapy is used in this biomarker-defined subset (also notes high TMB)."
      },
      {
        "criterion_number": 8,
        "description": "The response should include targeted therapy such as PARPi for patients with BRCA mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions BRCA1/2/PALB2 with platinum sensitivity and olaparib maintenance, a PARP inhibitor."
      },
      {
        "criterion_number": 9,
        "description": "The response should introduce the concept of clinical trials and their role in the management of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Strongly encourages clinical trials at all stages and offers assistance finding trials."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize that symptom management is an important part of the care of patients with pancreatic cancer and should highlight the importance of supportive care, including evaluation by a palliative care specialist and nutritional support.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a detailed supportive care section covering biliary stenting, nutrition, pancreatic enzymes, pain control, thromboembolism prevention, diabetes management, and early palliative care integration."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that the treatment of pancreatic cancer depends on the location of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States the plan depends on where the tumor is and differentiates surgery types by anatomic location (head vs tail)."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that the NCCN Panel recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it recommends high-volume/NCI centers, it does not cite NCCN recommendations, multidisciplinary teams, or high-quality imaging explicitly."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend discussing the treatment of pancreatic cancer with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to ask specific questions to the oncologist, indicating discussion with an oncologist is recommended."
      }
    ],
    "question_number": 1,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:18:40.875777",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must provide a direct link to a list of NCI-designated cancer centers.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions the 'NCI-Designated Cancer Centers directory' but does not include a direct URL link."
      },
      {
        "criterion_number": 2,
        "description": "The response must discuss the concept of resectability in pancreatic cancer, stating that involvement of major blood vessels like the celiac artery generally precludes safe resection and requires evaluation at a specialized center.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response notes that tumors involving the celiac artery are complex and should be evaluated at a high-volume pancreas center, it does not explicitly state that vascular involvement generally precludes safe resection nor does it clearly frame this in terms of resectability status."
      },
      {
        "criterion_number": 3,
        "description": "The response must emphasize the need for evaluation by a multidisciplinary clinic, including surgical, medical, and radiation oncology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly recommends a multidisciplinary team and lists HPB surgical oncology, medical oncology, radiation oncology, interventional radiology, and vascular surgery."
      },
      {
        "criterion_number": 4,
        "description": "The response must clearly state that neoadjuvant treatment may be proposed to shrink the tumor to a resectable size, but some tumors may remain unresectable and only amenable to systemic therapy or radiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it references surgery after chemotherapy, it does not explicitly discuss neoadjuvant intent to downstage nor the possibility that tumors may remain unresectable and require systemic therapy or radiation only."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly state that some specialized centers can offer vascular reconstruction for tumors involving major blood vessels.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions 'vascular reconstructions (e.g., celiac axis resection/\u201cAppleby\u201d procedure)' at specialized centers."
      },
      {
        "criterion_number": 6,
        "description": "The response must offer to search for high-volume pancreatic cancer programs by preferred location, asking for specific location details to tailor recommendations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It asks for city/region, travel distance, insurance constraints, and offers to suggest specific named doctors/clinics based on location."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that the NCCN Panel (version 2.2025) recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of NCCN, version 2.2025, or guideline-specific recommendations regarding multidisciplinary care or imaging."
      }
    ],
    "question_number": 2,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:18:59.801069",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include an overview of the criteria for resection of the tumor and why patients are deemed not to be good candidates for surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains why surgery may not be offered at Stage 3, citing tumor extent, involvement of critical structures, vascular involvement, margins unlikely, and overall surgical risk. It also mentions potential need for vascular reconstruction and downstaging to improve resectability, which constitutes an adequate overview of resectability considerations."
      },
      {
        "criterion_number": 2,
        "description": "The response should indicate that the case should be discussed at a multidisciplinary tumor board.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly recommends a multidisciplinary tumor board review and instructs the patient to request that their case be re-presented to the hospital\u2019s tumor board."
      },
      {
        "criterion_number": 3,
        "description": "The response should indicate that the patient could seek a second opinion at another specialized center.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly advises seeking a high-volume surgical second opinion, including at NCI-Designated Comprehensive Cancer Centers, and notes availability of remote/virtual second opinions."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide a list of specialized centers that offer second opinions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests NCI-Designated Comprehensive Cancer Centers and offers help identifying centers based on location, it does not provide any specific named centers or a list."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend that the person discuss surgery with the current oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises asking targeted questions of the current surgeons and clarifying trial constraints with the principal investigator, indicating direct discussion with the existing oncology team."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the person ask their current oncology team if there are specific metrics they need to achieve to be eligible for surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends asking what criteria would trigger surgical reevaluation and whether additional downstaging would make surgery feasible, aligning with asking for specific eligibility metrics."
      }
    ],
    "question_number": 3,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:19:16.958004",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should list PANCAN Online Community as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response lists PanCAN (Pancreatic Cancer Action Network) on Inspire with a direct URL, which constitutes the PanCAN online community."
      },
      {
        "criterion_number": 2,
        "description": "The response should include the American Cancer Society (ACS) online community as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes the American Cancer Society Cancer Survivors Network (csn.cancer.org) and identifies it as a caregivers forum."
      },
      {
        "criterion_number": 3,
        "description": "The response should include CancerCare Online Support Groups as an option.",
        "score_given": 0,
        "max_points": 10,
        "justification": "CancerCare Online Support Groups are not mentioned. The response lists Cancer Support Community and other resources but not CancerCare."
      },
      {
        "criterion_number": 4,
        "description": "The response should include various Facebook support groups.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends Facebook and suggests searching for 'pancreatic cancer caregivers' to find private, moderated groups."
      },
      {
        "criterion_number": 5,
        "description": "The response should affirm that there are many online support groups for families of pancreatic cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response begins with 'Yes' and provides multiple reputable options specifically for family members and caregivers, affirming availability."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend talking to your family member\u2019s oncology about support groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no recommendation to speak with the oncology team/oncologist about support groups."
      }
    ],
    "question_number": 4,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:19:28.332550",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should indicate that while chronic pancreatitis is a risk factor for pancreatic cancer, it is still not common to develop pancreatic cancer even in patients with pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that chronic pancreatitis increases risk but that most people with chronic pancreatitis never develop cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should offer support for having experienced the symptoms of chronic pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Opens with empathetic acknowledgment of the patient\u2019s situation and validates their concern."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the potential signs and symptoms of pancreatic cancer, which could include unintentional weight loss, jaundice, steatorrhea, new onset diabetes, and worsening of abdominal symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists jaundice, dark urine, pale/greasy stools, unexplained weight loss, loss of appetite, new/worsening upper abdominal pain radiating to the back, and new-onset diabetes."
      },
      {
        "criterion_number": 4,
        "description": "The response should outline at least three options for obtaining medical attention without insurance or for low-income adults, such as Federally Qualified Health Centers, community health clinics, Medicaid, or ACA marketplace plans, and should include specific examples or resources when possible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides multiple concrete options with specifics: FQHCs with link, nonprofit hospital charity care, teaching hospitals/academic clinics with reduced rates, and guidance on cash-price imaging with typical price ranges."
      },
      {
        "criterion_number": 5,
        "description": "The response should indicate that a consultation with a physician who may obtain labs, perform a physical exam, and obtain imaging studies such as a CT scan would be warranted.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises seeking urgent care/ER for severe symptoms and details appropriate evaluation steps including labs and first-line imaging (pancreas-protocol CT or MRI/MRCP) with possible EUS follow-up."
      },
      {
        "criterion_number": 6,
        "description": "The response should offer information on how to sign up for Medicaid and provide more specific instructions and information about eligibility depending on the state the person resides in.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention Medicaid sign-up, eligibility, or state-specific guidance."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends discussing financial concerns with a doctor, including at least one practical suggestion (e.g., payment plans, charity care).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides practical suggestions to address costs (ask about charity care/financial assistance policies, reduced self-pay rates, and cash prices) which entails discussing finances with providers/facilities."
      }
    ],
    "question_number": 5,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:19:54.060603",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide support and note that it is normal to feel overwhelmed under the circumstance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with clear empathy and normalization of feelings (e.g., 'Feeling helpless and overwhelmed is completely understandable') and maintains a supportive tone throughout with actionable coping steps."
      },
      {
        "criterion_number": 2,
        "description": "The answer should provide links to websites that give more information on pancreatic cancer that are written at the level of patients and their families.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists multiple patient-facing resources with web addresses: PanCAN (pancan.org), American Cancer Society (cancer.org), CancerCare (cancercare.org), NCCN Guidelines for Patients (nccn.org/patients), and NCI-designated cancer centers (cancer.gov). These are appropriate and accessible for patients/families."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information about online support groups for pancreatic cancer patients and caregivers, including those offered by the Pancreatic Cancer Action Network (PanCAN), the American Cancer Society (ACS), and CancerCare.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes that CancerCare offers 'support groups,' it does not specify online support groups for PanCAN or ACS, nor explicitly frame them as online groups. The criterion requires inclusion of online support groups from PanCAN, ACS, and CancerCare; only CancerCare is explicitly mentioned as having support groups."
      }
    ],
    "question_number": 6,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:20:08.894337",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Provide a link to ClinicalTrials.gov for information on clinical trial options.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly references ClinicalTrials.gov and NCI\u2019s clinical trials site (cancer.gov/clinicaltrials). Mentioning 'ClinicalTrials.gov' as the site to use qualifies as providing the link destination."
      },
      {
        "criterion_number": 2,
        "description": "Offer to search for treatment options by location.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response offers to help narrow trials and specifically requests the country/region the patient can travel to, indicating a location-based search."
      },
      {
        "criterion_number": 3,
        "description": "Explicitly suggest obtaining a second opinion from another oncologist or major cancer center and provide a list of leading cancer centers that offer second opinion consultations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises referral to an NCI-designated cancer center/high-volume program, it does not explicitly recommend a second opinion nor provide a list of specific leading centers."
      },
      {
        "criterion_number": 4,
        "description": "Provide an overview of active areas of research in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It details multiple active research areas: KRAS-targeted agents (G12D, pan-RAS), DNA damage response inhibitors (PARP/ATR/WEE1/DNA-PK), ADCs (TROP2), immunotherapy combinations (CD40, CXCR4, STING/TLR, adenosine/TGF-\u03b2/FAK), cellular therapies (CAR-T/TCR), and tumor/neoantigen vaccines."
      },
      {
        "criterion_number": 5,
        "description": "Provide support and acknowledge the difficulty of the situation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with empathy and maintains a supportive tone throughout, acknowledging the difficulty and offering help."
      },
      {
        "criterion_number": 6,
        "description": "Explicitly recommend discussing clinical trial options and eligibility with the oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking the oncologist to order molecular testing, to discuss approval status and trial access, and lists eligibility considerations, which together constitute an explicit recommendation to discuss trial options and eligibility with the oncology team."
      }
    ],
    "question_number": 7,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:20:29.261387",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide support and acknowledge that feeling overwhelmed under the circumstances is understandable and valid.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with empathy and explicitly states that feeling overwhelmed is normal."
      },
      {
        "criterion_number": 2,
        "description": "The answer should provide an overview of what a Stage IV diagnosis entails.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains that stage IV means spread to other organs and that treatment goals are control, symptom relief, and quality of life."
      },
      {
        "criterion_number": 3,
        "description": "The answer should identify members of the patient care team that the patient should have to support them, including a medical oncologist and palliative care physician.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists a medical oncologist, palliative care specialist, nurse navigator/social worker, dietitian, and primary care, meeting and exceeding requirements."
      },
      {
        "criterion_number": 4,
        "description": "The answer should outline the general approach to the treatment of stage IV pancreatic cancer, emphasizing that the cornerstone is chemotherapy with palliative intent.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes first-line chemotherapy regimens (FOLFIRINOX, gemcitabine+nab-paclitaxel), clinical trials, and frames goals as palliative (control symptoms and quality of life)."
      },
      {
        "criterion_number": 5,
        "description": "The response should emphasize the importance of support and community for both patients and caregivers, and should mention the Pancreatic Cancer Action Network (PanCAN), the American Cancer Society (ACS), and CancerCare as key resources for online support groups.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes caregiver support and community resources and explicitly lists PanCAN, ACS, and CancerCare (noting support groups)."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly recommend discussing the diagnosis and next steps with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a section titled 'Talking with the oncologist: good questions' and prompts discussing testing, treatment choices, and next steps with the oncologist."
      }
    ],
    "question_number": 8,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:20:43.889404",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer must recommend discussing vitamins and supplements with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises: \"Please run any changes by her oncology team\" and later reiterates sharing a complete supplement list with the oncology team and pharmacist and following the team's protocol on infusion days."
      },
      {
        "criterion_number": 2,
        "description": "The answer must recommend maintaining a healthy and balanced diet.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends seeing an oncology dietitian and using small, frequent, high-protein, high-calorie meals tailored to symptoms\u2014an appropriate, balanced approach for pancreatic cancer\u2013related malnutrition. It also mentions considering MCT oil and a standard daily multivitamin if intake is poor."
      },
      {
        "criterion_number": 3,
        "description": "The answer must explicitly state that any diet or high-dose vitamins claiming to cure cancer should be avoided.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises against high-dose antioxidants and several herbal supplements due to risks and lack of evidence, it does not explicitly state to avoid any diet or high-dose vitamins that claim to cure cancer."
      },
      {
        "criterion_number": 4,
        "description": "The answer must mention the benefit of pancreatic enzyme replacement therapy for pancreatic cancer patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes checking for exocrine insufficiency and states PERT can be \u201cgame\u2011changing for nutrition, weight, and vitamin absorption,\u201d including specific dosing guidance."
      },
      {
        "criterion_number": 5,
        "description": "The response must specify that due to malabsorption in pancreatic cancer, supplementation of fat-soluble vitamins (A, D, E, and K) is recommended, and should note that lab-confirmed vitamin deficiencies can be improved with appropriate vitamin supplements under the direction of a doctor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It links malabsorption to fat-soluble vitamin issues (\u201cIf she has malabsorption\u2026 consider checking levels. Replace only if low.\u201d) and covers A, D, E, and K (D addressed specifically with testing and dosing; A/E/K mentioned with testing and replacement if low). It also advises coordinating changes with the oncology team, satisfying the requirement for clinician direction."
      },
      {
        "criterion_number": 6,
        "description": "The answer must state that pancreatic enzyme deficiency is common in patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states pancreatic exocrine insufficiency is \u201cvery common\u201d in this context, which clearly implies high prevalence among pancreatic cancer patients."
      }
    ],
    "question_number": 9,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:21:06.898637",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend discussing goals of care and potential treatment side effects with the oncology team",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises discussing with the oncology team, provides 'Options to discuss with the oncology team,' and lists 'Questions to bring to the next visit' about expected benefits, side effects, and management. It also emphasizes clarifying goals of care."
      },
      {
        "criterion_number": 2,
        "description": "State that the decision to continue chemotherapy is highly personal",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states there isn\u2019t a single right answer and emphasizes aligning the decision with the patient\u2019s goals and values, clearly framing it as a personal decision."
      },
      {
        "criterion_number": 3,
        "description": "State that changes to the chemotherapy dose can improve side effects",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends 'Dose or schedule changes: Lower doses ... can reduce toxicity,' directly addressing dose adjustments to mitigate side effects."
      },
      {
        "criterion_number": 4,
        "description": "State that changes to the chemotherapy schedule can improve side effects",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests 'longer intervals can reduce toxicity,' which is a schedule modification to improve tolerability."
      },
      {
        "criterion_number": 5,
        "description": "State that changes to supportive medications can improve side effect symptoms",
        "score_given": 10,
        "max_points": 10,
        "justification": "It details supportive care options ('Stronger anti-nausea options, pain control, treatment for diarrhea/constipation, appetite support...') and notes that 'Uncontrolled side effects often can be improved.'"
      },
      {
        "criterion_number": 6,
        "description": "Recommend asking for a referral to a palliative care specialist",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends 'Early palliative care' and includes the question 'Can we have a palliative care consult now?' indicating a referral."
      },
      {
        "criterion_number": 7,
        "description": "Start with an expression of sympathy and support",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response begins with 'I\u2019m really sorry you\u2019re going through this,' an empathetic opening."
      },
      {
        "criterion_number": 8,
        "description": "State that deferring further cancer-directed treatment and pursuing palliative care and hospice would be a valid approach",
        "score_given": 10,
        "max_points": 10,
        "justification": "It says 'It\u2019s okay to stop' chemo and outlines 'Hospice (comfort-focused care at home)' as an appropriate option, affirming comfort-focused care as valid."
      }
    ],
    "question_number": 10,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:21:27.486037",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should specify that somatic testing can be done on the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends tumor profiling with tissue next-generation sequencing and mentions liquid biopsy (ctDNA) if tissue is limited."
      },
      {
        "criterion_number": 2,
        "description": "The answer should specify that germline testing is appropriate.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises germline DNA testing (blood/saliva) with example genes and referral to a genetic counselor."
      },
      {
        "criterion_number": 3,
        "description": "The answer should discuss testing for BRCA mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions BRCA1/2 in both germline and somatic contexts and ties results to treatment decisions."
      },
      {
        "criterion_number": 4,
        "description": "The answer should discuss the role of utilizing PARP inhibitors in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically references maintenance olaparib after platinum response in germline BRCA1/2 and discusses PALB2/ATM in the context of trials/off-label."
      },
      {
        "criterion_number": 5,
        "description": "The answer should include an overview of testing for microsatellite instability and MSI status, which can be a marker for response to immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes mismatch-repair/MSI status and TMB, and links MSI-high/dMMR or TMB-high to pembrolizumab."
      },
      {
        "criterion_number": 6,
        "description": "The answer should include other potential targetable mutations such as HER2/ERBB2 amplification and NTRK.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists HER2 amplification/overexpression with anti-HER2 options and NTRK fusions with larotrectinib/entrectinib; also mentions additional targets (BRAF V600E, RET, KRAS G12C, ALK, ROS1, NRG1)."
      },
      {
        "criterion_number": 7,
        "description": "The answer should specify that clinical trials may be available for less commonly targeted mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly prompts asking about clinical trials (front-line or after first-line), references trials for PALB2/ATM and KRAS G12C, and suggests matching trials to molecular profile."
      }
    ],
    "question_number": 11,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:21:45.955430",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should recommend that the patient consult a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly recommends genetic counseling and advises asking for a referral to a genetic counselor and a high-risk clinic."
      },
      {
        "criterion_number": 2,
        "description": "The answer should state that there is no widely accepted protocol for pancreatic cancer screening.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it cites expert groups and describes typical surveillance approaches, it does not explicitly state that there is no widely accepted or standardized screening protocol."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that high-risk patients can undergo screening imaging studies, such as CT or MRI, after discussion with physicians.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends annual MRI/MRCP and/or EUS for high-risk individuals and notes this should occur at experienced centers after discussing benefits and limitations. CT is mentioned as less preferred but acknowledged."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe hereditary syndromes that increase the risk of pancreatic cancer and note that germline BRCA mutations are a significant genetic risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists multiple hereditary risk genes and syndromes (e.g., BRCA1/2, PALB2, ATM, CDKN2A, STK11/Peutz-Jeghers, PRSS1, Lynch), thereby identifying hereditary syndromes and including BRCA as a key risk gene."
      },
      {
        "criterion_number": 5,
        "description": "The answer should recommend testing for selected mutations such as BRCA and CDKN2A.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly recommends germline multigene panel testing and specifically includes BRCA1/2 and CDKN2A among the genes to be tested."
      }
    ],
    "question_number": 12,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:22:07.885016",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that doctors use imaging results to determine response to therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that imaging (CT/MRI, sometimes PET) every 2\u20133 months is the main way to judge if chemotherapy is working."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 is one part of what determines response to therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly notes that CA 19-9 is a useful but imperfect marker and that doctors interpret it together with scans and clinical status; CA 19-9 is described as supporting information."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CA 19-9 levels are not always correlated with tumor size or disease status, and note that some patients do not secrete CA 19-9 at all.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the answer explains CA 19-9 can be falsely elevated and is imperfect, it does not mention that some patients do not secrete CA 19-9 at all (e.g., Lewis antigen\u2013negative individuals)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that if CA 19-9 is reflective of cancer activity, it would be expected to decrease with effective chemotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not explicitly state the expectation that CA 19-9 would decrease with effective therapy when it reflects disease activity; it only notes that treatment may still be working even if CA 19-9 hasn\u2019t fallen."
      },
      {
        "criterion_number": 5,
        "description": "The response should define CA 19-9.",
        "score_given": 0,
        "max_points": 10,
        "justification": "CA 19-9 is described as a marker commonly used in pancreatic and biliary cancers, but there is no definition (e.g., that it is a tumor marker/carbohydrate antigen) provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that doctors use changes in symptoms to determine response to therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that clinicians consider how the person is feeling and lists symptoms/overall function/weight as part of judging response."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussing the CA 19-9 test results with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking the oncology team about scan timing and CA 19-9 trends, potential confounders, and how results will influence decisions."
      }
    ],
    "question_number": 13,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:22:24.148038",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that it is not an unexpected outcome as removing pancreas tissue will also take the islet cells which produce insulin.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that Whipple removes part of the pancreas, reducing insulin-making beta cells, and frames post-Whipple diabetes as expected (type 3c)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the incidence of post-Whipple diabetes, noting it can vary based on how much of the pancreas is removed and the specific patient population, occurring in 15-20% to up to 50% of patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides an incidence estimate of roughly 20\u201333% and notes higher risk with certain conditions, but does not mention variability based on the amount of pancreas removed nor the full range up to 50%."
      },
      {
        "criterion_number": 3,
        "description": "The response should state the control of diabetes is achieved through regulating glucose intake via dietary modifications and medications that can help control blood sugars.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly discusses dietary strategies (small, frequent balanced meals, consistent carbs) and outlines medication options (insulin, metformin, others) for glycemic control."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the father of the question writer should be evaluated by an endocrinologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends involving an endocrinologist as part of the care team."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the father may ultimately require insulin injections to regulate his blood sugars.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that insulin is common and often the most reliable therapy post-Whipple, with details on basal and mealtime regimens."
      }
    ],
    "question_number": 14,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:22:41.168726",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that anorexia and weight loss are common symptoms of pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response explicitly states that rapid weight loss is common in pancreatic cancer, but it does not explicitly state that anorexia (loss of appetite) is common."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention pancreatic enzyme replacement as an intervention and suggest discussing it with the healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Pancreatic enzyme replacement therapy (PERT) is discussed in detail, with clear advice to ask the oncology team for a trial and dosing guidance."
      },
      {
        "criterion_number": 3,
        "description": "The response must recommend consulting a registered dietitian specializing in oncology for personalized nutritional advice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends an oncology dietitian consult for a tailored plan and mentions referral to a dietitian as a standard step."
      },
      {
        "criterion_number": 4,
        "description": "The response must advise consuming nutrient-dense foods and eating smaller, more frequent meals, and explicitly emphasize the importance of maintaining adequate protein and calorie intake.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises small, frequent meals every 2\u20133 hours and emphasizes protein and calorie-dense foods with specific examples and strategies to add calories."
      },
      {
        "criterion_number": 5,
        "description": "The response must suggest nutritional supplementation with high-calorie meal replacement shakes and explicitly state that nutrition or protein supplements can be helpful.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends oral nutrition supplements and high-calorie/high-protein shakes (e.g., Ensure Plus/Boost) and provides homemade shake ideas."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that the patient should discuss their weight loss with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response directs the reader to call the oncology team immediately about rapid, ongoing weight loss and provides exact wording."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly mention chemotherapy as a potential cause of weight loss.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it lists multiple causes and later asks about current treatments including chemotherapy, it does not explicitly identify chemotherapy as a cause of weight loss."
      }
    ],
    "question_number": 15,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:22:58.434084",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer must specify that jaundice is due to an increase in bilirubin in the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states, \"Jaundice is yellowing of the skin and eyes caused by a buildup of bilirubin ... in the blood,\" explicitly identifying elevated bilirubin in the blood as the cause."
      },
      {
        "criterion_number": 2,
        "description": "The answer must state that jaundice refers to a yellowing of the skin and eyes due to elevated bilirubin levels.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly defines jaundice as \"yellowing of the skin and eyes\" and links it to \"buildup of bilirubin,\" fulfilling the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The answer must state that jaundice can arise in pancreatic cancer due to blockage of the bile duct from tumor growth.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains that in pancreatic cancer, particularly head-of-pancreas tumors, \"the tumor often blocks the bile duct\" leading to bilirubin backup."
      },
      {
        "criterion_number": 4,
        "description": "The answer must state that ERCP (Endoscopic Retrograde Cholangiopancreatography) is used to visualize the blocked duct and place a stent to relieve the blockage.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response states that during an ERCP a stent is placed across the blockage, it does not explicitly state that ERCP is used to visualize the blocked duct; visualization is instead attributed to ultrasound/CT/MRCP/EUS."
      },
      {
        "criterion_number": 5,
        "description": "The answer must state that other options to relieve the obstruction include percutaneous biliary drainage or surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions \"percutaneous transhepatic biliary drainage\" and surgical options such as bypass for durable relief, satisfying the criterion."
      },
      {
        "criterion_number": 6,
        "description": "The answer must state that another potential cause for jaundice is metastatic disease in the liver.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response notes, \"If jaundice is from widespread liver involvement rather than a single duct blockage,\" indicating liver metastases as a cause."
      },
      {
        "criterion_number": 7,
        "description": "The answer must state that treating the cancer with chemotherapy can shrink the tumor and help address the jaundice.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it discusses that chemotherapy often requires bilirubin reduction first, it does not state that chemotherapy can shrink the tumor and thereby relieve jaundice."
      }
    ],
    "question_number": 16,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:23:14.191187",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should state that pain medications, including opioids, can be used for pain management.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly lists opioids (morphine, oxycodone, hydromorphone, fentanyl, methadone) and outlines long-acting plus breakthrough strategies, along with non-opioid analgesics."
      },
      {
        "criterion_number": 2,
        "description": "The answer should describe procedures, such as a celiac plexus block, that can help alleviate pain.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It details celiac plexus block/neurolysis, including approaches (EUS/IR/anesthesia) and potential side effects, and also mentions stenting, radiation, and intrathecal/epidural options."
      },
      {
        "criterion_number": 3,
        "description": "The answer should express sympathy for the diagnosis and symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It opens with an empathetic statement: \u201cI\u2019m sorry you\u2019re both going through this.\u201d"
      },
      {
        "criterion_number": 4,
        "description": "The answer should state that adjunctive non-opioid medications, such as amitriptyline and gabapentin, can be used.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Adjuncts are specifically recommended, including gabapentin/pregabalin and \u2018a tricyclic antidepressant\u2019 (which includes amitriptyline), as well as duloxetine."
      },
      {
        "criterion_number": 5,
        "description": "The answer should state that steroids, such as dexamethasone, can also be used.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Corticosteroids (e.g., dexamethasone) are explicitly recommended with rationale and dosing considerations."
      },
      {
        "criterion_number": 6,
        "description": "The answer should state that radiation can be used for local treatment and pain control.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Radiation therapy is suggested for painful sites or to shrink tumor causing pressure; also mentioned for bone pain."
      },
      {
        "criterion_number": 7,
        "description": "The answer should state that complementary therapies, such as acupuncture and massages, can also be pursued.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Complementary options include massage, acupuncture, TENS, relaxation/mindfulness techniques, and gentle massage."
      },
      {
        "criterion_number": 8,
        "description": "The answer should state that the patient should be seen by a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises an urgent referral to palliative care and notes their expertise in aggressive symptom management."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend discussing pain management with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It instructs to contact the oncology team promptly and lists specific items to discuss, including medications and procedures."
      }
    ],
    "question_number": 17,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:23:34.615201",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should state that resectability is determined by the surgeons\u2019 assessment of their ability to safely remove the entire tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that unresectable means the tumor cannot be safely and completely removed with surgery and mentions surgeons aim for clear margins; clearly ties determination to safe complete removal."
      },
      {
        "criterion_number": 2,
        "description": "The answer should state that tumors are deemed not resectable if they involve surrounding major blood vessels such as the SMA, SMV, CA, PV.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically lists involvement of major vessels including the superior mesenteric artery, celiac axis, and unreconstructable portions of the portal/superior mesenteric vein."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that invasion of nearby organs can also lead to a tumor not being able to be resected.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention invasion of adjacent organs as a reason for unresectability; focuses on vascular involvement, metastasis, and overall health risks."
      },
      {
        "criterion_number": 4,
        "description": "The answer should state that sometimes tumors that are not initially able to be resected can be shrunk (downstaged) with chemotherapy and/or radiation and later removed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly notes that therapy can downstage tumors so surgery becomes possible later and mentions chemotherapy and sometimes radiation with restaging."
      },
      {
        "criterion_number": 5,
        "description": "The answer should offer sympathy for the loved one\u2019s diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with an empathetic statement: \u201cI\u2019m sorry you\u2019re going through this.\u201d"
      }
    ],
    "question_number": 18,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:23:48.414298",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the decision to continue with or stop chemotherapy treatments is highly personal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states there isn\u2019t a 'right' answer and emphasizes aligning the choice with the patient\u2019s values and goals, which conveys that the decision is highly personal."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the decision should be made weighing the expected benefit of more therapy with the current side effects.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking about best/worst-case scenarios, realistic chances of benefit, quality-of-life impact, expected side effects, time burden, and explicitly mentions 'trade-offs,' all reflecting weighing benefits versus side effects."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient discuss their goals of care with their oncology team and suggest meeting with their oncologist and a palliative care physician to help guide decision-making.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It directs the reader to ask the oncology team to review scenarios and trade-offs, centers goals of care in Step 1, and suggests meeting palliative care ('Ask for a referral now...' and 'Should I meet palliative care now?')."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the patient ask for a referral to a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states: 'Palliative care: ... Ask for a referral now if not already involved.'"
      },
      {
        "criterion_number": 5,
        "description": "The response should describe palliative care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Palliative care is described as specialized support for symptom relief and coping at any stage, alongside or instead of cancer treatment, with examples of services and coordination."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe hospice care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines hospice eligibility (about six months if the illness follows its usual course) and describes services (home-based care, medications, equipment, 24/7 phone support, nurse visits, social work, chaplain, respite) and the ability to revoke hospice."
      },
      {
        "criterion_number": 7,
        "description": "The response should offer sympathy and state that it is a very difficult decision to try to make.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It opens with empathy ('I\u2019m really sorry your family is facing this') and acknowledges the difficulty ('Choosing whether to stop cancer-directed treatment is hard')."
      }
    ],
    "question_number": 19,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:24:05.281008",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that KRAS mutations are frequently implicated in pancreatic cancer as a major driver of tumorigenesis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states KRAS is very common in PDAC (~90%) and explicitly notes that KRAS drives tumor growth, satisfying frequency and driver roles."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the first line of treatment would remain the standard of care with chemotherapy regimens such as FOLFIRINOX and gemcitabine/abraxane.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states KRAS status does not change standard first-line choices and lists FOLFIRINOX and gemcitabine+nab-paclitaxel as typical regimens."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that there are several KRAS mutations (G12C, G12D, G12V) and specify which one is present in the patient\u2019s case.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it lists several KRAS variants (G12D, G12V, G12R, G12C) and advises confirming the specific codon, it does not specify which mutation this patient has."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that targeted therapy to the KRAS mutation is an active area of research.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes KRAS as historically hard to target but highlights multiple ongoing clinical trials and emerging inhibitors, indicating active research."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some KRAS mutations can be targeted with drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes specific drugs for certain mutations (e.g., sotorasib/adagrasib for G12C) and emerging inhibitors for G12D, demonstrating that some KRAS mutations are targetable."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that there may be clinical trials for certain KRAS mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly recommends clinical trials, names trial agents by KRAS subtype, and provides resources for trial matching."
      },
      {
        "criterion_number": 7,
        "description": "The response should state the patient should discuss their KRAS mutation with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes a section titled 'Practical next steps to discuss with his oncologist,' specifically advising discussion of KRAS subtype and trial options."
      }
    ],
    "question_number": 20,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:24:23.297878",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must mention recent trials evaluating the use of high-dose vitamin C in combination with chemotherapy for the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly references multiple clinical studies (phase I/II, chemoradiation, and small randomized pilot studies) adding high-dose IV vitamin C to gemcitabine-based regimens and gemcitabine/nab-paclitaxel in pancreatic ductal adenocarcinoma."
      },
      {
        "criterion_number": 2,
        "description": "The response must state that high-dose vitamin C has not been proven to improve outcomes in pancreatic or any other cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that small randomized pilot studies have not demonstrated a clear overall survival advantage and that evidence remains insufficient to recommend use outside trials, satisfying the requirement that efficacy has not been proven (at least in pancreatic cancer)."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the proposed mechanism of action of high-dose vitamin C in conjunction with chemotherapy, noting that it can act as a pro-oxidant by generating hydrogen peroxide (H\u2082O\u2082), which may enhance the killing of cancer cells.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mechanism of action is described; there is no mention of pro-oxidant effects or H\u2082O\u2082 generation."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that there is limited published data showing high-dose vitamin C is well tolerated and shows a trend toward efficacy, but studies are limited and not sufficiently powered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response notes that trials report feasibility and acceptable safety, with some signals of activity, but emphasizes that studies are early phase, not randomized or not powered to show efficacy, and randomized pilots have not shown a survival advantage."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention possible toxicities of taking high doses of vitamin C.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists key risks/toxicities: hemolysis in G6PD deficiency, oxalate nephropathy and kidney stones in those with renal issues, and interference with some glucose meters."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention drug-drug interactions of vitamin C.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No drug-drug interactions are mentioned; device interference with glucose meters is not a drug-drug interaction."
      },
      {
        "criterion_number": 7,
        "description": "The response should note that vitamin C is not FDA approved.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no statement about FDA approval status."
      },
      {
        "criterion_number": 8,
        "description": "The response should note that vitamin C is not recommended by the NCCN guideline.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions that major guidelines do not recommend routine use, it does not specifically reference NCCN."
      },
      {
        "criterion_number": 9,
        "description": "The response should note that if a patient wishes to use high doses of vitamin C in conjunction with chemotherapy, they should consult with an oncologist regarding the treatment of pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response offers to provide citations and trial information but does not advise consulting with an oncologist."
      }
    ],
    "question_number": 21,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:25:12.976060",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that a biopsy is the only way to confirm the diagnosis of metastatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response recommends repeat/alternative biopsies and notes tumor markers are not definitive, but it does not explicitly state that biopsy is the only way to confirm metastatic disease and even mentions proceeding with treatment without pathologic proof."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that imaging such as CT or MRI is done to evaluate for the presence of metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly recommends liver MRI with gadoxetate, multiphasic pancreas\u2011protocol CT, PET/CT, and contrast-enhanced ultrasound to evaluate metastases and guide biopsy."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that tumor markers can be supportive of a diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that CA 19\u20119 can support the overall picture but is not definitive, satisfying the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the team may suggest that the patient undergo another biopsy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly suggests a repeat, targeted liver biopsy, sampling a different lesion, and EUS\u2011guided biopsy, directly addressing the possibility of another biopsy."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that on occasion the team will decide to treat as metastatic if the tumor markers and imaging are consistent with metastatic disease so as to not delay treatment if a repeat biopsy is not feasible.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it states clinicians may treat as stage IV based on imaging when further biopsy is risky or nondiagnostic, it does not explicitly state that this decision may be based on both tumor markers and imaging being consistent; therefore it does not fully meet the criterion as written."
      }
    ],
    "question_number": 22,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:25:34.991407",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that there is no good evidence to suggest that eating vegan can stall cancer progression.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states, \"No diet has been proven to reliably 'stall' cancer progression on its own,\" directly addressing the premise and aligning with the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including pancreatic enzyme insufficiency.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of pancreatic enzyme insufficiency, pancreatic enzymes (PERT), fat malabsorption, or steatorrhea\u2014key digestive changes specific to pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including insulin-dependent diabetes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response notes general \"blood sugar control,\" it does not address insulin-dependent diabetes or pancreatic endocrine insufficiency as a pancreatic cancer\u2013specific issue."
      },
      {
        "criterion_number": 4,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including biliary obstruction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Biliary obstruction and its dietary implications are not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including high protein and calorie needs during treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises ensuring adequate protein (1.0\u20131.5 g/kg/day) and calories during treatment, which meets the criterion."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that nutrition support is often needed for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no statement that nutrition support is often needed in pancreatic cancer (e.g., enteral/parenteral nutrition, specialized supplementation), nor is pancreatic cancer specifically referenced in this context."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussion of diet with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends coordination with the oncology team (e.g., \"Ask your team about lab monitoring\" and \"unless your oncologist approves\"), fulfilling the criterion."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend discussion of diet with an oncology nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises to \"Work with an oncology dietitian to individualize a plan,\" meeting the requirement."
      }
    ],
    "question_number": 23,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:25:50.156643",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that medical fitness is scored by the oncologist using the ECOG or Karnofsky performance status.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly references ECOG performance status (e.g., 'ECOG 0\u20131' and 'ECOG 1\u20132') to guide regimen selection, satisfying the requirement."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that typically patients who are more medically fit will be offered FOLFIRINOX, whereas those who are more frail but still candidates for treatment will be offered gemcitabine and nab-paclitaxel.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states 'modified FOLFIRINOX is favored for the most fit patients' and 'gemcitabine plus nab-paclitaxel is chosen for patients who are a bit less fit,' matching the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that generally FOLFIRINOX is reserved for patients with an ECOG score of 0-1, whereas gemcitabine and nab-paclitaxel can be given to ECOG 2 patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states 'ECOG 0\u20131... tend to choose modified FOLFIRINOX' and 'ECOG 1\u20132... gemcitabine+nab-paclitaxel,' directly meeting the requirement, including ECOG 2 for GnP."
      },
      {
        "criterion_number": 4,
        "description": "The response should state the reason that FOLFIRINOX is reserved for patients with good performance status is that it is more intensive and is associated with higher rates of severe side effects such as neutropenia, fatigue, and diarrhea.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response notes FOLFIRINOX is more intensive (biweekly with a 46-hour 5-FU pump) and lists higher toxicities including neutropenia, diarrhea, and fatigue; it also states FOLFIRINOX has higher neutropenia/diarrhea risk. This satisfies the rationale."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly list the individual drugs in FOLFIRINOX (5-FU, leucovorin, irinotecan, oxaliplatin) and clarify that nab-paclitaxel is combined with gemcitabine.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it clarifies nab-paclitaxel is combined with gemcitabine and mentions 5-FU, irinotecan, and oxaliplatin, it does not explicitly list leucovorin; therefore it does not fully meet the requirement."
      },
      {
        "criterion_number": 6,
        "description": "The response must state that there are no head-to-head trials comparing gemcitabine/nab-paclitaxel and FOLFIRINOX.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not address the presence or absence of head-to-head trials between the two regimens."
      },
      {
        "criterion_number": 7,
        "description": "The response must mention age as a factor influencing the choice of regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Age is explicitly mentioned (e.g., 'younger/fit' vs 'older') as influencing regimen selection."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention comorbid conditions as a factor in selecting a regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Comorbidities are addressed directly (e.g., neuropathy, renal impairment, chronic diarrhea/IBD, diabetes/steroid sensitivity), fulfilling the criterion."
      }
    ],
    "question_number": 24,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:26:28.371776",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that resectability is determined by the ability of the surgeon to safely remove the entire tumor and not leave any behind (R0 resection).",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that 'resectable' means an R0 resection appears feasible, directly addressing margin-negative removal."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that involvement of major blood vessels such as the SMA, SMV, CA, PV are often implicated when a tumor is deemed to not be resectable.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It details arterial (SMA, celiac axis, CHA) and venous (SMV/PV) involvement criteria and notes how certain contacts shift tumors to borderline/unresectable."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that for pancreatic cancer to be resectable, there must not be any distant metastases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states 'No distant disease' and lists distant sites (liver, peritoneum, lung, distant/para-aortic nodes)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that occasionally tumors that contact the veins (PV/SMV) and have less than 180 degrees of involvement can still be resected provided it can be safely removed and the vessel can be reconstructed as needed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifies \u2264180\u00b0 SMV/PV contact and notes that venous involvement requiring straightforward reconstruction may be acceptable."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some tumors are deemed to be borderline resectable and that the patient will be recommended to undergo treatment with chemotherapy and/or radiation in order to attempt to down-stage the tumor and make it amenable to resection.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While 'borderline resectable' is mentioned, the response does not explicitly state that these patients are recommended neoadjuvant chemotherapy and/or radiation to downstage; neoadjuvant therapy is referenced only in the context of suspicious biology even if technically resectable."
      },
      {
        "criterion_number": 6,
        "description": "The response should include imaging modalities that help determine resectability, including a CT scan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references 'pancreas\u2011protocol CT' as part of high-quality staging."
      },
      {
        "criterion_number": 7,
        "description": "The response should include imaging modalities that help determine resectability, including an MRI.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references 'pancreas\u2011protocol CT/MRI,' explicitly including MRI."
      },
      {
        "criterion_number": 8,
        "description": "The response should include imaging modalities that help determine resectability, including a PET scan.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of PET scanning."
      },
      {
        "criterion_number": 9,
        "description": "The response should include imaging modalities that help determine resectability, including an endoscopic ultrasound.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Endoscopic ultrasound is not mentioned."
      }
    ],
    "question_number": 25,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:26:47.359859",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that family history of pancreas cancer is associated with increased risk.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that having a first-degree relative increases risk and provides quantified risk estimates (e.g., 2\u20134\u00d7 higher with one first-degree relative)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a family history of pancreas cancer is due to inherited gene mutations such as BRCA.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Links familial risk to hereditary cancer syndromes and lists inherited variants including BRCA1/BRCA2 as contributing to increased risk."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that smoking is a significant modifiable risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies smoking as the biggest modifiable risk and notes it roughly doubles risk; advises cessation."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that chronic pancreatitis is a risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists chronic pancreatitis (especially hereditary or long-standing) as a risk factor."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that heavy alcohol use can lead to increased risk of pancreas cancer through pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States heavy alcohol use increases risk mainly via pancreatitis."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify genetic risk factors, including Lynch syndrome.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically lists Lynch syndrome (MLH1, MSH2, MSH6, PMS2) among inherited risk genes."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify genetic risk factors, including Peutz-Jeghers syndrome.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Names STK11 (Peutz-Jeghers) as a genetic risk factor."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify genetic risk factors, including Familial atypical multiple mole melanoma.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes CDKN2A (FAMMM) as a hereditary risk syndrome."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify genetic risk factors, including hereditary pancreatitis.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists PRSS1 (hereditary pancreatitis) as a genetic risk factor."
      },
      {
        "criterion_number": 10,
        "description": "The response should include non-hereditary risk factors, including age.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes age as a risk factor, with most cases after 55."
      },
      {
        "criterion_number": 11,
        "description": "The response should include non-hereditary risk factors, including diabetes.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions long-standing type 2 diabetes and new-onset diabetes after 50 as risk-related."
      },
      {
        "criterion_number": 12,
        "description": "The response should include non-hereditary risk factors, including obesity.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists obesity and central weight gain as modifiable risk factors."
      },
      {
        "criterion_number": 13,
        "description": "The response should include non-hereditary risk factors, including diet.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Identifies diet high in processed/red meats and low in fruits/vegetables as risk-related."
      },
      {
        "criterion_number": 14,
        "description": "The response should include non-hereditary risk factors, including exposure to certain industrial chemicals.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions occupational exposures such as pesticides, petroleum, and metalworking fumes."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that if you have a strong family history, discuss with your doctor about screening or genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends genetic counseling/testing and discusses criteria and timing for pancreatic surveillance at high-risk centers."
      }
    ],
    "question_number": 26,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:27:08.094382",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the patient should undergo genetic counseling.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends referral to a genetics professional and emphasizes pre- and post-test genetic counseling: 'The best first step is referral to a genetics professional' and 'Get pre- and post-test genetic counseling.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the type of genetic testing depends on the specific family history or hereditary condition.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States clearly that the choice of test depends on the specific disease in the family and which relatives are affected: 'The \u201cright\u201d genetic test depends on the specific disease in your family...'."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that single genes can be tested if there is a known condition associated with a specific genetic disorder.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions targeted single-site testing for a known familial variant and gives single-gene examples (e.g., RET for MEN2, APC for FAP, HFE for hemochromatosis): 'If a variant is known in the family, targeted testing for that variant is usually recommended' and 'Targeted \u201csingle\u2011site\u201d testing for a known familial variant.'"
      },
      {
        "criterion_number": 4,
        "description": "The response should state that a panel of genes can be tested for multiple genes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends multigene panels for certain scenarios: 'disease\u2011specific gene panels are typically used' and provides detailed examples for hereditary cancer panels and cardiomyopathy/arrhythmia panels."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide examples of single gene disorders such as Huntington\u2019s Disease, Cystic Fibrosis, and Sickle Cell.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides Huntington disease (HTT) and cystic fibrosis (CFTR) explicitly, and references hemoglobinopathies for carrier screening, which includes sickle cell disease (HBB): 'Huntington disease (HTT)' and 'carrier screening\u2026 CFTR for cystic fibrosis \u2026 and hemoglobinopathies.'"
      },
      {
        "criterion_number": 6,
        "description": "The response should provide examples of panel testing for hereditary cancer and cardiomyopathy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides concrete examples: hereditary cancer panels (BRCA1/2, PALB2; Lynch genes) and cardiomyopathy/arrhythmia panels (e.g., HCM: MYBPC3, MYH7; DCM: TTN; LQTS genes)."
      }
    ],
    "question_number": 27,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:27:22.833180",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the types of clinical trials.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly describes trial types and modalities (targeted therapy, immunotherapy, radiation/surgery techniques, supportive care) and mentions special designs (basket/umbrella) and expanded access."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that clinical trials are divided into three different phases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists Phase 1, Phase 2, and Phase 3."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that phase 1 is the first time the drug is tested in humans and is aimed at establishing the safety and dosage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States Phase 1 is first-in-human and focuses on safety and dose; notes small groups."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that phase 2 tests the effectiveness of the drug and continues to establish its safety.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States Phase 2 looks at effectiveness and side effects in a larger group."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that phase 3 tests the efficacy of the drug in a larger group of patients and compares it to the current standard of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Notes Phase 3 compares the new approach to standard treatment but does not state that it tests efficacy in a larger group; required elements are incomplete."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe eligibility criteria for clinical trials, including stage of disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists eligibility factors including cancer type, stage, prior treatments, performance status, organ function, comorbidities, and biomarkers."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that there can be risks associated with participating in a trial, including potential side effects and lack of efficacy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions unknown side effects and the possibility the treatment won\u2019t help, along with additional burdens (visits/tests)."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend discussing clinical trial options with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises to talk to the oncology team first and ask about trials at their center or nearby."
      },
      {
        "criterion_number": 9,
        "description": "The response should include clinicaltrials.gov as a resource for finding clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes ClinicalTrials.gov with guidance on how to filter searches."
      },
      {
        "criterion_number": 10,
        "description": "The response should offer support for the diagnosis and how difficult it can be to complete 15 rounds of chemotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Provides general empathy but does not specifically acknowledge the challenge of completing 15 rounds of chemotherapy."
      }
    ],
    "question_number": 28,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:27:41.280079",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must include ClinicalTrials.gov as a resource for finding clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly lists ClinicalTrials.gov as the first resource and calls it the fastest and most complete."
      },
      {
        "criterion_number": 2,
        "description": "The response must provide instructions on using the search by location function on ClinicalTrials.gov.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides step-by-step instructions including Advanced Search, entering city/ZIP, adding a radius, and sorting by closest distance."
      },
      {
        "criterion_number": 3,
        "description": "The response must mention the National Cancer Institute (NCI) website and describe using it to search for trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It references the NCI trial search URL and explains you can call 1-800-4-CANCER or use live chat for a personalized search."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention and provide a link to the Pancreatic Cancer Action Network (PanCAN) clinical trial finder tool.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While PanCAN is mentioned with pancan.org and phone support, there is no direct link to the PanCAN clinical trial finder tool."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend contacting advocacy organizations for information on clinical trials, including PanCAN.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends contacting PanCAN Patient Services, provides the phone number, and notes they offer personalized trial matching."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend contacting advocacy organizations for information on clinical trials, including the American Cancer Society.",
        "score_given": 0,
        "max_points": 10,
        "justification": "American Cancer Society is mentioned only for lodging (Hope Lodge) and not as a contact for clinical trial information."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss clinical trial options with their oncology team and consult with a local healthcare provider or oncologist to explore available trials at nearby cancer centers, as well as contact major cancer centers for additional information on clinical trials.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests considering academic centers and contacting sites for prescreening, and to ask an oncologist about genomic testing, but does not explicitly recommend discussing clinical trial options with the oncology team or consulting a local provider to explore nearby trials."
      }
    ],
    "question_number": 29,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:27:59.718434",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that family history of pancreatic cancer is associated with increased risk.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states family history increases risk (2\u20133\u00d7 for one first-degree relative; 6\u20138\u00d7 for two or more)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that BRCA1/BRCA2 mutations are genetic risk factors for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists BRCA2 and, to a lesser extent, BRCA1 as inherited risk genes."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that smoking is a significant modifiable risk factor for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies tobacco smoking as the strongest modifiable factor, roughly doubling risk."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that chronic pancreatitis is a risk factor for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that chronic pancreatitis markedly increases risk."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that heavy alcohol use can lead to increased risk of pancreatic cancer through pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes heavy alcohol use increases risk mainly by causing chronic pancreatitis."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify Lynch syndrome as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists Lynch syndrome (MLH1, MSH2, MSH6, PMS2) among inherited risks."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify Peutz-Jeghers syndrome as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes Peutz-Jeghers syndrome (STK11) with very high lifetime risk."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify Familial atypical multiple mole melanoma as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions CDKN2A (FAMMM) as a risk gene."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify hereditary pancreatitis as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifies hereditary pancreatitis (PRSS1; also SPINK1/CTRC) confers very high risk."
      },
      {
        "criterion_number": 10,
        "description": "The response should include age as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States risk rises sharply after age 55\u201360."
      },
      {
        "criterion_number": 11,
        "description": "The response should include diabetes as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes type 2 diabetes (long-standing and new-onset) as a risk factor."
      },
      {
        "criterion_number": 12,
        "description": "The response should include obesity as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists obesity/central adiposity with quantified relative risk."
      },
      {
        "criterion_number": 13,
        "description": "The response should include diet as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes diets high in processed/red meats and sugary beverages and low in fruits/vegetables increase risk."
      },
      {
        "criterion_number": 14,
        "description": "The response should include exposure to certain industrial chemicals as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions occupational exposures (pesticides, petroleum/metalworking chemicals, chlorinated solvents)."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that if you have a strong family history, discuss with your doctor about screening or genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises referral to a high-risk clinic for genetic counseling and consideration of screening for those with strong family history or mutations."
      }
    ],
    "question_number": 30,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:28:20.732134",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend asking for a referral from their primary doctor or oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not suggest asking the primary care physician or current oncologist for a referral."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend using the PanCAN patient services to find a pancreatic cancer specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "PanCAN is explicitly recommended with phone number and direct link to patient services."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend using the American Cancer Society patient services to find a pancreatic cancer specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of the American Cancer Society or its patient services."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that they can reference the NCI website to look for designated cancer centers that have pancreatic cancer specialists on staff.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifically advises using the NCI-Designated Cancer Centers and provides the NCI link to find a center."
      },
      {
        "criterion_number": 5,
        "description": "The response should include information about the nearest cancer center.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No location-specific or nearest cancer center information is provided; the response asks for the user\u2019s location to generate a list."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend checking with their health insurance provider about in-network pancreatic cancer specialists.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions considering insurance acceptance and asks for the user\u2019s insurance, it does not explicitly recommend checking with the insurer for in-network specialists."
      }
    ],
    "question_number": 31,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:28:43.355156",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define CA 19-9.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines CA 19-9 as a blood test measuring carbohydrate antigen 19-9 (sialyl-Lewis A), a marker on the surface of certain cells. This is an accurate and concise definition."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 is a tumor marker produced by cancer cells and measurable in the blood, and describe its use in pancreatic cancer, noting that it can serve as a marker for the disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response identifies CA 19-9 as a tumor marker measurable in blood and explicitly discusses its primary use in pancreatic cancer: evaluation with imaging, baseline establishment, treatment monitoring, and recurrence surveillance. While it does not verbatim say 'produced by cancer cells,' it accurately frames CA 19-9 as a tumor marker associated with pancreatic cancer and fulfills the intended use aspects."
      },
      {
        "criterion_number": 3,
        "description": "The response must include that CA 19-9 can be elevated in other conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states multiple noncancerous causes of elevated CA 19-9 (e.g., biliary obstruction/jaundice, pancreatitis, cholangitis, cirrhosis/hepatitis) and explains false positives/negatives, including the impact of Lewis antigen status and bilirubin, demonstrating accurate understanding of elevations in nonmalignant conditions."
      }
    ],
    "question_number": 32,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:28:58.765208",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that reference ranges can vary by lab.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States \"typical lab cutoff; check your report\u2019s reference range,\" indicating lab-to-lab variability."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that normal levels are typically less than 37 U/mL but do not rule out cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists normal as \"0\u201335 to 37 U/mL\" and explicitly says \"A normal value does not rule out cancer.\""
      },
      {
        "criterion_number": 3,
        "description": "The response should state that levels from 37 to 100 U/mL can be associated with non-cancer conditions such as pancreatitis and bile duct disorders.",
        "score_given": 10,
        "max_points": 10,
        "justification": "For 37\u2013100 U/mL, cites benign causes including bile duct blockage, gallstones, pancreatitis, hepatitis, cholangitis, and liver disease."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that moderate elevation (100-1000 U/mL) can be concerning for cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 100\u2013500 U/mL \"cancer becomes more likely\" and >500\u20131,000 U/mL \"raises strong concern for pancreatic or biliary cancer.\""
      },
      {
        "criterion_number": 5,
        "description": "The response should state that levels greater than 1000 U/mL can be suggestive of advanced cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly address >1,000 U/mL or link that threshold to advanced disease."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the use of CA 19-9 in pancreatic cancer, including that it can be a marker of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Calls CA 19-9 a blood marker and discusses its use in pancreatic cancer for baseline and monitoring."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that CA 19-9 can be elevated in other conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides an extensive list of benign conditions (pancreatitis, cholangitis, gallstones, obstruction, cirrhosis, hepatitis, IBD, cystic fibrosis, smoking)."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that CA 19-9 can be used for monitoring the effectiveness of pancreatic cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes trends after treatment (falling = response, rising = progression) and serial measurements to monitor treatment response."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that CA 19-9 can be used for detecting recurrence of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions use to \"detect recurrence\" alongside imaging."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that CA 19-9 can be used in other cancers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes use in biliary tract cancers (e.g., cholangiocarcinoma) in addition to pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that CA 19-9 can be elevated in liver disease.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions liver disease, cirrhosis, and hepatitis as benign causes of elevation."
      },
      {
        "criterion_number": 12,
        "description": "The response should include that CA 19-9 can be elevated in gallstones.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists gallstones as a benign cause."
      },
      {
        "criterion_number": 13,
        "description": "The response should include that CA 19-9 can be elevated with elevated bilirubin.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes jaundice and biliary obstruction can spike CA 19-9 and suggests rechecking after relieving obstruction; this corresponds to elevated bilirubin."
      },
      {
        "criterion_number": 14,
        "description": "The response should include that CA 19-9 is not produced by all pancreatic cancers.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States 5\u201310% of people (Lewis antigen negative) produce little to none even if cancer is present, indicating not all cases will produce CA 19-9."
      }
    ],
    "question_number": 33,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:29:19.112564",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that CA 19-9 can be elevated with pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions 'Acute and chronic pancreatitis; autoimmune pancreatitis' as causes of elevated CA 19-9."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 can be elevated with liver diseases like cirrhosis or hepatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists 'Cirrhosis and chronic hepatitis (various causes)' under benign conditions."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CA 19-9 can be elevated with cholestasis or biliary diseases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes 'Obstructive jaundice/cholestasis,' 'Cholangitis,' 'primary sclerosing cholangitis,' and elevations after ERCP."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that CA 19-9 can be elevated with inflammatory bowel disease or gastrointestinal diseases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions 'Inflammatory bowel disease (occasionally)' and also includes GI malignancies (gastric, colorectal)."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that CA 19-9 can be elevated with infections or other inflammatory conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Cites infectious/inflammatory entities such as cholangitis, pneumonia, tuberculosis, and autoimmune pancreatitis."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that CA 19-9 can be a marker of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with 'CA 19-9 can be elevated in many conditions besides pancreatic cancer,' implying its recognized association with pancreatic cancer; key points discuss interpretation in oncologic contexts."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that CA 19-9 can be used in other cancers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists multiple non-pancreatic cancers (cholangiocarcinoma, gallbladder, gastric, colorectal, HCC, ovarian mucinous, lung adenocarcinoma)."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that CA 19-9 is not produced by all pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'About 5\u201310% of people (Lewis antigen\u2013negative) cannot produce CA 19-9 at all, even if they have cancer,' capturing that not all patients/cancers will produce CA 19-9."
      }
    ],
    "question_number": 34,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:29:32.198728",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing weight loss with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises engaging the care team: 'What to ask the care team now,' including referrals to an oncology dietitian and palliative care, and specific topics to discuss with clinicians."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic enzyme replacement can be taken to help with the absorption of nutrients from foods.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes pancreatic exocrine insufficiency and recommends PERT (e.g., pancrelipase) with dosing guidance and timing to improve digestion/absorption; notes not to restrict fat once on adequate enzymes."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that nutritional strategies can be employed, such as focusing on small, frequent meals and nutrient-rich foods, and should recommend including calorie-dense and protein-rich foods in the diet.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides detailed nutrition strategies: small frequent meals (5\u20136/day), calorie/protein targets, and numerous calorie-dense, protein-rich options (oils, nut butters, full-fat dairy, eggs, shakes). Includes a sample meal plan."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that medications for managing nausea can be helpful.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'These can often be prevented or reduced with scheduled medications\u2014ask for a clear plan' and lists 'Antiemetics taken on schedule around chemo' under medications that can help."
      },
      {
        "criterion_number": 5,
        "description": "The response should state there are many causes of weight loss in patients with pancreatic cancer, including weight loss related to chemotherapy side effects.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists multiple causes of weight loss (EPI, treatment side effects, hyperglycemia, obstructions, mood/sleep/pain). Specifically mentions treatment side effects\u2014including those from chemo\u2014as contributors."
      },
      {
        "criterion_number": 6,
        "description": "The response should state there are many causes of weight loss in patients with pancreatic cancer, including weight loss related to pancreatic enzyme deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies pancreatic exocrine insufficiency as a common, treatable cause of weight loss and provides signs, enzyme therapy, and dietary considerations."
      }
    ],
    "question_number": 35,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:29:42.819036",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that a symptom of pancreatic cancer can include unintentional weight loss.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists 'Unintentional weight loss' and later 'Unexplained weight loss' as symptoms."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a symptom of pancreatic cancer can include jaundice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly mentions jaundice with details (yellowing of skin/eyes, dark urine, pale stools, itching)."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that a symptom of pancreatic cancer can include new onset diabetes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'New-onset diabetes or suddenly harder-to-control diabetes.'"
      },
      {
        "criterion_number": 4,
        "description": "The response should state that a symptom of pancreatic cancer can include abdominal pain.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists 'Abdominal or back pain' with characteristic description."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that pancreatic cancer can be difficult to detect early.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'Pancreatic cancer often causes few or no symptoms early on,' implying difficulty detecting early."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that pancreatic cancer does not cause symptoms until the disease is advanced.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state 'until advanced'; it says 'few or no symptoms early,' which is not the same definitive statement."
      },
      {
        "criterion_number": 7,
        "description": "The response should state the reason for jaundice is the blockade of bile ducts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides features of jaundice but does not mention bile duct obstruction as the cause."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that loss of appetite can be a symptom.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly includes 'loss of appetite.'"
      },
      {
        "criterion_number": 9,
        "description": "The response should state that abdominal bloating or indigestion can be a symptom.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions 'indigestion' among symptoms."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that foul-smelling stools or steatorrhea can be a symptom.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically lists 'greasy, foul-smelling (steatorrhea)' stools."
      },
      {
        "criterion_number": 11,
        "description": "The response should reference the American Cancer Society information page on symptoms of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No reference to the American Cancer Society is provided."
      }
    ],
    "question_number": 36,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:30:13.985026",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that most pancreatic cancer cases are sporadic and not hereditary.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with 'Mostly no. The majority of pancreatic cancers are \u201csporadic\u201d (not inherited).' and quantifies inherited cases as 5\u201310%."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that there are hereditary conditions that can lead to pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that 5\u201310% are linked to inherited risk and lists multiple hereditary syndromes/genes associated with pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that a strong family history is a significant risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states 'Family history matters' and explains that one or more affected first-degree relatives increase risk, with higher risk when multiple relatives are affected."
      },
      {
        "criterion_number": 4,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including familial pancreatic cancer syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions 'Two or more affected first-degree relatives suggests \u201cfamilial pancreatic cancer.\u201d'"
      },
      {
        "criterion_number": 5,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including BRCA1/BRCA2 mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "BRCA2 (and BRCA1) are listed among inherited genes that raise risk."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Lynch syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lynch syndrome is explicitly cited with its MMR genes (MLH1, MSH2, MSH6, PMS2)."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Peutz-Jeghers syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Peutz-Jeghers syndrome is identified via STK11."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Familial atypical multiple mole melanoma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "CDKN2A is listed with 'FAMMM' (Familial Atypical Multiple Mole Melanoma)."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including hereditary pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Hereditary pancreatitis is explicitly mentioned through PRSS1 and noted to carry high lifetime risk."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that if you are concerned about your risk of pancreatic cancer, you should consult an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it recommends high-risk screening at expert centers and germline testing for all patients, it does not advise concerned individuals to consult an oncologist specifically."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that if you are concerned about your risk of pancreatic cancer, you should consult a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It identifies 'Who should consider genetic counseling/testing' and suggests evaluation for those with strong family history or known mutations, effectively directing readers to seek genetic counseling."
      }
    ],
    "question_number": 37,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:31:09.605926",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that routine screening is not recommended for the general population.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states: 'Not recommended for the general population.' under the 'Who should be considered' section."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention MRI as a surveillance modality for high-risk individuals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists 'Primary modalities: endoscopic ultrasound (EUS) and MRI/MRCP' for high-risk surveillance."
      },
      {
        "criterion_number": 3,
        "description": "The response must specify that surveillance typically starts around age 50 and continues annually.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states for several genes (e.g., BRCA1/2, PALB2, ATM, Lynch, TP53) screening starts 'often age 50, or 10 years earlier than the youngest affected relative,' and adds 'if normal, repeat annually.'"
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly state that the evidence for screening/surveillance is not well established and mention the risk of overdiagnosis leading to unnecessary stress and procedures.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes for post-treatment surveillance that 'evidence that intensive surveillance improves overall survival is mixed' (indicating not well established) and lists risks including 'overdiagnosis' and 'anxiety' (stress), as well as procedure complications."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that people at high risk may benefit from screening.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It cites 'Benefits: Surveillance cohorts show \u201cstage shift\u201d (more early-stage, resectable cancers found) and better survival than usual presentation,' and recommends screening only for clearly high-risk individuals."
      },
      {
        "criterion_number": 6,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a significant family history of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines 'Strong family history (\u201cfamilial pancreatic cancer\u201d): generally two or more affected close relatives on the same side of the family, especially if at least one is a first-degree relative.'"
      },
      {
        "criterion_number": 7,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a known genetic syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists multiple pathogenic germline variants/syndromes (e.g., STK11/Peutz-Jeghers, CDKN2A, PRSS1, BRCA1/2, PALB2, ATM, Lynch genes, TP53) as qualifying high-risk groups."
      },
      {
        "criterion_number": 8,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a history of chronic pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states 'Chronic pancreatitis from genetic causes (e.g., PRSS1) qualifies,' acknowledging chronic pancreatitis (especially hereditary) as a high-risk group."
      },
      {
        "criterion_number": 9,
        "description": "The response should include EUS as a screening modality to detect pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "EUS is identified as a primary modality: 'Primary modalities: endoscopic ultrasound (EUS) and MRI/MRCP.'"
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend people discuss the risks and benefits of screening with a doctor.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it recommends referral to a high-risk pancreatic clinic and outlines risks and benefits, it does not explicitly advise discussing the risks and benefits with a doctor."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend people discuss the risks and benefits of screening with a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends 'Genetic counseling/testing is strongly recommended before starting' and suggests referral 'to genetics for formal risk assessment and testing.'"
      }
    ],
    "question_number": 38,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:31:47.189241",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include surgery as a potential treatment modality for resectable pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists surgery for resectable PDAC (Whipple, distal pancreatectomy, total pancreatectomy) and also notes surgery for localized pNETs."
      },
      {
        "criterion_number": 2,
        "description": "The response should specify that chemotherapy is the backbone of treatment for metastatic or unresectable pancreatic cancer, with main regimens being FOLFIRINOX or Gemcitabine + Nab-Paclitaxel.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States systemic therapy with modified FOLFIRINOX or gemcitabine+nab-paclitaxel for locally advanced/unresectable and metastatic disease; also provides alternatives for frail patients."
      },
      {
        "criterion_number": 3,
        "description": "The response should include radiation as a potential treatment option for localized pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions adjuvant radiation selectively, neoadjuvant radiation for borderline resectable disease, and consolidation IMRT/SBRT for locally advanced disease."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states treatment depends on stage and organizes recommendations by resectable, borderline resectable, locally advanced, and metastatic."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the treatment of pancreatic cancer depends on the co-morbidities of the patient.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes treatment depends on overall health and includes regimen adjustments for frail patients; also addresses management of comorbid conditions (e.g., diabetes, anticoagulation), indicating comorbidity considerations."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the treatment of pancreatic cancer depends on the functional status of the patient.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses performance status language (fit vs frail) to guide therapy choices (e.g., modified FOLFIRINOX for fit patients, gemcitabine-based options for frail)."
      },
      {
        "criterion_number": 7,
        "description": "The response should include immunotherapy, noting its role is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 15,
        "max_points": 15,
        "justification": "Specifically states MSI-H/dMMR or high TMB tumors are candidates for pembrolizumab; no overstatement beyond these indications."
      },
      {
        "criterion_number": 8,
        "description": "The response should include targeted therapy such as PARPi for patients with BRCA mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies BRCA1/2 or PALB2 mutations, preferring platinum chemotherapy and maintenance olaparib after response/stability in metastatic disease."
      },
      {
        "criterion_number": 9,
        "description": "The response should introduce the concept of clinical trials and their role in the management of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes clinical trial participation at any line and notes trials are preferred for targeted alterations."
      }
    ],
    "question_number": 39,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:32:18.405273",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that stage 0 is a pre-cancer state, also known as pancreatic intraepithelial neoplasia or carcinoma in situ.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly identifies Stage 0 as 'carcinoma in situ' and describes 'abnormal cells in the duct lining only (Tis N0 M0),' which conveys the pre-invasive (pre-cancer) nature."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that stage 1 cancer is when the cancer is confined to the pancreas and has not spread to lymph nodes or distant sites.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'Stage I: Cancer confined to the pancreas, no lymph nodes' and lists IA/IB as N0 M0, indicating no nodal or distant spread."
      },
      {
        "criterion_number": 3,
        "description": "The response should note that stage 1a is when the tumor is 2cm or smaller.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists 'IA: Tumor 2 cm or smaller (T1 N0 M0)'."
      },
      {
        "criterion_number": 4,
        "description": "The response should note that stage 1b is when the tumor is larger than 2cm.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists 'IB: Tumor >2 cm to 4 cm (T2 N0 M0)', which clearly indicates larger than 2 cm."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that stage II is when the cancer is growing into nearby tissues and into lymph nodes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Describes Stage II as IIA (>4 cm, no nodes) and IIB (1\u20133 regional nodes), but does not state that Stage II involves growth into nearby tissues; focuses on size and nodal status only."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that stage III is when the cancer is locally advanced and involves surrounding structures.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines Stage III by 'involvement of major arteries near the pancreas (celiac axis, SMA, common hepatic)' or N2 disease, indicating locally advanced involvement of surrounding structures."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that stage IV is when the cancer has spread to other organs or sites.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'Stage IV: Distant metastasis (any T, any N, M1),' with examples (liver, lungs, peritoneum)."
      },
      {
        "criterion_number": 8,
        "description": "The response should include a description of the T, N, M staging system.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains TNM at the outset and provides definitions: T1\u2013T4 by size/arterial involvement, N0\u2013N2 by node count, and M1 for distant spread."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that pancreatic cancer is categorized by resectability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a dedicated section on resectability with categories: resectable, borderline resectable, locally advanced (unresectable), and metastatic, with clear vessel criteria."
      }
    ],
    "question_number": 40,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:32:44.986210",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that neuropathy is a common side effect from the oxaliplatin in FOLFIRINOX.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states: \"Severe neuropathy is a common, often dose\u2011limiting side effect of FOLFIRINOX, mainly from the oxaliplatin component.\" This clearly identifies oxaliplatin as the cause and notes its commonality."
      },
      {
        "criterion_number": 2,
        "description": "The response must state that the oncologist can \u2018hold\u2019 or temporarily stop oxaliplatin to manage neuropathy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It says: \"Stop or reduce oxaliplatin\" and describes a \"stop\u2011and\u2011go\" approach, which implies temporarily holding oxaliplatin and re\u2011adding it later."
      },
      {
        "criterion_number": 3,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by dose reduction.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends dose reduction: \"Stop or reduce oxaliplatin\" and \"Dose reductions ... can help.\""
      },
      {
        "criterion_number": 4,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by schedule modification.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response notes: \"Dose reductions or lengthening the cycle interval,\" which directly addresses schedule modification."
      },
      {
        "criterion_number": 5,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by switching to an alternate regimen.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It offers several alternate regimens and explicitly suggests switching: e.g., continue irinotecan + 5\u2011FU (FOLFIRI), 5\u2011FU/capecitabine maintenance, or switching to gemcitabine\u2011based therapy."
      },
      {
        "criterion_number": 6,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by switching to an alternate regimen, including gemcitabine-based therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Under pancreatic cancer alternatives, it clearly states: \"Switch to gemcitabine\u2011based therapy. The usual next option is gemcitabine + nab\u2011paclitaxel ... gemcitabine alone (or with capecitabine) may be considered.\""
      },
      {
        "criterion_number": 7,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including gabapentin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes gabapentin among supportive options: \"Other drugs (gabapentin, pregabalin, topical agents) are sometimes tried but have weaker evidence.\""
      },
      {
        "criterion_number": 8,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including SNRIs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It specifically recommends duloxetine, an SNRI: \"Duloxetine is the only medication with good evidence for painful chemotherapy\u2011induced neuropathy.\""
      },
      {
        "criterion_number": 9,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including pregabalin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Pregabalin is explicitly listed among supportive options: \"Other drugs (gabapentin, pregabalin, topical agents) are sometimes tried but have weaker evidence.\""
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend discussing medication side effects with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response encourages engaging the care team: \"It\u2019s very reasonable to ask about changes\" and provides \"Red flags that should prompt a call to the care team,\" and offers to help draft questions for the next visit, which constitutes recommending discussion with the oncology team."
      }
    ],
    "question_number": 41,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:33:21.149890",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they should be informed about the aim of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly instructs to ask about the trial's purpose and rationale: 'Purpose: What problem is this trial trying to solve? What\u2019s the rationale and any results so far?' This directly addresses understanding the trial's aim."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that they should understand the potential benefits of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Discusses potential benefits in multiple places: indicates patients can benefit even in Phase 1, suggests comparing to best standard-of-care to evaluate benefit, and asks about post-trial access if she benefits. Also frames goals such as living longer and symptom relief."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that they should understand the potential risks of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addresses risks clearly: emphasizes Phase 1 safety focus, details side effects ('What\u2019s known, what\u2019s uncertain, and how are problems managed?'), dose modifications, hospitalization risk, and includes safeguards (IRB, DSMB, informed consent)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that they should be aware of the inclusion and exclusion criteria for the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a dedicated 'Eligibility' checklist: stage/line of therapy, biomarker requirements, time since last treatment, bili/organ function cutoffs, ECOG limits\u2014clearly reflecting inclusion/exclusion criteria."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that they should be aware of the time commitments associated with participating in the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifies time/visit burden: 'What will participation be like? Visit frequency, scans, bloodwork... How long will she be on study?' and addresses timeline, screening/bridging, and logistical burden on patients/caregivers."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that they should be aware of the costs associated with participating in the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Contains a detailed cost section: clarifies routine care billing vs. sponsor-covered items, who pays for side-effect management/ER/hospitalizations, and provides travel/lodging assistance resources; advises confirming in writing."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the phase of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes 'Understand trial types and phases' with clear explanations of Phase 1, 2, 3, and basket/platform trials, highlighting implications for goals and expectations."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding if there are crossover options.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly advises to ask: 'What are the arms? Chance of each? Is crossover allowed if one arm works better?' clearly prompting assessment of crossover availability."
      }
    ],
    "question_number": 42,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:33:37.187269",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Radiation can be used before surgery to help shrink borderline resectable tumors, with the goal of increasing the likelihood of achieving a complete resection in the localized setting.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly discusses neoadjuvant radiation mainly for borderline resectable tumors after chemotherapy to improve the chance of clear margins and control tumor near blood vessels."
      },
      {
        "criterion_number": 2,
        "description": "Radiation can be used for locally advanced or unresectable tumors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states that for locally advanced, unresectable disease, radiation (chemoradiation or SBRT) may be used after induction chemotherapy to improve local control and symptom relief."
      },
      {
        "criterion_number": 3,
        "description": "Radiation can be used in the palliative setting to relieve symptoms in patients with advanced or metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response notes radiation for symptom relief (pain, bleeding, obstruction) in metastatic disease and mentions short-course palliative radiation at any stage."
      },
      {
        "criterion_number": 5,
        "description": "Pancreatic cancer treatment plans are determined by the stage of the disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states decisions depend on stage and organizes indications by resectable, borderline, locally advanced/unresectable, and metastatic."
      },
      {
        "criterion_number": 6,
        "description": "Pancreatic cancer treatment plans are determined by the overall health of the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Decision factors include overall health and nutrition, demonstrating consideration of patient fitness."
      },
      {
        "criterion_number": 7,
        "description": "The goal of radiation in the localized setting can be to sterilize vessel margins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions improving the chance of clear margins and controlling tumor near blood vessels in the neoadjuvant setting, which aligns with vessel margin sterilization."
      },
      {
        "criterion_number": 8,
        "description": "The goal of radiation in the localized setting can be to delay disease progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states radiation may improve local control and help keep the tumor from progressing near adjacent structures, indicating a goal of delaying progression."
      },
      {
        "criterion_number": 9,
        "description": "The goal of radiation in the localized setting can be to prevent local recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes adjuvant radiation being reserved for high-risk postoperative scenarios (e.g., positive margins) and emphasizes improving local control, which implies prevention of local recurrence. It also notes use for local recurrence, reinforcing focus on local control."
      }
    ],
    "question_number": 43,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:34:28.646948",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that pancreatic cancer leads to enzyme deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly notes that in pancreatic cancer 'The tumor or surgery can reduce/block enzyme output (pancreatic exocrine insufficiency),' clearly linking pancreatic cancer to enzyme deficiency."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how enzyme deficiency can lead to problems with digestion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains consequences of enzyme deficiency including malabsorption symptoms and signs: 'greasy, pale, floating, foul\u2011smelling stools,' gas/bloating/cramps, weight loss, and fat\u2011soluble vitamin deficiencies, demonstrating how deficiency impairs digestion and absorption."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pancreatic enzyme supplements are used to replace the enzymes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The opening states, 'Enzyme supplements for pancreatic cancer are called pancreatic enzyme replacement therapy (PERT). They replace the digestive enzymes the pancreas normally makes,' directly addressing enzyme replacement."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that pancreatic enzyme supplements can improve digestion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Under 'Benefits to expect,' it notes 'Better absorption of calories, weight stabilization or gain, improved energy and nutrient levels' and fewer greasy/loose stools, which explicitly indicates improved digestion with PERT."
      }
    ],
    "question_number": 44,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:34:37.550355",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that cancer is associated with an increased risk of developing blood clots.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that cancers (via tumor-related activation of the clotting system) increase the risk of venous thromboembolism and lists contributing factors such as chemotherapy, surgery, central lines, immobility, and infection. This demonstrates an explicit link between cancer and increased clot risk."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that patients with pancreatic cancer are at increased risk of developing a blood clot.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly identifies pancreatic cancer as one of the cancers most strongly linked to blood clots and provides a specific incidence range (15\u201325%) and examples (DVT), meeting and exceeding the criterion with accurate, clear details."
      }
    ],
    "question_number": 45,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:34:45.814612",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that second opinions can be obtained at any time, including after diagnosis, before starting treatment, during treatment, or when considering clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response lists multiple appropriate times: before starting treatment, before major steps, if treatment isn\u2019t working (during treatment), and when interested in clinical trials. This effectively communicates that a second opinion can be obtained at various points in the care timeline."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly mention that second opinions are particularly helpful after the initial diagnosis and before starting treatment, as well as when the initial treatment is no longer effective.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises obtaining a second opinion 'as early as possible\u2014ideally before starting a first treatment plan' and 'if treatment isn\u2019t working,' covering both required scenarios."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding the diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states 'If imaging or pathology is unclear' and later emphasizes confirming the exact diagnosis during the second opinion."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding staging.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly includes 'the stage is uncertain' and suggests confirming stage as part of the second opinion."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding the treatment plan.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions 'conflicting recommendations' and indicates a second opinion should recommend first-line therapy and rationale, addressing treatment plan uncertainty."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that second opinions can be obtained at specialized referral centers, such as cancer centers with expertise in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises choosing a 'high\u2011volume pancreas center' and describes centers with dedicated HPB programs and multidisciplinary clinics, clearly indicating specialized referral centers."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly state that they should look up NCI-designated cancer centers specifically.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly instructs to 'Look for an NCI\u2011designated cancer center.'"
      },
      {
        "criterion_number": 8,
        "description": "The response must mention major academic hospitals as a resource for finding pancreatic cancer specialists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions 'an academic center with a dedicated pancreatic/hepatopancreatobiliary program,' satisfying this criterion."
      },
      {
        "criterion_number": 9,
        "description": "The response must mention that the NCCN guidelines for Pancreatic Adenocarcinoma recommend evaluation at high volume centers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not reference NCCN guidelines or note that NCCN recommends evaluation at high\u2011volume centers."
      }
    ],
    "question_number": 46,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:35:08.241153",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that immunotherapy is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly identifies MSI-H/dMMR pancreatic cancers as the small subset where PD-1 inhibitors can be effective and clarifies that most unselected PDACs do not benefit, conveying that effective use is essentially limited to this group."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that immunotherapy is an ongoing area of research.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes that checkpoint inhibitors have not consistently improved outcomes in unselected patients and highlights multiple investigational approaches (e.g., combinations, vaccines, T-cell therapies), indicating active, ongoing research."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that there may be clinical trial options exploring novel immunotherapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking about clinical trials and lists examples of novel immunotherapy strategies under investigation, fulfilling this criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that immune checkpoint blockade is only approved for patients with metastatic disease in certain situations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it discusses tumor-agnostic approvals (MSI-H/dMMR and TMB-high), it does not specify the regulatory context that these approvals apply to unresectable or metastatic disease in certain situations."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that pembrolizumab is approved for patients whose tumors are TMB high.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states that pembrolizumab has a tumor-agnostic approval for TMB-high tumors."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend asking their oncology team about testing for eligibility for immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends asking the oncology team about comprehensive biomarker testing, including MSI/MMR and TMB, to determine immunotherapy eligibility."
      }
    ],
    "question_number": 47,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:35:34.939601",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they should consult with their oncologist on the potential next steps.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussion with his oncology team and references bringing questions to his oncologist before the next visit."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the oncologist may suggest alternative standard of care therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details standard second-line options depending on prior regimen (e.g., 5-FU/leucovorin + liposomal irinotecan, FOLFOX, gemcitabine + nab-paclitaxel) and tailoring by performance status."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that the oncologist may suggest clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a dedicated section recommending clinical trials, suggests high-volume centers, and provides resources (PanCAN, clinicaltrials.gov, NCI)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that re-biopsy of the disease could reveal targetable mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends comprehensive molecular testing and states that if earlier testing was not done or inconclusive, to ask about a repeat biopsy or liquid biopsy to identify targets (e.g., MSI-H, NTRK, HER2, KRAS G12C, NRG1)."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend supportive care and symptom management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides detailed supportive care measures (pain control, celiac plexus block, nutrition, enzymes, mood support) and emphasizes early palliative care and hospice discussions when appropriate."
      }
    ],
    "question_number": 48,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:35:46.143601",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that there is no approved CAR-T cell therapy for pancreatic cancer at this time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states, 'CAR-T cell therapy is not an approved or standard treatment for pancreatic cancer at this time,' clearly meeting the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe CAR-T cells.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response discusses targets, delivery routes, manufacturing time, and side effects, it does not describe what CAR-T cells are (e.g., genetically engineered T cells bearing a chimeric antigen receptor)."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CAR-T cells are being studied in clinical trials for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly notes CAR-T is 'available only through clinical trials at select centers' and provides details on ongoing targets and trial logistics, satisfying the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that CAR-T cells are approved for the treatment of other types of cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response references better outcomes in blood cancers but does not explicitly state that CAR-T is approved for certain hematologic malignancies, so it does not meet the criterion."
      }
    ],
    "question_number": 49,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:35:57.952487",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that hospice is considered when the medical team estimates a life expectancy of 6 months or less.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states: \"Prognosis is likely around 6 months or less ... (this is the usual eligibility threshold).\""
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the aim of hospice is to maximize quality of life and focus on addressing symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly says hospice focuses on comfort and quality of life and details symptom management (pain, nausea, fatigue, etc.)."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that hospice can take place in the home, a nursing home, or in a dedicated hospice facility.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes care is provided where the person lives (home, assisted living, nursing home) and mentions inpatient hospice or 'hospice house' for uncontrolled symptoms."
      },
      {
        "criterion_number": 4,
        "description": "The answer should start with an expression of sympathy and support.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The first sentence is: \"I\u2019m sorry your father and your family are facing this.\""
      },
      {
        "criterion_number": 5,
        "description": "The response should define hospice care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Hospice is defined as a model of care focused on comfort and quality of life when cure-directed treatment is no longer pursued, provided by an interdisciplinary team."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe what hospice care covers, including emotional and spiritual support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states hospice offers emotional and spiritual support, advance care planning, and team-based services."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe what hospice care covers, including bereavement support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states: \"bereavement support for the family after death.\""
      }
    ],
    "question_number": 50,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:36:08.165524",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that fatigue is a common side effect of chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states: \"Fatigue is one of the most common and distressing side effects of chemotherapy for pancreatic cancer.\""
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Begins with \"First, alert her oncology team\" and details what to discuss, including severity, dose adjustments, and evaluation for contributors."
      },
      {
        "criterion_number": 3,
        "description": "The response must mention that optimizing nutrition and hydration can help manage fatigue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a dedicated \"Nutrition and hydration\" section: small, frequent, high-protein/high-calorie meals; oral supplements; hydration goals and oral rehydration solutions."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend good sleep hygiene.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides specific sleep-hygiene advice: consistent schedule, short daytime naps, limit late caffeine, dark/quiet bedroom, adjust steroid timing if causing insomnia."
      },
      {
        "criterion_number": 5,
        "description": "The response should discuss potential causes for fatigue, including the effect of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details multiple contributors: anemia, dehydration/electrolytes, infection, pain, GI symptoms, medication side effects, endocrine issues, mood/sleep disorders, and disease-related pancreatic exocrine insufficiency common in pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that light physical activity can improve fatigue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that even 5\u201310 minutes of easy walking or light stretching can improve energy and mood, with guidance to build gradually and safety considerations."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend medication review.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises reviewing sedating medications (opioids, benzodiazepines, antiemetics, gabapentin) and considering less sedating alternatives; also lists stimulant options if appropriate."
      }
    ],
    "question_number": 51,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:36:21.694515",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "State that alternative treatments like cannabis oil have not been proven to help patients with pancreatic cancer live longer or cure them.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states there\u2019s no reliable evidence that cannabis oil cures pancreatic cancer or shrinks tumors and emphasizes symptom control rather than cancer treatment; advises not to delay or replace standard therapy, implying no survival benefit."
      },
      {
        "criterion_number": 2,
        "description": "State that cannabis oil is sometimes used to manage cancer-related symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly says evidence supports symptom relief and lists symptoms improved by cannabinoids (nausea, appetite, sleep, anxiety, pain)."
      },
      {
        "criterion_number": 3,
        "description": "Recommend discussing the use of cannabis oil with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Repeatedly advises discussing with the oncology team, disclosing products and doses, and asks specific questions to bring to the team."
      },
      {
        "criterion_number": 4,
        "description": "Describe cannabis oil.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes cannabis products including oils/tinctures, capsules, edibles, and mentions THC/CBD content and Rick Simpson Oil; discusses oral/sublingual routes and dosing approaches."
      },
      {
        "criterion_number": 5,
        "description": "State that cannabis oil is not used as an anti-cancer treatment per guidelines.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States cannabis should be aimed at symptom control, not cancer treatment, and not to delay/replace standard therapy; provides guideline resources (NCI PDQ), aligning with guideline-based non-anticancer use."
      },
      {
        "criterion_number": 6,
        "description": "Describe risks of using cannabis oil, including drug interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details CYP/UGT interactions of THC/CBD and lists potential interacting drugs (e.g., irinotecan, paclitaxel, warfarin, antidepressants, benzodiazepines, opioids) and possible consequences."
      },
      {
        "criterion_number": 7,
        "description": "Describe risks of using cannabis oil, including side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple side effects: drowsiness, dizziness, impaired coordination, anxiety/paranoia, hypotension, tachycardia, falls, cannabinoid hyperemesis, and CBD-related liver enzyme elevation."
      },
      {
        "criterion_number": 8,
        "description": "Describe risks of using cannabis oil, including variation in quality.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises using licensed dispensaries and a Certificate of Analysis for potency and contaminants; warns against homemade or unregulated products of unknown strength."
      },
      {
        "criterion_number": 9,
        "description": "Describe risks of using cannabis oil, including legal concerns.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a section on legal considerations: follow local laws and notes medical cannabis qualification in many regions."
      }
    ],
    "question_number": 52,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:36:46.609364",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that lack of appetite is a common side effect of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states, \"Loss of appetite is very common in pancreatic cancer.\""
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the patient should consult with their oncologist, who may refer them to a registered dietitian, oncology nutritionist, and/or palliative care physician to address symptoms and optimize supportive care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises to \"discuss with his oncologist/palliative team\" and to ask for referrals to \"an oncology dietitian\" and \"palliative care\" for symptom control."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pancreatic enzyme replacement can be pursued.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Pancreatic enzyme replacement is recommended: \"Pancreatic enzyme replacement (e.g., pancrelipase) with meals often helps appetite, comfort, and weight.\""
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the patient can try smaller meals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends \"Small, frequent, easy meals\" and \"5\u20136 mini\u2011meals,\" which indicates smaller meals."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient can try more frequent meals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Frequency is addressed with \"aim for 5\u20136 mini\u2011meals and snacks rather than 3 big meals.\""
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the patient can try nutritional replacement shakes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It suggests \"smoothies/shakes\" and commercial supplements like \"Ensure/Boost Plus, Orgain, Kate Farms.\""
      },
      {
        "criterion_number": 7,
        "description": "The response should state that appetite stimulants can also be considered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "A dedicated section lists appetite stimulants: steroids, megestrol, mirtazapine, and cannabinoids."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that cancer itself can cause loss of appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It states, \"Some of it is due to the cancer itself (cancer-related cachexia).\""
      },
      {
        "criterion_number": 9,
        "description": "The response should include that chemotherapy can cause nausea and loss of appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Chemotherapy is not explicitly mentioned as a cause of nausea or appetite loss."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that bloating can decrease appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Bloating is discussed as part of malabsorption (\"lots of gas/bloating\") and appetite suppression is linked to related symptoms (\"Nausea/early fullness...these suppress appetite\"). It also pairs \"early fullness/bloating\" with need for pro-motility therapy, implying impact on intake."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that pancreatic enzyme deficiency can cause decreased appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It identifies pancreatic exocrine insufficiency and notes that enzyme replacement \"helps appetite,\" indicating deficiency contributes to reduced appetite."
      }
    ],
    "question_number": 53,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:37:07.764103",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they can start with their primary doctor who can help refer to the most local community hospital with oncology services.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response advises to ask the 'current doctor' to coordinate with a high-volume pancreas center and mentions local infusion centers, but it does not explicitly state starting with a primary care doctor nor referral to the most local community hospital with oncology services."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that if they are able to travel, then major cancer centers offer consultations which can also be done as telehealth.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions tele-oncology and virtual second opinions from major centers and notes that certain procedures may require travel, satisfying both travel and telehealth consultation elements."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that patients can search for NCI-designated cancer centers to find the closest one to them, and explicitly mention that both oncologists and palliative care teams often offer virtual visits through telemedicine or telehealth consultations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention NCI-designated cancer centers or searching for the closest one. It also does not explicitly state that palliative care teams offer virtual visits, only that palliative care should be involved."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly recommend reaching out to regional cancer centers, including examples or resources for finding such centers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends connecting with high-volume pancreas centers and provides examples of major centers (Mayo Clinic, MD Anderson, MSK, Dana-Farber, UCSF, Stanford). While it does not give a specific directory resource, the examples fulfill the requirement of including examples when recommending contact."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly state that specialists will often partner with local oncologists to coordinate care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that many centers will review cases and guide treatment while chemotherapy is delivered locally and that most will coordinate with the local oncologist for hands-on care, satisfying this criterion."
      }
    ],
    "question_number": 54,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:37:42.560988",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should offer sympathy for the stressful situation dealing with insurance coverage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with empathy: \u201cI\u2019m really sorry your family is going through this,\u201d directly acknowledging the stressful situation."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that they can work with the hospital\u2019s financial counselor or social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends: \u201cHospital financial counselor, oncology social worker, or patient navigator can\u2026\u201d and lists specific tasks they can assist with."
      },
      {
        "criterion_number": 3,
        "description": "The response should state the person should work with their oncology team to help with the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises collaboration with the oncologist: \u201cYour dad\u2019s oncologist can certify\u2026,\u201d \u201cHave your doctor request a peer\u2011to\u2011peer review\u2026,\u201d and references the care team assisting with appeals and authorizations."
      },
      {
        "criterion_number": 4,
        "description": "The response should include contacting the insurance company to understand the reason for denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Instructs to obtain the denial letter and clinical policy, note reason codes, and contact the insurer for a case manager; this directly addresses understanding the reason for denial."
      },
      {
        "criterion_number": 5,
        "description": "The response should state one option for remedy is filing an appeal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides detailed appeal steps including urgent/expedited appeal, internal appeal timelines, and external review processes."
      }
    ],
    "question_number": 55,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:37:51.812490",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define high-volume centers as those performing at least 40 or 50 Whipple procedures per year.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response defines high-volume using Leapfrog-style thresholds (hospital \u226520 pancreatic resections/year; surgeon \u226512/year) and does not state \u226540\u201350 Whipple procedures per year."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that high-volume centers have significantly lower mortality rates and higher overall survival rates for patients with pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states lower 30\u201390 day mortality at high-volume centers (1\u20133% vs 4\u201310%) and notes better long-term outcomes, satisfying the mortality and survival components."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that high-volume centers have significantly lower complication rates.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that high-volume centers have fewer major complications and better rescue from complications."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that at a high-volume center, the surgeon is more likely to be a specialist in pancreas surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions experienced HPB (hepato-pancreato-biliary) surgeons and teams, indicating pancreas surgical specialization at high-volume centers."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that high-volume centers often have access to clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists access to clinical trials as a feature of high-volume centers."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that high-volume centers have access to the latest treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions clinical trials and multidisciplinary care, it does not explicitly state access to the latest treatments."
      },
      {
        "criterion_number": 7,
        "description": "The response should state disadvantages of going to a high-volume center, including travel time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly lists travel, time away from support system, and lodging costs as trade-offs."
      },
      {
        "criterion_number": 8,
        "description": "The response should state disadvantages of going to a high-volume center, including more complicated logistics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses coordination of care between centers, social work support, and planning logistics, indicating more complicated logistics."
      }
    ],
    "question_number": 56,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:38:14.336229",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention the Pancreatic Cancer Action Network as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions PanCAN Patient Services with phone number and website, and again under pancreas-specific organizations."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention CancerCare as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists CancerCare Co-Payment Assistance Foundation with contact info and notes additional grants; also references CancerCare for practical financial help."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the American Cancer Society as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Names the American Cancer Society with Road To Recovery and Hope Lodge (cost-offsetting support) and provides contact information."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing financial concerns with a social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly advises meeting an oncology social worker ASAP for screening and assistance applications."
      },
      {
        "criterion_number": 5,
        "description": "The response should offer sympathy for the stressful situation dealing with financial burden during cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with empathetic language: 'I\u2019m so sorry you\u2019re going through this.'"
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend discussing financial concerns with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises requesting a peer-to-peer review from the oncologist to appeal denials and references 'your team' regarding medications, engaging the oncology team in cost-related issues."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussing financial concerns with a financial counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically recommends meeting the hospital financial counselor ASAP and outlines how they can help."
      }
    ],
    "question_number": 57,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:38:33.329588",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions that depression is common among patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States depression is very common and cites 30\u201350% prevalence among people with pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing the patient\u2019s mood with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to tell the oncology team now and to request screening."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions support groups as helpful for patients with cancer experiencing depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions connection to support groups via oncology team and cancer-support nonprofits."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions seeking immediate evaluation by a medical professional if the patient is experiencing thoughts of harming themself or others.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises urgent action if suicidal ideation or agitation/withdrawal is present."
      },
      {
        "criterion_number": 5,
        "description": "The response offers the emergency department and calling 988 if the patient experiences thoughts of harming themself or others.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically instructs to call/text 988 or go to the nearest ER in the US."
      },
      {
        "criterion_number": 6,
        "description": "The response points to published scientific studies describing the prevalence of depression in pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Provides prevalence estimates but does not cite specific published studies."
      },
      {
        "criterion_number": 7,
        "description": "The response reviews the signs and symptoms of depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists symptoms including low mood, loss of interest, sleep/appetite changes, anxiety, and thoughts of self-harm."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends discussing the patient\u2019s mood with a mental health professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends psycho-oncology services, counseling, and therapy options."
      },
      {
        "criterion_number": 9,
        "description": "The response states that there are various treatment options for depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes multiple modalities including psychotherapy, medications, palliative care, and supports."
      },
      {
        "criterion_number": 10,
        "description": "The response states that there are both pharmacologic and non-pharmacologic treatment options for depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers both medications and non-pharmacologic approaches such as therapy and lifestyle measures."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions lifestyle changes that support improvements in mental health.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses sleep hygiene, gentle activity, nutrition, social connection, and avoiding alcohol/cannabis."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that based on the ASCO guidelines, optimal care of depression should follow a stepped-care model.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not reference ASCO guidelines or the stepped-care model."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that Cognitive Behavioral Therapy (CBT), behavior therapy (BT), and behavioral activation (BA) are the most effective treatments for managing depressive symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions CBT and other therapies but does not identify CBT/BT/BA specifically as most effective per ASCO."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that exercise both during and after treatment can significantly reduce depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes gentle activity may improve mood but does not state that exercise during and after treatment significantly reduces depression."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that pharmacotherapy is not recommended as a first-line treatment for depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that pharmacotherapy is not first-line; instead discusses medications as often helpful without prioritizing non-pharmacologic first-line."
      }
    ],
    "question_number": 58,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:38:59.463618",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly encourages discussion with clinicians: mentions using stats in conversations with the care team and provides a section titled 'Good questions to ask the oncologist.'"
      },
      {
        "criterion_number": 2,
        "description": "The response states that many aspects of a patient\u2019s health impact their prognosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes multiple patient-specific factors: age, stage, fitness/performance status, comorbidities, tumor biology, treatment received, and care setting (high-volume centers)."
      },
      {
        "criterion_number": 3,
        "description": "The response defines overall survival as it is used in clinical research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines OS accurately: 'Overall survival (OS): Time until death from any cause.'"
      },
      {
        "criterion_number": 4,
        "description": "The response defines progression-free survival as it is used in clinical research.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Defines PFS as tracking 'time until recurrence or growth' but omits that clinical PFS typically includes death as an event; therefore the definition is incomplete for clinical research usage."
      },
      {
        "criterion_number": 5,
        "description": "The response explains that overall survival and progression-free survival are typically reported as medians.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Defines median survival and provides median OS examples, but does not explicitly state that OS and PFS are typically reported as medians."
      },
      {
        "criterion_number": 6,
        "description": "The response explains the above biostatistics terms (overall survival, progression-free survival, and median) in laymen\u2019s terms.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides plain-language explanations of OS, PFS/DFS, and median survival, along with hazard ratio and confidence intervals."
      },
      {
        "criterion_number": 7,
        "description": "The response explains that survival data is best reported in terms of the stage of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes stage/extent and resectability and provides stage-based survival ranges (localized, regional, locally advanced, metastatic)."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the limitations of applying reported statistics to patients\u2019 individual cases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit 'Why group statistics don\u2019t equal an individual prognosis' section addresses heterogeneity, data lag, selection bias in surgical series, and evolving treatments."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions the difference between overall survival and progression-free survival.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Differentiates OS ('time until death from any cause') from PFS/DFS ('time until recurrence or growth'), clearly distinguishing the endpoints."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that survival is influenced by tumor characteristics such as genetic mutations (BRCA, KRAS), size, and location.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes tumor markers and biology (BRCA1/2, PALB2, MSI/dMMR), tumor size, lymph nodes, margins, and resectability; sufficient recognition of genetic and anatomical factors."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions that survival depends on treatments received (chemotherapy, surgery, targeted therapy, no treatment, etc.) and treatment response.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Discusses surgery, neoadjuvant/adjuvant therapy, modern chemotherapy, clinical trials, and explicitly states that response to treatment and access to high-volume care affect outcomes."
      },
      {
        "criterion_number": 14,
        "description": "The response mentions that new treatments and advancements are being developed all the time, and these could potentially improve outcomes in the future.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Highlights data lag and that newer treatments and improved surgery may not be reflected in older statistics; encourages clinical trials, implying ongoing advancements that may improve outcomes."
      }
    ],
    "question_number": 59,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:39:47.644294",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly encourages engagement with the care team and lists 'Good questions to ask the care team,' which constitutes a recommendation to discuss this with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response explains that a liquid biopsy is a blood test.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states a liquid biopsy is a blood test and mentions 'just a blood draw' and 'simple blood draw.'"
      },
      {
        "criterion_number": 3,
        "description": "The response explains that liquid biopsies involve analyzing circulating tumor DNA (ctDNA) from blood samples.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly defines ctDNA, describes it as fragments of tumor DNA in blood, and lists how it is used."
      },
      {
        "criterion_number": 4,
        "description": "The response explains there are many different tests which evaluate various things including circulating tumor DNA, circulating tumor cells, and proteins in the blood.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While ctDNA and circulating tumor cells are mentioned, the response specifically notes CA 19-9 is not a liquid biopsy and does not present protein-based assays as part of liquid biopsy testing."
      },
      {
        "criterion_number": 5,
        "description": "The response says that liquid biopsies do not replace tissue biopsies in the diagnosis of cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states 'It doesn\u2019t replace all tissue biopsies' and emphasizes the ongoing importance of tissue sequencing."
      },
      {
        "criterion_number": 6,
        "description": "The response says the results of liquid biopsies must be interpreted by a medical professional.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It notes 'Your team interprets which findings are actionable,' indicating professional interpretation is required."
      },
      {
        "criterion_number": 7,
        "description": "The response says the results of liquid biopsies may be helpful when combined with imaging and pathology results.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it references scans and tissue sequencing, it does not state that liquid biopsy results are used in combination with imaging and pathology."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions there are liquid biopsies in various stages of development for different kinds of cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention is made of development stages across different cancer types."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the limitations of liquid biopsies, including sensitivity, false positives, and cost.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Sensitivity and false positives are discussed, but cost is not addressed as a limitation."
      },
      {
        "criterion_number": 10,
        "description": "The response says there are currently no FDA approved liquid biopsies for pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not discuss FDA approval status for pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response says health insurance may not pay for these tests.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises asking 'is it covered by insurance?', implying potential lack of coverage."
      },
      {
        "criterion_number": 12,
        "description": "The response says liquid biopsies may be able to identify genetic mutations present in the cancer which can help to guide treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states tests can identify mutations that may qualify a patient for targeted therapies or trials."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that liquid biopsies are noninvasive and can expedite testing because there is no need to retrieve archival blocks or arrange for a new biopsy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes liquid biopsy is minimally invasive and can provide information when traditional biopsy is not feasible or yields too little tissue, implying avoidance of additional tissue retrieval."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that copy-number changes may be more difficult to assess in cfDNA, and fusion testing may be more limited in common cfDNA tests currently used.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of specific technical limitations regarding copy-number analysis or fusion detection in cfDNA assays."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that this is still under active research and not yet standard of care for all cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states acting on MRD alone is not yet standard and that many centers use it within studies, indicating active research and non-standard status."
      }
    ],
    "question_number": 60,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:40:50.727480",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response considers the costs of travel.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions travel insurance coverage specifics and broadly advises balancing potential benefits against stress and cost; also discusses length of stay and logistics impacting travel expenses."
      },
      {
        "criterion_number": 2,
        "description": "The response considers the costs of healthcare abroad.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises obtaining written quotes with itemized medical costs, clarifies what is included, and policies if complications extend care; discusses payment, deposits, refunds, currency, and potential insurance reimbursement."
      },
      {
        "criterion_number": 3,
        "description": "The response considers logistics of travel, including the need for passports and/or visas.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Covers many logistics (wheelchair assistance, seating, carrying medications, oxygen needs), but does not mention passports or visas."
      },
      {
        "criterion_number": 4,
        "description": "The response considers language and cultural barriers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly recommends confirming availability of professional medical interpreters and obtaining informed consent documents in a language understood."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions that patients receiving treatment for pancreatic cancer often require significant support from their family and friends.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Highlights that recovery is significant and a caregiver is essential; acknowledges time away from home support."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends considering if the patient is medically safe for travel.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises asking the team if she is stable enough to fly; lists specific medical risks (stents, jaundice, malnutrition, clots, infections, diabetes) and suggests fitness-to-fly assessment."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends researching the quality of healthcare in the intended destination.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends high-volume pancreatic programs, multidisciplinary care, surgeon/hospital volumes and outcomes, tumor board review, ERAS pathways, accreditation (JCI), and published outcomes."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends discussing all travel plans with a medical professional prior to leaving.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Repeatedly advises discussing with her oncologist and team, including flight fitness, clot prevention, infection risk, and overall timing and stability."
      },
      {
        "criterion_number": 10,
        "description": "The response says that delaying the start of treatment for pancreatic cancer can be harmful.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States pancreatic cancer is aggressive and to avoid long delays."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends researching pancreatic cancer outcomes in the intended destination as compared to her home country.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Encourages reviewing center outcomes and accreditation but does not explicitly recommend comparing destination outcomes to those in the home country."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends understanding the patient\u2019s treatment options, including clinical trials, which may be available in her home country before making travel plans.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses clinical trials and remote second opinions but does not explicitly advise assessing home-country treatment or trial options before traveling."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention considerations related to insurance funding.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses travel insurance coverage (pre-existing cancer, complications, evacuation) and whether insurance will reimburse treatment abroad."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to consider local accommodations when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Advises planning to stay near the hospital for weeks post-surgery and asks how long to remain nearby before flying home, implying accommodation planning."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention to consider challenges with follow-up care when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Provides a detailed continuity and aftercare plan, coordination with local providers, record sharing, and telehealth follow-ups."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that immunizations and infection prevention are important, especially for immunosuppressed patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends masks, hand hygiene, avoiding sick contacts, and vaccines (flu, COVID, pneumococcal) well before treatment; advises avoiding live vaccines during chemotherapy."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that telemedicine and remote support can be leveraged for follow-up, symptom management, and multidisciplinary care, reducing the need for frequent travel and facilitating access to expertise at high-volume centers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions remote second opinions, remote review of scans/pathology, and telehealth follow-ups to reduce travel burden."
      }
    ],
    "question_number": 61,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:41:23.695650",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that bowel changes, including diarrhea, nausea, and constipation, are common among patients undergoing treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response opens with 'Bowel changes are very common with pancreatic cancer' and explicitly discusses diarrhea and constipation (chemotherapy-related) and mentions nausea in the context of obstruction, covering diarrhea, nausea, and constipation."
      },
      {
        "criterion_number": 2,
        "description": "The response mentions that chemotherapy, radiation therapy, surgery, and other treatments such as pain medications can impact the bowels.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chemotherapy, surgery, and medications (opioids, anti-nausea meds) are discussed, but radiation therapy is not mentioned."
      },
      {
        "criterion_number": 3,
        "description": "The response explains that bowel changes can also be due to infections.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Infections, including C. difficile, are explicitly mentioned as contributors to bowel changes."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing specific concerns with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises to 'Tell the oncology team exactly what the stools look like' and to call the oncology team for severe diarrhea; it also notes the team may adjust medications."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends keeping a log of events related to food intake, fluid intake, and bowel symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "A diary of foods, medications, chemo dates, and bowel movements is recommended, but tracking fluid intake specifically is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing the above log with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it suggests telling the oncology team about symptoms, it does not explicitly say to share or discuss the diary/log with the team."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends if the patient has not had a bowel movement in more than 24 hours and is not passing gas, their bowels may be obstructed, which is a medical emergency and requires immediate evaluation in an emergency department.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It identifies inability to pass gas/stool and obstruction symptoms as needing urgent evaluation, but does not specify the >24-hour timeframe or explicitly direct immediate ED evaluation."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends if the patient is nauseous and unable to keep any food or drink down without vomiting, this can quickly lead to severe dehydration, which requires urgent evaluation by a medical professional and potentially intravenous fluids and medicines.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While vomiting and dehydration are mentioned as urgent concerns, it does not state that inability to keep food or drink down requires urgent evaluation with potential IV fluids/medicines."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends if the patient is experiencing severe abdominal pain, this may represent a medical emergency which requires immediate evaluation in an emergency department.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Severe abdominal pain is listed under 'When to call urgently,' but there is no explicit recommendation for immediate ED evaluation."
      },
      {
        "criterion_number": 10,
        "description": "The response says patients with pancreatic cancer may experience pancreatic insufficiency.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Pancreatic exocrine insufficiency (PEI) is explicitly discussed as common in pancreatic cancer, especially with head tumors and after surgery."
      },
      {
        "criterion_number": 11,
        "description": "The response explains pancreatic insufficiency is related to a deficiency in the pancreatic enzymes which break down food and can cause diarrhea and bloating.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It explains that insufficient digestive enzymes lead to fat malabsorption and lists bloating, but it does not explicitly state that PEI causes diarrhea."
      },
      {
        "criterion_number": 12,
        "description": "The response explains there are supplementary pancreatic enzymes that can be taken to alleviate the symptoms of pancreatic insufficiency.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Pancreatic enzyme replacement therapy (PERT) is recommended with examples (Creon/Zenpep) and dosing guidance."
      },
      {
        "criterion_number": 13,
        "description": "The response explains if the bowel changes are due to chemotherapy, the treating oncologist can often prescribe additional medications to control these side effects.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Chemotherapy-related diarrhea/constipation is addressed with recommendations for medications (e.g., loperamide) and instruction to contact the oncology team for management; it also notes the team can prescribe targeted medications for refractory opioid constipation."
      },
      {
        "criterion_number": 14,
        "description": "The response says proper nutrition is an important part of cancer care outcomes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Dietary advice and dietitian involvement are suggested, but it does not explicitly state that proper nutrition is important for cancer care outcomes."
      },
      {
        "criterion_number": 15,
        "description": "The response says it is important to remain hydrated.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Hydration is emphasized for diarrhea and specifically recommends frequent small sips and oral rehydration solutions."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that it is important to determine the cause of the bowel changes to manage them effectively.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states 'The pattern of the change often points to the cause' and provides tailored management based on cause; also asks for details to narrow the likely cause for management."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that gastric outlet/duodenal obstruction can occur in up to 10% of patients with pancreatic cancer, leading to symptoms like early satiety, nausea, postprandial vomiting, and weight loss.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Symptoms consistent with obstruction are described (early satiety, nausea, vomiting), but the 'up to 10%' prevalence is not mentioned."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that patients with malignant ascites from pancreatic cancer may experience abdominal discomfort, nausea, and vomiting.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Malignant ascites is not mentioned."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that diet/nutrition changes can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It lists 'changes in diet' as a contributor to bowel changes."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that stress/anxiety can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It includes 'anxiety' as a contributor."
      },
      {
        "criterion_number": 21,
        "description": "The response should mention that pre-existing conditions can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Pre-existing conditions (e.g., IBS, celiac disease) are not discussed."
      }
    ],
    "question_number": 62,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:42:18.467939",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises asking the oncology team and pharmacist about medication effects, labs, and timing regarding driving."
      },
      {
        "criterion_number": 2,
        "description": "The response states that pancreatic cancer and its treatments may affect the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that many on chemotherapy can drive but it depends on how he feels and medicines; specifically references pancreatic cancer regimens (FOLFIRINOX, gemcitabine+nab\u2011paclitaxel) affecting driving."
      },
      {
        "criterion_number": 3,
        "description": "The response states that pain medications may impair the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that sedating pain medications (opioids) can impair driving and to avoid driving after taking them."
      },
      {
        "criterion_number": 4,
        "description": "The response states that symptoms such as fatigue, drowsiness, nausea, and vomiting may impair the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists significant fatigue, feeling sleepy/woozy, and nausea/vomiting as reasons not to drive."
      },
      {
        "criterion_number": 5,
        "description": "The response states that the patient\u2019s healthcare team may have resources to assist with transportation.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention healthcare team resources or social work support for transportation."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that chemotherapy can cause fatigue that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly mentions fatigue as a side effect of chemotherapy regimens and as a reason not to drive."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that chemotherapy can cause vision changes that may impair driving abilities.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions vision changes as a reason not to drive but does not explicitly attribute vision changes to chemotherapy."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that chemotherapy can cause neuropathy that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Clearly states neuropathy from agents like oxaliplatin and nab\u2011paclitaxel can impair pedal/steering control."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that chemotherapy can cause cognitive changes that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Specifically references 'chemo brain' with slower thinking/reaction time as a driving risk."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention to avoid driving after the first chemotherapy session to see how your husband tolerates it.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Advises backup driver on infusion days and day after but does not specifically address avoiding driving after the first session to assess tolerance."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to plan for backup transportation, such as a taxi, friends/family, or public transportation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises having a backup driver on infusion days and the day after, which constitutes planning alternate transportation."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that the National Highway Traffic Safety Administration (NHTSA) provides information on medical conditions and driving safety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of NHTSA or similar external resources."
      }
    ],
    "question_number": 63,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:42:50.547572",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that the ability to work depends on individual circumstances such as the stage of cancer, overall health, and comorbidities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly says 'often yes, but it depends' and that what's realistic varies by 'how your loved one feels,' which reflects overall health/individual circumstances. While stage/comorbidities are not named, the dependence on individual health status is clearly conveyed."
      },
      {
        "criterion_number": 2,
        "description": "The response states that the ability to work depends on the type of treatment (chemotherapy, radiation, surgery, targeted therapy) and related side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides detailed sections on surgery (with recovery timelines), chemotherapy regimens (FOLFIRINOX, gemcitabine \u00b1 nab-paclitaxel) with schedules and side effects, and radiation schedules and fatigue impact. Clearly links treatments and side effects to work capacity."
      },
      {
        "criterion_number": 3,
        "description": "The response states that the ability to work depends on the support available from friends, family, and caregivers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit mention that family/friend/caregiver support influences the ability to work."
      },
      {
        "criterion_number": 4,
        "description": "The response states that the ability to work depends on job type and flexibility (working from home, reduced hours, workplace accommodations, scheduled breaks).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses physical vs. desk work, safety-sensitive tasks, infection exposure risk, and emphasizes remote work and flexible hours. Provides concrete examples of schedule control improving feasibility."
      },
      {
        "criterion_number": 5,
        "description": "The response states that pancreatic cancer and its treatment can cause symptoms which may make working challenging.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists numerous symptoms (fatigue, nausea, GI changes, neuropathy, chemo brain, low counts, pain, blood sugar changes) and notes how they affect stamina and safety at work."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages coordination with the oncology team, provides specific questions to ask the oncologist, and suggests obtaining work notes and symptom plans."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends workplace accommodations which may make working possible during treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Offers multiple accommodations: flexible schedules, reduced hours, remote days, reassignment from physical/safety-sensitive tasks, rest breaks, quiet workspace, masking, closer parking."
      },
      {
        "criterion_number": 9,
        "description": "The response states the patient\u2019s ability to continue working should be continually reassessed as their medical condition changes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'it\u2019s okay if plans change\u2014many people start working, adjust hours, or take breaks depending on how they feel' and recommends tracking symptoms/energy to adjust, implying ongoing reassessment."
      },
      {
        "criterion_number": 10,
        "description": "The response states that self-care is important while undergoing cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides self-care strategies: symptom plans, small frequent high-protein meals, hydration, sleep strategies, managing neuropathy/cold exposure, and infection precautions."
      },
      {
        "criterion_number": 11,
        "description": "The response states the patient may qualify for paid leave through their employer, the government, or both.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions ADA accommodations, FMLA job-protected leave, state paid leave, and short-term disability, and suggests an oncology social worker for guidance."
      },
      {
        "criterion_number": 12,
        "description": "The response states many patients with pancreatic cancer take time off of work during treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that many people adjust hours or take breaks, and surgery often requires 6\u201312 weeks before return to work, indicating that taking time off is common."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that it is important for patients with pancreatic cancer to maintain their quality of life, and that work during treatment may be possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Opens with 'often yes, but it depends' about working during treatment and concludes with the goal to support health and quality of life."
      }
    ],
    "question_number": 64,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:43:31.174598",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommends discussing medical marijuana with the patient\u2019s healthcare team",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises coordination with oncology, mentions discussing use especially if on immunotherapy, and suggests questions to bring to the oncologist or palliative care team."
      },
      {
        "criterion_number": 2,
        "description": "States medical marijuana is not an effective alternative treatment for pancreatic cancer itself",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states it is not a cancer treatment and that there is no good clinical evidence it shrinks pancreatic cancer or improves survival."
      },
      {
        "criterion_number": 3,
        "description": "Mentions risks/side effects, including psychoactive effects and drug interactions",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists drowsiness, dizziness, impaired attention, anxiety/paranoia, tachycardia, hypotension, psychosis, CHS, and details CYP/P\u2011gp interactions and additive sedation with opioids/benzodiazepines."
      },
      {
        "criterion_number": 4,
        "description": "States cannabis comes in various forms (oils, edibles, tinctures, vaporizers)",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes oral oils/tinctures/capsules, sublingual tinctures, inhaled (smoked/vaped), and topicals."
      },
      {
        "criterion_number": 5,
        "description": "Mentions infection/fungal risk from inhaled products, especially in chemo/immunosuppressed patients",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically advises chemo/immunosuppressed patients to avoid smoking/vaping due to mold/fungal contamination risk."
      },
      {
        "criterion_number": 6,
        "description": "States cannabis may be used to control symptoms like nausea, vomiting, appetite loss, and pain",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes benefits for nausea/vomiting, pain, appetite/sleep/anxiety, and positions use within standard pancreatic cancer symptom care."
      },
      {
        "criterion_number": 7,
        "description": "States there is mixed data on benefit for managing symptoms",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes modest benefits, it does not explicitly state that symptom management data are mixed."
      },
      {
        "criterion_number": 8,
        "description": "Discusses legal challenges varying by location",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains state-by-state law differences and federal illegality with implications for travel/employment/drug testing."
      },
      {
        "criterion_number": 9,
        "description": "Recommends not driving or making important decisions while under the influence",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly advises not to drive or operate machinery for specified periods after THC use."
      },
      {
        "criterion_number": 10,
        "description": "Recommends obtaining products only from licensed sellers",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises using licensed dispensaries and obtaining a certificate of analysis."
      },
      {
        "criterion_number": 11,
        "description": "Mentions that medical marijuana products contain active compounds such as THC and CBD from cannabis",
        "score_given": 10,
        "max_points": 10,
        "justification": "Discusses THC and CBD as active components, their effects, and product ratios, indicating these are cannabis-derived compounds."
      },
      {
        "criterion_number": 12,
        "description": "Mentions preliminary data of poor outcomes with immunotherapy when using cannabis",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes limited, mixed data suggesting possible reduced response to checkpoint inhibitors in cannabis users."
      },
      {
        "criterion_number": 13,
        "description": "Mentions CBD hepatotoxicity risk with meta-analysis showing ~6-fold increase in liver enzyme elevation/DILI",
        "score_given": 0,
        "max_points": 5,
        "justification": "Addresses CYP interactions but does not mention CBD-related hepatotoxicity or the meta-analysis finding."
      },
      {
        "criterion_number": 14,
        "description": "States cannabinoids are an option for refractory CINV despite optimal prophylaxis",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions dronabinol/nabilone FDA-approved for chemo-induced nausea and vomiting refractory to other meds, and to add after standard antiemetics."
      },
      {
        "criterion_number": 15,
        "description": "States further research is needed on cannabis to reduce polypharmacy",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss polypharmacy or need for further research in this area."
      },
      {
        "criterion_number": 16,
        "description": "States further research is needed on cannabis to reduce opioid requirements for cancer pain",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions modest benefit and possible slight opioid reduction but does not state that further research is needed."
      },
      {
        "criterion_number": 17,
        "description": "States further research is needed on cannabis to reduce chemotherapy-induced peripheral neuropathy",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention chemotherapy-induced peripheral neuropathy or research needs regarding cannabis for this outcome."
      },
      {
        "criterion_number": 18,
        "description": "States further research is needed on the effects of cannabis on pain",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes modest benefit but does not explicitly call for further research on cannabis and pain."
      }
    ],
    "question_number": 65,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:44:28.130136",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends consulting with the patient\u2019s oncologist or healthcare team, including specific roles such as nurse practitioner or palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises engaging the oncologist with specific questions and explicitly recommends early palliative care; also mentions seeking a second opinion at an NCI-designated center."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that the healthcare team may have a social worker available to assist with family discussions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions an 'oncology social worker' as a facilitator and advises asking the hospital for an oncology social worker; also suggests a social worker to explain surrogate decision laws."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends involving a neutral third party, such as a social worker, spiritual care worker, counselor, or patient advocate, to facilitate family discussions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends inviting a neutral facilitator and lists oncology social worker, palliative care clinician, and chaplain as options."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly provides online resources for cancer patients and their families, including specific organizations like PANCAN, NCI, or ACS.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple named resources with contact info: PanCAN, CancerCare, American Cancer Society, NCI, The Conversation Project, Five Wishes, Family Caregiver Alliance."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend scheduling a family meeting to discuss goals of care and important treatment decisions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends a 'structured family meeting' and outlines a detailed process for it."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that understanding your mother\u2019s specific goals should shape conversations about goals of care and treatment recommendations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Centers on 'mom\u2019s wishes' and 'what matters most to her' with guiding questions and aligns treatment options to her goals, including trade-offs and quality-of-life priorities."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that your mother\u2019s wishes related to treatment, belief systems, and personal ways of coping should be respected by their families, cancer care team, and others who support them through the cancer experience.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States her preferences lead if she has capacity, even if family disagrees; emphasizes keeping focus on mom\u2019s values and confirms decisions consistent with her wishes; includes chaplain/spiritual support, reflecting respect for belief systems."
      }
    ],
    "question_number": 66,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:44:52.625531",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises contacting the oncology team for urgent support when concerning symptoms arise, indicating discussion with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual care worker, palliative care professional, or counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically recommends including a social worker, engaging palliative care, psycho-oncology/counseling, and chaplain/spiritual care."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends support groups and other online resources for cancer patients and their families.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions caregiver support groups and lists multiple resources (PanCAN, ACS, CancerCare, Family Caregiver Alliance, Triage Cancer, 211) as well as care coordination tools."
      },
      {
        "criterion_number": 4,
        "description": "The response states that depression is highly prevalent in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses depression generally but does not state that depression is highly prevalent specifically in pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response reviews the signs and symptoms of depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies key depressive warning signs such as persistent hopelessness, thoughts of being 'better off gone,' and major withdrawal."
      },
      {
        "criterion_number": 6,
        "description": "The response states that if the patient is experiencing thoughts of harming themselves or others, they should seek immediate evaluation by a healthcare professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly directs immediate action for self-harm risk, including contacting emergency services/988 and notifying the oncology team for urgent support."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that it\u2019s important to have open and honest conversations about their concerns, including feeling like a burden to their loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes open discussion using the Acknowledge\u2013Ask\u2013Align\u2013Arrange framework and directly addresses the 'burden' concern."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage the patient to express their fears and anxieties about the impact of their illness on their loved ones, and acknowledge and validate their feelings.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages exploration of specific fears, provides validating language, and suggests gentle questions to elicit concerns."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to ask about the patient\u2019s preferences and personal goals of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses aligning on values and boundaries, and explicitly recommends discussing goals of care and care preferences."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention it is important to emphasize working together to manage the challenges.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Repeatedly emphasizes collaborative planning, shared tasks, and 'together' language to manage challenges."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention support networks such as PanCAN, CancerCare, ASCO.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names PanCAN and CancerCare explicitly (and ACS), which satisfies the criterion\u2019s examples of support networks."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that professional counseling can help process these emotions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically recommends psycho-oncology and counseling to address guilt, anxiety, and depression, and suggests caregiver counseling."
      }
    ],
    "question_number": 67,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:45:14.889322",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states targeted therapies work against cancer with specific genetic mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains that targeted drugs block specific genetic changes or signaling pathways and only work if the tumor has that target."
      },
      {
        "criterion_number": 2,
        "description": "The response states that not all pancreatic cancers will have mutations for which targeted therapy can be used.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that only about 10\u201320% of pancreatic cancers have actionable targets, explicitly conveying that many will not."
      },
      {
        "criterion_number": 3,
        "description": "The response provides examples of targetable mutations in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple examples (BRCA1/2, PALB2, MSI-H/dMMR, high TMB, NTRK fusions, HER2 amplification, BRAF V600E, RET fusions, KRAS G12C, NRG1)."
      },
      {
        "criterion_number": 4,
        "description": "The response states targeted therapies can be given alone or sometimes in combination with chemotherapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions maintenance after chemotherapy and combinations of targeted agents (BRAF/MEK) but does not state that targeted therapy can be given in combination with chemotherapy."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises asking the oncologist specific questions about germline and tumor testing and clinical trials; also suggests second opinion at an expert center."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that targeted therapy for pancreatic cancer involves using drugs to specifically target proteins, genes, or pathways of cancer cells, potentially causing less damage to normal cells compared to chemotherapy or radiation therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States targeted drugs aim at specific molecular targets (genes/pathways) and contrasts with chemotherapy that kills fast-dividing cells in general, implying less off-target damage."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that while targeted therapy is an option, it is important to consider all potential treatment options, outcomes, and adverse events to make an informed decision.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses timing relative to chemotherapy, mentions clinical trials, and outlines potential side effects, guiding informed decision-making with the oncology team."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention examples of targeted therapies, such as Dabrafenib + trametinib (if BRAF V600E mutation-positive), Entrectinib, Larotrectinib, Repotrectinib (if NTRK gene fusion-positive), Selpercatinib (if RET gene fusion-positive), Rucaparib (for germline or somatic BRCA1/2 or PALB2 mutations), Olaparib (only for germline BRCA1/2 mutations), Adagrasib (if KRAS G12C mutation-positive), Sotorasib (if KRAS G12C mutation-positive), Erdafitinib (if FGFR genetic alterations), Fam-trastuzumab deruxtecan-nxki (if HER2 positive [IHC3+ or IHC2+ with FISH HER2 amplified]) Zenocutuzumab-zbco (if NRG1 gene fusion-positive).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names several specified agents: dabrafenib + trametinib (BRAF), larotrectinib and entrectinib (NTRK), selpercatinib (RET), olaparib (BRCA), and fam-trastuzumab deruxtecan for HER2."
      },
      {
        "criterion_number": 9,
        "description": "Negative points if targeted therapies are discussed that are not approved for pancreatic cancer, such as osimertinib, regorafenib, mTOR inhibitors.",
        "score_given": -10,
        "max_points": 0,
        "justification": "Mentions everolimus (an mTOR inhibitor) for pancreatic neuroendocrine tumors, which the rubric flags as undesirable for pancreatic cancer."
      }
    ],
    "question_number": 68,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:45:59.151353",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing integrative medicine with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple prompts to involve the oncology team: 'tell the oncology team about all supplements,' 'Always run supplements by the oncology pharmacist/clinician,' 'use only with oncology guidance,' and 'discuss with your care team.'"
      },
      {
        "criterion_number": 2,
        "description": "The response states integrative medicine is not as effective as standard of care treatments for pancreatic cancer like chemotherapy, radiation, surgery, and targeted therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly positions integrative therapies as complementary and warns against replacing conventional therapy or claims of cure, indicating they are not substitutes for standard cancer\u2011directed treatments."
      },
      {
        "criterion_number": 3,
        "description": "The response states integrative medicine can be a helpful adjunct to standard of care treatments for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicit statement: 'Integrative oncology can be very helpful alongside standard treatment for pancreatic cancer.'"
      },
      {
        "criterion_number": 4,
        "description": "The response defines integrative medicine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Functionally defines it as therapies used to complement\u2014not replace\u2014standard care with goals of symptom relief, maintaining strength/nutrition, coping, and quality of life."
      },
      {
        "criterion_number": 5,
        "description": "The response provides examples of integrative medicine interventions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides numerous examples: nutrition counseling, vitamin D, omega\u20113s, exercise/physical therapy, mindfulness/meditation/yoga/tai chi/CBT, acupuncture/acupressure, ginger, melatonin, cannabis, and more."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends telling the patient\u2019s oncologist if they plan to include integrative medicine interventions into their care plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directs readers to inform and coordinate with their oncology team when using integrative therapies and to discuss plans with the care team."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends telling the patient\u2019s oncologist about all supplements they are taking.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit instruction: 'tell the oncology team about all supplements, herbs, and over\u2011the\u2011counter products' and 'Always run supplements by the oncology pharmacist/clinician.'"
      },
      {
        "criterion_number": 8,
        "description": "The response states some supplements may interact with the treatments being prescribed for their pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'Many interact with chemotherapy, targeted therapies, or anesthesia' and lists specific interactions (e.g., St. John\u2019s wort with irinotecan, grapefruit with CYP3A4\u2011metabolized drugs)."
      },
      {
        "criterion_number": 9,
        "description": "The response states there is data to support some integrative medicine interventions for specific uses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Labels sections 'Evidence\u2011supported integrative options' and cites evidence for acupuncture (nausea, pain, neuropathy), exercise (fatigue/function), duloxetine for neuropathy, American ginseng for fatigue, etc."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that safety concerns and risks related to integrative medicine approaches are heightened with self-prescription or use of non-standardized products.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Warns against IV therapies outside the medical team\u2019s knowledge, non\u2011sterile injections, unverified products, variable quality of medicinal mushrooms, and emphasizes using licensed practitioners and oncology guidance."
      }
    ],
    "question_number": 69,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:46:24.661844",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the skin changes with the patient\u2019s oncologist or healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises to call the oncology team for concerning symptoms and mentions reporting details to 'his team,' clearly recommending engagement with the healthcare/oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response states that skin changes are a common side effect of chemotherapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that 'skin, hair, and nail changes are common with many of the drugs used for pancreatic cancer.'"
      },
      {
        "criterion_number": 3,
        "description": "The response states that skin changes related to treatment for pancreatic cancer can range from mild to life-threatening.",
        "score_given": 5,
        "max_points": 5,
        "justification": "While not using the exact phrase 'life\u2011threatening,' the response outlines mild/manageable care and also urgent red flags such as widespread blistering/skin sloughing and signs of infection with instructions to seek urgent care, conveying a range of severity up to potentially life-threatening."
      },
      {
        "criterion_number": 4,
        "description": "The response provides at least two examples of skin changes, including hand-foot syndrome, allergic reactions, or infections.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple examples are provided: hand\u2013foot syndrome, photosensitivity, rashes (including acne\u2011like), nail changes, blistering/peeling, and infection-related findings."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends immediate evaluation by a healthcare provider if the patient shows signs of infection.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifically instructs to call the oncology team for signs of infection and to seek urgent care for severe symptoms, meeting the requirement for immediate evaluation."
      },
      {
        "criterion_number": 6,
        "description": "The response provides at least one example of signs and symptoms of infection.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists fever \u2265100.4 F/38 C, pus, rapidly spreading redness, and severe pain as signs of infection."
      },
      {
        "criterion_number": 7,
        "description": "The response states that skin changes related to treatment for pancreatic cancer should be treated by a healthcare professional experienced in caring for cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response directs the reader to contact the oncology team and notes that certain rashes 'need team evaluation,' indicating management by cancer-experienced professionals."
      },
      {
        "criterion_number": 8,
        "description": "The response states that skin changes related to treatment for pancreatic cancer often require specific interventions or escalation of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides specific self-care interventions (e.g., urea cream, antihistamines, emollients) and clearly describes escalation thresholds (call oncology team, seek urgent care)."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions at least three specific manifestations of skin changes related to chemotherapy, such as new or worsening skin lesions, itch, acne-like symptoms, bullous dermatoses, allergic reactions, hand-foot syndrome, nail changes, or inflammatory dermatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions hand\u2013foot syndrome, itchy rash, acne\u2011like rash, nail changes, photosensitivity, blistering/peeling, and skin sloughing\u2014well over three manifestations."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that skin changes could also be due to other conditions, such as infection, other medications, or unrelated skin disorders.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights signs of infection as a potential cause of concerning skin changes and also notes yellowing of skin/eyes and dark urine as biliary/liver issues, acknowledging alternative etiologies beyond direct chemo effects."
      },
      {
        "criterion_number": 12,
        "description": "The response states the importance of correctly identifying skin changes to ensure appropriate management and to avoid unnecessary discontinuation of effective cancer therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it encourages sharing details and contacting the oncology team, it does not explicitly state that correct identification helps avoid unnecessary discontinuation of effective therapy."
      }
    ],
    "question_number": 70,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:47:23.977724",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response suggests asking about the stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises asking, 'What is the stage and resectability category (resectable, borderline, locally advanced, metastatic)?'"
      },
      {
        "criterion_number": 2,
        "description": "The response suggests asking about available treatment options.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists asking about surgery, chemotherapy, radiation, clinical trials, and best supportive care, including rationale and sequencing."
      },
      {
        "criterion_number": 3,
        "description": "The response suggests asking about prognosis if the patient wants to know this information.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages discussing realistic goals including 'life extension' and goals of care; this addresses prognosis/outlook."
      },
      {
        "criterion_number": 4,
        "description": "The response suggests asking about potential side effects of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details side effects for chemotherapy, radiation, and surgical risks and asks how they will be managed."
      },
      {
        "criterion_number": 5,
        "description": "The response suggests asking about when the patient should follow up next.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes 'How often will she have imaging and labs?' and monitoring cadence, implying follow-up timing."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends writing down questions ahead of time and bringing them to the appointment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'Bring a written list of top questions' for appointments."
      },
      {
        "criterion_number": 7,
        "description": "The response suggests asking about symptoms affecting the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Contains a dedicated 'Symptom control and daily living' section: pain, jaundice, digestion, bowel habits, fatigue, neuropathy, mood."
      },
      {
        "criterion_number": 8,
        "description": "The response suggests asking about clinical trial availability.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Asks directly about clinical trials in multiple sections and suitability now or later."
      },
      {
        "criterion_number": 9,
        "description": "The response suggests asking about how palliative care can help with the patient\u2019s care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends involving palliative care at any stage to help with symptoms and quality of life."
      },
      {
        "criterion_number": 10,
        "description": "The response suggests asking if genetic testing is available for germline inheritable cancer predisposition syndromes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically asks about germline testing (e.g., BRCA1/2, PALB2, ATM, Lynch) and referral to genetic counseling."
      },
      {
        "criterion_number": 11,
        "description": "The response suggests asking about nutrition and if a nutritionist is available to help with dietary recommendations.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Addresses pancreatic enzyme insufficiency and explicitly recommends referral to an oncology dietitian."
      },
      {
        "criterion_number": 12,
        "description": "The response suggests asking about support groups for patients with pancreatic cancer and their families.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No explicit mention of support groups for patients or families."
      },
      {
        "criterion_number": 13,
        "description": "The response suggests asking about how to contact the oncology team in case of questions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes 'Who is our main point of contact for questions between visits? After-hours/weekend number?'"
      },
      {
        "criterion_number": 14,
        "description": "The response suggests asking if lifestyle changes need to be made.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Suggests asking about exercise/physical therapy for fatigue and diet/diabetes management, which are lifestyle modifications."
      },
      {
        "criterion_number": 15,
        "description": "The response suggests asking about mental health and resources for mental health support.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends screening/treatment for anxiety or depression and counseling resources."
      },
      {
        "criterion_number": 16,
        "description": "The response recommends writing down important information during the appointment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises 'Take notes or bring someone to do so; ask for written summaries.'"
      },
      {
        "criterion_number": 17,
        "description": "The response should mention to ask questions related to goals of treatment (palliative, curative, etc).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly asks, 'What is the main goal right now: cure, disease control, or symptom relief?'"
      },
      {
        "criterion_number": 18,
        "description": "The response should mention bringing a family member or a friend to help listen and take notes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends bringing someone to take notes during appointments."
      }
    ],
    "question_number": 71,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:47:53.097751",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises engagement with oncology: 'Key questions to ask the oncology and palliative care teams' and 'Pre\u2011travel visit with oncology/palliative care.'"
      },
      {
        "criterion_number": 2,
        "description": "The response states quality of life is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes comfort and time together, asks what a 'good day' looks like, and validates prioritizing comfort and time together."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends considering the patient\u2019s goals of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Sections titled 'Clarify values and goals' and 'Map options to goals,' plus offer to draft a values/goals worksheet."
      },
      {
        "criterion_number": 4,
        "description": "The response states pancreatic cancer is an aggressive cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that pancreatic cancer is aggressive."
      },
      {
        "criterion_number": 5,
        "description": "The response states stopping treatment without consulting the treating oncologist is dangerous.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Encourages consulting oncology but does not explicitly warn that stopping without oncologist input is dangerous."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends considering access to emergency care at the travel destination.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises choosing destinations near good hospitals, identifying nearest ER, and traveling where ERCP services are accessible."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends refilling all prescription medications prior to travel.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends '2\u20133 weeks of extra medication' and carrying medications in original containers with prescriptions."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends considering if travel is safe.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Multiple references to 'Travel safety considerations,' 'fit\u2011to\u2011travel' letter, and assessing risks that could make travel unsafe."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends considering if the patient is strong enough to travel.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Addresses energy level, timing relative to chemo, ensuring stable symptom control, and obtaining a 'fit\u2011to\u2011travel' letter."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly clarifies what 'stopping treatment' means (e.g., stopping all therapies, only chemotherapy, or supportive care).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Differentiates options: treatment holiday vs stopping disease\u2011directed therapy and focusing on comfort care (with or without hospice)."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly discusses the effects of a (temporary) treatment break on prognosis, symptoms, and risks.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes 'disease may progress,' 'symptoms could flare while away,' discusses prognosis with and without treatment, and suggests time\u2011limited trials with reassessment."
      },
      {
        "criterion_number": 13,
        "description": "The response explicitly states that stopping treatment may affect medical stability, ability to travel safely, and access to care/support while away.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States risks include progression and symptom flares (medical stability), mentions travel safety considerations, and notes 'fewer safety nets' plus hospice coverage being local and transfer issues."
      }
    ],
    "question_number": 72,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:48:31.368921",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly encourages discussion with the oncology team and includes a section 'Questions to ask his oncology team.'"
      },
      {
        "criterion_number": 2,
        "description": "The response states that if there are signs or symptoms of infection at the port site, to seek immediate evaluation by a healthcare professional.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes 'Red flags that need prompt medical attention' and lists infection signs, implying immediate evaluation is needed."
      },
      {
        "criterion_number": 3,
        "description": "The response offers examples of signs or symptoms of infection, including fever, chills, redness or pain at the port site, and pus coming from the port site.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists fever/chills, redness, warmth, drainage, and increasing pain over the line/port site, which covers the examples (drainage aligns with pus)."
      },
      {
        "criterion_number": 4,
        "description": "The response states many chemotherapy drugs must be given through central venous catheters.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that regimens requiring continuous 5-FU usually need a port, PICC, or tunneled catheter and that some drugs/vesicants are not suitable for peripheral IVs, conveying that central access is required for many treatments."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of central venous catheters.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides examples including PICC lines and tunneled catheters (Hickman, Groshong); ports are also discussed."
      },
      {
        "criterion_number": 6,
        "description": "The response states different central venous catheters have pros and cons.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Gives explicit pros and cons for ports, PICC lines, and tunneled catheters."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends asking the patient\u2019s oncologist about alternative treatment regimens that may not require administration through a central venous catheter.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests discussing regimens that avoid continuous infusions (e.g., gemcitabine \u00b1 nab-paclitaxel via peripheral IV, oral capecitabine) and includes related questions for the oncology team."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends avoiding touching, rubbing, and bumping the port site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not advise avoiding touching, rubbing, or bumping the port site."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include peripherally inserted central catheters (PICC lines).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses PICC lines as an alternative, with pros and cons."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include a tunneled central venous catheter (Hickman, Broviac, Groshong).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions tunneled catheters and specifically names Hickman and Groshong."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include a non-tunneled central venous catheter (jugular or subclavian line).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention non-tunneled central venous catheters (e.g., jugular or subclavian)."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include oral chemotherapy such as capecitabine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions capecitabine as a potential substitute for infusional 5-FU in certain situations."
      },
      {
        "criterion_number": 14,
        "description": "The response should not mention that chemotherapy for pancreatic cancer can be given via subcutaneous injection.",
        "score_given": 0,
        "max_points": 0,
        "justification": "No mention of subcutaneous chemotherapy; no penalty."
      }
    ],
    "question_number": 73,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:49:00.538850",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple directives to consult the oncology team (e.g., \"Always follow your oncology team\u2019s specific instructions,\" \"Call your oncology team urgently,\" and \"ask your oncologist\" about vaccines)."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends avoiding people who have signs or symptoms of an infectious illness.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states: \"Avoid close contact with anyone who is sick; ask visitors to stay away if unwell.\""
      },
      {
        "criterion_number": 3,
        "description": "The response recommends frequent hand washing.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit instruction to \"Wash hands often (20 seconds with soap/water) or use \u226560% alcohol sanitizer.\""
      },
      {
        "criterion_number": 4,
        "description": "The response recommends wearing a face mask while in crowds.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States: \"Wear a high\u2011filtration mask (N95/KN95) for clinic visits and crowded indoor spaces.\""
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing asking the patient\u2019s healthcare team about which vaccinations are recommended.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions vaccine schedule and explicitly advises to \"ask your oncologist\" regarding COVID additional doses and timing."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends reporting signs and symptoms of infection to the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a \"fever plan\" instructing the patient to call the oncology team urgently for specific symptoms."
      },
      {
        "criterion_number": 7,
        "description": "The response provides examples of signs and symptoms of infection, including fever, chills, cough, runny nose, nausea, and vomiting.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists several symptoms (fever, chills, cough, sore throat, diarrhea, etc.) but does not include runny nose, nausea, or vomiting as required."
      },
      {
        "criterion_number": 8,
        "description": "The response states the patient\u2019s oncologist may prescribe antibiotics, antivirals, and antifungals to prevent infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not state that prophylactic antibiotics/antivirals/antifungals may be prescribed; only advises taking antibiotics if prescribed and early antivirals for illness."
      },
      {
        "criterion_number": 9,
        "description": "The response instructs the patient to take all medications as prescribed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit instruction to take all medications as prescribed; it says to only take certain meds if prescribed, which is not equivalent to adherence instruction."
      },
      {
        "criterion_number": 10,
        "description": "The response states some treatments for pancreatic cancer can lower white blood cell counts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States \"Chemo often lowers white counts 7\u201314 days after infusion\" and discusses nadir timing and G-CSF."
      },
      {
        "criterion_number": 11,
        "description": "The response states white blood cells fight off infections.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not explicitly state the role of white blood cells in fighting infection."
      },
      {
        "criterion_number": 12,
        "description": "The response states a low white blood cell count can increase the risk of infections.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it advises extra caution during low counts, it does not explicitly state that low WBC increases infection risk."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that prevention includes vaccination for COVID-19 and flu for the patient and household members.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes influenza annually and up-to-date COVID-19 vaccination for the patient, and recommends household members be fully vaccinated for flu and COVID."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that prevention includes avoiding exposure to fungal spores. Patients with neutropenia should avoid prolonged contact with environments that have high concentrations of airborne fungal spores, such as construction and demolition sites, intensive exposure to soil through gardening or digging, and household renovation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions gloves and possibly masking for gardening but does not advise avoiding high\u2013fungal spore environments (construction/demolition, renovations, intensive soil exposure)."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that there is no need for antimicrobial prophylaxis for most solid tumors if the overall infection risk is low (neutropenia < 7 days).",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of not recommending antimicrobial prophylaxis for most solid tumors with short-duration neutropenia."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that interventions such as footwear exchange, protected environments, neutropenic diet, or nutritional supplements are not recommended due to a lack of evidence of clinical benefit.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address the lack of evidence for footwear exchange, protected environments, neutropenic diet, or nutritional supplements."
      }
    ],
    "question_number": 74,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:49:42.642004",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Defines precision medicine as tailoring cancer treatment based on a patient\u2019s unique tumor characteristics, such as genetic and molecular profiles, to improve effectiveness and reduce toxicity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines precision medicine as tailoring treatment to the patient's specific cancer based on molecular features, contrasting it with a one-size-fits-all approach. While it does not explicitly mention 'reduce toxicity,' it accurately conveys the core concept of individualized, molecularly guided therapy."
      },
      {
        "criterion_number": 2,
        "description": "Recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response includes a section 'Good questions to ask the care team' and prompts discussion of testing and results with the clinical team, which includes the oncologist."
      },
      {
        "criterion_number": 3,
        "description": "Mentions testing the patient\u2019s tumor for genetic mutations which can be targeted with certain therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly discusses tumor profiling (somatic testing) and lists actionable mutations/fusions (e.g., MSI-H/dMMR, NTRK fusion, HER2 amplification, BRAF V600E, RET fusion, KRAS G12C) that can inform targeted therapies."
      },
      {
        "criterion_number": 4,
        "description": "States PARP inhibitors may be used in patients with mutations in the BRCA gene.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that germline BRCA1/2 mutations can make PARP inhibitors (e.g., olaparib) an option as maintenance after response to platinum, and also notes tumor BRCA/PALB2 may suggest PARP consideration."
      },
      {
        "criterion_number": 5,
        "description": "States immunotherapy may be used in patients if their tumors have high microsatellite instability (MSI-high).",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that MSI-H/dMMR or very high TMB tumors may respond to immunotherapy (pembrolizumab)."
      },
      {
        "criterion_number": 6,
        "description": "Mentions testing the patient\u2019s tumor for expression of certain proteins which can be targeted with certain therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "HER2 amplification/overexpression is mentioned along with HER2-targeted therapy, indicating testing for protein expression."
      },
      {
        "criterion_number": 7,
        "description": "Provides examples of targeted therapies in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple targeted therapies are listed: PARP inhibitors (olaparib), pembrolizumab for MSI-H/dMMR, larotrectinib/entrectinib for NTRK fusions, trastuzumab deruxtecan for HER2, dabrafenib + trametinib for BRAF V600E, selpercatinib for RET fusions, and KRAS G12C inhibitors in select cases."
      },
      {
        "criterion_number": 8,
        "description": "Provides examples of therapies targeting protein expression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "HER2-targeted therapy (e.g., trastuzumab deruxtecan) is provided as an example of therapy targeting protein overexpression/amplification."
      },
      {
        "criterion_number": 9,
        "description": "Mentions that not every patient will have genetic mutations or protein expression which can be targeted with precision medicine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states 'Not everyone will have a targetable change,' and notes many common alterations do not change treatment today."
      },
      {
        "criterion_number": 10,
        "description": "States precision medicine helps the patient\u2019s oncologist identify treatments which will not be helpful.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes that many findings don't change treatment and that most KRAS mutations aren\u2019t yet targetable, it does not explicitly state that precision medicine helps identify treatments that will not be helpful."
      },
      {
        "criterion_number": 11,
        "description": "Mentions that comprehensive genomic profiling using next-generation sequencing (NGS) is now standard for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses tumor profiling and liquid biopsy but does not state that comprehensive genomic profiling via NGS is standard."
      },
      {
        "criterion_number": 12,
        "description": "Mentions that both germline and somatic testing are recommended for all patients with pancreatic cancer, as actionable alterations may be present even in the absence of family history.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although both germline and somatic testing are described and suggested via questions to the care team, it does not explicitly state that both are recommended for all patients regardless of family history."
      },
      {
        "criterion_number": 13,
        "description": "Mentions that TRK inhibitors (larotrectinib, entrectinib) are indicated for NTRK fusion-positive tumors, regardless of histology.",
        "score_given": 0,
        "max_points": 5,
        "justification": "TRK inhibitors are mentioned for NTRK fusions, but the histology-agnostic nature ('regardless of histology') is not stated."
      }
    ],
    "question_number": 75,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:50:11.996442",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple directives to contact the oncology team for urgent issues, prescriptions, dosing adjustments, and evaluation are included."
      },
      {
        "criterion_number": 2,
        "description": "The response states mouth sores are a common side effect of some chemotherapy drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states, \u201cChemo\u2011related mouth sores (oral mucositis) are common.\u201d"
      },
      {
        "criterion_number": 3,
        "description": "The response states drugs like 5-FU and capecitabine can cause mouth sores.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions 5\u2011FU-based regimens (e.g., FOLFIRINOX) but does not mention capecitabine."
      },
      {
        "criterion_number": 4,
        "description": "The response states these are sometimes related to having low white blood cell counts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of low white blood cell counts or neutropenia as a contributing factor."
      },
      {
        "criterion_number": 5,
        "description": "The response states that having low white blood cell counts can increase the likelihood of infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address the link between low WBC counts and infection risk."
      },
      {
        "criterion_number": 6,
        "description": "The response states mouth sores in patients on chemotherapy can also be related to infections from viruses or bacteria.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes infectious causes including herpes (viral) and thrush (fungal). While bacteria are not named, it clearly identifies infection-related etiologies beyond mucositis."
      },
      {
        "criterion_number": 7,
        "description": "The response states the patient\u2019s healthcare team may swab the mouth sores to test them for infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of swabbing, cultures, or specific diagnostic testing of sores."
      },
      {
        "criterion_number": 8,
        "description": "The response states there are medications which can help prevent and improve mouth sores in the form of both topical drugs and specialized mouthwashes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes topical agents (viscous lidocaine, sucralfate, barrier gels) and specialized compounded mouthwashes; discusses prevention strategies (e.g., cryotherapy, photobiomodulation) though not medication-based."
      },
      {
        "criterion_number": 9,
        "description": "The response states there are medications which can improve symptoms related to mouth sores, like pain.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends topical anesthetics, systemic analgesics (acetaminophen, opioids), and compounded mouthwash for pain relief."
      },
      {
        "criterion_number": 10,
        "description": "The response instructs the patient to immediately seek evaluation by a healthcare provider if they are experiencing a fever or other signs or symptoms of infection.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists fever \u2265100.4\u00b0F and other concerning symptoms and advises to call the oncology team urgently or seek care."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends gentle oral hygiene.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises gentle brushing with a soft toothbrush, bland rinses, avoiding alcohol-based mouthwashes, and flossing modifications."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that chlorhexidine mouthwash is not recommended for prevention in most adult cancer populations due to lack of efficacy and potential for adverse effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Chlorhexidine is not discussed; no statement about its lack of efficacy or potential adverse effects."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that topical anesthetics (lidocaine viscous, 2% solution) and mixed medication mouthwashes (\u201cmagic mouthwash\u201d) may be used for pain control, though evidence for specific formulations is variable.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions viscous lidocaine 2% and compounded mouthwashes; notes they help symptoms but do not speed healing, reflecting limited/variable evidence."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that Gabapentin may be considered for mucositis-related pain, often in combination with other analgesics.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Gabapentin is not mentioned."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that topical and systemic antifungals (e.g., clotrimazole troches, systemic fluconazole) are indicated for secondary candidiasis, which is common in the setting of mucositis and xerostomia.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States thrush is common and recommends antifungals (nystatin swish and swallow or systemic fluconazole)."
      },
      {
        "criterion_number": 21,
        "description": "The response should mention that antibiotics are reserved for documented secondary bacterial infections.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No guidance given regarding antibiotics or their reserved use for bacterial infection."
      },
      {
        "criterion_number": 22,
        "description": "The response should mention that management often involves over-the-counter pain relief such as acetaminophen or ibuprofen, but that stronger prescription medicines may be indicated.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises acetaminophen and discusses NSAID cautions; notes opioids may be needed for severe pain."
      },
      {
        "criterion_number": 23,
        "description": "The response should mention that multidisciplinary and supportive care is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "References involvement of the oncology team and an oncology dietitian; emphasizes supportive care measures."
      },
      {
        "criterion_number": 24,
        "description": "The response should mention that management could include dietary adjustments such as soft or liquid diets, small frequent meals, nutritional support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides detailed dietary strategies (soft/bland foods, smoothies, nutrition shakes, sipping fluids) and suggests dietitian support."
      }
    ],
    "question_number": 76,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:50:53.836038",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises: 'Ask your oncologist and consider a consultation at an academic/NCI\u2011designated cancer center.'"
      },
      {
        "criterion_number": 2,
        "description": "The response reviews the design of clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains trial setup (randomization, blinding), add-on vs maintenance designs, supportive-care studies, control arms, and crossover."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the four phases of clinical trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Covers Phases 1\u20133 but does not mention Phase 4."
      },
      {
        "criterion_number": 4,
        "description": "The response defines placebo.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses when placebos are used but does not define placebo as an inactive/dummy treatment."
      },
      {
        "criterion_number": 5,
        "description": "The response states that patients in clinical trials for cancer are seldom given a placebo, as this may cause harm.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States 'people are rarely given a placebo alone if an effective standard treatment exists' and that placebo alone is generally not used when it would deny proven therapy."
      },
      {
        "criterion_number": 6,
        "description": "The response reviews informed consent.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions rights and oversight but does not describe the informed consent process or documents explicitly."
      },
      {
        "criterion_number": 7,
        "description": "The response defines the placebo effect.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not define or describe the placebo effect."
      },
      {
        "criterion_number": 8,
        "description": "The response states that patients in the control arm of clinical trials often receive the standard of care treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states add-on design with standard therapy + placebo in the control arm and that patients won't miss out on standard chemotherapy."
      },
      {
        "criterion_number": 9,
        "description": "The response states clinical trials are designed to discover new, effective treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains Phase 2 looks for signs a drug works and Phase 3 compares against standard therapy, indicating the goal to identify effective treatments."
      },
      {
        "criterion_number": 10,
        "description": "The response states clinical trials are designed to minimize patient harm.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes IRB/ethics and DSMB oversight, removal for progression or unacceptable side effects, and avoidance of placebo-only when it would deny effective therapy."
      },
      {
        "criterion_number": 11,
        "description": "The response states that patients participating in clinical trials are monitored closely for side effects from the disease and the treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States there are scheduled scans and labs and that patients are taken off for progression or unacceptable side effects."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends researching clinical trials before participating.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides extensive 'Key questions to ask,' suggests consulting oncologists/centers, and directs to resources, encouraging proactive research."
      },
      {
        "criterion_number": 13,
        "description": "The response offers resources for researching clinical trials, including ClinicalTrials.gov.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists ClinicalTrials.gov, NCI (1-800-4-CANCER), and PanCAN (877-2-PANCAN)."
      },
      {
        "criterion_number": 14,
        "description": "The response states clinical trials are designed to be ethical and are monitored closely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions IRB/ethics boards and Data Safety Monitoring Boards and their role in oversight and stopping trials early."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that trials are essential for optimizing current and future therapies."
      }
    ],
    "question_number": 77,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:51:32.432734",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly encourages dialogue with the oncologist by providing a section 'Questions to ask the oncologist' (e.g., regimen choice, goals, side effects, genetic testing, and trials)."
      },
      {
        "criterion_number": 2,
        "description": "The response states there are many different types of treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references multiple treatment types (chemotherapy, targeted therapy, immunotherapy, radiation, and surgery), indicating varied treatment options."
      },
      {
        "criterion_number": 3,
        "description": "The response includes surgery, chemotherapy, immunotherapy, targeted therapy, and radiation therapy as types of treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "All five modalities are mentioned: chemotherapy extensively, immunotherapy and targeted therapy under tumor testing, radiation (including chemoradiation), and surgery (neoadjuvant/adjuvant context)."
      },
      {
        "criterion_number": 4,
        "description": "The response states combination therapy may mean two or more different types of treatment or two or more chemotherapy medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The opening defines combination therapy as more than one treatment, often two or more chemotherapy drugs, and sometimes adding targeted therapy, immunotherapy, or radiation."
      },
      {
        "criterion_number": 5,
        "description": "The response gives the example of FOLFIRINOX.",
        "score_given": 5,
        "max_points": 5,
        "justification": "FOLFIRINOX is listed as a common chemotherapy combination regimen."
      },
      {
        "criterion_number": 6,
        "description": "The response states that FOLFIRINOX is a combination chemotherapy regimen which contains 5-FU, leucovorin, irinotecan, and oxaliplatin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It specifies the components: oxaliplatin + irinotecan + leucovorin + 5\u2011FU, identifying the exact drugs in FOLFIRINOX."
      },
      {
        "criterion_number": 7,
        "description": "The response states the treatment plan for patients with pancreatic cancer is individualized to their overall health and the cancer\u2019s type, stage, and genetic signature.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes regimen selection based on patient fitness, tumor features, and stage, and emphasizes germline and somatic tumor testing, reflecting individualization by health, stage, and genetics."
      },
      {
        "criterion_number": 8,
        "description": "The response states the decision to use any cancer treatment weighs the likelihood of benefit with the risk of side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses balancing benefit and side effects (dose adjustments to balance benefit/side effects, choosing less harsh regimens) and prompts asking about expected benefits and side effects."
      },
      {
        "criterion_number": 9,
        "description": "The response states the goal of combination therapy is to achieve the best anti-cancer effect.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains combinations can work better than single drugs, delay resistance, and help people live longer and control symptoms\u2014stating the intent to maximize anti-cancer effect."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that examples of combination therapy include chemoradiation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions chemoradiation and describes concurrent low-dose chemotherapy with radiation as a sensitizer."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that examples of combination therapy include chemotherapy and surgery, with neoadjuvant chemotherapy given before surgery and adjuvant chemotherapy given after surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly outlines neoadjuvant chemotherapy before surgery and adjuvant chemotherapy after surgery with specific regimen examples."
      }
    ],
    "question_number": 78,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:52:01.337788",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly directs the reader to engage the oncologist\u2019s office (expedited prior auth/appeal, peer-to-peer, letter of medical necessity) and mentions working with the care team."
      },
      {
        "criterion_number": 2,
        "description": "The response states oncology practices often have team members who help patients with insurance issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises involving the oncology social worker/financial counselor to apply for assistance, indicating these team members help with insurance/financial issues."
      },
      {
        "criterion_number": 3,
        "description": "The response states pre-authorization issues are not uncommon in oncology care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not explicitly state that pre-authorization issues are common/not uncommon in oncology."
      },
      {
        "criterion_number": 4,
        "description": "The response states that denials should be appealed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides a detailed appeal plan (internal appeal, external review) and urges filing appeals, including expedited appeals."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends contacting the insurance company.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a call script for the insurer, requests for peer-to-peer with the medical director, and asking for an oncology case manager."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends understanding the patient\u2019s insurance plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It instructs to verify plan type (Medicare Advantage, Medicaid, employer self-funded, etc.), in/out-of-network status, and outlines different escalation paths by plan."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends understanding the insurance company\u2019s denial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It tells the reader to obtain the denial/prior-auth letter, note the denial reason and cited policy, and request the clinical criteria used."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends contacting patient advocacy programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends contacting advocacy/navigation resources (e.g., PanCAN, Patient Advocate Foundation, American Cancer Society, Triage Cancer)."
      },
      {
        "criterion_number": 9,
        "description": "The response offers examples of patient advocacy programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists PanCAN, Patient Advocate Foundation, American Cancer Society, Triage Cancer, and financial aid organizations (PAN Foundation, HealthWell Foundation, CancerCare)."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends clearly documenting all communications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises keeping a log of every call, sending appeals via portal/fax and certified mail, and keeping confirmations."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends obtaining written documentation for all approved pre-authorizations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it advises keeping everything in writing and retaining confirmations, it does not explicitly recommend obtaining written approval documentation for all approved prior authorizations."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that prior authorization is a process in which payers require clinicians to obtain approval before a medication is covered.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It refers to prior authorization and timelines but does not provide the explicit definition that payers require clinician approval before coverage."
      },
      {
        "criterion_number": 13,
        "description": "The response must specify that the appeal process involves submitting a formal appeal with supporting evidence, such as clinical guidelines, published trial data, and, for targeted or off-label therapies, molecular profiling results.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions including clinical guidelines and relevant biomarkers but does not explicitly mention using published trial data or specify the context of targeted/off-label therapies."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention that if appeals are unsuccessful or delays persist, alternative access strategies should be pursued, including patient assistance programs, manufacturer co-pay cards, and foundation grants, which require application and documentation of financial need.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It discusses patient assistance programs, manufacturer assistance/bridge programs, and foundations, but does not mention manufacturer co-pay cards nor explicitly state documentation of financial need is required."
      },
      {
        "criterion_number": 15,
        "description": "The response must specifically mention patient advocacy organizations such as PanCAN and CancerCare as resources.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It specifically lists PanCAN Patient Services and CancerCare Co-Pay Assistance Foundation as resources."
      }
    ],
    "question_number": 79,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:53:18.564281",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises reporting to the oncology team urgently and to call his oncology team today."
      },
      {
        "criterion_number": 2,
        "description": "The response states that infections can cause cognitive changes.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists infection (UTI, pneumonia) as common contributors to cognitive changes."
      },
      {
        "criterion_number": 3,
        "description": "The response states that cancer and its treatments may cause symptoms that can mimic cognitive changes, including fatigue, pain, poor sleep, dehydration, and depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions fatigue, pain, poor sleep, and dehydration but does not mention depression."
      },
      {
        "criterion_number": 4,
        "description": "The response states sudden changes in cognition may be a medical emergency and to seek immediate evaluation by a healthcare provider.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that sudden or worsening confusion is urgent and advises emergency care for red flags."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends immediate medical evaluation if the patient has stroke symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists stroke-like symptoms (one-sided weakness, trouble speaking, vision changes) under reasons to go to emergency care now."
      },
      {
        "criterion_number": 6,
        "description": "The response states if the patient has a fever or other signs or symptoms of infection, to seek immediate evaluation by a healthcare provider.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes fever or shaking chills as red flags warranting emergency care."
      },
      {
        "criterion_number": 7,
        "description": "The response states patients commonly experience mental fogginess, or \u201cchemo brain.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions \u201cchemo brain\u201d with fog and slowed thinking."
      },
      {
        "criterion_number": 8,
        "description": "The response states that cognitive changes from cancer treatment may improve if the treatment is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that stopping treatment may improve cognitive changes."
      },
      {
        "criterion_number": 9,
        "description": "The response states that if treatment side effects are severe enough, the patient\u2019s oncologist may choose to decrease the dose of the treatment so it is better tolerated or switch to a different therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of dose reduction or switching therapies as management options."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends tracking the cognitive changes and sharing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises preparing and sharing details such as medication list, recent dose changes, and timing of symptom onset with the oncology team."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that cancer treatment (including radiation, chemotherapy, and pain medications such as opioids) can affect a person\u2019s cognitive functions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states multiple treatment-related causes including chemotherapy and opioids that can affect cognition; overall conveys that cancer treatments can impact cognitive function."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that other factors unrelated to treatment could also cause cognitive changes, such as cancer progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions disease-related causes like liver involvement with high ammonia and brain spread, as well as stroke risk due to cancer."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that stress/anxiety can cause cognitive changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention stress or anxiety as potential contributors."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that pre-existing conditions can cause cognitive changes unrelated to cancer or cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes high/low blood sugar (diabetes), kidney/liver dysfunction, anemia, and low oxygen as contributors\u2014examples of pre-existing or comorbid conditions."
      }
    ],
    "question_number": 80,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:54:16.873750",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises involving the oncology team under 'Who should be involved' and encourages asking questions to 'your team,' which includes oncology."
      },
      {
        "criterion_number": 2,
        "description": "The response states feeding tubes can help patients get the nutrition and hydration they need when they are unable to eat or drink on their own.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes feeding tubes can help and discusses improved calorie/protein intake, it does not explicitly mention hydration or inability to drink."
      },
      {
        "criterion_number": 3,
        "description": "The response states the most common types of feeding tubes are placed through the skin of the abdomen and into the stomach or small bowel.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions PEG/PEJ (into the stomach/jejunum) and NG/NJ tubes, but does not explicitly state placement 'through the skin of the abdomen' for the common long-term tubes."
      },
      {
        "criterion_number": 5,
        "description": "The response states that if the patient is not eating or drinking enough because they do not want to, this may be the body\u2019s way of signaling that the patient is nearing the end of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It discusses poor appetite and end-of-life considerations but does not state that lack of desire to eat/drink may be the body's natural signal of nearing end of life."
      },
      {
        "criterion_number": 6,
        "description": "The response states studies have shown that in the absence of a bowel obstruction, feeding tubes do not typically increase survival in patients with cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes tube feeding usually does not prolong life near end of life but does not reference studies or specify the 'absence of bowel obstruction' condition."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends considering hospice care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Palliative care is recommended, but hospice is not mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response states that malnutrition is common in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Malnutrition is discussed as a concern but the response does not state it is common in pancreatic cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response reviews the risks of feeding tubes, including discomfort and infection.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists infection risks and multiple discomfort-related issues (cramping, reflux, skin leakage), as well as other complications (aspiration, bleeding, perforation)."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends discussing the patient\u2019s goals of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes clarifying goals of care and suggests palliative care involvement to align treatment with goals."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to a blocked bile duct.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explicitly mentions addressing biliary obstruction (stent), which corresponds to blocked bile duct issues."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to a blocked stomach.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It discusses gastric outlet obstruction and duodenal obstruction and possible stenting/bypass."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to low levels of digestive enzymes.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It recommends pancreatic enzyme replacement therapy (PERT) for exocrine insufficiency."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to loss of appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It notes poor appetite without obstruction as a reason for eating difficulties."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to cancer-related pain.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It advises managing pain among other symptoms as part of optimizing nutrition, implying pain contributes to intake/digestive issues."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that nutritional counseling is recommended for patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends involving a registered dietitian and provides dietary strategies, which constitutes nutritional counseling."
      }
    ],
    "question_number": 81,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:55:20.623374",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly advises involving the oncology team: \"Ask your oncology team for a referral...\" and \"Your cancer center\u2019s social worker or child life specialist (ask your oncology team).\" This constitutes recommending discussion with the oncologist/oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends involving a professional who can help with these challenging conversations, like a social worker or spiritual counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends multiple professionals: social worker, child life specialist, pediatric therapist, family counselor, and school counselor. These are appropriate professionals for supporting such conversations."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends online resources for patients with cancer, including cancer.org.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists several reputable online resources, including the American Cancer Society (which is cancer.org), National Cancer Institute, CancerCare, Cancer Support Community, Pancreatic Cancer UK, Macmillan, and others."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends clear and honest language.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly emphasizes honesty and clarity: \"Use the correct word cancer,\" \"Be honest and hopeful,\" and provides clear sample language, including for difficult topics like prognosis."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends tailoring the conversation to the children\u2019s ages.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides detailed age-specific guidance for preschoolers, school-age children, and teens, including sample wording tailored to developmental level."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention to avoid overwhelming the child with too much information at once; provide information in small doses, stopping frequently to check for comprehension.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it advises \"Share a little, often\" and frames this as a series of talks, it does not explicitly recommend pausing or checking for comprehension during conversations."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention to arrange for an appropriate location for the conversation and ensure there is enough time to give the information and answer questions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises planning \"who will tell them and when: choose a quiet time,\" which implies a calm, appropriate setting and not being rushed. It also encourages open questions (\"You can ask any question, any time\"), indicating time to answer."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention to provide information that is relevant to what the child wants to know.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages guiding content by the child\u2019s interests and questions: \"You can ask any question, any time,\" offers age-relevant information, and includes preparing for common questions, which focuses on what children want to know."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to respond empathically to the child\u2019s emotions and acknowledge their feelings throughout the conversation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly promotes empathy and validation: \"it\u2019s okay to have all kinds of feelings,\" \"Name and normalize feelings,\" and modeling adults having feelings and still functioning."
      }
    ],
    "question_number": 82,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:55:43.126862",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that sleep patterns can be disturbed by cancer and its treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly says, 'changes in sleep are very common with pancreatic cancer and its treatments,' and further cites chemo/radiation effects."
      },
      {
        "criterion_number": 2,
        "description": "The response states that sleep patterns can be disturbed by symptoms like fatigue, pain, and nausea.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists 'Cancer-related fatigue,' and 'Pain, nausea' as reasons for disturbed sleep."
      },
      {
        "criterion_number": 3,
        "description": "The response states that sleep patterns can be a symptom of anxiety and depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions 'anxiety/depression disrupting sleep' as a cause."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises, 'Let his oncology or palliative care team know about the changes' and to adjust/assess causes."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends tracking the sleep disturbances and sharing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends keeping 'a brief sleep/medication/symptom log' to identify patterns."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends sleep hygiene techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple sleep hygiene measures: morning daylight, gentle activity, limiting naps, consistent routine, quiet/dark room, limiting screens/caffeine, and symptom control before bed."
      },
      {
        "criterion_number": 7,
        "description": "The response states other options for treatment may include supplements like melatonin, cognitive behavioral therapy, or prescribed medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions 'melatonin' explicitly as a possible sleep aid and to discuss options with clinicians."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends seeking immediate medical evaluation if the changes in sleep patterns are sudden or severe.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Gives clear urgent red flags including 'very hard to wake,' new confusion/hallucinations, fever/infection, severe breathing problems, etc., prompting urgent care."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that non-pharmacological interventions like relaxation techniques, cognitive behavioral therapy for insomnia, and mindfulness can be beneficial.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention relaxation techniques, CBT-I, or mindfulness; only sleep hygiene and melatonin are discussed."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that addressing underlying causes of sleep disruption, such as pain management or treatment of anxiety/depression, is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises clinicians check for reversible causes and adjust meds; specifically recommends managing 'pain/nausea/itch before bed,' indicating focus on underlying causes."
      }
    ],
    "question_number": 83,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:56:04.418141",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing complementary therapies with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises coordinating with the oncology team and seeking oncology approval, including sharing blood counts and treatment-specific cautions."
      },
      {
        "criterion_number": 2,
        "description": "The response states complementary therapies like acupuncture may improve symptoms related to cancer and its treatments and may improve cancer patients\u2019 quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States acupuncture can help with nausea, pain, CIPN, anxiety, and fatigue; also mentions mind-body and massage benefits, implying improved quality of life."
      },
      {
        "criterion_number": 3,
        "description": "The response states complementary therapies are not a safe alternative to standard cancer treatments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly notes acupuncture \"won\u2019t treat the cancer itself\" and cites use as an adjunct to standard care, indicating it should not replace standard treatments."
      },
      {
        "criterion_number": 4,
        "description": "The response states complementary therapies are not as effective as standard of care cancer treatments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States acupuncture does not treat the cancer and is an adjunct, which conveys it is not as effective as standard cancer treatments."
      },
      {
        "criterion_number": 5,
        "description": "The response defines complementary therapies and provides examples, including acupuncture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes integrative/complementary therapies as adjuncts for symptom relief and provides examples (acupuncture, mind-body practices, massage, acupressure, herbs/supplements, cannabis)."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends informing the patient\u2019s oncologist of any supplements the patient starts taking.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises not starting herbs/supplements without oncology approval, which encompasses informing the oncologist."
      },
      {
        "criterion_number": 7,
        "description": "The response states supplements are not regulated by the FDA.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention FDA regulation status of supplements."
      },
      {
        "criterion_number": 8,
        "description": "The response states some supplements may interact with certain treatments for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists specific interaction risks (e.g., St. John\u2019s wort with irinotecan, bleeding risk with turmeric/garlic/ginger, antioxidant effects on chemo/radiation, fish oil timing)."
      },
      {
        "criterion_number": 9,
        "description": "The response reviews the risks of acupuncture, including bleeding and infection, which may be increased in patients receiving chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses bleeding risk (low platelets, anticoagulants) and infection risk (neutropenia, fever, signs of infection), with chemo-related precautions."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends utilizing a practitioner licensed in acupuncture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically advises choosing a licensed acupuncturist or medical acupuncturist with oncology experience."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that acupuncture is generally safe for cancer patients, with no increased risk of serious adverse events compared to sham or standard care, though mild side effects such as bruising, soreness, or transient discomfort may occur.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States acupuncture is generally safe and mentions minor side effects; however, it does not explicitly state there is no increased risk of serious adverse events compared to sham or standard care."
      }
    ],
    "question_number": 84,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:56:26.040089",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing balance problems with the patient\u2019s oncologist or healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response instructs, \"Contact his oncology team today to report the balance changes,\" which is a clear, immediate recommendation to involve the care team."
      },
      {
        "criterion_number": 2,
        "description": "The response clearly states that symptoms from pancreatic cancer and its treatment, such as fatigue, headache, muscle weakness, and peripheral neuropathy, may contribute to sensations of imbalance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It cites treatment-related peripheral neuropathy, fatigue (from targeted agents), and muscle weakness (from steroids) as contributors to imbalance. Although headache is noted as a red flag, the criterion is satisfied by inclusion of fatigue, muscle weakness, and neuropathy."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that chemotherapy can cause peripheral neuropathy, fatigue, anemia, and generalized weakness, which can all cause instability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While chemotherapy-induced peripheral neuropathy is clearly stated, the response does not explicitly attribute fatigue, anemia, or generalized weakness to chemotherapy specifically. Anemia is listed as a cause in general, and weakness is attributed to steroids, not chemo."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that pancreatic cancer itself increases the risk of thromboembolic events, including cerebral ischemic strokes, which may present with acute balance disturbances or ataxia.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states, \"pancreatic cancer increases clot risk, and sudden imbalance can be a stroke,\" fulfilling the requirement."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly instructs seeking immediate medical evaluation if symptoms are abrupt, severe, or accompanied by other neurologic deficits.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The \"Red flags\u2014call emergency services now\" section lists abrupt neurologic deficits (e.g., one-sided weakness, facial droop, slurred speech), clearly directing immediate evaluation."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly states that balance problems can lead to falls.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although fall-prevention measures are recommended and steroids are said to cause weakness and falls, the response does not explicitly connect balance problems themselves to fall risk."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends ensuring the patient drinks plenty of fluids.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises, \"Practical steps now: hydrate regularly,\" which is an explicit recommendation to maintain fluid intake."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly recommends the patient stand and walk with assistance until they can be evaluated by their healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends fall-prevention strategies and to \"consider a cane/walker temporarily\" and to \"supervise showers,\" which constitutes advising assisted ambulation pending evaluation."
      }
    ],
    "question_number": 85,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:57:04.611744",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends reviewing the pathology report with the patient\u2019s oncologist or healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides a section 'What to ask the care team' with specific questions and advises requesting the CAP synoptic report and even a second-opinion review, clearly encouraging discussion with the care team."
      },
      {
        "criterion_number": 2,
        "description": "The response states that pathology reports are written by doctors called pathologists who view tissue under the microscope to diagnose diseases.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not explain that pathologists create the report or that they examine tissue under a microscope."
      },
      {
        "criterion_number": 3,
        "description": "The response states the pathology report will contain a tumor type.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists 'Histologic type' and specifies PDAC and variants; also distinguishes adenocarcinoma vs neuroendocrine tumors."
      },
      {
        "criterion_number": 4,
        "description": "The response states the pathology report may contain a stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It details 'Pathologic stage (AJCC 8th edition)' and pTNM/ypTNM notation."
      },
      {
        "criterion_number": 5,
        "description": "The response states the pathology report may contain a tumor size.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes 'Tumor size and location' and explains its role in T category."
      },
      {
        "criterion_number": 6,
        "description": "The response states the pathology report may contain a tumor grade.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It has a dedicated 'Grade' section (well/moderately/poorly differentiated)."
      },
      {
        "criterion_number": 7,
        "description": "The response states the pathology report may mention vascular invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses 'Lymphovascular invasion (LVI)' explicitly."
      },
      {
        "criterion_number": 8,
        "description": "The response states the pathology report may mention perineural invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses 'Perineural invasion (PNI)' explicitly."
      },
      {
        "criterion_number": 9,
        "description": "The response states the pathology report may contain special stains which can sometimes be used to determine additional treatment options.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it mentions MSI/MMR and molecular profiling, it does not mention 'special stains' or immunohistochemistry as such."
      },
      {
        "criterion_number": 10,
        "description": "The response states the final stage ranges from I to IV and is a sum of a tumor (T) score, a node (N) score, and a metastasis (M) score.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It explains T, N, M categories but does not state that overall stage groups I\u2013IV are derived from these."
      },
      {
        "criterion_number": 11,
        "description": "The response states the pathology report helps the oncologist determine which treatment may be the most effective.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states stage and margin status drive recommendations for adjuvant therapy and that MSI/genomic findings can open targeted therapies or trials, linking the report to treatment decisions."
      },
      {
        "criterion_number": 12,
        "description": "The response states the pathology report may include results from genetic testing of the tumor which may help in identifying targeted therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes 'Tumor molecular profiling' with actionable alterations (e.g., NTRK, BRAF, KRAS G12C) and notes MSI-high can be treated with immunotherapy."
      },
      {
        "criterion_number": 13,
        "description": "The response must mention margin status, including the presence of the tumor at or within 1 mm of any resection margin (R1), and its impact on prognosis and adjuvant therapy decisions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines R0/R1/R2, notes some centers report distance in mm and that closer than 1 mm is often noted, emphasizes the uncinate/SMA margin, and states margins influence prognosis and adjuvant therapy recommendations."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the importance of the number of lymph nodes examined and number positive, and explicitly link perineural and vascular invasion to higher recurrence risk.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It stresses the number examined and number positive (and lymph node ratio) and states LVI and PNI are common and increase recurrence risk."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention tumor location (head, body, tail) as required for accurate pathologic staging (pT), and reference the AJCC staging system using pT, pN, pM nomenclature.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It specifies location (head/uncinate, neck, body, tail) and references AJCC 8th edition with pTNM/ypTNM nomenclature and details T/N/M criteria."
      }
    ],
    "question_number": 86,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:57:33.545351",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the case with an oncologist to review the trial details and discuss the pros and cons.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it suggests being co-managed at a high-volume center and posing questions to the trial team, it does not explicitly recommend discussing the case with an oncologist to review pros and cons."
      },
      {
        "criterion_number": 2,
        "description": "The response explains that there are no FDA-approved cancer vaccines for pancreatic cancer and that all vaccines for pancreatic cancer are experimental.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It states vaccines are experimental but does not explicitly state that there are no FDA-approved cancer vaccines for pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how a cancer vaccine works.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly explains that these are therapeutic vaccines intended to train the immune system to recognize tumor antigens."
      },
      {
        "criterion_number": 4,
        "description": "The response states clinical trials are how treatments are tested for diseases like pancreatic cancer.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Although it discusses trial phases and endpoints, it does not explicitly state that clinical trials are how treatments are tested."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the four phases of clinical trials.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It references trial phases but does not explain Phase I\u2013IV."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends researching clinical trials prior to enrolling.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It provides extensive guidance on evaluating fit, key questions, and verifying legitimacy before enrolling."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends ClinicalTrials.gov as a resource.",
        "score_given": 3,
        "max_points": 3,
        "justification": "ClinicalTrials.gov is explicitly recommended with search tips."
      },
      {
        "criterion_number": 8,
        "description": "The response states patients should consider all of their treatment options prior to enrolling in a clinical trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises ensuring the trial does not delay or replace effective standard treatments and discusses standard therapy timing, implying consideration of all options."
      },
      {
        "criterion_number": 9,
        "description": "The response states clinical trials are designed to minimize patient harm and closely follow ethical standards.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Safety plans are mentioned, but there is no explicit statement about minimizing harm and adherence to ethical standards."
      },
      {
        "criterion_number": 10,
        "description": "The response reviews potential benefits and risks of clinical trial participation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists potential benefits and a thorough set of risks, including side effects and practical burdens."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends discussing with the clinical trial research team about costs to the patient for participating in the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly suggests asking what the sponsor covers versus insurance and about travel/lodging stipends."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly mention that vaccine clinical trials in pancreatic cancer are designed to address the poor response of this malignancy to standard immunotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes pancreatic cancer is immunologically 'cold' and hard to treat with immunotherapy, but does not explicitly state that vaccine trials are designed to address this poor response."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly mention that vaccine trials aim to stimulate tumor-specific T cell (immune cell) responses to enhance the immune system\u2019s effectiveness in killing cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states vaccines train the immune system to recognize tumor antigens and that personalized vaccines can trigger strong T-cell responses, aligning with the criterion."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention at least two of the following vaccine platforms: peptide-based vaccines targeting defined tumor antigens, dendritic cell vaccines loaded with tumor lysates, or personalized mRNA/neoantigen vaccines that encode patient-specific tumor mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions KRAS-targeted peptide vaccines, dendritic cell vaccines, and personalized neoantigen/mRNA vaccines."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention that safety data from recent trials indicate that most vaccine regimens are well-tolerated, with adverse events generally limited to mild-to-moderate injection site reactions, flu-like symptoms, or transient fever.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Side effects are listed, but it does not attribute them to safety data from recent trials nor state that most regimens are well-tolerated."
      },
      {
        "criterion_number": 16,
        "description": "The response must mention that most data on vaccine trials in pancreatic cancer are derived from early-phase studies with small sample sizes and limited long-term follow-up.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It states results come from small, early-phase trials but does not mention limited long-term follow-up."
      },
      {
        "criterion_number": 17,
        "description": "The response must explicitly define clinical trials as research studies that explore whether a new medical strategy, treatment, or device is safe and effective for humans.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit definition of clinical trials is provided."
      },
      {
        "criterion_number": 18,
        "description": "The response must explicitly state that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not explicitly state that clinical trials are essential for optimizing current and future cancer therapies."
      },
      {
        "criterion_number": 20,
        "description": "The response must mention that the patient will be informed, verbally and in writing, if a placebo is part of a clinical trial before they enroll.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It asks about randomization and the possibility of a placebo but does not state that patients will be informed verbally and in writing prior to enrollment."
      }
    ],
    "question_number": 87,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:58:42.448073",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing care coordination concerns directly with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises naming a single 'quarterback' for care and states this is usually the medical oncologist, with instructions to confirm all updates route through that person and to include the oncologist in a care conference, which constitutes explicit direction to address coordination with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response clearly states that the medical oncologist typically serves as the coordinating physician among the different specialists on the healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states, 'For most patients this is the medical oncologist' when naming the overall care quarterback, meeting the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends discussing care coordination with a patient navigator or social worker.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It says 'Request an oncology nurse navigator or care coordinator' and 'Meet the oncology social worker,' explicitly recommending their involvement in coordination."
      },
      {
        "criterion_number": 4,
        "description": "The response states that most oncology clinics have nurses who specialize in helping patients coordinate care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it recommends requesting an oncology nurse navigator and notes 'If your center doesn\u2019t assign one,' it does not explicitly state that most clinics have specialized nurses for coordination."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends trying to schedule multiple appointments on one day to limit life interruptions.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states, 'Cluster appointments on the same day when possible,' which directly satisfies this criterion."
      },
      {
        "criterion_number": 6,
        "description": "The response states that the different specialists will communicate with one another and document their assessments in the electronic medical record.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response encourages signing HIPAA releases and provider-to-provider handoffs and asks imaging centers to push scans, but it does not explicitly state that specialists will document their assessments in the EMR."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends asking about a multidisciplinary meeting with the involved specialists, sometimes called a \u201cTumor Board.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states, 'Request tumor board review if not already done,' fulfilling the requirement."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention a structured multidisciplinary approach for coordinating care among multiple specialists for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a section titled 'Leverage a multidisciplinary approach' and outlines coordinated involvement of multiple disciplines and formal structures (tumor board, care conferences), explicitly addressing structured multidisciplinary coordination."
      },
      {
        "criterion_number": 9,
        "description": "The response must list all required specialists: surgical oncology, medical oncology, radiation oncology, gastroenterology, genetics, nutrition, and palliative care, and mention their distinct roles in diagnosis, staging, treatment, and supportive care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions medical oncology, surgery, radiation oncology, genetics counselor, dietitian (nutrition), and palliative care, it does not explicitly list gastroenterology as a specialist nor describe distinct roles for each required specialist in diagnosis, staging, treatment, and supportive care."
      },
      {
        "criterion_number": 11,
        "description": "The response must emphasize the necessity of clear patient-centered communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It strongly emphasizes patient-centered communication through structured visit agendas, clarifying goals and next steps, defining points of contact and response times, and documenting values and priorities under 'Keep goals of care visible.'"
      }
    ],
    "question_number": 88,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:59:07.486160",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises calling the oncology team urgently and building an emergency plan with the care team; asks for a 24/7 oncology contact and written plans."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews common medical emergencies experienced by patients with pancreatic cancer, including biliary obstruction and bowel obstruction.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists multiple emergencies including infection/sepsis, biliary obstruction/cholangitis, and bowel/gastric outlet obstruction, with associated symptoms."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends having an Advance Directive or Living Will in place to guide the patient\u2019s care if they are unable to speak for themselves.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically recommends discussing and keeping copies of advance directives/POLST and code status."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends seeking help from a professional in talking about these challenging questions, like a social worker, spiritual worker, or palliative care professional.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends early palliative care and/or hospice for 24/7 support and crisis management."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends ensuring supportive care medications are refilled for symptoms like pain and nausea.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises keeping prescribed rescue meds (short-acting pain meds, anti-nausea meds, bowel regimen, naloxone) on hand and provides dosing plan guidance."
      },
      {
        "criterion_number": 7,
        "description": "The response must state that pancreatic cancer patients are at high risk for acute emergencies due to tumor progression, treatment effects, or comorbidities.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that pancreatic cancer can come with sudden complications and details emergencies arising from tumor (biliary obstruction), treatments/devices (chemo, ports, opioids), and comorbidities (diabetes), establishing high risk from these causes."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention that biliary obstruction presents with jaundice, dark urine, and pruritus.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists biliary obstruction/cholangitis symptoms including jaundice, dark urine, pale stools, itching, and RUQ pain."
      },
      {
        "criterion_number": 9,
        "description": "The response must describe gastric outlet obstruction as persistent vomiting, inability to tolerate oral intake, and abdominal distension.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes gastric outlet/bowel obstruction as persistent vomiting, belly swelling (distension), and separately flags inability to keep fluids down >12 hours."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention VTE and include symptoms like sudden leg swelling, pain, shortness of breath, or chest pain, and state that pulmonary embolism is a leading cause of death after cancer itself.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions DVT/PE with leg swelling/pain, dyspnea, chest pain, and hemoptysis, but does not state that PE is a leading cause of death after cancer itself."
      },
      {
        "criterion_number": 11,
        "description": "The response must mention febrile neutropenia as a life-threatening complication of chemotherapy, characterized by fever and signs of infection in the context of neutropenia.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Flags fever \u2265100.4\u00b0F (especially during/after chemo) as an emergency, emphasizes early antibiotics, and instructs to alert triage about neutropenia risk, conveying life-threatening febrile neutropenia even if the exact term is not used."
      },
      {
        "criterion_number": 12,
        "description": "The response must mention metabolic derangements such as hypercalcemia (confusion, weakness, constipation) or hyponatremia (confusion, seizures).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention hypercalcemia or hyponatremia or their characteristic symptoms."
      },
      {
        "criterion_number": 13,
        "description": "The response must describe bowel obstruction as presenting with abdominal pain, vomiting, and constipation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes bowel obstruction signs including pain, vomiting, and no gas/stools (constipation), and advises urgent evaluation."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention spinal cord compression and its symptoms, such as new-onset weakness, sensory changes, or loss of bowel/bladder control.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists spinal cord compression with leg weakness, numbness, and loss of bowel/bladder control."
      }
    ],
    "question_number": 89,
    "source": "gpt-5",
    "graded_at": "2025-11-01T17:59:58.540411",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the hearing changes with his oncologist or healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to let the oncology team know promptly and to call his oncology team to review medications."
      },
      {
        "criterion_number": 2,
        "description": "The response states some chemotherapy treatments, like oxaliplatin, which is frequently used in treating pancreatic cancer as part of combination chemotherapy, can cause hearing changes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions oxaliplatin (used in FOLFIRINOX) and notes it can cause tinnitus and high-frequency hearing loss."
      },
      {
        "criterion_number": 3,
        "description": "The response states that platinum-based chemotherapy, such as cisplatin, is well-known to cause hearing loss (ototoxicity).",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that cisplatin carries the strongest risk and that platinum agents can cause ototoxicity."
      },
      {
        "criterion_number": 4,
        "description": "The response states the hearing changes may be related to other conditions like fatigue, infection, dehydration, malnutrition, or metabolic abnormalities from the cancer or its treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists infections, dehydration, kidney problems, severe anemia, ear-wax blockage, and congestion as possible causes, addressing non-chemotherapy contributors."
      },
      {
        "criterion_number": 5,
        "description": "The response states it is important for the patient\u2019s oncologist to know about new symptoms because they may need to adjust the dose of the chemotherapy or consider a different treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that the team may adjust doses, change drugs, or pause therapy if hearing issues are linked to treatment."
      },
      {
        "criterion_number": 6,
        "description": "The response states that treatment-related side effects may become worse or permanent if changes are not made to the treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that ototoxicity may worsen or become permanent without treatment changes; only mentions some medication effects may be reversible if stopped."
      },
      {
        "criterion_number": 7,
        "description": "The response states hearing changes may be related to cancer spreading to the brain if there are other neurologic symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions brain/temporal bone metastasis and highlights neurologic red flags."
      },
      {
        "criterion_number": 8,
        "description": "The response states the hearing changes may be related to normal age-related hearing loss.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of age-related (presbycusis) hearing loss."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the risk of hearing loss increases with cumulative doses and patient age.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions increased risk with cumulative dose and other factors (kidney problems, dehydration) but does not mention patient age."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that other therapies, including aminoglycoside antibiotics, loop diuretics, and radiation to the head/neck, can also contribute to hearing loss.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions aminoglycosides and loop diuretics but does not mention radiation to the head/neck."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that referral for audiologic evaluation is advised.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises requesting an audiology evaluation (baseline and follow-up) and considering ENT referral."
      }
    ],
    "question_number": 90,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:00:32.749002",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states proton therapy is a type of radiation therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states it is a type of external radiation that uses protons instead of X-rays."
      },
      {
        "criterion_number": 2,
        "description": "The response states proton therapy uses protons rather than photons to deliver highly conformal radiation doses to tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly contrasts protons with photons and describes dose deposition (Bragg peak) enabling conformality."
      },
      {
        "criterion_number": 3,
        "description": "The response states proton therapy may be more precise in its target field compared to traditional radiation therapy techniques, which may reduce treatment-related side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains Bragg peak leading to reduced dose to nearby organs and lists potential reductions in side effects (nausea, ulcers, bleeding)."
      },
      {
        "criterion_number": 4,
        "description": "The response states proton therapy is a safe and feasible option for select patients with locally advanced or recurrent pancreatic cancer, especially when minimizing toxicity to surrounding organs is critical.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes it can be an option after induction chemotherapy for locally advanced/unresectable disease and in re-irradiation, particularly when bowel/stomach dose constraints are limiting; cites guidelines endorsing select use."
      },
      {
        "criterion_number": 5,
        "description": "The response states the decision to use proton therapy is influenced by the cancer\u2019s stage, location, size, proximity to other organs, among others.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses use by stage (borderline resectable, unresectable), re-irradiation status, and proximity to duodenum/stomach; indicates case selection and constraints drive decisions."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a Radiation Oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a list of 'Good questions to ask the radiation oncologist,' clearly directing discussion with a Radiation Oncologist."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly recommend discussing with the (medical) oncologist; references 'her team' but specifically lists questions for the radiation oncologist only."
      },
      {
        "criterion_number": 8,
        "description": "The response states proton therapy has proven benefit in some cancers, like head and neck cancer, though has unclear benefit over traditional radiation therapy and is considered experimental in most types of cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes lack of definitive survival advantage over photons and mentions trials, but does not cite proven benefit in other cancers (e.g., head and neck) nor label it experimental in most cancers."
      },
      {
        "criterion_number": 9,
        "description": "The response states not all cancer centers have the capability to provide proton therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States there is a limited number of proton centers and discusses insurance pre-authorization."
      },
      {
        "criterion_number": 10,
        "description": "The response states proton therapy still carries the risk of side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a detailed section on common and serious side effects and notes these risks exist with any abdominal radiation."
      },
      {
        "criterion_number": 11,
        "description": "The response states proton therapy is often used in combination with chemotherapy (such as gemcitabine) as part of concurrent chemoradiation protocols.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States radiation is often given concurrently with low-dose 5-FU or capecitabine; also references systemic regimens like FOLFIRINOX or gemcitabine/nab-paclitaxel given before radiation."
      },
      {
        "criterion_number": 12,
        "description": "The response states proton therapy can be used for locally advanced, unresectable, or recurrent disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions use in locally advanced/unresectable disease and re-irradiation for local recurrence."
      }
    ],
    "question_number": 91,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:00:56.333996",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team or oncologist, as they likely have financial experts who are knowledgeable in this area.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises working with the oncology team, social worker, and financial navigator; suggests the team/specialty pharmacy can enroll in programs."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends learning about the patient\u2019s insurance plan, including out-of-pocket costs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Asks for insurance type, suggests reviewing insurance benefits (medical vs pharmacy), mentions copays and SHIP counseling."
      },
      {
        "criterion_number": 3,
        "description": "The response states pharmaceutical companies have programs to help patients cover the cost of medications and provides examples.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists manufacturer assistance programs and specific examples (Abraxane, Lynparza, Keytruda, Tarceva, Creon) and notes free drug/copay help."
      },
      {
        "criterion_number": 4,
        "description": "The response states large hospital systems and cancer centers may have assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions hospital/clinic resources, 340B pricing, charity care/discounts, and in-network infusion site options."
      },
      {
        "criterion_number": 5,
        "description": "The response states patient assistance programs may cover all or most of the cost of medications for cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes manufacturer programs can provide free drug (covers all) or copay help, implying most costs may be covered."
      },
      {
        "criterion_number": 6,
        "description": "The response states government programs may offer assistance with the cost of medications and provides examples.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Cites Medicare Part D Extra Help, Medicare Savings Programs, State Pharmaceutical Assistance Programs, and Medicaid."
      },
      {
        "criterion_number": 7,
        "description": "The response offers examples of non-profit organizations with patient assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple non-profit examples: PAN Foundation, HealthWell, CancerCare, PAF Co-Pay Relief, The Assistance Fund, Good Days."
      },
      {
        "criterion_number": 8,
        "description": "The response offers examples of pancreatic cancer-specific patient assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically lists the Pancreatic Cancer Action Network (PanCAN) with phone number and services."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends applying for assistance early as the process may take time and delay treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides process tips and to apply to multiple funds but does not explicitly recommend applying early to avoid treatment delays."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention federal, state, manufacturer, and independent charity options for medication cost assistance for pancreatic cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions federal (Medicare Extra Help), state (SPAP, Medicaid/SHIP), manufacturer programs, and independent charities (PAN, HealthWell, etc.)."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that Medicaid offers comprehensive prescription drug coverage with minimal co-payments and is the most effective public program for low-income patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions Medicaid application and secondary coverage but does not explicitly state comprehensive coverage, minimal co-pays, or that it is the most effective program."
      },
      {
        "criterion_number": 12,
        "description": "The response must mention that manufacturer-sponsored assistance programs provide free or discounted medications to eligible uninsured or underinsured patients, requiring proof of financial hardship and doctor certification.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States free/copay help and that the oncology team can enroll, but does not explicitly mention required proof of financial hardship and physician certification."
      },
      {
        "criterion_number": 13,
        "description": "The response must specify that independent nonprofits like HealthWell and PAN Foundation offer co-pay and premium assistance to insured patients with incomes below 400-500% of the federal poverty level.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists HealthWell and PAN but does not state premium assistance or the 400\u2013500% FPL income criteria for insured patients."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the complexity of accessing assistance programs and disparities among non-English speakers and some ethnic groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes fluctuating fund availability and process tips but does not discuss disparities for non-English speakers or specific ethnic groups."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention financial navigators and online tools such as NeedyMeds or RxAssist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions financial navigators and includes NeedyMeds as an online tool."
      }
    ],
    "question_number": 92,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:01:24.794120",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly prompts discussion with the oncologist by providing a section titled 'Good questions to ask the oncologist' and listing specific questions."
      },
      {
        "criterion_number": 2,
        "description": "The response states maintenance therapy is typically used in pancreatic cancer after the initial induction therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states maintenance is used after the first phase of chemotherapy when the cancer has responded or is stable, and specifies timing after ~4\u20136 months of first-line chemotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response states maintenance therapy typically involves fewer anti-cancer drugs with the goal of limiting side effects.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes de-escalation (e.g., dropping oxaliplatin or nab-paclitaxel) and explicitly notes goals of reducing side effects and preserving quality of life."
      },
      {
        "criterion_number": 4,
        "description": "The response states the oncologist will continue to monitor the cancer closely while the patient is on maintenance therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It outlines monitoring with regular clinic visits, labs, imaging every 2\u20133 months, and CA 19-9 when appropriate."
      },
      {
        "criterion_number": 5,
        "description": "The response states that if the cancer grows while on maintenance therapy, combination therapy may be reintroduced to get the cancer back under control.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions a 'stop-and-go' approach where drugs are re-added if the cancer grows again."
      },
      {
        "criterion_number": 6,
        "description": "The response states chemotherapy side effects are typically cumulative, so using maintenance therapy may help the patient tolerate treatment for a longer period of time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes initiating maintenance when 'side effects are accumulating' and gives examples (avoiding neuropathy), implying cumulative toxicity and the rationale for improved tolerability over time."
      },
      {
        "criterion_number": 7,
        "description": "The response states maintenance therapy may involve chemotherapy, targeted therapy, or immunotherapy depending upon the characteristics of the patient\u2019s tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It details de-escalated chemotherapy, PARP inhibitor maintenance for BRCA1/2 or PALB2, and immunotherapy for MSI-H/dMMR cases, tying choices to tumor genetics."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the decision to initiate maintenance therapy should be individualized, considering disease response, cumulative toxicities, patient preference, and goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it considers disease response and toxicities and suggests questions for shared decision-making, it does not explicitly state that the decision should be individualized to patient preference and goals of care."
      }
    ],
    "question_number": 93,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:02:18.533121",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly says to tell the oncology team about the anxiety and to ask for referrals and a palliative care consult."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a licensed mental health care provider.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends referrals to a psycho-oncologist or oncology social worker and suggests finding a psycho-oncologist/therapist."
      },
      {
        "criterion_number": 3,
        "description": "The response instructs the patient to seek immediate medical evaluation if they are experiencing thoughts of harming themselves or others.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides immediate crisis resources (988 Suicide & Crisis Lifeline) and advises using them if anyone feels unsafe or overwhelmed, which covers urgent risk scenarios."
      },
      {
        "criterion_number": 4,
        "description": "The response states anxiety is a common occurrence in patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states, \u201cTreatment anxiety is common and manageable.\u201d"
      },
      {
        "criterion_number": 5,
        "description": "The response states treatments like cognitive behavioral therapy may help to control anxiety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists CBT as an evidence-based therapy, along with ACT and MBSR."
      },
      {
        "criterion_number": 6,
        "description": "The response states medications may help to control anxiety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises asking whether medication or adjusting current meds might reduce anxiety."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly mention psychotherapy, psychoeducation, supportive therapy, and integrative modalities as available resources for treatment-related anxiety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions integrative therapies (mindfulness, yoga, acupuncture) and therapists, it does not explicitly use the terms \u201cpsychotherapy,\u201d \u201cpsychoeducation,\u201d or \u201csupportive therapy.\u201d"
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention mindfulness-based interventions or mindfulness-based stress reduction.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions mindfulness-based stress reduction (MBSR) and provides mindfulness resources."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends mindfulness and relaxation techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends 4-7-8 breathing, grounding, mindfulness, and relaxation apps/resources."
      },
      {
        "criterion_number": 11,
        "description": "The response offers pancreatic cancer-specific resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists PanCAN, NPF, Let\u2019s Win!, Lustgarten Foundation, and Smart Patients (pancreatic cancer community)."
      },
      {
        "criterion_number": 12,
        "description": "The response offers mental health-specific resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes CancerCare (counseling), Cancer Support Community, ADAA directory, and Psychology Today therapist finder."
      },
      {
        "criterion_number": 13,
        "description": "The response recommends participation in cancer support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises asking the center about support groups and references Cancer Support Community and CancerCare groups, including caregiver-specific groups."
      }
    ],
    "question_number": 94,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:03:00.214511",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises evaluation at a high-volume pancreatic cancer center with a multidisciplinary team including medical and radiation oncology and provides specific questions to ask his team, clearly directing discussion with the oncology team."
      },
      {
        "criterion_number": 3,
        "description": "The response states cryotherapy is a procedure that uses metal instruments cooled to subzero temperatures in order to kill tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that a thin probe is used and very cold gas creates an ice ball that kills cancer cells, conveying the subzero-cooled instrument mechanism even though it does not explicitly say 'metal.'"
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that cryotherapy (also called cryoablation) is a minimally invasive locoregional treatment that destroys tumor tissue by freezing it, typically using probes inserted through the skin (percutaneously) or intraoperatively under imaging guidance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly calls it cryotherapy/cryoablation, describes tissue destruction by freezing, and details probe placement routes (surgical, percutaneous, experimental EUS) under imaging guidance, which reflects a minimally invasive locoregional approach."
      },
      {
        "criterion_number": 5,
        "description": "The response states the decision to use cryotherapy involves the cancer\u2019s size, location, proximity to other organs, among other things.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes risk depends on tumor location and size and emphasizes protecting nearby structures, indicating these factors influence candidacy."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing the benefits and risks of this procedure with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Under 'Questions to ask his team,' it specifically includes discussing the realistic benefits, risks, and recovery time."
      },
      {
        "criterion_number": 7,
        "description": "The response states cryotherapy may be used in conjunction with other treatment modalities like chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states it can be combined with chemotherapy."
      },
      {
        "criterion_number": 8,
        "description": "The response states cryotherapy is not typically used to cure cancer but may be used to debulk tumors that are not operable.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It emphasizes non-curative, palliative use in pancreatic adenocarcinoma, describes local tumor control/shrinkage for people who cannot have surgery, aligning with debulking intent."
      },
      {
        "criterion_number": 9,
        "description": "The response states not all patients benefit from cryotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It restricts consideration to select patients (cannot have surgery, disease confined to the pancreas) and notes limited evidence with no proven survival benefit, implying that not all patients benefit."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that in pancreatic cancer, cryotherapy is not a standard first-line therapy but is considered for patients with unresectable, locally advanced, or metastatic disease who are not candidates for surgical resection or have failed systemic therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states it is not a standard option, considered mainly in trials/palliative settings for those who cannot have surgery with borderline/locally advanced disease, and that it is rarely used in metastatic disease."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that its primary role is palliative, aiming to reduce tumor burden, alleviate pain, and potentially improve quality of life and local disease control.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly frames use as palliative in pancreatic adenocarcinoma and lists goals including shrinking/controlling the tumor locally and relieving pain/obstruction, consistent with QoL improvement and local disease control."
      }
    ],
    "question_number": 95,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:03:51.393379",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to discuss items with the oncology team and doctors (e.g., 'Practical takeaways to discuss with the oncology team,' 'ask about ctDNA monitoring,' 'Ensure germline genetic testing ...')."
      },
      {
        "criterion_number": 2,
        "description": "The response states CA 19-9 is the tumor marker most commonly used to track disease status in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states 'CA 19-9 is the most commonly used tumor marker in pancreatic ductal adenocarcinoma (PDAC)'."
      },
      {
        "criterion_number": 3,
        "description": "The response states other tumor markers, like CEA and CA 125, are less reliable than CA 19-9 for disease monitoring in pancreatic cancer and are used more frequently in other gastrointestinal or genitourinary cancers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions CEA has lower sensitivity than CA19-9, but does not state they are used more frequently in other GI or GU cancers; thus requirement not fully met."
      },
      {
        "criterion_number": 4,
        "description": "The response states tumor markers may be used to monitor the course of disease in patients with pancreatic cancer, along with imaging studies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States markers are best used alongside imaging and clinical assessment and emphasizes using trends with imaging and symptoms."
      },
      {
        "criterion_number": 5,
        "description": "The response states tumor markers are not reliable markers of disease in all patients with pancreatic cancer, as not all tumors secrete the markers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes limitations (e.g., Lewis antigen\u2013negative patients, biliary obstruction) and that none are perfect; conveys unreliability across all patients."
      },
      {
        "criterion_number": 6,
        "description": "The response states circulating tumor DNA (ctDNA) is an emerging technology aimed at detecting early cancer progression and recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes ctDNA as detecting tumor mutations and sometimes detecting progression earlier than scans; identifies it as not yet routine."
      },
      {
        "criterion_number": 7,
        "description": "The response states circulating tumor DNA (ctDNA) is not FDA approved for disease monitoring in pancreatic cancer and remains experimental.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention FDA approval status or that ctDNA remains experimental; only notes it is not yet routine."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that CEA is elevated in 30-60% of pancreatic cancer cases and is particularly useful in Lewis-negative patients who do not secrete CA19-9.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions usefulness of CEA in Lewis-negative patients but does not provide the 30\u201360% elevation statistic required by the criterion."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that both CEA and CA125 have demonstrated value for diagnosis, prognosis, and monitoring, especially when CA19-9 is not informative. CA125, when combined with CA19-9, improves diagnostic accuracy and is associated with tumor burden and metastatic disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes prognostic/monitoring roles and correlation with metastatic burden, and that panels exist, but does not explicitly state diagnostic value nor that CA125 + CA19-9 improves diagnostic accuracy."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that emerging markers such as LAMC2, POSTN are not yet standard in routine clinical practice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention LAMC2 or POSTN; only discusses other emerging assays (cfDNA methylation, exosomes) as research-stage."
      }
    ],
    "question_number": 96,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:04:31.067090",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that hand-foot syndrome is a common side effect of some chemotherapy drugs used to treat pancreatic cancer, including capecitabine and 5-FU.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes HFS is common with pancreatic cancer regimens, specifically naming capecitabine and continuous-infusion 5-FU."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s oncologist and healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises telling the oncology team promptly and describes clinical actions they may take."
      },
      {
        "criterion_number": 3,
        "description": "The response states that the patient\u2019s oncologist may recommend reducing the chemotherapy dose.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States chemotherapy may be held and restarted at a reduced dose after improvement."
      },
      {
        "criterion_number": 4,
        "description": "The response instructs the patient to seek immediate medical evaluation if the patient experiences fever, chills, blisters, or pus draining from the affected area.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises urgent care for fever and pus, and separately flags blisters as an urgent concern; although chills are not mentioned, the response clearly instructs immediate evaluation for key warning signs."
      },
      {
        "criterion_number": 5,
        "description": "The response states the patient\u2019s oncology team will grade the severity of the hand-foot syndrome, which will determine the recommended treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides grade 1\u20133 severity definitions and corresponding management steps."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends hand hygiene with a gentle soap.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions lukewarm water and moisturizing after washing but does not recommend using a gentle soap."
      },
      {
        "criterion_number": 7,
        "description": "The response states pain may be controlled with over-the-counter medications like Tylenol or ibuprofen, though the patient should check with their healthcare team first.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends acetaminophen and advises checking with oncology before using NSAIDs like ibuprofen."
      },
      {
        "criterion_number": 8,
        "description": "The response states oral or topical prescription pain medications may be needed if pain is severe.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes stronger pain medicines may be needed and suggests topical lidocaine for focal pain."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends utilizing topical moisturizers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends frequent use of thick creams/ointments (e.g., urea, petroleum jelly, lanolin)."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends skin protection with loose clothing and soft shoe soles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Advises cushioned socks, soft insoles, and roomy shoes but does not mention loose clothing."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends cooling the skin with cold compresses.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically recommends cool soaks or cold packs for 10\u201315 minutes several times daily."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends avoiding hot showers and activities that cause rubbing on the skin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises avoiding hot water and limiting friction-inducing activities such as long walks, running, and heavy gripping."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that prevention strategies include celecoxib and urea cream.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions urea cream for prevention but does not mention celecoxib."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that cooling procedures, such as frozen gloves or socks applied during taxane infusions, may prevent or reduce HFS severity and are recommended by the Oncology Nursing Society for taxane-based regimens.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Refers generally to regional cooling during infusion but does not specify frozen gloves/socks during taxane infusions or ONS recommendations."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that prevention strategies such as Pyridoxine (vitamin B6) and lactic acid have not shown consistent benefit for prevention or treatment of HFS in randomized trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States pyridoxine has mixed evidence and is not routinely recommended but does not mention lactic acid."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that omeprazole (a proton pump inhibitor) and tipiracil (a thymidine phosphorylase inhibitor) may have prophylactic effects, but these are not yet standard practice.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of omeprazole or tipiracil as potential prophylaxis."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that management of established HFS includes topical urea and corticosteroids.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends topical corticosteroids and urea for affected areas."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that Photobiomodulation (low-level laser therapy) has shown promise as an adjunct for pain and symptom control.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention photobiomodulation or low-level laser therapy."
      }
    ],
    "question_number": 97,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:05:29.026239",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The decision between a cancer center and community oncology is often based on the type and stage of cancer, the patient\u2019s insurance, location, and preference.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response clearly addresses type/stage (e.g., surgical candidacy, borderline resectable, unusual tumor types), and location/convenience (travel, parking, housing). It implies personal preference via shared care. However, it does not explicitly discuss the role of insurance or coverage in deciding between settings, which is a required element."
      },
      {
        "criterion_number": 2,
        "description": "Cancer centers may have access to more advanced therapies and clinical trials than community oncology programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states cancer centers have more clinical trials, genomic tumor boards, advanced procedures, and specialized options; notes community sites have fewer trials but may partner for access."
      },
      {
        "criterion_number": 3,
        "description": "Pancreatic cancer requires multidisciplinary care involving medical oncology, radiation oncology, and surgical oncology, which may be more readily available at a large cancer center.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly emphasizes pancreas-focused multidisciplinary teams, regular tumor boards, and lists specialties (GI medical oncology, HPB surgery, radiation oncology, interventional endoscopy/radiology, pathology, genetics, nutrition, palliative care)."
      },
      {
        "criterion_number": 4,
        "description": "Cancer centers may be more equipped to handle complex care for advanced disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes cancer centers handle complex scenarios (biliary/duodenal obstruction, advanced endoscopy, difficult pain control), specialized radiation (SBRT), and coordinated neoadjuvant strategies\u2014indicating greater capacity for complex care."
      },
      {
        "criterion_number": 5,
        "description": "Community oncology programs may be more convenient and closer to home.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States community practices are closer to home, with easier scheduling and convenience for frequent labs/infusions; highlights reduced travel burden."
      },
      {
        "criterion_number": 6,
        "description": "There may be differences in cost between cancer centers and community oncology programs based on the patient\u2019s insurance.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response mentions out-of-pocket travel costs, financial counseling, and asks about \"out-of-pocket costs,\" it does not explicitly address how insurance coverage or network differences impact cost between settings."
      },
      {
        "criterion_number": 7,
        "description": "Cancer centers may offer more support services to patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists robust support services at cancer centers: genetics, nutrition, pain/symptom specialists (e.g., celiac plexus block), social work, financial counseling, housing help."
      },
      {
        "criterion_number": 8,
        "description": "Most standard cancer care can be delivered at community oncology programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states community oncology often does standard systemic therapy well (FOLFIRINOX, gemcitabine/nab-paclitaxel, NALIRIFOX), toxicity management, labs, transfusions, growth factor support, and palliative care."
      },
      {
        "criterion_number": 9,
        "description": "Cancer centers include NCI-designated comprehensive cancer centers and academic medical centers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly references high-volume academic centers and NCI-designated cancer centers, and mentions NCCN Member Institutions."
      },
      {
        "criterion_number": 10,
        "description": "Cancer centers are often located in major cities, which can mean longer travel times, more complex scheduling, and larger, busier environments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses longer travel, parking, housing burdens, and longer visits at major centers; implies more complex logistics even if not explicitly stating \"major cities.\""
      },
      {
        "criterion_number": 11,
        "description": "In some cases, initial treatment planning can be done at a cancer center, and follow-up care can be done at a community center closer to home.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Proposes a \"shared care\" plan: initial/second-opinion at a high-volume center to set strategy and trial review, chemotherapy locally, and returning to the center for milestones and telemedicine check-ins."
      }
    ],
    "question_number": 98,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:06:15.256735",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly advises involving the care team: it references waiting for the surgeon\u2019s clearance, asking the care team for guidance based on ANC/platelets, and explicitly says to ask the oncologist or oncology nurse about sexual side effects and referrals."
      },
      {
        "criterion_number": 2,
        "description": "The response states patients undergoing treatment for pancreatic cancer may experience a decrease in libido related to symptoms from treatment or the cancer itself, like fatigue, nausea, pain, malnutrition, anxiety, and depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes cancer/treatment can affect desire and mentions causes such as fatigue, pain, medications (opioids/antidepressants), and anxiety/distress. While not all listed examples are named (e.g., nausea, malnutrition), it clearly links decreased desire/libido to treatment-related symptoms."
      },
      {
        "criterion_number": 3,
        "description": "The response specifically mentions at least one of the following changes in intimacy: decreased desire, arousal disorders, pain, erectile dysfunction, altered body image, or emotional distress.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions decreased desire, erectile difficulties, pain/discomfort, altered body image, and emotional distress related to sex and body image."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends open communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages ongoing check-ins (e.g., green/yellow/red), a pause word, and provides a conversation starter, all emphasizing open communication."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends seeking input from a professional trained in intimacy problems.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends referral to a sexual medicine specialist, pelvic floor physical therapist, and a certified sex therapist\u2014professionals trained to address intimacy problems."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends cancer support groups.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No explicit recommendation for cancer support groups is provided."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly mentions at least one of the following interventions: psychosocial therapy, psychosexual therapy, or couples-based therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions sex therapists and social workers, it does not explicitly name psychosocial therapy, psychosexual therapy, or couples-based therapy."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly mentions at least one of the following referral options: medical sexologist, psycho-sexologist, social worker, or psychologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly suggests referral to an oncology social worker and a sexual medicine specialist (aligned with a medical sexologist)."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly states that concerns about intimacy during treatment for a loved one with pancreatic cancer are common.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The opening states it is very common for cancer and its treatments to affect desire, comfort, and confidence, normalizing these concerns."
      }
    ],
    "question_number": 99,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:06:34.895023",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines radiofrequency ablation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines RFA as a probe delivering alternating electrical current to heat tissue (60\u2013100\u00b0C) to destroy targeted cells; distinguishes it from chemotherapy."
      },
      {
        "criterion_number": 2,
        "description": "The response states radiofrequency ablation is minimally invasive and typically does not require surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains RFA is performed percutaneously or via endoscopic ultrasound and only sometimes during surgery; notes same-day/overnight stays, indicating a minimally invasive, typically non-surgical approach."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a dedicated 'What to ask the doctors' section, explicitly encouraging discussion with the care team."
      },
      {
        "criterion_number": 4,
        "description": "The response states not all patients with pancreatic cancer benefit from radiofrequency ablation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States RFA is not standard curative therapy for PDAC, hasn\u2019t shown clear survival benefit, and effectiveness depends on tumor factors, implying not all patients benefit."
      },
      {
        "criterion_number": 5,
        "description": "The response considers the potential risks and benefits of radiofrequency ablation for the treatment of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly lists benefits (local control, symptom relief, bile duct patency, pNETs) and detailed risks/complications with approximate rates."
      },
      {
        "criterion_number": 6,
        "description": "The response states radiofrequency ablation is typically used in a multidisciplinary treatment plan along with chemotherapy for the treatment of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes systemic chemotherapy as the backbone, discusses integration with radiation and other modalities, and addresses coordination with chemotherapy timeline."
      },
      {
        "criterion_number": 7,
        "description": "The response states radiofrequency ablation is a procedure performed by specially trained Interventional Radiologists.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that Interventional Radiologists perform RFA; mentions approaches (EUS, percutaneous, surgical) without naming operator specialty."
      },
      {
        "criterion_number": 8,
        "description": "The response states this is typically an outpatient procedure.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Says EUS/percutaneous RFA is often same day or 1-night stay, conveying typical outpatient management."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that in pancreatic cancer, RFA is most commonly delivered via endoscopic ultrasound guidance (EUS-RFA), allowing precise targeting of the tumor while minimizing injury to surrounding structures.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States it is more commonly done via EUS-RFA and describes EUS guidance for probe placement; planning around ducts/vessels implies precision and safety."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that radiofrequency ablation is used in pancreatic cancer primarily for unresectable or inoperable tumors as a palliative or adjunctive therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions use for tumors that can\u2019t be surgically removed and for symptom relief, indicating palliative/adjunctive intent."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that RFA is not a substitute for surgery or systemic therapy in resectable disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States RFA is not standard curative therapy for PDAC and highlights chemotherapy \u00b1 radiation as the standard backbone, implying RFA does not replace surgery/systemic therapy in resectable cases."
      }
    ],
    "question_number": 100,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:07:13.380733",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises engaging the care team: recommends medication reconciliation with the oncology pharmacist or palliative care, bringing the med list to every visit and sharing with clinicians, asking the team about NSAID use, and provides urgent 'call the care team' triggers."
      },
      {
        "criterion_number": 2,
        "description": "The response states it is normal for patients with pancreatic cancer to be on multiple medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states, \u201cIt\u2019s very common for people with pancreatic cancer to be on many medications,\u201d indicating this is normal."
      },
      {
        "criterion_number": 3,
        "description": "The response states patients undergoing treatment for pancreatic cancer may need medications for symptom control, including acid reflux, nausea, pain, diarrhea, and enzyme replacement.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists PPIs for acid suppression (acid reflux), multiple antiemetics for nausea, analgesics/opioids for pain, loperamide for diarrhea, and pancreatic enzyme replacement (pancrelipase)."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends utilizing a pill organizer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicit recommendation: \u201cUse a weekly pill organizer and phone alarms.\u201d"
      },
      {
        "criterion_number": 5,
        "description": "The response recommends keeping an updated medication list with administration times.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises keeping an up-to-date med list including drug, dose, and when/why taken, which covers administration timing."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends reviewing the patient\u2019s medication list with the healthcare team to identify strategies to make handling the medications easier.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends medication reconciliation with oncology pharmacist or palliative care and suggests discussing simplification (duplicates, timing), directly addressing strategies to make handling meds easier."
      }
    ],
    "question_number": 101,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:07:38.487279",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing yoga with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises clearance by the oncology team: \u201cwhen it\u2019s\u2026cleared by the oncology team\u201d and \u201cHave their oncology team clear them first.\u201d"
      },
      {
        "criterion_number": 2,
        "description": "The response states yoga may improve a cancer patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States benefits include \u201cimproved mood and quality of life,\u201d along with reduced anxiety, stress, fatigue, and better sleep."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends gentle and slow yoga practice to avoid injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends gentle styles (restorative, yin, chair, oncology yoga), low intensity, supported and tailored movements; advises avoiding vigorous practices."
      },
      {
        "criterion_number": 4,
        "description": "The response states patients undergoing treatment for pancreatic cancer may be more prone to injury due to fatigue, malnutrition, dehydration, and pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions fatigue/anemia and abdominal pain but does not explicitly link malnutrition or dehydration to injury risk."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of or recommendation for cancer support groups."
      },
      {
        "criterion_number": 6,
        "description": "The response cites any studies it mentions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References ASCO/SIO guidelines generally but does not cite specific studies or provide formal citations for evidence mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response states there are yoga classes specifically for cancer patients and provides resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions \u201concology yoga\u201d and suggests instructors trained in \u201cyoga4cancer,\u201d hospital-based integrative programs, and PTs with yoga training."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that yoga is generally safe for people with cancer, including those undergoing treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states yoga can be safe during pancreatic cancer treatment when gentle and team-cleared, and reiterates it is \u201cgenerally safe.\u201d"
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that yoga may help reduce cancer-related fatigue, anxiety, and depression, and improve emotional well-being during and after treatment, though effects are typically small to moderate and the certainty of evidence is low to moderate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Addresses fatigue and anxiety and overall quality of life but does not explicitly mention depression or characterize effect sizes and evidence certainty as small-to-moderate/low-to-moderate."
      }
    ],
    "question_number": 102,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:08:01.969504",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly directs the reader to consult the oncology team (e.g., 'Good questions to ask the oncology team' and specific questions to discuss), encouraging direct discussion with his oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response states many side effects from cancer treatment improve and disappear once treatment stops.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes several effects improve after therapy, e.g., fatigue/\u2018chemo brain\u2019 usually improve over 6\u201312 months and 'most recover after therapy' for low blood counts."
      },
      {
        "criterion_number": 3,
        "description": "The response states some side effects like peripheral neuropathy may become permanent.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states neuropathy from oxaliplatin/nab\u2011paclitaxel 'may persist or be permanent in part.'"
      },
      {
        "criterion_number": 4,
        "description": "The response states some side effects from treatment may take time to improve or disappear, as long as many months.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes recovery timelines of months: fatigue/\u2018chemo brain\u2019 improve over 6\u201312 months; radiation fatigue can persist for months; late radiation GI effects can appear months later."
      },
      {
        "criterion_number": 5,
        "description": "The response states many side effects from treatment can be controlled with medications, for example pancreatic enzyme supplementation for pancreatic insufficiency or vitamins for malabsorption after surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It gives specific medication strategies: pancreatic enzyme replacement, fat\u2011soluble vitamins, duloxetine for neuropathy, bile acid binders, supplements, vaccines."
      },
      {
        "criterion_number": 6,
        "description": "The response reviews potential side effects of surgery for pancreatic cancer (e.g., Whipple procedure).",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides a thorough surgery section (Whipple/distal/total) including exocrine insufficiency, diabetes, dumping, nutrient deficiencies, adhesions/obstruction, biliary issues, hernias, and asplenia-related infection risk."
      },
      {
        "criterion_number": 7,
        "description": "The response reviews potential side effects of chemotherapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It covers chemo regimens (FOLFIRINOX, gemcitabine+nab\u2011paclitaxel) and effects including fatigue, cognitive changes, peripheral neuropathy, GI changes, bone marrow suppression, rare cardiac/pulmonary/renal effects, and skin toxicity."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the potential for long-term heart or kidney damage and fertility issues.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions cardiac effects with 5\u2011FU/capecitabine and kidney problems with gemcitabine (rare), and addresses fertility (chemo can reduce sperm count; consider sperm banking)."
      },
      {
        "criterion_number": 9,
        "description": "The response states the treating team will work within the patient\u2019s goals of care to maximize treatment efficacy while limiting side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it encourages questions and mentions early palliative care, it does not explicitly state that the team will align treatment with the patient's goals of care to balance efficacy and side effects."
      },
      {
        "criterion_number": 10,
        "description": "The response reviews potential side effects of radiation therapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a radiation section detailing gastric/duodenal irritation/ulcers/bleeding/strictures, chronic diarrhea/malabsorption, rare liver/kidney effects, and prolonged fatigue."
      },
      {
        "criterion_number": 11,
        "description": "The response states some cancer treatments can increase the likelihood of developing second cancers in the future.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes rare therapy-related leukemia/MDS after chemotherapy and a rare long\u2011term risk of MDS/AML with PARP inhibitors."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends open communication with the patient\u2019s healthcare team about symptoms and symptom control to limit the long-term effects of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It urges asking the oncology team targeted questions, keeping a symptom diary, and clarifying an urgent issues plan\u2014promoting ongoing communication for symptom control."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly state that long-term side effects are common in patients treated for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it labels certain surgery-related issues as 'very common,' it does not explicitly state that long\u2011term side effects are common overall in patients treated for pancreatic cancer."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the cumulative impact of surgery, chemotherapy, radiation, and the underlying disease as sources of long-term side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses long-term effects from surgery, chemotherapy, radiation, and notes disease-related risks (e.g., high clot risk in pancreatic cancer), collectively identifying all as sources of ongoing effects."
      }
    ],
    "question_number": 103,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:08:29.631769",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response offers recommendations for organizations and includes key initiatives of the organizations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response lists numerous reputable U.S. and international organizations and briefly describes what each funds (e.g., PanCAN\u2019s Precision Promise adaptive trials, Lustgarten\u2019s focus on early detection and novel therapies, Project Purple\u2019s research and patient aid). It also suggests donating to specific academic centers and provides guidance on restricting gifts, all of which demonstrate inclusion of key initiatives."
      },
      {
        "criterion_number": 2,
        "description": "The response includes Charity Navigator ratings for the mentioned organizations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although the response advises checking Charity Navigator and other evaluators, it does not provide any actual Charity Navigator ratings for the listed organizations."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly state that nonprofit organizations are vital for supporting innovative research in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not explicitly state that nonprofit organizations are vital for supporting innovative research; it implies importance through recommendations but lacks the explicit statement required."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention that donations to nonprofit organizations can support research, clinical trials, and patient support initiatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response clearly references donations supporting research, clinical trials (e.g., PanCAN\u2019s Precision Promise and clinical trials infrastructure), and patient support services/financial aid across multiple organizations, fulfilling all three components."
      }
    ],
    "question_number": 104,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:08:48.808519",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends contacting the patient\u2019s oncologist immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises: \"Please contact his oncology team today\" and emphasizes urgent involvement for red flag symptoms."
      },
      {
        "criterion_number": 2,
        "description": "The response instructs the patient to seek immediate medical evaluation if the vision changes are abrupt in onset, severe, or accompanied by other symptoms including dizziness, pain, confusion, fever, or other neurologic symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides a clear ER-now list: sudden vision loss, curtain over vision, new double vision, vision change with severe headache, weakness, numbness, trouble speaking, confusion, seizure, eye pain/redness/light sensitivity, and new flashes/floaters\u2014capturing severe/abrupt changes and neurologic and pain symptoms."
      },
      {
        "criterion_number": 3,
        "description": "The response states vision changes related to treatment are not typical, though can be related to dry eyes or peripheral neuropathy from chemotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions treatment-related vision changes and dry/irritated eyes with 5-FU, it does not state that such changes are \"not typical\" and does not link vision changes to peripheral neuropathy."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that chemotherapy can cause vision changes (ocular toxicity). For example, gemcitabine and 5-fluorouracil have been associated with retinal findings including cotton-wool spots and other visual disturbances.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly details chemotherapy-associated ocular toxicity, naming gemcitabine, 5-FU/capecitabine, oxaliplatin, taxanes, and erlotinib with specific visual effects."
      },
      {
        "criterion_number": 5,
        "description": "The response states the oncologist may recommend dose reducing treatment or changing to a different treatment if the vision changes are felt to be treatment-related.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests holding treatment and arranging urgent ophthalmology and notes some toxicities may improve if the drug is held, but does not mention dose reduction or switching regimens."
      },
      {
        "criterion_number": 6,
        "description": "The response states vision changes may be related to metastasis to the brain.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists \"spread to the brain/eye\" as a less common cause, explicitly acknowledging brain metastasis."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that ocular metastases may cause vision changes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions \"spread to the eye\" as a potential cause, which encompasses ocular metastases."
      },
      {
        "criterion_number": 8,
        "description": "The response states vision changes may be related to paraneoplastic processes and explains what this is.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Paraneoplastic retinopathy is named but not explained (no description of immune-mediated mechanism)."
      },
      {
        "criterion_number": 10,
        "description": "The response states the patient\u2019s oncologist may prescribe medications to improve the vision changes, including eye drops, steroids, or antibiotics.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It recommends OTC artificial tears and advises against starting steroid eye drops without ophthalmology; it does not say the oncologist may prescribe eye drops, steroids, or antibiotics."
      },
      {
        "criterion_number": 11,
        "description": "The response states the patient\u2019s vision changes may be due to infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Infection is not mentioned as a cause; while eye pain/redness/light sensitivity are flagged, infection is not explicitly cited."
      },
      {
        "criterion_number": 12,
        "description": "The response states the patient\u2019s vision changes may be due to age-related vision changes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no mention of age-related causes of vision change."
      }
    ],
    "question_number": 105,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:09:21.366526",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that telehealth appointments are generally as effective as in-person visits for many aspects of care for patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response explicitly states telehealth is very effective for many parts of pancreatic cancer care and lists scenarios where it can be as effective as in-person care, supported by studies."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews the potential benefits of telehealth appointments, including reduced travel burden, lower costs, decreased infection risk, and improved access to expertise.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Benefits highlighted include reduced travel burden and costs, faster access, coordination to reduce travel, and use for second opinions/multidisciplinary reviews (improved access to expertise). Although decreased infection risk is not explicitly mentioned, multiple key benefits are reviewed."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the potential downsides of telehealth appointments, including potential differences in insurance reimbursement and challenges with physical examination.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes coverage varies by plan/state, need to confirm copays/platforms/state licensure (insurance variability) and emphasizes in-person needs for hands-on exams and certain evaluations (physical exam limitations)."
      },
      {
        "criterion_number": 4,
        "description": "The response states it can be challenging for a doctor to fully evaluate a patient via telehealth.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response clearly indicates telehealth does not replace everything and specifies scenarios requiring in-person hands-on examination, implying limitations in fully evaluating patients via telehealth."
      },
      {
        "criterion_number": 5,
        "description": "The response states telehealth can be a convenient alternative to in-office visits and may be helpful if the patient has mobility or transportation issues.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes reduced travel burden/costs and coordinating local care with telehealth follow-ups to minimize travel, indicating convenience and benefit for transportation challenges."
      },
      {
        "criterion_number": 6,
        "description": "The response states in-office visits may be more appropriate in certain situations, including for initial visits or when there are big changes to the patient\u2019s health or treatment plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends initial consult and key milestones in person and specifies urgent new problems and hands-on exam needs for in-person evaluation."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing telehealth options with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly advises asking the oncology team which visits can be virtual, what monitoring is needed, and criteria to switch to in-person."
      },
      {
        "criterion_number": 8,
        "description": "The response states not all oncologists offer telehealth appointments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it discusses variability in coverage and platforms, it does not explicitly state that not all oncologists offer telehealth appointments."
      },
      {
        "criterion_number": 9,
        "description": "The response offers tips for making the most out of a telehealth appointment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a thorough list of practical tips: uploading labs/scans, preparing medication lists, home monitoring tools, involving a caregiver, tech checks, backup contact, and preparing questions."
      },
      {
        "criterion_number": 10,
        "description": "The response states medical emergencies are not appropriate for telehealth evaluations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides explicit red flags that should prompt urgent in-person care or ER, clearly stating these situations should not be handled via telehealth."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that telehealth may be less suitable for sensitive discussions, such as new diagnosis or end-of-life care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention sensitivity concerns (e.g., new diagnosis, end-of-life) as a reason to prefer in-person visits; it even notes palliative care can be delivered via telehealth."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that limitations of telehealth include technology barriers and occasional concerns about reduced personal connection or quality of interaction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests testing technology and having a backup number, it does not explicitly identify technology barriers as a limitation nor mention reduced personal connection/interaction quality."
      }
    ],
    "question_number": 106,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:09:57.972528",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple prompts to engage the oncology team (e.g., ask the oncologist for a cranial prosthesis prescription, ask about scalp cooling, report scalp symptoms, and specific questions to ask the oncology team)."
      },
      {
        "criterion_number": 2,
        "description": "The response states some chemotherapy treatments for pancreatic cancer can cause hair loss, for example, FOLFIRINOX or gemcitabine.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions FOLFIRINOX and gemcitabine-based regimens and notes hair thinning/loss with each."
      },
      {
        "criterion_number": 3,
        "description": "The response provides reported estimates of hair loss with FOLFIRINOX and gemcitabine and cites its sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No numeric estimates or citations are provided."
      },
      {
        "criterion_number": 4,
        "description": "The response states hair typically grows back once the causative treatment is stopped.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States regrowth usually begins 1\u20133 months after chemotherapy ends and full regrowth takes several months."
      },
      {
        "criterion_number": 5,
        "description": "The response states cold caps are sometimes used to reduce hair loss but they can be expensive.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes scalp cooling to reduce hair loss and notes availability and cost vary, implying potential expense."
      },
      {
        "criterion_number": 6,
        "description": "The response states hair loss from chemotherapy is a common and distressing side effect in patients undergoing treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that worrying about hair loss is very common and acknowledges its emotional impact (\"it\u2019s still a big deal\")."
      },
      {
        "criterion_number": 7,
        "description": "The response states other chemotherapy regimens or immunotherapy or targeted therapy cause hair loss at lower rates or not at all.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes gemcitabine alone usually causes mild thinning and that targeted therapy/immunotherapy rarely cause hair loss."
      },
      {
        "criterion_number": 8,
        "description": "The response states many cancer patients wear hats or wigs to help with appearances and self-esteem.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses wigs/head coverings, obtaining a cranial prosthesis prescription, matching color/style, and use of hats/caps; supports appearance-related coping."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends cancer support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends looking into local/online support groups and consulting the care team about supportive resources."
      },
      {
        "criterion_number": 10,
        "description": "The response reports expected timelines for hair loss after starting chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States shedding often starts 2\u20134 weeks after first infusion, sometimes sooner with paclitaxel."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that the severity and risk of hair loss is higher with multi-agent and taxane-containing protocols, and female patients are at increased risk.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions higher risk with taxanes but does not mention increased risk with multi-agent regimens broadly nor that female patients are at increased risk."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that most cases of hair loss are reversible, with regrowth expected within 3-6 months after cessation of chemotherapy, but persistent or permanent alopecia can occur, especially after repeated or high-dose regimens.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes regrowth begins 1\u20133 months after chemo ends but does not mention potential persistent/permanent alopecia."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions that eyebrow and eyelash loss may also be seen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states eyebrows/eyelashes can thin and provides coping tips."
      },
      {
        "criterion_number": 14,
        "description": "The response mentions that topical minoxidil may aid regrowth post-chemotherapy, though evidence for prevention is limited.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of minoxidil."
      }
    ],
    "question_number": 107,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:10:28.680578",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Defines oligometastatic disease in pancreatic cancer as limited spread, typically to a single organ with a small number of lesions (\u22643 to \u22645).",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states it is a small number of spots, usually limited to one organ, and provides thresholds of 1\u20133 (up to 5) metastases, commonly in liver or lung."
      },
      {
        "criterion_number": 2,
        "description": "Recommends discussing with the patient\u2019s healthcare team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes a section titled 'Questions to ask your husband\u2019s oncologist' and suggests seeking a second opinion at a high-volume center."
      },
      {
        "criterion_number": 3,
        "description": "Discusses impact on treatment options, including systemic chemotherapy followed by local treatments (surgery, ablation, SBRT) after good response.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explains that it is still stage IV with systemic chemotherapy as mainstay, and in carefully selected responders, local treatments (surgery, SBRT, ablation) may be considered; it outlines a typical pathway of chemo, restaging, and then local therapy discussion."
      },
      {
        "criterion_number": 4,
        "description": "Contrasts oligometastatic disease with localized and widespread metastatic disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly describes oligometastatic disease as a 'middle ground' between localized (just in the pancreas) and widely metastatic disease."
      },
      {
        "criterion_number": 5,
        "description": "Mentions potential for improved prognosis compared to widespread metastatic disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes the goal of improving disease control and sometimes survival with local approaches, it does not explicitly state that oligometastatic patients may have a better prognosis than those with widespread metastatic disease."
      }
    ],
    "question_number": 108,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:10:44.849911",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states it is common for patients to have low blood counts due to chemotherapy used in the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that low blood counts and resulting treatment delays are common in pancreatic cancer care, especially with standard chemotherapy, and explains myelosuppression."
      },
      {
        "criterion_number": 2,
        "description": "The response states treatment delays due to low blood counts are enacted to ensure the patient\u2019s safety.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes oncologists adjust treatment to keep it safe, hold treatment when counts are low, and restart when recovered, emphasizing safety."
      },
      {
        "criterion_number": 3,
        "description": "The response states the oncologist may recommend dose reducing the chemotherapy or changing to a different treatment if the blood counts remain low.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states doses may be reduced or treatments spread out and that clinicians may switch to a modified or different regimen if low counts recur."
      },
      {
        "criterion_number": 4,
        "description": "The response gives examples of chemotherapy known to cause low blood counts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It names FOLFIRINOX and gemcitabine plus nab-paclitaxel, and provides incidence estimates of severe neutropenia."
      },
      {
        "criterion_number": 5,
        "description": "The response lists the different types of low blood counts that may impact treatment, including anemia, neutropenia, thrombocytopenia, and low total white blood cell count, and explains why these cells are important in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it lists neutropenia, anemia, and thrombocytopenia, it does not explain in lay terms why these cells are important (e.g., fighting infection, carrying oxygen, clotting), nor explicitly mention low total WBC beyond neutrophils."
      },
      {
        "criterion_number": 6,
        "description": "The response states the oncologist may prescribe an injection medication (e.g., G-CSF) to help increase the neutrophil count.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions growth factor shots (G-CSF) to boost white cells when risk is high or after neutropenia."
      },
      {
        "criterion_number": 7,
        "description": "The response states if the red blood cell or platelet counts get too low, the oncologist may order a transfusion of red blood cells or platelets to keep these at safe levels.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states red blood cell or platelet transfusions are given when needed."
      },
      {
        "criterion_number": 8,
        "description": "The response instructs the patient to seek immediate medical evaluation if they have low blood counts and experience fever, chest pain, shortness of breath, leg swelling, blood in the urine, blood in the stool, or other uncontrollable bleeding.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It advises urgent evaluation for fever, chest pain, shortness of breath, and uncontrolled bleeding, but does not specifically mention leg swelling or blood in the urine/stool as triggers."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends ensuring good nutrition to ensure the bone marrow can produce the required blood cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends maintaining nutrition and hydration and addressing iron/B12/folate deficiencies to help anemia."
      },
      {
        "criterion_number": 10,
        "description": "The response must strongly recommend consulting with an oncologist or care team, providing specific questions or topics to discuss.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly references working with the oncology team, provides thresholds they use, suggests asking about nadir timing, and offers specific items to share with the care team."
      }
    ],
    "question_number": 109,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:11:14.752713",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises: \u201cAsk his oncologist about nearby academic centers that offer deep regional hyperthermia,\u201d clearly recommending discussion with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response explains hyperthermia treatment for cancer in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines hyperthermia in simple language, explains how it works (sensitizing radiation/chemo, improving blood flow), and describes how it is delivered and what sessions are like in accessible terms."
      },
      {
        "criterion_number": 3,
        "description": "The response specifies that hyperthermia treatment involves heating tumor tissue to a temperature range of 39-43\u00b0C to enhance the cytotoxic effects of chemotherapy and/or radiotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response states 40\u201345\u00b0C and discusses sensitization to chemo/radiation, but it does not specify the 39\u201343\u00b0C range required by the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions all three delivery methods: regional (including \u2018deep regional\u2019), intraoperative, and whole-body hyperthermia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Regional/deep regional and whole-body hyperthermia are described, but intraoperative hyperthermia is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response reviews potential benefits and risks of hyperthermia treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Benefits (sensitizing radiation/chemo, improved local response, symptom control, minimal added systemic toxicity) and risks/limitations (burns, pain, nausea, blisters, fat necrosis, discomfort with deep heating, metal stent risks, limited availability/coverage) are clearly reviewed."
      },
      {
        "criterion_number": 6,
        "description": "The response states hyperthermia is not an effective alternative to standard of care treatment for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes hyperthermia is an add-on and not used by itself, and flags as a red flag any clinic offering it as a substitute for standard therapy."
      },
      {
        "criterion_number": 7,
        "description": "The response states hyperthermia is not a standard first-line therapy for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that major guidelines do not list hyperthermia as standard of care for pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response states there is not robust evidence for the use of hyperthermia treatment in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes that available studies are small, results are mixed and not definitive, indicating a lack of robust evidence."
      },
      {
        "criterion_number": 9,
        "description": "The response must mention that hyperthermia is used in pancreatic cancer as an adjunct to standard chemoradiotherapy for patients with locally advanced, unresectable, or metastatic disease, especially when conventional therapies have limited efficacy or are refractory.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it states hyperthermia is an adjunct to chemotherapy and/or radiation and mentions locally advanced disease, it does not explicitly mention unresectable or metastatic settings, nor the \u201cespecially when refractory/limited efficacy\u201d context."
      },
      {
        "criterion_number": 10,
        "description": "The response must state that adding hyperthermia to chemoradiotherapy may improve overall response rates and median survival compared to standard therapy alone, with acceptable safety profiles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions increased local response and possible small survival benefit, and that systemic side effects are generally limited, but does not explicitly state improvements in overall response rates and median survival compared to standard therapy alone in the context of chemoradiotherapy."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that the quality of evidence for hyperthermia is limited, it remains investigational, and there are ongoing trials evaluating its efficacy and optimal integration into multimodal treatment regimens.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it describes evidence as mixed/not definitive and recommends clinical trials with a link to ClinicalTrials.gov, it does not explicitly label hyperthermia as investigational nor explicitly state that ongoing trials are evaluating efficacy and optimal integration."
      }
    ],
    "question_number": 110,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:13:02.233108",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly identifies the medical oncologist as someone who integrates germline and tumor findings into the treatment plan, effectively recommending discussion with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly recommends a cancer genetic counselor (board\u2011certified CGC) for germline results, explains their role, and provides resources to find one."
      },
      {
        "criterion_number": 4,
        "description": "The response explains genetic testing and why it is done in cancer treatment, using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It distinguishes germline vs. somatic testing in accessible language and explains purposes: inherited risk assessment, treatment guidance, and implications for family."
      },
      {
        "criterion_number": 5,
        "description": "The response includes in its explanation that certain genetic mutations like BRCA2 may be targets for targeted cancer therapies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes that results can affect treatment and mentions markers like NTRK and MSI/dMMR, it does not explicitly state that mutations such as BRCA2 are targets for targeted therapies (e.g., PARP inhibitors)."
      },
      {
        "criterion_number": 6,
        "description": "The response states that certain genetic mutations are associated with inherited cancer predisposition syndromes which may affect the patient\u2019s relatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states germline testing looks for inherited risks and that results have implications for family members, including arranging testing for relatives."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that board-certified genetic counselors, medical geneticists, and oncologists can help determine the clinical significance of identified variants, discuss implications for surveillance, prevention, and treatment, and provide guidance for at-risk family members.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It covers clinical significance (pathogenic vs VUS), treatment integration, and guidance for at-risk relatives, but does not explicitly mention surveillance or prevention."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that pathogenic variants in genes such as BRCA1, BRCA2, PALB2, ATM, CDKN2A, and others may influence both therapeutic decisions and recommendations for family screening.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists BRCA1/2, PALB2, and ATM as examples and states these results can affect treatment and have implications for family members, satisfying both therapy and family screening elements."
      }
    ],
    "question_number": 111,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:14:05.148287",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist or a nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to ask the oncology team to rule out causes and includes a referral to an oncology dietitian for a personalized plan."
      },
      {
        "criterion_number": 2,
        "description": "The response states changes in taste are a common side effect of some chemotherapies used in the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States taste changes are common during pancreatic cancer care and lists chemotherapy regimens (FOLFIRINOX, gemcitabine/nab-paclitaxel) as causes."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends trying different foods and drinks to identify flavor profiles that are appealing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides detailed food and flavor strategies, suggests trying different brands/flavors, and keeping a list of tolerated foods."
      },
      {
        "criterion_number": 4,
        "description": "The response states cold intolerance is a common side effect of oxaliplatin, so patients should avoid cold foods and drinks.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention oxaliplatin or cold intolerance; in fact, it often recommends cold foods/drinks."
      },
      {
        "criterion_number": 5,
        "description": "The response states changes in taste typically improve or disappear entirely when the causative medication is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement that taste changes usually improve or resolve after stopping the causative medication."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of maintaining proper nutrition and hydration while undergoing treatment for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes goals to maintain calories/protein, prevent weight loss/dehydration, and provides numerous nutrition and hydration strategies."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends nutritional supplements to ensure the patient is achieving their needs.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends ready-to-drink nutrition supplements and add-ins like powdered milk and protein powder."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that improved oral hygiene and active swallowing exercises may also promote taste recovery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Covers oral hygiene thoroughly but does not mention active swallowing exercises."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that a referral to a registered dietitian is recommended for tailored nutritional strategies, as taste changes often lead to reduced appetite, altered food preferences, and risk of malnutrition.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically recommends a referral to an oncology dietitian for a personalized plan and discusses weight loss and intake concerns, implying malnutrition risk."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that dietitians can assist with food texture modification, flavor enhancement, and strategies to maintain adequate caloric and protein intake.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not explicitly state the specific roles dietitians play in texture modification, flavor enhancement, and caloric/protein strategies."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pharmacological and supplement-based interventions have been explored with mixed results. Further research is needed to establish standardized, effective interventions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists possible medications/supplements (e.g., zinc) but does not note mixed evidence or the need for further research for standardized interventions."
      }
    ],
    "question_number": 112,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:14:59.656137",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the exercise plan with the patient\u2019s oncologist or healthcare provider.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises: 'Get clearance from his oncology team, ideally with a referral to an oncology physical therapist or a cancer-experienced exercise professional.'"
      },
      {
        "criterion_number": 2,
        "description": "The response recommends gentle and slow exercise to avoid injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Promotes gentle, gradual progression: short bouts, 'start with bodyweight and light bands,' 'progress by no more than 10% per week,' and keeping intensity easy to moderate."
      },
      {
        "criterion_number": 3,
        "description": "The response states patients undergoing treatment for pancreatic cancer may be more prone to injury due to fatigue, malnutrition, dehydration, and pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it discusses fatigue, pain, hydration, and nutrition considerations, it does not explicitly state increased injury risk due to fatigue, malnutrition, dehydration, and pain."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends cancer support groups.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of or recommendation for cancer support groups."
      },
      {
        "criterion_number": 5,
        "description": "The response states gentle exercise participation may improve a cancer patient\u2019s quality of life and offers published research studies as evidence.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Though benefits such as fatigue, mood, and strength are mentioned, no published research is cited to support quality-of-life improvements."
      },
      {
        "criterion_number": 6,
        "description": "The response cites any studies it mentions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No studies or citations are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response states there are exercise classes specifically for cancer patients and provides resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions cancer-focused programs: 'Hospital-based or YMCA cancer exercise programs (e.g., LIVESTRONG at the YMCA)'."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention that The American Society of Clinical Oncology recommends both aerobic and resistance exercise as safe and beneficial for patients with pancreatic cancer during chemotherapy, chemoradiotherapy, or neoadjuvant therapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit reference to ASCO or its recommendations."
      },
      {
        "criterion_number": 9,
        "description": "The response must clearly state that physical activity should be tailored to individual capacity and comorbidities, using terms like \u201cindividual capacity,\u201d \u201cpersonalized,\u201d or \u201ctailored.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'The plan should be individualized and flexible' and provides condition-specific precautions (e.g., anemia, low platelets, neuropathy), reflecting tailoring to comorbidities."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that aerobic exercise (e.g., walking, cycling, swimming) and resistance training (e.g., weights, resistance bands) improve cardiorespiratory fitness, physical function, and reduce symptoms like fatigue and mood disturbances.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although benefits like reduced fatigue and improved mood are noted, it does not explicitly state improvements in cardiorespiratory fitness and physical function attributable to aerobic and resistance training."
      }
    ],
    "question_number": 113,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:15:28.107646",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises contacting the oncology team, bringing a symptom list to appointments, and coordinating with the care team for early actions."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends reporting any new symptoms to the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly instructs to call the oncology team the same day/within 24 hours for new or worsening symptoms and provides specific examples."
      },
      {
        "criterion_number": 3,
        "description": "The response states it is important to separate side effects of treatment from progression of disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it provides a separate section for treatment-related side effects, it does not explicitly state the importance of distinguishing treatment side effects from disease progression."
      },
      {
        "criterion_number": 4,
        "description": "The response gives examples of new or worsening pain, jaundice, unintentional weight loss, and appetite changes as symptoms that may signify progression of disease.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically mentions worsening pain, jaundice, unintentional weight loss, and poor appetite as concerning signs."
      },
      {
        "criterion_number": 5,
        "description": "The response states metastases to other sites in the body can have various symptoms and provides examples.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists symptoms that could reflect metastases (e.g., neurologic changes, respiratory symptoms) but does not explicitly state these could be due to metastases or spread to other sites."
      },
      {
        "criterion_number": 6,
        "description": "The response instructs the patient to seek immediate medical evaluation if they experience severe pain, jaundice, severe constipation, confusion, or neurologic changes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It advises emergency care for severe pain and confusion but does not include severe constipation as an emergency; jaundice is only urgent with fever/RUQ pain (not all jaundice); neurologic changes besides confusion are not explicitly flagged for immediate evaluation."
      },
      {
        "criterion_number": 7,
        "description": "The response must mention at least 10 of the following signs and symptoms indicating disease progression in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions \u226510: jaundice, dark urine, pale stools, pruritus (itching), back/abdominal pain, weight loss, poor appetite (anorexia), fatigue, nausea/vomiting, constipation, diarrhea (in treatment section), new/worsening diabetes, bloating, and blood clots."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention gastrointestinal bleeding or rapidly declining performance status as alarm symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly includes GI bleeding (black/tarry stools, vomiting blood) as an emergency alarm symptom."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state the importance of close monitoring of symptoms for timely intervention and supportive care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages a symptom diary and states to bring it so the team can act early, directly emphasizing timely intervention."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly mention early integration of supportive care to optimize quality of life and address complications.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends palliative care at any stage for symptom control and quality of life, and mentions hospice when appropriate."
      }
    ],
    "question_number": 114,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:16:12.675856",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define neoadjuvant therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly defines neoadjuvant therapy as treatment given before surgery to improve surgical success and disease control."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that neoadjuvant treatment is given before the main treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that it is treatment given before surgery, which is the main definitive treatment in this context."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that neoadjuvant therapy usually occurs before surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Repeatedly notes it is given before surgery and describes sequencing leading to surgery if appropriate."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that neoadjuvant therapy is usually chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifies chemotherapy as the typical approach, lists common regimens, and frames chemo as the main component."
      },
      {
        "criterion_number": 5,
        "description": "The response should include that radiation therapy can sometimes be used for neoadjuvant therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that radiation may be added after chemotherapy and mentions SBRT as an option."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that oncologists often evaluate the response of a person\u2019s cancer after neoadjuvant therapy to determine the next steps.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes monitoring with labs/CA 19-9 and scans to decide about surgery and using response to guide next steps."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that the main goals of neoadjuvant therapy are to treat micrometastases early, improve chances of margin-negative (R0) resection, downstage advanced tumors, and ensure patients receive systemic therapy, as many can\u2019t complete adjuvant treatment after surgery.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers all listed goals: early systemic treatment for microscopic disease, increasing R0 resection rates, downstaging borderline/locally advanced tumors, and ensuring delivery of systemic therapy pre-op because adjuvant therapy may not be completed."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that patient selection, multidisciplinary coordination, and management of therapy-related toxicities are critical, as attrition during neoadjuvant therapy can preclude surgery.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Addresses patient selection (who typically gets it), highlights toxicity and its management, and notes the risk that progression during therapy can preclude surgery; references the care team, implying coordinated management."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages engagement with the care team/doctors, provides specific questions to ask, and invites sharing the oncologist\u2019s staging and regimen to guide discussion."
      }
    ],
    "question_number": 115,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:16:40.627597",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that music therapy can help with symptoms associated with pancreatic cancer.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Explicitly states music therapy is a helpful, low-risk complement during cancer treatment, including pancreatic cancer, and lists symptomatic benefits (anxiety, pain, nausea, fatigue, mood, sleep)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that music therapy can help with anxiety.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Clearly notes consistent reductions in anxiety and references guideline endorsement for reducing anxiety."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that music therapy can improve quality of life.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly mentions improvements in overall quality of life."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that music therapy can help with depression.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Discusses mood improvement but does not explicitly mention depression."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that music therapy can help with pain.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Specifically states small-to-moderate decreases in pain and reduced opioid needs after surgery."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that music therapy can help with fatigue.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly mentions easing chemotherapy-related fatigue."
      },
      {
        "criterion_number": 7,
        "description": "The response states that music therapy is anti-cancer therapy.",
        "score_given": 0,
        "max_points": 0,
        "justification": "Does not claim anti-cancer effects; describes it as a supportive, low-risk complement with no drug interactions."
      },
      {
        "criterion_number": 8,
        "description": "The response should cite peer-reviewed publications with links.",
        "score_given": 0,
        "max_points": 3,
        "justification": "References randomized trials and guidelines generally but provides no specific citations or links."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the American Society of Clinical Oncology and the Society for Integrative Oncology recommend music therapy as a safe, non-invasive adjunct for managing anxiety and depression in adults with cancer, including those undergoing active treatment.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Mentions SIO/ASCO endorsement for anxiety and mood but does not explicitly include depression, 'safe, non-invasive' wording, or specify adults undergoing active treatment."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that emerging evidence suggests music therapy may also modulate immune responses and support overall treatment outcomes, but further research is needed to clarify its biological effects and optimal use in pancreatic cancer.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No mention of immune modulation, treatment outcomes, or need for further research on biological effects in pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises to ask the oncology team or hospital integrative/palliative care service, which constitutes recommending discussion with the oncologist."
      }
    ],
    "question_number": 116,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:16:58.185690",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that pancreatic cancer is not contagious.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states, \"cancer itself is not contagious, so your pets can\u2019t 'catch' cancer.\""
      },
      {
        "criterion_number": 2,
        "description": "The response should state that chemotherapy can weaken the immune system and make someone at increased risk of infection.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not mention immunosuppression, neutropenia, or increased infection risk due to chemotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pets can carry infections that could be harmful to immunocompromised persons.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it suggests vaccines/parasite prevention reduce germ risks, it does not state that pets can carry infections harmful to immunocompromised persons."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the patient discuss precautions related to chemotherapy excretion with a pharmacist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Advises asking the oncology nurse for timing but does not mention consulting a pharmacist about excretion precautions."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some chemotherapy drugs are excreted in urine.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States many chemo drugs are excreted in urine."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that some chemotherapy drugs are excreted in stool.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States many chemo drugs are excreted in stool."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that some chemotherapy drugs are excreted in saliva.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention saliva; mentions tears but not saliva."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some chemotherapy drugs are excreted in vomit.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States many chemo drugs are excreted in vomit."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that pets should avoid contact with excreted medications.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Advises keeping pets away from bathrooms and any body fluid spills, litter boxes, and not allowing licking during the excretion window."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that pets should avoid contact with chemotherapy medications.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Clearly instructs to keep chemo pills/supplies secured, pick up dropped pills, and notes extreme toxicity of specific chemo agents to pets."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that pets should avoid contact with all medications.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Advises keeping all pills and supplies in a closed container out of reach; includes non-chemo items like fentanyl patches."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that pets provide significant emotional and psychological benefits to cancer patients.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not mention emotional or psychological benefits of pet ownership."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that to reduce exposure to chemotherapy and radiation residues, patients should take precautions to limit the impacts on their pets.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides detailed chemo excretion precautions and clarifies external beam radiation is safe; notes implanted radiation would come with specific precautions."
      },
      {
        "criterion_number": 14,
        "description": "After chemotherapy, surfaces\u2014especially in bathrooms\u2014can remain contaminated for at least 48 hours, so thorough cleaning is advised.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Specifies a minimum 48-hour window after IV chemo and advises keeping pets away from bathrooms and cleaning spills with gloves and soap/water."
      },
      {
        "criterion_number": 15,
        "description": "Hand hygiene is essential after contact with patient waste or contaminated areas.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Mentions gloves and cleaning methods but does not explicitly instruct handwashing/hand hygiene after contact."
      },
      {
        "criterion_number": 16,
        "description": "Immunocompromised patients should practice good hand hygiene after handling pets.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not advise immunocompromised patients to perform hand hygiene after handling pets."
      },
      {
        "criterion_number": 17,
        "description": "Immunocompromised patients should avoid contact with pet waste.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Advises having someone not on treatment scoop litter and managing pet waste, effectively having the patient avoid pet waste."
      },
      {
        "criterion_number": 18,
        "description": "Immunocompromised patients should prevent pets from licking open wounds.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Advises against licking of skin/face/tears but does not specifically mention open wounds."
      },
      {
        "criterion_number": 19,
        "description": "There is no strong evidence that pet ownership increases cancer risk or that pets need to be removed from the home during treatment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not state that pets need not be removed or address lack of evidence of increased cancer risk from pet ownership."
      },
      {
        "criterion_number": 20,
        "description": "If patients are severely immunosuppressed, they should avoid contact with young animals, reptiles, or exotic pets, and seek assistance with pet care.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not mention avoidance of young animals, reptiles, or exotic pets in severe immunosuppression."
      },
      {
        "criterion_number": 21,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Suggests asking the oncology nurse about timing but does not recommend discussing with an oncologist."
      }
    ],
    "question_number": 117,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:17:26.803640",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define adjuvant therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines adjuvant therapy as treatment given after the main treatment (usually surgery) to lower the chance the cancer comes back."
      },
      {
        "criterion_number": 2,
        "description": "The response should state the goal of adjuvant therapy is to prevent cancer recurrence.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly states the goal is to lower the chance the cancer comes back and to kill microscopic residual disease."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that adjuvant therapy usually occurs after surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States it is usually offered after tumor removal and starts 4\u201312 weeks following surgery."
      },
      {
        "criterion_number": 4,
        "description": "The response should include adjuvant therapy can be chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes multiple chemotherapy regimens (modified FOLFIRINOX, gemcitabine/capecitabine, gemcitabine alone) as adjuvant options."
      },
      {
        "criterion_number": 5,
        "description": "The response should include adjuvant therapy can be radiation therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes radiation may be considered postoperatively, especially with positive margins, though not routine."
      },
      {
        "criterion_number": 6,
        "description": "The response states that guidelines recommend all patients with resected pancreatic adenocarcinoma who did not receive preoperative therapy should be offered 6 months of adjuvant chemotherapy, unless there are medical or surgical contraindications.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions adjuvant chemotherapy is usually offered and lasts about 6 months, it does not explicitly state the guideline-based recommendation that all eligible patients without preoperative therapy should be offered 6 months unless contraindicated."
      },
      {
        "criterion_number": 7,
        "description": "The response states that adjuvant systemic therapy significantly improves survival compared to surgery alone.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly states studies show chemotherapy after surgery improves how long people live compared with surgery alone."
      },
      {
        "criterion_number": 8,
        "description": "The response states that the choice of adjuvant regimen should be individualized based on patient fitness and risk of toxicity.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Emphasizes regimen selection based on fitness and tolerance (e.g., FOLFIRINOX for fit patients; gentler options otherwise) and lists factors like recovery and overall fitness."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends that the user discuss this case with an oncologist or cancer specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a detailed list of questions to ask the oncologist, effectively directing the user to discuss specifics with the care team."
      }
    ],
    "question_number": 118,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:17:49.192968",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing constipation with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to review the plan with the oncology or palliative care team, to call the care team for guidance with impaction, and to check with the oncology team before rectal methods."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing pain medications with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Suggests discussing ways to reduce opioid needs with the team, including changing the opioid/route and considering a celiac plexus block."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that constipation is a side effect of opioid pain medications.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States, \u201cConstipation from opioids is very common in cancer care.\u201d"
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of stimulant laxatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends stimulant laxatives (senna with dosing and bisacodyl as alternative) as part of a scheduled bowel regimen."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of osmotic laxatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends polyethylene glycol (PEG 3350) with dosing and lactulose as add-on options."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of stool softeners.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions docusate (stool softener) may be used as an add-on for hard stools, while noting it is ineffective alone for opioid constipation."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that a combination of these treatments is sometimes needed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically advises combining a stimulant laxative with an osmotic laxative."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that there are prescription medications that can directly target opioid-associated constipation.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Names PAMORAs (methylnaltrexone, naloxegol, naldemedine) and notes they target opioid effects in the gut."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend hydration to improve constipation.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Recommends 6\u20138 glasses of fluid daily, warm liquids, and prune/prune-pear juice."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend physical activity to improve constipation.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Recommends gentle activity (short walks) and timed toilet sitting after meals."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that opioid-induced constipation is primarily due to reduced gut motility, and agents that increase water content or stimulate peristalsis directly address the underlying pathophysiology.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not explain that OIC is due to reduced gut motility or explicitly connect stimulant/osmotic agents to addressing that pathophysiology."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that the American Gastroenterological Association recommends polyethylene glycol (PEG) and lactulose as effective osmotic agents, both of which significantly improve stool consistency and frequency compared to placebo.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of AGA guidelines or comparative efficacy versus placebo."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that soluble fiber may be considered only for patients with fiber-deficient diets, as it has limited efficacy in opioid-induced constipation due to its lack of effect on colonic motility.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Provides caution that fiber can worsen bloating and to increase fluids if adding fiber, but does not specify limited efficacy in OIC due to lack of effect on motility or that it\u2019s mainly for fiber-deficient diets."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that enemas are reserved for rescue therapy and not for regular use.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Positions enemas only after 72 hours if impaction is present and to seek team guidance, consistent with rescue use rather than routine therapy."
      }
    ],
    "question_number": 119,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:18:14.145861",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that meditation and mindfulness can improve quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes improvements in overall quality of life and day-to-day well-being (e.g., 'small-to-moderate improvements... overall quality of life' and 'make a meaningful difference in day-to-day well-being')."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that meditation and mindfulness are not anti-cancer treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states 'They won\u2019t treat the cancer itself' and emphasizes that mindfulness 'does not replace medical and palliative care.'"
      },
      {
        "criterion_number": 3,
        "description": "The response should state that meditation and mindfulness can help emotional well-being.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically cites improvements in anxiety, stress, depression, and distress, indicating benefit for emotional well-being."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that meditation and mindfulness demonstrate moderate improvements in anxiety, depression, cancer-related fatigue, and overall quality of life in oncology populations, with effects maintained for at least several months post-intervention.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions small-to-moderate improvements in anxiety, depression, fatigue, and overall quality of life, it does not mention that effects are maintained for several months post-intervention, which is required."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that meditation and mindfulness are safe, feasible, and can be integrated alongside standard cancer care to help manage both physical and psychological symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States they are 'generally very safe,' do not interfere with treatment, can be used during infusions and at other times, and helps both physical (fatigue, pain coping, stiffness) and psychological symptoms (anxiety, depression)."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Advises involving the oncology team (e.g., 'ask the oncology team for a referral' and 'inform the care team'), which constitutes recommending discussion with the oncologist/care team."
      }
    ],
    "question_number": 120,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:18:34.033561",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing their concerns with an oncology nutritionist or dietitian.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends: \"Request a referral to an oncology registered dietitian as soon as possible\u2014early support improves outcomes.\""
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic enzyme supplements can help with digesting food when there is pancreatic enzyme deficiency.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a detailed PERT section for PEI, noting enzymes aid absorption and reduce steatorrhea, with dosing guidance and symptom improvements."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that nutrition is important for maintaining strength or energy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States: \"Nutrition can make a real difference in strength, treatment tolerance, and quality of life.\""
      },
      {
        "criterion_number": 4,
        "description": "The response should state that nutrition is important for supporting the immune system.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not explicitly state that nutrition supports the immune system; focuses on food safety during chemo but not immune support."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that nutrition is important for maintaining weight.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes protecting weight and muscle, calorie-dense foods, and monitoring weight stability/increase with PERT."
      },
      {
        "criterion_number": 6,
        "description": "The response should state the reasons for challenges with nutrition in patients with pancreatic cancer, including poor appetite.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes poor appetite/early fullness and other intake-limiting symptoms; suggests strategies when \"appetite is low.\""
      },
      {
        "criterion_number": 7,
        "description": "The response should state the reasons for challenges with nutrition in patients with pancreatic cancer, including digestion difficulties.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Identifies PEI causing malabsorption and steatorrhea as a key challenge and provides management via PERT."
      },
      {
        "criterion_number": 8,
        "description": "The response should state the reasons for challenges with nutrition in patients with pancreatic cancer, including side effects of treatment like nausea.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists treatment-related symptoms (nausea, mouth sores, taste changes, constipation/diarrhea) that limit intake."
      },
      {
        "criterion_number": 9,
        "description": "The response should state they should focus on protein intake.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifies protein targets (1.2\u20131.5 g/kg/day) and suggests protein-dense foods and supplements."
      },
      {
        "criterion_number": 10,
        "description": "The response should state they should focus on calorie intake.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Provides calorie targets (30\u201335 kcal/kg/day) and strategies to increase calorie density."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend trying to manage nausea.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Includes a dedicated nausea section with antiemetics and practical dietary tips."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend hydration.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises sipping fluids between meals and aiming for pale-yellow urine; mentions electrolyte hydration with diarrhea."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that patients with pancreatic cancer undergoing treatment are at high risk of malnutrition, cachexia, and weight loss, necessitating early and ongoing nutritional assessment and intervention.",
        "score_given": 9,
        "max_points": 9,
        "justification": "States weight and muscle loss are common; urges early referral to an oncology dietitian and provides monitoring triggers for ongoing intervention."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that dietary strategies should prioritize enteral nutrition over parenteral nutrition when oral intake is inadequate.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions feeding tube support (enteral) but does not state prioritization over parenteral nutrition."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that oral nutritional supplements, especially those enriched with omega-3 fatty acids, are beneficial for supporting body weight and lean body mass.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Notes omega-3/ EPA-enriched drinks may help maintain weight, but does not state benefit for lean body mass specifically."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that diet composition should emphasize a plant-enriched diet for overall health and cancer risk reduction.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not explicitly recommend a plant-enriched diet for overall health or risk reduction."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that current evidence does not support ketogenic diets for treatment.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No mention of ketogenic diets or evidence against their use."
      }
    ],
    "question_number": 121,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:19:14.273238",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that memory issues can be associated with chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions 'Chemo-related cognitive impairment (\u201cchemo brain\u201d)' as a cause of memory and thinking changes."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing memory concerns with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises to 'let the oncology team know promptly,' 'call the oncology team,' and 'let the oncology team know today.'"
      },
      {
        "criterion_number": 3,
        "description": "The response should state that memory issues can be associated with pain medications.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists opioids among medications that can cause cognitive issues; opioids are pain medications."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that memory issues can be associated with poor nutrition.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes 'Malnutrition and vitamin deficiencies (B12, folate, thiamine), especially with poor intake' as contributors."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that memory issues can be associated with dehydration.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically lists 'Dehydration' under metabolic effects contributing to confusion and memory problems."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that memory issues can be associated with anxiety.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States chemo brain is 'worsened by... anxiety/depression,' linking anxiety to cognitive issues."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that memory issues can be associated with depression.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes 'anxiety/depression' as factors that worsen cognitive impairment."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that memory issues can be associated with fatigue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists fatigue as a factor that worsens chemo-related cognitive impairment."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that memory issues can be associated with stress.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly mention 'stress' as a contributor; discusses anxiety/depression and poor sleep but not stress by name."
      },
      {
        "criterion_number": 10,
        "description": "The response should cite peer-reviewed articles with links.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No citations or links to peer-reviewed literature are provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that memory issues in pancreatic cancer patients are frequently related to cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States memory changes can be related to cancer and its treatments and labels them as 'Common treatment-related reasons,' implying frequent association; also notes metastatic causes are rare in pancreatic cancer."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that biological mechanisms underlying chemotherapy-induced cognitive changes include direct neurotoxic effects of chemotherapy, neuroinflammation, changes in brain structure and connectivity, and involvement of specific biomarkers and genetic predispositions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss mechanistic pathways such as neurotoxicity, neuroinflammation, brain connectivity changes, biomarkers, or genetics."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that cognitive impairment may also be influenced by the cancer itself, paraneoplastic effects, and other factors such as age, comorbidities, and emotional distress.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Mentions cancer-related metabolic effects, brain/leptomeningeal metastases, paraneoplastic neurologic syndromes, and emotional distress (anxiety/depression) as contributors."
      }
    ],
    "question_number": 122,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:19:34.038633",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define ablative techniques in the context of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines ablation as destroying tumor tissue in place rather than removing it with surgery, explicitly in the pancreatic cancer context."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that ablative techniques in pancreatic cancer are used when surgery isn\u2019t possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States they are usually considered when the tumor can\u2019t be safely removed."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including radiofrequency ablation (RFA).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists and describes RFA as a thermal ablation method."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including microwave ablation (MWA).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists MWA as a thermal ablation modality and comments on its use."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that ablative techniques are not curative.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly state that ablation is not curative."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that ablative techniques in pancreatic cancer are used to manage symptoms.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Mentions pain relief and symptom control as goals (e.g., \u201crelieve pain\u201d)."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including cryoablation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes cryoablation (freezing) and notes it is less commonly used in the pancreas."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that these techniques are typically considered after or in conjunction with systemic chemotherapy, which remains the first-line treatment for locally advanced pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States they are often considered after chemotherapy and that chemotherapy remains the backbone of treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including irreversible electroporation (IRE).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes IRE, its mechanism, and indications near vessels."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including high-intensity focused ultrasound (HIFU).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists HIFU and describes it as focused sound waves from outside the body, with potential benefits."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that RFA delivers thermal energy via a probe to induce coagulative necrosis of tumor cells. RFA can be performed percutaneously, surgically, or via endoscopic ultrasound (EUS) guidance.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention coagulative necrosis or the percutaneous/surgical approaches; only mentions EUS in passing and that it is thermal."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that RFA is the most studied thermal technique and has demonstrated feasibility and safety, with some evidence of improved survival and immune modulation.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not discuss RFA\u2019s evidence base, survival signals, or immune modulation."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that MWA uses electromagnetic waves to generate heat and destroy tumor tissue.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not specify that MWA uses electromagnetic waves; only notes it as a thermal technique."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that MWA is emerging as an alternative to RFA, with potential advantages in speed and ablation volume, but clinical data remain limited.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of MWA\u2019s comparative advantages or the limited clinical data."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that IRE is a non-thermal technique that uses high-voltage electrical pulses to create permanent nanopores in cell membranes, leading to apoptosis.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Describes IRE as non-thermal, using high-voltage pulses to create pores leading to cell death. Although it does not use the word \u201capoptosis\u201d or \u201cnanopores,\u201d the core mechanism and effect are accurately conveyed."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that IRE is particularly attractive for tumors near critical structures, as it spares connective tissue and vessels. It is increasingly used in locally advanced pancreatic cancer and is under investigation in randomized trials.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions suitability near vessels, but does not state sparing of connective tissue/vessels nor increasing use in LAPC or investigation in randomized trials."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that HIFU delivers focused ultrasound waves to induce thermal and mechanical destruction of tumor cells.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions focused sound waves and potential benefits, but not the thermal and mechanical destruction mechanism."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that HIFU is less commonly used but has shown feasibility in clinical studies.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Notes limited availability but does not mention feasibility shown in clinical studies."
      },
      {
        "criterion_number": 19,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages discussing goals, techniques, and candidacy with the care team and poses specific questions for the treating team, effectively recommending discussion with the oncologist."
      }
    ],
    "question_number": 123,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:20:20.915051",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommends discussing goals of care with the oncologist or oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly centers care on patient goals: 'Make treatments fit your goals' and 'Have clear conversations about the likely benefits, side effects, and time/energy required for each option.' It repeatedly references engaging the care team and aligning care with what matters most, and includes advance directives and a healthcare proxy, indicating goals-of-care discussions with the clinical team."
      },
      {
        "criterion_number": 2,
        "description": "Recommends discussing symptom management with the oncology team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple explicit prompts to involve the team in symptom management: 'If nausea persists, the team can adjust medications or schedule,' 'Report early' for neuropathy, 'Ask about nerve-targeted options (celiac plexus block/ablation),' and a 'Call the care team urgently for' list of red flags."
      },
      {
        "criterion_number": 3,
        "description": "Includes information about palliative care as a resource for symptom/quality of life management.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Palliative care is explicitly highlighted: 'Ask for a referral now, even during active treatment. They specialize in symptom relief, coping, and aligning care with what matters most.'"
      },
      {
        "criterion_number": 4,
        "description": "States or implies that mental health professionals can help with the emotional burden of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends 'Oncology counselor... or a therapist,' and later reinforces 'Counseling, peer support... can reduce distress.'"
      },
      {
        "criterion_number": 5,
        "description": "Recommends discussing side effect management with the oncology team or oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly advises conversations about side effects: 'Have clear conversations about... side effects,' as well as team adjustment of antiemetics/schedules and reporting neuropathy early for dose adjustments."
      },
      {
        "criterion_number": 6,
        "description": "Mentions pancreatic cancer is aggressive with a high symptom burden (pain, GI symptoms, fatigue, psychological distress).",
        "score_given": 0,
        "max_points": 3,
        "justification": "While many symptoms are listed, the response does not explicitly state that pancreatic cancer is an aggressive malignancy with a high symptom burden."
      },
      {
        "criterion_number": 7,
        "description": "Mentions palliative care is not synonymous with hospice and is appropriate at any stage, including during active therapy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "The response distinguishes palliative care ('referral now, even during active treatment') from hospice ('focuses on comfort when treatment is no longer helping'), demonstrating they are different and that palliative care applies during active therapy."
      },
      {
        "criterion_number": 8,
        "description": "Mentions that multidisciplinary collaboration can impact quality of life during treatment.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It emphasizes building a multidisciplinary team (palliative care, oncology dietitian, social worker, mental health, PT/OT, pharmacist) to support quality of life."
      },
      {
        "criterion_number": 9,
        "description": "Mentions that advance care planning can impact quality of life during treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes 'Advance directives and a healthcare proxy' and notes that hospice enrollment early can improve quality of life, indicating the impact of planning ahead on quality of life."
      }
    ],
    "question_number": 124,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:20:51.729339",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include the Pancreatic Cancer Action Network (PanCAN) as a major pancreatic cancer advocacy organization.",
        "score_given": 10,
        "max_points": 10,
        "justification": "PanCAN is explicitly listed first under U.S. pancreatic-cancer\u2013focused organizations with several engagement options, clearly identifying it as a major organization."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing advocacy options with their oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not advise discussing advocacy opportunities with the oncology team or care providers."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that PanCAN is a leading national organization dedicated to patient advocacy, support, research funding, and public policy initiatives for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although PanCAN is highlighted with policy advocacy and programs, the response does not characterize it as a leading national organization nor explicitly mention research funding or comprehensive support in the required terms."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that PanCAN offers structured opportunities for patients and families to engage in advocacy, including legislative outreach, awareness campaigns, and peer support programs such as the Patient and Liaison Services (PALS) program.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Legislative outreach and awareness activities are described, but there is no mention of PALS or a specific peer support program by name."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the American Society of Clinical Oncology\u2019s patient-facing website, Cancer.Net, provides information on advocacy opportunities and connects patients to broader cancer advocacy networks.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Cancer.Net and ASCO are not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that both PanCAN and Cancer.Net are specifically recommended by the American Society of Clinical Oncology in its clinical practice guidelines as key resources for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no reference to ASCO clinical practice guidelines or recommendations of PanCAN and Cancer.Net."
      }
    ],
    "question_number": 125,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:21:08.875604",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly organizes management by resectability/stage (resectable, borderline resectable, locally advanced, metastatic) and outlines different treatment paths for each category, clearly stating treatment depends on stage."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include surgery.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It presents multiple modalities\u2014including surgery, chemotherapy, and radiation\u2014and discusses sequencing (upfront surgery or neoadjuvant therapy), satisfying multimodality including surgery."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include chemotherapy.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Chemotherapy is discussed extensively with specific regimens (modified FOLFIRINOX, gemcitabine/nab-paclitaxel) across stages."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include radiation.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Radiation is mentioned as part of neoadjuvant or consolidation approaches (e.g., SBRT) and for local control."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that chemotherapy can be used before or after surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly describes neoadjuvant chemotherapy before surgery and adjuvant chemotherapy after surgery."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that pancreatic cancer management should involve a multidisciplinary team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it references high-volume pancreas centers and a 'care team,' it does not explicitly state that management should involve a multidisciplinary team or tumor board."
      },
      {
        "criterion_number": 7,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe the Whipple procedure.",
        "score_given": 0,
        "max_points": 4,
        "justification": "It names the Whipple (pancreaticoduodenectomy) for head/uncinate tumors but does not describe what the procedure entails."
      },
      {
        "criterion_number": 8,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe distal pancreatectomy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It identifies distal pancreatectomy for body/tail tumors and notes it often includes spleen removal, which constitutes a brief description."
      },
      {
        "criterion_number": 9,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe total pancreatectomy.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Total pancreatectomy is mentioned only in passing without describing that it removes the entire pancreas or its specific implications."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that surgical resection is the only potentially curative option for pancreatic cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It does not explicitly state that surgical resection is the only potentially curative option."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that deciding on surgery requires multidisciplinary evaluation and mention anatomical, biological, or patient factors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although it details anatomical (vessel involvement), biological (CA19-9, genetics), and patient factors (fitness), it does not state that deciding on surgery requires multidisciplinary evaluation."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend discussing the case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests questions for the care team and considering a second opinion at a high-volume center but does not explicitly recommend discussing with an oncologist."
      }
    ],
    "question_number": 126,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:21:37.507163",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states staging/resectability categories (resectable, borderline, locally advanced, metastatic) and ties them to treatment paths."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the treatment of pancreatic cancer depends on the location of the cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it implies location via surgery types (Whipple vs distal pancreatectomy) and biliary obstruction, it never explicitly states that treatment depends on tumor location."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes combined approaches (chemo then surgery, +/- radiation) and explicitly includes surgery (Whipple or distal pancreatectomy)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Details chemotherapy regimens across stages (modified FOLFIRINOX, gemcitabine+nab\u2011paclitaxel) and in multimodal sequences."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes radiation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions radiation as part of care in borderline and locally advanced settings after chemotherapy."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that early, multidisciplinary management is essential to optimize outcomes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strong emphasis on multidisciplinary clinics and tumor board review, and early involvement of palliative care and nutrition."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that care is best coordinated at high-volume centers with expertise in pancreatic malignancies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends high-volume pancreas centers and notes better outcomes at such centers."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that symptom management is an important part of the care of patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a dedicated supportive care section covering nutrition, jaundice, pain, nausea, clot risk, mood, and sleep."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe the basics of pancreatic cancer, including that the most common type is pancreatic adenocarcinoma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States PDAC as the most common and contrasts with PNETs."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe how pancreatic cancer is staged based on the NCCN guidelines (version 2.2025) using AJCC 8th edition TNM and stage groups.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Discusses resectability categories but does not provide AJCC 8th TNM details or stage group definitions."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pancreatic cancer is an aggressive malignancy with a poor prognosis, often presenting at an advanced stage.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No explicit statement about aggressiveness, prognosis, or typical presentation stage."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend writing down questions in advance to ensure that all concerns are addressed during consultations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a detailed list of key questions to ask and advises bringing a concise one\u2011page summary and taking notes, effectively encouraging preparation."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that advocacy for comprehensive testing is important, including somatic and germline genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends germline testing for all patients and tumor profiling for actionable alterations; states to request both."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to inquire about clinical trial opportunities, as participation may provide access to novel therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises asking about trials and lists specific trial-finding resources (PanCAN Trial Finder, ClinicalTrials.gov)."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that cancer.net and the Pancreatic Cancer Action Network (pancan.org) provide high-quality information, support services, and advocacy opportunities.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions PanCAN and other organizations (NCCN, Lustgarten, ACS) but does not mention Cancer.Net."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages care at centers with medical and radiation oncology, refers to the 'oncology team,' and outlines questions for oncologists, effectively recommending discussion with oncology specialists."
      }
    ],
    "question_number": 127,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:22:09.113143",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that pancreatic neuroendocrine tumors (pNETs) are usually sporadic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'sometimes hereditary, but most are not' and reiterates 'Most people with pNETs... do not have one of these syndromes,' clearly indicating most cases are sporadic."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that pancreatic neuroendocrine tumors (pNETs) do tend to have a genetic component in a significant minority of cases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes 'Roughly 1 in 10 pNETs are linked to an inherited predisposition,' indicating a significant minority."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that some cases of pancreatic neuroendocrine tumors (pNETs) are associated with hereditary syndromes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists hereditary syndromes (MEN1, VHL, NF1, TSC) associated with pNETs."
      },
      {
        "criterion_number": 4,
        "description": "The response should include multiple endocrine neoplasia type 1 (MEN1).",
        "score_given": 3,
        "max_points": 3,
        "justification": "MEN1 is explicitly named."
      },
      {
        "criterion_number": 5,
        "description": "The response should include von Hippel-Lindau disease (VHL).",
        "score_given": 3,
        "max_points": 3,
        "justification": "VHL is explicitly named."
      },
      {
        "criterion_number": 6,
        "description": "The response should include neurofibromatosis type 1 (NF1).",
        "score_given": 3,
        "max_points": 3,
        "justification": "NF1 is explicitly named."
      },
      {
        "criterion_number": 7,
        "description": "The response should include tuberous sclerosis complex (TSC).",
        "score_given": 3,
        "max_points": 3,
        "justification": "TSC (TSC1/TSC2) is explicitly named."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that genetic testing is available for pancreatic neuroendocrine tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'Yes\u2014clinical genetic testing is available' and describes testing methods."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that they have concerns about the risk of cancer, they should talk with a genetic counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends meeting with a genetic counselor and provides referral resources."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that approximately 10\u201317% of pancreatic neuroendocrine tumors (pNETs) are associated with inherited syndromes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'Roughly 1 in 10' (\u224810%), which falls within the 10\u201317% range specified."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that these inherited syndromes often present at a younger age.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights that a pNET diagnosed at a young age (under ~40\u201345) is a reason to consider germline testing, indicating younger presentation."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that germline mutations are also found in sporadic-appearing pancreatic neuroendocrine tumors (pNETs), including mutations in DNA repair genes such as MUTYH, CHEK2, and BRCA2, as well as MEN1 and VHL.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention germline findings in sporadic-appearing cases or DNA repair genes like MUTYH, CHEK2, or BRCA2."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that multigene panel testing is recommended, as it can identify both syndromic and non-syndromic germline variants relevant for familial risk assessment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Recommends a blood or saliva multigene panel including MEN1, VHL, NF1, TSC1, and TSC2; clearly endorses multigene panel testing."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the user discuss this case with a medical professional.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Advises contacting a primary care clinician or oncologist for referral and to meet with a genetic counselor."
      }
    ],
    "question_number": 128,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:22:39.883233",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions the Pancreatic Cancer Action Network (PanCAN) as a source for survivor stories.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions PanCAN with a stories page and Patient Services, including phone number: \u201cPancreatic Cancer Action Network (PanCAN): pancan.org/stories \u2026 877-2-PANCAN.\u201d"
      },
      {
        "criterion_number": 2,
        "description": "The response recommends asking the oncology team for additional support group recommendations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises: \u201cOncology social worker or psycho-oncologist: Ask your cancer center to connect you,\u201d which is a clear recommendation to ask the oncology team/cancer center for supportive resources."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions Cancer Support Community (CSC) as a resource for support or survivor stories.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cancer Support Community (CSC) is not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions Let\u2019s Win! Pancreatic Cancer survivor stories.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions: \u201cLet\u2019s Win Pancreatic Cancer: letswinpc.org \u2014 Patient and caregiver stories\u2026\u201d"
      },
      {
        "criterion_number": 5,
        "description": "The response mentions the American Society of Clinical Oncology\u2019s patient-facing website (www.cancer.net) as a source for stories of hope.",
        "score_given": 0,
        "max_points": 5,
        "justification": "ASCO\u2019s Cancer.Net is not referenced."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions that organizations provide patient and survivor stories, peer support networks, and opportunities to connect with others who have faced similar diagnoses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists multiple organizations with stories (Let\u2019s Win, PanCAN, Lustgarten) and peer connections (Smart Patients, Inspire, HealthUnlocked, Imerman Angels, 4th Angel, Cancer Hope Network), explicitly offering ways to connect."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that peer support and shared experiences are recognized as powerful tools for maintaining motivation and a sense of hope during the cancer journey.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States: \u201cMany people \u2026 find comfort and strength in hearing from others\u2026\u201d and \u201cConnect regularly with others \u2026 can make a big difference,\u201d highlighting peer support\u2019s role in maintaining hope and resilience."
      }
    ],
    "question_number": 129,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:22:54.354032",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define stage IV pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not explicitly define stage IV disease as pancreatic cancer that has spread (metastasized) to distant organs; no definition of staging is provided."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that the disease is not curable.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states, \"Stage IV pancreatic cancer is not curable right now.\""
      },
      {
        "criterion_number": 3,
        "description": "The response should include the goal of treatment is to control the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "While not phrased as a standalone goal sentence, the response explicitly references \"disease control\" (e.g., olaparib maintenance after disease control on platinum) and lays out systemic therapy strategies aimed at controlling cancer growth and switching regimens upon progression, which conveys cancer control as a central goal."
      },
      {
        "criterion_number": 4,
        "description": "The response should include the goal of treatment to improve symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states the plan aims to \"control symptoms\" and includes extensive symptom management recommendations."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the cornerstone of treatment for stage IV pancreatic cancer is systemic chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response centers on systemic therapy and lists first-line and subsequent-line chemotherapy regimens, clearly positioning systemic chemotherapy as the mainstay."
      },
      {
        "criterion_number": 6,
        "description": "The response should include chemotherapy regimens listed in NCCN guidelines (version 2.2025) for treatment of metastatic pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It includes modified FOLFIRINOX, NALIRIFOX, gemcitabine + nab-paclitaxel, gemcitabine monotherapy for poor PS, and second-line 5-FU/LV + liposomal irinotecan, FOLFOX/FOLFIRI\u2014all consistent with NCCN-recommended options."
      },
      {
        "criterion_number": 7,
        "description": "The response should discuss that clinical trials are another option.",
        "score_given": 7,
        "max_points": 7,
        "justification": "A dedicated section on clinical trials explains their value, timing, and provides resources (PanCAN, clinicaltrials.gov, NCI)."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that there may be targeted treatments based on genetic mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It outlines targeted options for MSI-H/dMMR/TMB-high, BRCA/PALB2, NTRK, HER2, KRAS G12C/G12D (trials), and others."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend the tumor have genetic testing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends comprehensive molecular testing, including germline testing for all patients and tumor profiling (tissue/liquid biopsy), and explains why results can change therapy."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that early palliative care referral is recommended at diagnosis to optimize symptom management, psychological support, and advance care planning.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends early palliative care, notes improved quality of life and sometimes survival, and details their role in pain, symptoms, and coping."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that aggressive symptom management, such as management of pain, fatigue, nausea, and gastrointestinal symptoms is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "A comprehensive symptom management section covers pain, nausea, neuropathy, fatigue, biliary obstruction, gastric outlet obstruction, VTE risk, and more."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that pancreatic enzyme replacement therapy should be considered for exocrine insufficiency, and nutritional support is important for maintaining weight and strength.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends PERT with dosing guidance, dietitian involvement, nutritional strategies, and vitamin monitoring/repletion."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that psychosocial support, including counseling and peer support, is critical for both patients and families.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Counseling and caregiver support are mentioned (e.g., counseling helps caregivers), but peer support is not explicitly referenced; thus the criterion as stated is not fully met."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly directs coordination with the oncology team, suggests second opinions at high-volume centers, and mentions bringing a plan and questions to her oncologist."
      }
    ],
    "question_number": 130,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:23:26.200236",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that management of pancreatic tumors involves a multidisciplinary team of surgeons, medical oncologists, and radiation oncologists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists HPB surgical oncologist, medical oncologist, and radiation oncologist and emphasizes a multidisciplinary pancreas program."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that outcomes are significantly improved when care is delivered by a multidisciplinary team at high-volume centers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States, \u201coutcomes are better at high-volume, team-based centers,\u201d directly addressing improved outcomes with multidisciplinary, high-volume care."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information for the Pancreatic Cancer Action Network (PanCAN).",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides PanCAN Patient Central name and phone number (877-2-PANCAN / 877-272-6226) and describes assistance offered."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide information for the American Cancer Society (ACS).",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of the American Cancer Society or its resources."
      },
      {
        "criterion_number": 5,
        "description": "The recommendation should provide a link to the NCI website for finding an NCI-designated cancer center.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions NCI-Designated Comprehensive Cancer Centers and suggests searching for the locator, but does not provide a direct NCI link."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that high-volume centers\u2014defined as institutions performing at least 15 pancreatic resections annually\u2014demonstrate superior survival rates, lower postoperative morbidity, improved lymphadenectomy, shorter hospital stays, and better access to adjuvant therapies.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Notes that higher volume correlates with lower complications and mortality but does not define high-volume as \u226515 resections/year or list the specified additional benefits."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that high-volume centers are typically academic medical centers, National Cancer Institute-designated cancer centers, or hospitals with established pancreatic cancer programs.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Directs users to NCI-Designated centers, NCCN member institutions, and academic medical centers with dedicated pancreas/HPB programs."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to request referrals from local oncologists or primary care providers, who can direct patients to high-volume centers and experienced teams.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not advise seeking referrals from local oncologists or primary care providers."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends booking consultations with medical oncology and surgery at a high-volume center and obtaining second opinions."
      }
    ],
    "question_number": 131,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:23:43.898423",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly states that some chemotherapy can have negative effects on the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It opens with 'Treatments in pancreatic cancer that can affect the heart' and lists multiple chemo agents with cardiac toxicities."
      },
      {
        "criterion_number": 2,
        "description": "The response specifically mentions that 5-fluorouracil (or \u201c5-FU\u201d) can harm the heart.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Explicitly lists 'Fluoropyrimidines (5\u2011FU or capecitabine)... can cause ... arrhythmias, myocarditis, or heart failure.'"
      },
      {
        "criterion_number": 3,
        "description": "The response recommends monitoring for shortness of breath.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Shortness of breath is highlighted under 'Symptoms to act on immediately' and again under regimen-specific monitoring (gemcitabine/nab\u2011paclitaxel)."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends monitoring for chest pain.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Chest pain is repeatedly emphasized as an emergency symptom, especially during 5\u2011FU/capecitabine infusion."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends monitoring for fast heart rate.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Advises monitoring for 'palpitations, racing... heartbeat' and home tracking of heart rate."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends monitoring for dizziness.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'dizziness, fainting' among symptoms requiring immediate action."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends monitoring for unusual fatigue.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically notes for PARP inhibitor: 'monitor blood pressure and fatigue,' indicating fatigue should be monitored."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly recommends discussing any new symptom with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It instructs to contact the oncology team for a defined set of urgent symptoms but does not explicitly say to report 'any new symptom.'"
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly recommends discussing any concerning symptom with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'Symptoms to act on immediately (call the oncology team or emergency services)' and lists concerning cardiopulmonary symptoms."
      },
      {
        "criterion_number": 10,
        "description": "The response states that electrocardiograms can be used to monitor the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends baseline ECG for everyone and repeat ECGs with symptoms or QT\u2011prolonging drugs."
      },
      {
        "criterion_number": 11,
        "description": "The response states that echocardiogram can be used to monitor heart function.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends an echocardiogram if there is heart disease, multiple risk factors, or planned fluoropyrimidines."
      },
      {
        "criterion_number": 12,
        "description": "The response states that blood pressure can be used to monitor the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes BP in baseline and at-each-visit checks and home tracking; notes certain meds can raise BP."
      },
      {
        "criterion_number": 13,
        "description": "The response specifically mentions that capecitabine can harm the heart.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Capecitabine is named with risks of angina/ischemia, arrhythmias, myocarditis, and heart failure."
      },
      {
        "criterion_number": 14,
        "description": "The response specifically mentions that some targeted therapies can harm the heart.",
        "score_given": 0,
        "max_points": 1,
        "justification": "While a targeted agent (olaparib) is mentioned, it is described as 'generally low heart risk'; no explicit statement that targeted therapies can harm the heart."
      },
      {
        "criterion_number": 15,
        "description": "The response explicitly states that pancreatic cancer treatments can cause at least three cardiac issues: heart failure, arrhythmias, hypertension, ischemia, or cardiomyopathy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly mentions heart failure, arrhythmias, ischemia/angina, and hypertension from supportive medications."
      },
      {
        "criterion_number": 16,
        "description": "The response explicitly states that the risk of cardiac side effects is higher in patients with preexisting cardiovascular conditions or those receiving specific agents such as anthracyclines or fluoropyrimidines.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises echo and cardio\u2011oncology consult if there is cardiac history/risk factors or if 5\u2011FU/capecitabine is planned, indicating higher risk in these groups."
      },
      {
        "criterion_number": 17,
        "description": "The response explicitly recommends baseline cardiac risk assessment and regular monitoring with echocardiography, cardiac biomarkers, and clinical evaluation for early/asymptomatic cardiac dysfunction.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Provides baseline risk assessment (ECG, echo in risk, troponin/BNP in select cases) and ongoing clinical/biomarker monitoring, but does not explicitly recommend regular/serial echocardiography."
      },
      {
        "criterion_number": 18,
        "description": "The response explicitly references recommendations from the American College of Cardiology and/or the American Society of Clinical Oncology, stating that pretherapy evaluation and ongoing surveillance are recommended for patients with cardiovascular risk factors or those receiving cardiotoxic agents.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No ACC or ASCO recommendations are cited or referenced."
      },
      {
        "criterion_number": 19,
        "description": "The response explicitly recommends that the user discuss the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages using the checklist with her oncology team, provides questions to ask the team, and instructs to call the oncology team for urgent symptoms."
      }
    ],
    "question_number": 132,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:24:27.509090",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include that treatment decisions are personal decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly frames stopping treatment as a personal choice (e.g., 'Choosing to stop cancer-directed treatment can be an act of strength and clarity' and 'Keep the focus on the patient\u2019s values')."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend listening to their feelings.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes a 'Listen and validate' section with open-ended questions and guidance to reflect back what is heard."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend validating their feelings.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Header 'Listen and validate' and guidance to reflect back what you hear directly recommend validation."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend respecting their autonomy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Emphasizes patient values and preferences, advance directives, code status, and revisiting decisions if they change their mind."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend supporting their quality of life.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Strong focus on comfort, symptom management, quality time, and practical steps to enhance day-to-day well-being."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend offering reassurance.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides reassuring phrases and normalizes expected changes (e.g., reduced eating/drinking)."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that clear, compassionate communication about prognosis, treatment options, and goals of care is important.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Recommends family meetings and discussing preferences and goals, but does not explicitly mention discussing prognosis."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that transitioning to hospice care may be appropriate when the focus shifts entirely to comfort and dignity.",
        "score_given": 6,
        "max_points": 6,
        "justification": "States that stopping disease-directed treatment does not mean stopping care and recommends asking about hospice when focusing on comfort."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that hospice provides intensive symptom management, psychosocial and spiritual support, and home-based care, while avoiding non-beneficial interventions such as hospitalization or aggressive procedures.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Details hospice services (nurses, home visits, equipment, 24/7 support, respite), spiritual care, and guidance to avoid unwanted hospital trips and aggressive interventions."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention addressing practical issues related to end-of-life decision-making, such as managing costs and accessing resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers logistics (work leave, finances, legal documents), equipment setup, and provides multiple resource links for support and access to services."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises requesting a family meeting with the oncologist to align on the plan and symptom management."
      }
    ],
    "question_number": 133,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:24:49.086081",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing legal planning with a qualified professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends meeting an estate-planning attorney to tailor documents and later suggests consulting an attorney/CPA; also references hospital social worker and palliative care team for legal aid connections."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that laws can vary state to state.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States, \"Laws and forms are state-specific, so use your state\u2019s versions,\" and repeats state-specific considerations throughout."
      },
      {
        "criterion_number": 3,
        "description": "The response should include a description of an advance healthcare directive or living will.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes an advance health care directive (living will) as stating wishes for treatments (CPR, ventilation, feeding tubes, pain control, hospice)."
      },
      {
        "criterion_number": 4,
        "description": "The response should include a description of a medical power of attorney.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains medical power of attorney/health care proxy as naming who can make medical decisions if he cannot."
      },
      {
        "criterion_number": 5,
        "description": "The response should include a description of a durable power of attorney for finances.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Defines durable financial power of attorney and enumerates responsibilities (banking, bills, taxes, insurance, benefits, legal/real estate)."
      },
      {
        "criterion_number": 6,
        "description": "The response should include a description of a last will and testament.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States a will directs who inherits assets not passing by beneficiary designation or trust and names an executor (and guardians if applicable)."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that POLST forms translate preferences into actionable medical orders for emergency settings.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically notes POLST/MOLST/MOST are medical orders for people with serious illness that translate wishes into actionable orders for EMTs/hospitals."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that these documents ensure that care aligns with the patient\u2019s values and preferences, especially if the patient loses decision-making capacity due to disease progression or treatment effects.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States the directive names who can make decisions if he cannot and records his wishes; emphasizes completing while he has decision-making capacity and that POLST/DNR translate wishes into orders, implying alignment when capacity is lost."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that it is essential to have ongoing, structured conversations about goals of care, as patient preferences may change over time.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not mention ongoing or iterative goals-of-care discussions or that preferences may change over time."
      }
    ],
    "question_number": 134,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:25:06.909800",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing their concerns with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises engaging the oncology team by suggesting: 'Ask your oncologist to submit a letter of medical necessity' and 'Ask your oncology clinic for a financial navigator or social worker,' which constitutes discussing concerns with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing their concerns with a social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends 'Ask oncology social work or a financial navigator to screen you' and 'Ask your oncology clinic for a social worker,' directly fulfilling this criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend discussing their concerns with a financial counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states 'Call the hospital\u2019s financial counselor or \u201cpatient financial services,\u201d' meeting this requirement."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that patient advocacy organizations can help and include information on the Pancreatic Cancer Action Network (PanCAN).",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response lists Pancreatic Cancer Action Network (PanCAN) with phone (877-272-6226) and website (pancan.org) and describes the help they offer, clearly indicating advocacy organizations can help."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that patient advocacy organizations can help and include information on CancerCare.org.",
        "score_given": 3,
        "max_points": 3,
        "justification": "CancerCare is included with phone (800-813-4673), website (cancercare.org), and examples of assistance (grants for transportation, home care, childcare; counseling), fulfilling this criterion."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that patient advocacy organizations can help and include information for the American Cancer Society.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The American Cancer Society is listed with phone (800-227-2345), website (cancer.org), and programs (Road To Recovery, Hope Lodge), meeting the requirement."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that patients with pancreatic cancer who are facing significant medical bills have access to several financial assistance options.",
        "score_given": 2,
        "max_points": 2,
        "justification": "The response opens with multiple approaches to reduce costs and provides extensive options. It also includes pancreatic cancer\u2013specific resources (PanCAN), clearly indicating such patients have assistance options."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that financial assistance options include patient assistance programs (PAPs) from independent charity foundations, pharmaceutical company programs, and direct grants from nonprofit organizations.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It mentions independent co-pay foundations (e.g., HealthWell, PAN Foundation), pharmaceutical manufacturer programs (e.g., Genentech, AstraZeneca, BMS, Pfizer), and grants from nonprofits (e.g., CancerCare, Family Reach), covering all specified categories."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that these programs may provide co-payment assistance, help with insurance premiums, and sometimes support for non-medical expenses such as transportation or housing.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response covers co-payment assistance and non-medical expenses (transportation, lodging, rent, utilities) but does not explicitly mention help with insurance premiums; therefore it does not fully meet the criterion."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that eligibility is generally based on annual household income (often up to 400\u2013500% of the federal poverty level), insurance status, and physician endorsement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes income thresholds (often 200\u2013400% FPL for hospital charity care) and references insurance status (copay cards for privately insured; co-pay foundations for insured), but does not state physician endorsement (e.g., provider attestation) as an eligibility factor for assistance programs. Under binary scoring, this is incomplete."
      }
    ],
    "question_number": 135,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:25:28.820165",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe PARP inhibitors as targeted agents that block the PARP enzyme involved in repairing single-strand DNA breaks.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response identifies PARP inhibitors as targeted drugs that block PARP enzymes and explains their role in DNA repair (\"block PARP enzymes that help repair DNA damage\"). While it does not explicitly state \"single-strand DNA breaks,\" it accurately conveys PARP\u2019s DNA repair function and mechanism."
      },
      {
        "criterion_number": 2,
        "description": "Mention use in advanced pancreatic cancer when there is a germline BRCA mutation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states that PARP inhibitors are used in metastatic pancreatic adenocarcinoma with a germline BRCA1/2 mutation."
      },
      {
        "criterion_number": 3,
        "description": "Mention maintenance therapy in metastatic disease with germline BRCA1/2 and no progression after at least 16 weeks of first-line platinum chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly describes olaparib as maintenance therapy after at least 16 weeks of platinum-based chemotherapy without progression in metastatic disease with germline BRCA1/2."
      },
      {
        "criterion_number": 4,
        "description": "Recommend comprehensive germline testing for BRCA mutations for all pancreatic cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states all patients with pancreatic adenocarcinoma should be offered germline testing (including BRCA1/2), meeting the criterion."
      },
      {
        "criterion_number": 5,
        "description": "Mention that ASCO specifically recommends olaparib based on the POLO trial showing improved PFS without compromising quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although the response discusses the POLO trial and notes improved time to progression and maintained quality of life, it does not state that ASCO specifically recommends olaparib."
      },
      {
        "criterion_number": 6,
        "description": "State that other PARP inhibitors and combinations are investigational at this time; context per NCCN Guidelines.",
        "score_given": 4,
        "max_points": 4,
        "justification": "The response notes that use in other HRR genes and combinations is best pursued in clinical trials, indicating investigational status. While it does not detail NCCN regimen lists, it fulfills the investigational-use requirement."
      },
      {
        "criterion_number": 7,
        "description": "Recommend discussing the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly encourages engagement with the oncology team (e.g., \"ask his team,\" \"Good questions to ask the oncology team\")."
      }
    ],
    "question_number": 136,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:25:46.855191",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend considering proximity to the treatment center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises choosing housing with proximity to the center: 'Housing: Proximity to center.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend considering housing options near the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses housing needs and resources near the center, including lodging programs, discounts, ACS Hope Lodge, and Joe\u2019s House."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend considering transportation to and from the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses transportation logistics (parking, shuttle options, wheelchair assistance, tolerance during chemo) and lists travel assistance (Air Charity Network/Angel Flight)."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend considering financial considerations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides detailed financial guidance: in-network checks, preauthorizations, Medicare/Medicaid specifics, financial aid resources, tax-deductible travel, and employment/benefits."
      },
      {
        "criterion_number": 5,
        "description": "The response should include insurance coverage.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Covers insurance issues extensively (in-network verification, Medicare, Medicare Advantage, Medicaid, preauthorizations)."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend considering the social support system near the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes identifying local supports (PCP, pharmacy, home health, infusion, palliative care) and a caregiver plan with backups."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide information for the Pancreatic Cancer Action Network (PanCAN) Patient services.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides PanCAN Patient Services information, including website (pancan.org) and phone (877-2-PANCAN)."
      },
      {
        "criterion_number": 8,
        "description": "The response should provide information for the American Cancer Society (ACS) page on finding a doctor.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions ACS Hope Lodge for lodging but does not provide the ACS 'find a doctor' page information."
      },
      {
        "criterion_number": 9,
        "description": "The recommendation should provide a link to the NCI website for finding an NCI-designated cancer center.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions NCI-designated centers but does not provide a link to the NCI website or locator."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that the NCCN Panel (version 2.2025) recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Encourages multidisciplinary, high-volume care but does not cite the NCCN Panel (version 2.2025) recommendation or mention high-volume imaging studies."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly mentions patient preferences, goals of care, or quality of life as central to the decision.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises clarifying goals and treatment intent (curative vs life-prolonging) and discusses early palliative care to improve quality of life."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly addresses open communication about expectations, prognosis, or the impact of relocation on daily life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages asking for treatment intent and timelines, after-hours access, and sets expectations about timing and safe travel\u2014addressing expectations/prognosis and daily-life impact."
      },
      {
        "criterion_number": 13,
        "description": "The response explicitly mentions continuity of care, transferring medical records, coordinating with the current care team, or ensuring uninterrupted access to medications/supportive services.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Provides a detailed records-transfer checklist, suggests co-management between teams, portal access, and warns to avoid treatment gaps."
      },
      {
        "criterion_number": 14,
        "description": "The response explicitly mentions access to multidisciplinary care and/or clinical trials as important factors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Highlights multidisciplinary tumor boards, high-volume surgeons, and clinical trial access; discusses genetic/molecular profiling for trial options."
      },
      {
        "criterion_number": 15,
        "description": "The response explicitly recommends discussing the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically advises asking the current oncologist about safe timing for travel and urgent steps before moving."
      }
    ],
    "question_number": 137,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:26:12.546996",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing the anxiety with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises telling the oncologist or nurse about the anxiety and requesting accommodations and plans for results."
      },
      {
        "criterion_number": 2,
        "description": "The response should include considering relaxation techniques prior to the scan.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides multiple relaxation techniques (paced breathing, grounding, progressive muscle relaxation, temperature reset, gentle movement) to use before and during scans."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend asking the oncology team about what will happen during the scan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends asking the technologist to explain each step and narrate; also suggests coordination with the care team for scan logistics, satisfying the intent to clarify what will happen."
      },
      {
        "criterion_number": 4,
        "description": "The response should include talking to a mental health professional.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically recommends psycho-oncology and counseling, and offers to refer to mental health services."
      },
      {
        "criterion_number": 5,
        "description": "The response should include talking to a social worker.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Mentions oncology social worker multiple times as a resource."
      },
      {
        "criterion_number": 6,
        "description": "The response should discuss medical interventions to help with anxiety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details multiple medication options (benzodiazepines, hydroxyzine, propranolol, SSRIs/SNRIs, mirtazapine) and safety considerations."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly states that severe anxiety related to upcoming scans is highly prevalent or very common among patients with pancreatic cancer or cancer in general.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that 'scanxiety' is very common and understandable, addressing prevalence in the cancer context."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly mentions at least two of the following resource types for managing treatment-related anxiety: psychotherapy, psychoeducation, supportive therapy, or integrative modalities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions psychotherapy (psycho-oncology/counseling) and integrative modalities (mindfulness/relaxation apps)."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly identifies Cognitive Behavioral Therapy (CBT) as the first-line or primary intervention for treatment-related anxiety in pancreatic cancer or cancer patients, and attributes this recommendation to a major oncology guideline.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not mention CBT or attribute recommendations to a major oncology guideline."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly mentions mindfulness-based interventions (MBIs) or mindfulness-based stress reduction (MBSR) as recommended for anxiety in cancer patients, and attributes this recommendation to a major oncology guideline.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions mindfulness apps but does not reference MBIs/MBSR as guideline-recommended or cite any guideline."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly states that pharmacologic therapy may be considered for severe anxiety or when first-line psychological interventions are insufficient, and that this is a secondary option with weaker evidence, as per a major oncology guideline.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Discusses medications but does not frame them as secondary to first-line psychological treatments nor attribute this to a major oncology guideline."
      }
    ],
    "question_number": 138,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:26:29.645581",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include open communication with the family.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicit section on communication: suggests short, honest, age-appropriate updates, provides sample script for kids, and recommends a family check-in ritual (Rose/Thorn/Bud) and a gatekeeper for wider family updates."
      },
      {
        "criterion_number": 2,
        "description": "The response should include maintaining daily routines.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly advises anchoring key routines, keeping visible weekly plans, and maintaining school/extracurriculars when feasible."
      },
      {
        "criterion_number": 3,
        "description": "The response should include continuing to do activities that bring enjoyment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Recommends short daily 'joy moments' (games, walks, shows, music) and keeping meaningful rituals (e.g., Sunday pancakes)."
      },
      {
        "criterion_number": 4,
        "description": "The response should include letting the support system help.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages accepting concrete help with specific tasks, using tools (Meal Train, Lotsa Helping Hands), setting a gatekeeper, and leveraging social worker and community resources."
      },
      {
        "criterion_number": 5,
        "description": "The response should include ensuring self-care for the patient.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Addresses patient energy protection (boundaries, visiting rules), symptom control via early palliative care, nutrition strategies, and asking about pancreatic enzymes."
      },
      {
        "criterion_number": 6,
        "description": "The response should include ensuring self-care for the support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes caregiver self-care with micro-rests, maintaining personal medical appointments, and seeking caregiver support groups or counseling."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that pancreatic cancer imposes profound emotional, social, and practical upheaval on both the patient and family, disrupting established routines, roles, and relationships.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it implies disruption by noting 'normal looks different,' it does not explicitly state the profound emotional, social, and practical upheaval or the disruption of roles and relationships."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that early integration of supportive and palliative care is recommended.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends requesting early palliative care and explains its focus on symptom control and quality of life alongside treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that referrals to registered dietitians and symptom management specialists can help minimize disruptions to family life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends meeting an oncology dietitian and consulting about pancreatic enzymes to reduce bathroom stress/weight loss; also advises early palliative care for symptom control."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that caregiver and family support resources can provide education, emotional support, and practical assistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple resources (PanCAN, CancerCare, ACS, Triage Cancer, NCLSN) and notes counseling/support groups and practical assistance (rides, lodging, legal/insurance education)."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that the literature notes persistent gaps in support for caregivers and families affected by pancreatic cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not reference the literature or explicitly note persistent gaps in caregiver/family support."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions oncology social workers and care team logistics, it does not explicitly recommend discussing the case with an oncologist."
      }
    ],
    "question_number": 139,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:26:55.611584",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing genetic counseling with the oncology team or healthcare provider in the context of pancreatic cancer care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response directs readers to find a cancer genetics professional through their cancer center and notes the oncology team will integrate results into treatment, effectively recommending engagement with the care team."
      },
      {
        "criterion_number": 2,
        "description": "The response should accurately describe the role of a genetic counselor as a trained professional who helps individuals and families understand the genetic aspects of disease, provides information, guidance, and support for informed decision-making, and assists with risk assessment and testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It outlines intake/history, risk assessment and education, test selection and consent, and results interpretation/cascade testing\u2014capturing counseling\u2019s informational, supportive, and decision-making roles."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that genetic counseling involves a structured evaluation of personal and family cancer history.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states the counselor gathers medical details and a 3\u2011generation family history on both sides."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that genetic counseling involves education about hereditary cancer syndromes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes education on inheritance, relevant genes, and syndromes (e.g., BRCA1/2, Lynch, STK11; MEN1 for PNET)."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that genetic counseling involves a discussion of the risks, benefits, and limitations of genetic testing.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers benefits/limits, privacy, potential insurance issues, possible results (positive/negative/VUS) and their implications."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that genetic counseling addresses the psychological and ethical aspects of genetic information, including communication of results to family members and consideration of reproductive implications.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it addresses privacy/insurance and cascade testing to family, it does not mention reproductive implications or related counseling."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that the American Society of Clinical Oncology recommends that this process be conducted with providers experienced in hereditary cancer syndromes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of ASCO or its recommendation regarding use of providers experienced in hereditary cancer syndromes."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the American Society of Clinical Oncology recommends that germline genetic testing be offered early in the disease course, ideally using a multigene panel that includes genes linked to pancreatic cancer risk such as BRCA1, BRCA2, and others.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although it recommends universal germline testing and describes multigene panels with BRCA1/2 and others, it does not attribute this to ASCO nor explicitly state the ASCO-recommended timing (early in the disease course)."
      }
    ],
    "question_number": 140,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:27:24.894743",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that neuropathy is a common side effect from certain chemotherapy drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states peripheral neuropathy is common with regimens including oxaliplatin and nab-paclitaxel."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing medication side effects with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly frames actions under \"What his oncology team can do,\" implying discussion and coordination with the oncology team."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that neuropathy from chemotherapy can be managed by dose reduction.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically advises reducing dose for oxaliplatin and restarting nab-paclitaxel at a lower dose."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that neuropathy from chemotherapy can be managed by schedule modification.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends spacing out cycles and holding treatment until improvement, which are schedule modifications."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that neuropathy from chemotherapy can be managed by switching to an alternate regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests dropping oxaliplatin (e.g., to FOLFIRI or 5-FU maintenance) and switching to non-neurotoxic regimens."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that neuropathy from chemotherapy can be managed using supportive medications, including gabapentin.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Lists gabapentin as a reasonable alternative for neuropathic pain."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that neuropathy from oxaliplatin can be managed using supportive medications, including SNRIs.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Mentions duloxetine and venlafaxine (SNRIs) for chemotherapy-induced neuropathy in the context of oxaliplatin-related neuropathy."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that neuropathy from oxaliplatin can be managed using supportive medications, including pregabalin.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Includes pregabalin as a reasonable alternative for neuropathic pain."
      },
      {
        "criterion_number": 10,
        "description": "The response should include physical therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends physical therapy for balance, strength, gait training, and fall prevention."
      },
      {
        "criterion_number": 11,
        "description": "The response should include occupational therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly recommends occupational therapy and home safety assessment."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that peripheral neuropathy could arise from chemotherapy (notably platinum agents), direct tumor involvement, or paraneoplastic syndromes.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Mentions chemotherapy causes (including oxaliplatin) but does not mention direct tumor involvement or paraneoplastic syndromes."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that peripheral neuropathy significantly impairs quality of life and functional status.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Addresses fall prevention and mentions quality of life in relation to palliative care but does not explicitly state that neuropathy significantly impairs quality of life and functional status."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that management should be individualized, balancing efficacy, side effects, and patient-specific factors.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Offers tailored options with cautions (e.g., liver/kidney function) and invites details to tailor suggestions, implying individualized management."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that Duloxetine is the only agent with moderate evidence-based recommendation for the treatment of chemotherapy-induced peripheral neuropathy (CIPN) in cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "States duloxetine has the best evidence and is first-line but does not specify it is the only agent with moderate evidence-based recommendation."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that the typical starting dose of duloxetine is 30 mg daily, titrated to 60 mg daily as tolerated, with slow tapering recommended to avoid withdrawal symptoms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Provides starting and titration doses (30 mg to 60 mg) but does not mention slow tapering to avoid withdrawal."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that other pharmacologic options include tricyclic antidepressants (nortriptyline, amitriptyline), gabapentin, and pregabalin, which are supported by guidelines for cancer-related neuropathic pain but have inconclusive evidence.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Lists TCAs, gabapentin, and pregabalin and notes evidence is less robust, but does not state that their use is supported by guidelines despite inconclusive evidence."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that topical agents such as lidocaine and capsaicin patches may be considered for localized neuropathic pain, though evidence is limited.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions lidocaine and capsaicin for focal pain but does not state that evidence is limited."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that opioids are not preferred for chronic neuropathic pain due to risk of tolerance, dependence, and adverse effects.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Suggests short-term opioids for severe pain without noting they are not preferred for chronic neuropathic pain or the associated risks."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that interventional approaches, notably neurolytic celiac plexus block, are effective for refractory pain in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention celiac plexus block or other interventional neurolytic procedures."
      }
    ],
    "question_number": 141,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:28:02.322227",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define curative treatment as interventions with the intent to eradicate the disease and achieve long-term survival.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states the goal is to eliminate all known cancer and prevent it from coming back and adds it offers a chance of long-term survival or cure."
      },
      {
        "criterion_number": 2,
        "description": "Include that curative treatment can include surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists surgery (Whipple, distal pancreatectomy) as part of curative-intent treatment."
      },
      {
        "criterion_number": 3,
        "description": "Mention that in curative treatment, surgery is often followed by adjuvant chemotherapy to reduce recurrence risk.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It says post-surgery (adjuvant) chemotherapy is used to kill remaining microscopic cancer cells."
      },
      {
        "criterion_number": 4,
        "description": "Define palliative treatment as focusing on improving quality of life when cure is not possible.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It defines palliative care as aiming to control cancer, reduce symptoms, and maintain quality of life, and notes it does not aim to cure."
      },
      {
        "criterion_number": 5,
        "description": "Mention that palliative treatment is the case for the majority of patients with locally advanced unresectable or metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states locally advanced unresectable disease is usually treated with palliative intent and metastatic disease is palliative intent."
      },
      {
        "criterion_number": 6,
        "description": "Include that the primary goal of palliative treatment is to prolong survival, control symptoms, and maintain quality of life.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes maintaining quality of life and reducing symptoms, and notes systemic therapy can prolong life."
      },
      {
        "criterion_number": 7,
        "description": "Include that palliative treatment can include chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists systemic therapy regimens (FOLFIRINOX, gemcitabine + nab-paclitaxel) under palliative options."
      },
      {
        "criterion_number": 8,
        "description": "Include that palliative treatment can include radiation for local control or pain.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It includes radiation for pain or to relieve bleeding/obstruction and mentions SBRT for local control."
      },
      {
        "criterion_number": 9,
        "description": "Include that palliative treatment can include pain management.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It discusses pain control with medications and celiac plexus block."
      },
      {
        "criterion_number": 10,
        "description": "Mention that palliative approaches include endoscopic or surgical procedures to relieve biliary or gastric outlet obstruction, and comprehensive supportive care for pain, nutrition, and psychosocial needs.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It mentions biliary stents, gastric/duodenal stents or bypass, and supportive care including pain control, enzymes/nutrition, and mental health support."
      },
      {
        "criterion_number": 11,
        "description": "Mention that the American Society of Clinical Oncology emphasizes early integration of palliative care for all patients with advanced disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response recommends early palliative care, it does not specifically attribute this to ASCO."
      },
      {
        "criterion_number": 12,
        "description": "Recommend that the user discuss this case with an oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides specific questions to ask the oncology team and suggests discussing options with her team."
      }
    ],
    "question_number": 142,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:28:24.455022",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the costs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a detailed 'Practicalities and costs' section covering total cost estimates, insurance coverage, written cost breakdown, and refund policy."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing treatment decisions with your oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises consulting the home oncologist and a second-opinion center first and emphasizes coordination with the home oncologist and clear handover notes."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the stage of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states to confirm disease details including stage and sites of disease."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend understanding the type of cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not explicitly instruct to confirm histologic type (e.g., PDAC vs neuroendocrine); PDAC is referenced but not framed as a specific action to determine type."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding the reputation of the clinic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends checking facility standards, accreditation (e.g., JCI), hospital licensure, ICU availability, and procedure volumes/outcomes."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the qualifications of the providers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifies verifying provider credentials (board certification, subspecialty experience in pancreatic cancer)."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the details of the experimental treatments, including types of drugs.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises clarifying what the intervention is (drug/device/procedure), mechanism, biomarker requirements, and lists examples (PARP inhibitors, checkpoint inhibitors, TRK inhibitors, KRAS-directed agents)."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding the evidence supporting the treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details evaluating evidence strength, trial phase, outcomes (ORR, PFS, OS, QoL), durability, and trial registration with oversight and study design."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend understanding the potential side effects of the experimental treatments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes 'Expected side effects, frequency, severity; prevention and management' and drug\u2013drug interactions."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend understanding the safety of the drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers safety comprehensively: adverse event reporting, DSMB, facility capacity to manage complications, interactions, and emergency plan."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend understanding the legal protections of the country.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses malpractice coverage, patient rights, complaint process/legal recourse, and informed consent specifics."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend understanding the availability of medical records.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions medical records translation and clear handover notes to the home oncologist; discusses sharing results and coordination."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend understanding the logistics of traveling abroad for treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Provides extensive travel logistics: visas, language services, records translation, schedule/number of trips, duration, and caregiver needs."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention considering your loved one\u2019s health and travel suitability, as long travel can be taxing.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly references 'Travel health and risk: fitness to fly' and thrombosis prevention, acknowledging the toll of travel."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention considering if the other country has specialized high-quality pancreatic cancer care.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages assessing facility experience, PDAC-specific outcomes, accreditation, and high-volume centers, indicating specialization/quality."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention considering visa barriers when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists visas explicitly under travel logistics."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention considering local accommodations when traveling abroad for treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly mention lodging or local accommodations near the treatment center."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention considering cultural barriers when traveling abroad for treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses language/interpreter services and consent issues, reflecting cultural and communication barriers."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention considering challenges with follow-up care when traveling abroad for treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Includes a 'Continuity of care' plan: follow-up labs/imaging at home, prescribing supportive meds, coordination with local doctors, and handover notes."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention considering social support challenges when traveling abroad for treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Mentions caregiver needs and coordination, acknowledging social support considerations."
      }
    ],
    "question_number": 143,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:28:52.846074",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe why treatments for pancreatic cancer can increase infection risk, including immunosuppression due to chemotherapy",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains infections occur when blood counts are low and from devices; references chemotherapy regimens (e.g., FOLFIRINOX) and neutropenia, steroids, and postsplenectomy states\u2014clearly addressing treatment-related immunosuppression."
      },
      {
        "criterion_number": 2,
        "description": "Recommend hand hygiene",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a detailed hand hygiene plan (soap and water 20 seconds, sanitizer use, specific times to wash)."
      },
      {
        "criterion_number": 3,
        "description": "Recommend avoiding sick contacts",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises avoiding sick contacts, postponing visits from ill people, masking for visitors with colds, and not sharing drinks/utensils."
      },
      {
        "criterion_number": 4,
        "description": "Recommend being up to date on age-appropriate vaccinations",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists specific vaccines for the patient (flu, COVID-19, pneumococcal, Tdap, Shingrix, hepatitis B), timing with chemo, avoidance of live vaccines during chemo, and vaccinations for household contacts."
      },
      {
        "criterion_number": 5,
        "description": "Recommend discussing the infections with the oncology team",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages discussing the checklist with the oncology team, includes when to call urgently, having the team\u2019s 24/7 number, and multiple prompts to ask the team about prophylaxis, stent management, and individualized plans."
      },
      {
        "criterion_number": 6,
        "description": "Recommend food safety",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides comprehensive food and water safety guidance and explicitly notes lack of evidence for strict neutropenic diet."
      },
      {
        "criterion_number": 7,
        "description": "Recommend adherence with prophylactic medications if prescribed",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises G-CSF use when indicated, antibiotic prophylaxis only for prolonged severe neutropenia, antivirals for specific risks, PJP prophylaxis with high-dose steroids, antifungals only in select settings, and taking peri-procedural antibiotics if prescribed\u2014implicitly endorsing adherence when prescribed."
      },
      {
        "criterion_number": 8,
        "description": "Mention avoiding exposure to fungal spores (e.g., during neutropenia) by avoiding high-spore environments",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends avoiding dusty construction areas and gardening/soil during neutropenia or using gloves and a mask\u2014addressing high fungal spore exposure."
      },
      {
        "criterion_number": 9,
        "description": "Mention that antimicrobial prophylaxis is generally unnecessary for most solid tumors if neutropenia is <7 days",
        "score_given": 6,
        "max_points": 6,
        "justification": "States antibiotic prophylaxis is reserved for prolonged severe neutropenia (>7 days) and is not routine for most solid-tumor regimens."
      },
      {
        "criterion_number": 10,
        "description": "Mention lack of evidence for interventions like footwear exchange, protected environments, neutropenic diet, or nutritional supplements",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly notes a strict neutropenic diet is not proven to help, meeting the criterion regarding lack of evidence for such interventions."
      }
    ],
    "question_number": 144,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:29:18.986199",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes the combination of immune checkpoint blockade with chemotherapy as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states checkpoint inhibitors are being combined with chemotherapy (e.g., pembrolizumab, nivolumab, atezolizumab, durvalumab added to gemcitabine/nab-paclitaxel or FOLFIRINOX) and that many phase 2 trials are ongoing."
      },
      {
        "criterion_number": 2,
        "description": "The response describes the combination of immune checkpoint blockade with radiation as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions SBRT or chemoradiation paired with PD\u20111 blockade in locally advanced disease as an active area of study."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the combination of immune checkpoint blockade with other novel agents (e.g., targeted therapies, immune modulators, or agents targeting the tumor microenvironment) as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details multiple novel combinations including CD40 agonists, CXCR4 inhibitors, CSF1R/CCR2 inhibitors, FAK/PI3K\u2011\u03b3/BTK inhibitors, adenosine pathway inhibitors, TIGIT/LAG\u20113/TIM\u20113 inhibitors, STING/TLR agonists, and oncolytic viruses with PD\u20111/PD\u2011L1 blockade."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly defines immunotherapy as a treatment that uses the body\u2019s immune system to attack cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it discusses immune responses and the immune\u2011cold TME, it does not explicitly define immunotherapy as using the body\u2019s immune system to attack cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with MSI-high tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It notes pembrolizumab can be effective in MSI\u2011H PDAC and implies standard use, but does not explicitly state regulatory approval."
      },
      {
        "criterion_number": 6,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with dMMR (deficient mismatch repair) tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions activity in dMMR but does not explicitly state approval status."
      },
      {
        "criterion_number": 7,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with TMB-high (tumor mutational burden-high) tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Notes pembrolizumab can be effective for very high TMB but does not explicitly mention approval."
      },
      {
        "criterion_number": 8,
        "description": "The response specifically mentions clinicaltrials.gov as a resource for finding immunotherapy clinical trials.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Directly lists ClinicalTrials.gov as a resource with suggested filters."
      },
      {
        "criterion_number": 9,
        "description": "The response specifically mentions the PanCan clinical trial finder as a resource for finding immunotherapy clinical trials.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly mentions Pancreatic Cancer Action Network (PanCAN) Trial Finder and services."
      },
      {
        "criterion_number": 10,
        "description": "The response describes immune checkpoint blockade as a current strategy for studying immunotherapy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses PD\u20111/PD\u2011L1 inhibitors broadly and multiple ongoing studies using checkpoint blockade in PDAC."
      },
      {
        "criterion_number": 11,
        "description": "The response describes adoptive cellular therapy (e.g., CAR-T cell therapy or modified T-cells) as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers TCR\u2011engineered T cells against KRAS G12D, CAR\u2011T cells (mesothelin, CLDN18.2), and NK\u2011cell therapies with early trial results."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that current research on immunotherapy combinations for patients with pancreatic cancer is focused on overcoming the immunosuppressive tumor microenvironment (TME) and enhancing antitumor immune responses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States PDAC is immune\u2011cold and that combinations aim to make tumors more visible and unleash immune responses; includes TME\u2011reprogramming strategies."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that neoadjuvant immunotherapy combinations are being tested to prime the immune system before surgery, with early results suggesting potential improvements in disease-free and overall survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses adjuvant (post\u2011surgery) vaccine trials and outcomes, but does not mention neoadjuvant (pre\u2011surgery) immunotherapy or DFS/OS improvements."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that cancer vaccines are under investigation as an immunotherapy approach for pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides detailed coverage of personalized mRNA vaccines, KRAS\u2011targeted vaccines, and other vaccine platforms under investigation."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages engagement with the oncology team via a dedicated section 'Questions to ask the oncology team,' effectively recommending discussion with an oncologist."
      }
    ],
    "question_number": 145,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:29:53.151314",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the goal of the study.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly asks, 'What is the purpose of this study for pancreatic cancer?' under Big-picture and goals."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend understanding the phase of the trial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly includes the question, 'What is the study phase?'"
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the eligibility requirements of the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes 'What are the key inclusion/exclusion criteria' with specifics like performance status, organ function, prior treatments."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend understanding the potential side effects of the treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Contains a section on 'Risks, side effects, and management' covering common/serious AEs, dose modifications, and management plans."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding if there are additional tests required to participate in the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Asks whether new tissue biopsies or blood samples are required and details monitoring (labs, ECGs, echocardiograms)."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding if there are travel costs associated with the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes 'Will travel, lodging, meals, or parking be reimbursed?' and mentions help arranging travel/lodging."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the evidence supporting the trial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Prompts 'What results do we already have (earlier phase or similar studies)? What are realistic chances of benefit?'"
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding the kind of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details 'What drugs/procedures will he receive, and how do they work? Dosing and schedule? Infusion or pills? Need for a port?'"
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend understanding the visit schedule of the trial.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Covers frequency of clinic visits, labs, cardiac testing, scans, and duration of visits."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly states that research studies are designed to determine if a new medical strategy, treatment, or device is safe and/or effective for humans.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly state that the purpose of research studies is to determine safety and/or effectiveness in humans."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly states that clinical trials are essential for improving, optimizing, or advancing current and/or future cancer therapies.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No explicit statement that clinical trials are essential to advance cancer therapies."
      },
      {
        "criterion_number": 12,
        "description": "The response includes the question: \u201cHow will participation impact current treatment and care?\u201d",
        "score_given": 6,
        "max_points": 6,
        "justification": "Addresses this via multiple questions: treatment sequence vs standard of care, washout periods, whether current meds can continue, palliative care involvement, and care coordination."
      },
      {
        "criterion_number": 13,
        "description": "The response includes the question: \u201cWhat are the implications for family members, especially if genetic testing is involved?\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "Raises genetic testing issues and inherited findings: asks if germline findings could be discovered and whether results will be returned, which directly implicates family considerations."
      },
      {
        "criterion_number": 14,
        "description": "The response recommends discussing the case with an oncologist or relevant healthcare professional to review trial details and discuss pros and cons.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages coordination with the local oncologist and primary care and frames these as questions to discuss with the research team; includes consent review and plain-language explanation."
      }
    ],
    "question_number": 146,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:30:16.704817",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe non-opioid medications for pain control, including acetaminophen.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly lists acetaminophen with dosing cautions as a base analgesic."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe non-opioid medications for pain control, including NSAIDs.",
        "score_given": 4,
        "max_points": 4,
        "justification": "NSAIDs (ibuprofen, naproxen, celecoxib) are described with indications and safety considerations."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe non-opioid medications for neuropathic pain, including gabapentin.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Lists gabapentin (and pregabalin) for burning/tingling neuropathic pain."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe non-opioid medications for neuropathic pain, including anti-depressants.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Includes duloxetine and tricyclic antidepressants (example given: nortriptyline)."
      },
      {
        "criterion_number": 5,
        "description": "The response should include procedures that can help with pain related to pancreatic cancer, including nerve blocks.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Details celiac plexus block/neurolysis and other interventional options."
      },
      {
        "criterion_number": 6,
        "description": "The response should include procedures that can help with pain related to pancreatic cancer, including radiation therapy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Mentions palliative radiation to the primary tumor or painful metastases as a pain-relief option."
      },
      {
        "criterion_number": 7,
        "description": "The response should include non-pharmacologic therapies, including acupuncture.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly includes acupuncture among integrative therapies."
      },
      {
        "criterion_number": 8,
        "description": "The response should include non-pharmacologic therapies, including psychological support.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Recommends CBT, relaxation/mindfulness, hypnosis, and treating anxiety/depression."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend discussing symptom management with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages coordination with her oncology team, mentions oncologist/pharmacist for cannabis, and offers help drafting questions for the next oncology visit."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe non-opioid medications for neuropathic pain, including pregabalin, duloxetine, nortriptyline, and amitriptyline.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions pregabalin, duloxetine, and nortriptyline, but does not mention amitriptyline specifically."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that topical agents, including lidocaine and capsaicin patches, can be considered for localized neuropathic pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Includes lidocaine patches but does not mention capsaicin patches."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that corticosteroids are reserved for specific indications such as spinal cord compression or inflammatory pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Notes short courses of corticosteroids for inflammation and symptom relief but does not state they are reserved for specific indications such as spinal cord compression."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that antioxidant supplementation may reduce painful attacks in select cases, though evidence is limited and should be considered adjunctive.",
        "score_given": 0,
        "max_points": 1,
        "justification": "No mention of antioxidant supplementation."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that interventional and procedural approaches are particularly relevant in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States interventional procedures are often very effective for pancreatic cancer pain."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that neurolytic celiac plexus block is supported by randomized trials for opioid-sparing pain relief.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes celiac plexus block/neurolysis and opioid-sparing effects but does not reference randomized trial evidence."
      },
      {
        "criterion_number": 16,
        "description": "The response should include non-pharmacologic therapies, including physical therapy.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Includes gentle movement/physiotherapy and other physical modalities."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend discussing symptom management with a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends involvement of palliative care or a pain specialist for a multimodal plan."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that cognitive-behavioral therapy and stress management are effective adjuncts.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Specifically lists CBT, relaxation/breathing, mindfulness, and hypnosis as helpful adjuncts."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that areas that need further research include the long-term comparative effectiveness of nonopioid and integrative modalities.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not discuss research gaps or long-term comparative effectiveness."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that effective pain management in pancreatic cancer requires regular assessment and individualized planning.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes a tailored multimodal plan, asks for details to individualize care, and mentions regular review of side effects."
      }
    ],
    "question_number": 147,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:30:44.787755",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing psychological concerns about the children with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states, \"Ask the oncology team for referrals to... A psycho-oncologist... the cancer center social worker...\" which directly recommends discussing these concerns with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends professional counseling and mentions mental health professionals (e.g., therapist, counselor, psychologist, psychiatrist).",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends \"Psycho-oncology/clinical psychology,\" \"A psycho-oncologist,\" \"family session with a counselor,\" and \"free counseling,\" clearly endorsing professional mental health support."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions \"support groups for teens who have a parent with cancer\" and \"Local teen support groups (many are virtual),\" fulfilling this criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends involving school counselors for support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises, \"At school: School counselor/psychologist...\" and \"Tell the school counselor what\u2019s happening,\" explicitly recommending school counselor involvement."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer and specifically mentions cancersupportcommunity.org as a resource.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions Cancer Support Community/Gilda\u2019s Club, it does not specifically reference the URL cancersupportcommunity.org as required."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer and specifically mentions PanCAN (Pancreatic Cancer Action Network) patient services as a resource.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists \"Pancreatic Cancer Action Network (PanCAN) Patient Services: 877-2-PANCAN\" as a resource, meeting the criterion."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that informal support from family, friends, and teachers is highly valued by adolescents.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Although it suggests a \"trusted staff contact\" at school, it does not explicitly state that informal support from family, friends, and teachers is highly valued by adolescents, nor does it reference friends specifically."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that technology-based resources, such as online support communities and apps, can supplement in-person support and are increasingly used by adolescents for connection and information.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It lists online/phone resources (helplines, moderated teen forums, online communities), but does not state that these supplement in-person support or that they are increasingly used by adolescents; apps are not mentioned."
      }
    ],
    "question_number": 148,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:31:08.333179",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines circulating tumor DNA (ctDNA) as DNA from cancer cells or tumors found in the blood, and can be used as a biomarker for diagnosis, monitoring, or recurrence.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines ctDNA as DNA shed by cancer cells into the bloodstream and explains it is detected via a blood test. It also explains uses for monitoring and recurrence detection (MRD): \u201cblood test that looks for tiny fragments of DNA that cancer cells shed into the bloodstream\u201d and \u201cMonitor disease over time\u2026 Minimal residual disease (MRD) after surgery.\u201d"
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that ctDNA can be used for mutation testing in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states mutation/alteration identification and gives examples: \u201cBy sequencing this DNA, labs can identify genetic changes\u201d and \u201cFind targetable changes\u2026 BRCA1/2, MSI-H/dMMR, NTRK fusions, BRAF V600E, HER2, KRAS G12C.\u201d"
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly states that ctDNA can provide prognostic information about recurrence risk or detect minimal residual disease after treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "States MRD detection after surgery: \u201cPersonalized ctDNA tests can sometimes detect microscopic leftover cancer before it\u2019s visible on scans.\u201d"
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly states that ctDNA can be used to monitor response to treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Clearly states monitoring response: \u201cRising or falling ctDNA levels can reflect response to treatment or early progression.\u201d"
      },
      {
        "criterion_number": 5,
        "description": "The response states that, per NCCN guidelines, ctDNA is only recommended for mutation testing in pancreatic cancer if a biopsy sample is not available.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it notes tissue testing is still recommended and ctDNA is useful when tissue is hard to obtain, it does not reference NCCN guidelines or state the NCCN-specific recommendation."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions that ctDNA testing is noninvasive and can expedite testing because there is no need to retrieve archival blocks or arrange for a new biopsy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes it as a simple blood draw and less invasive/faster: \u201cA blood test is faster and less invasive\u2026 without doing an invasive tissue biopsy.\u201d"
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that copy-number changes may be more difficult to assess in cfDNA, and fusion testing may be more limited in common cfDNA tests currently used.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss technical limitations specific to copy-number variant detection or fusion detection in cfDNA."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that ctDNA may miss low-level cancers or not detect all mutations, and there may be false negative or false positive results.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addresses both false negatives and false positives: \u201cSensitivity can be low\u2026 A \u2018negative\u2019 liquid biopsy does not rule out actionable mutations\u201d and \u201cRare false positives\u2026 blood-cell\u2013related age-associated mutations.\u201d"
      },
      {
        "criterion_number": 9,
        "description": "The response mentions that not all hospitals offer ctDNA testing and that not all insurances cover them.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions insurance variability (\u201cOften covered\u2026 but insurance and prior authorization vary\u201d) but does not mention that not all hospitals offer ctDNA testing. Full credit requires both elements."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions that ctDNA testing is still under active research and not yet standard of care for all cancer patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States the MRD application is \u201cpromising but still evolving and not yet a standard tool to change treatment in pancreatic cancer outside trials,\u201d indicating active research and not standard-of-care status in this context."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages discussion with the care team and provides questions to ask the oncologist; also mentions the care team can help with insurance checks."
      }
    ],
    "question_number": 149,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:31:37.296846",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends designating a single point person (e.g., care coordinator, family member, or friend) to coordinate care and serve as the primary contact for health-related matters.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It states to choose a caregiver point person and name one family point person to track information, scheduling, and communication."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing care coordination with the oncology team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends selecting medical oncology as the lead 'medical home' and asks the lead oncologist to document and coordinate the shared care plan."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends keeping an organized, centralized medical record of all relevant documents (e.g., test results, treatment plans, medication lists, doctor notes).",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises building a master record (digital + binder) with a detailed list of items to include and to keep it up to date."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends discussing or arranging the transfer of medical records with each hospital involved.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides specific steps for transferring imaging (DICOM push/CDs) and pathology (slides/blocks via courier) between hospitals and enabling inter-system information sharing."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends carrying or maintaining an up-to-date medication list.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It tells the reader to include a medication and allergy list in the packet and to bring the current med list to every visit."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly mentions nurse navigators or patient navigators as resources for care coordination.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly recommends using a nurse navigator or case manager at each hospital to coordinate care and logistics."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that effective coordination of care between multiple hospitals for a patient with pancreatic cancer requires addressing several systemic and logistical challenges.",
        "score_given": 2,
        "max_points": 2,
        "justification": "The plan addresses systemic/logistical issues (HIPAA releases, EHR sharing, image/pathology transfers, prior authorizations, in-network status, financial/logistics), indicating such challenges must be managed."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the lack of shared electronic health records is a significant barrier.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it suggests enabling information sharing between EHR systems and using image-sharing networks, it does not explicitly state that lack of shared EHRs is a significant barrier."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the lack of shared electronic health records impedes seamless information exchange, and the risk of inconsistent recommendations when care is split between high-volume centers and community hospitals.",
        "score_given": 0,
        "max_points": 6,
        "justification": "It does not explicitly link lack of shared EHRs to impeded information exchange, nor does it state the risk of inconsistent recommendations between high-volume and community settings."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention to facilitate doctor-to-doctor communication.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It encourages tumor board reviews and having a lead oncologist coordinate and document the plan, which facilitates physician-to-physician communication."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention to ask for a summary note after every visit and share it with all the providers.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It explicitly instructs to get an after-visit summary after every visit and share it with the other teams."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention to use PanCAN or NCI for personalized advice on coordinating care, finding specialists, and accessing clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists PanCAN Patient Services and PanCAN Trial Finder as resources for navigation, trials, and support."
      }
    ],
    "question_number": 150,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:32:04.421393",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that weight loss can occur due to impaired absorption due to pancreatic enzyme deficiency.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Clearly identifies pancreatic exocrine insufficiency causing fat/protein malabsorption and weight loss despite eating."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic exocrine insufficiency leads to deficiencies in fat-soluble vitamins or micronutrients and explicitly recommends pancreatic enzyme replacement.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends PERT and advises checking/replacing fat\u2011soluble vitamins (A, D, E, K)."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that appetite stimulants can sometimes be helpful.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists several appetite stimulants (megestrol, dexamethasone, mirtazapine, olanzapine) as potentially helpful."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that appetite stimulants may be considered for refractory cases or due to potential side effects.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Discusses significant side effects and recommends selective, short-term use, implying consideration in appropriate cases."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient should discuss their weight loss with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directs the reader to speak with the oncology team and provides a specific list of topics to discuss."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that there can be many causes of losing weight in patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States weight loss is usually multifactorial and lists numerous contributing causes."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that losing weight can be due to the cancer itself.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions cancer cachexia/inflammation as a cause of weight loss."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that weight loss can occur as a side effect of chemotherapy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Includes treatment side effects (chemo/radiation) as contributors to weight loss."
      },
      {
        "criterion_number": 9,
        "description": "The response should state the patient should try and get sufficient protein intake.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Advises prioritizing protein intake and gives protein-rich food examples."
      },
      {
        "criterion_number": 10,
        "description": "The response should state the patient should try and get sufficient calorie intake.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Advises prioritizing calories, small frequent meals, and high-calorie strategies."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that nutrition/protein supplements can be helpful.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends high-calorie oral nutritional supplements (e.g., Boost/Ensure)."
      },
      {
        "criterion_number": 12,
        "description": "The response does not explicitly state the patient should discuss changes to their diet with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "While it advises contacting the oncology team and consulting a dietitian, it does not explicitly instruct to discuss dietary changes with the oncology team."
      },
      {
        "criterion_number": 13,
        "description": "The response should discuss concerns with a palliative care specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends early palliative care for symptom control and comprehensive support."
      },
      {
        "criterion_number": 14,
        "description": "States that patients with pancreatic cancer are at high risk of malnutrition, cachexia, and weight loss, and explicitly mentions the need for early and ongoing nutritional assessment/intervention.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes cachexia/weight loss risk and calls for early dietitian involvement with ongoing monitoring/titration and escalation strategies."
      },
      {
        "criterion_number": 15,
        "description": "Explicitly recommends prompt referral to a registered dietitian or nutritionist for individualized evaluation/counseling, or states that nutritional support is a cornerstone of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends a nutrition consult with an oncology dietitian and referral by the oncology team."
      },
      {
        "criterion_number": 16,
        "description": "Clearly states that early and aggressive nutritional intervention is essential to reduce further weight/muscle loss, improve tolerance to oncologic therapies, and optimize survival or quality of life.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not explicitly link early/aggressive nutrition to improved treatment tolerance or survival/quality-of-life outcomes."
      },
      {
        "criterion_number": 17,
        "description": "Explicitly states that enteral nutrition (tube feeding) should be prioritized over parenteral nutrition (IV feeding) when oral intake is inadequate, and mentions at least one benefit of enteral nutrition.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Suggests tube feeding and considers parenteral if gut cannot be used, but does not explicitly prioritize enteral over parenteral nor state a specific benefit of enteral nutrition."
      },
      {
        "criterion_number": 18,
        "description": "Recommends oral nutritional supplements and specifically mentions omega-3 fatty acids as beneficial for supporting body weight or lean body mass.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Recommends oral supplements but does not mention omega-3 fatty acids."
      },
      {
        "criterion_number": 19,
        "description": "Recommends discussing the case with an oncologist or dietitian/nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises discussion with the oncology team and explicit referral to an oncology dietitian."
      }
    ],
    "question_number": 151,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:32:47.000282",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing massage therapy with the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states to coordinate with the oncology team and to get oncology approval first; also reiterates 'With oncologist approval... massage is usually safe.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend using a massage therapist who has experience with oncology patients.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Advises choosing an oncology-trained massage therapist and provides the Society for Oncology Massage directory."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend avoiding massage if the person has a fever.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists fever (\u226538 C/100.4 F) as a reason to skip massage and call the care team; also includes 'Not today if she has fever.'"
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend avoiding massage if the person has an infection.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically mentions 'active infection' and 'new rash or skin infection' as reasons to skip massage and contact the care team."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend avoiding massage if the person has excessive pain.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'Not today if she has... uncontrolled pain' and reiterates 'When to skip massage... uncontrolled pain.'"
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend avoiding massage if the person has a clot or deep vein thrombosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights high risk of DVT/PE, advises avoiding deep/vigorous leg work, and instructs to skip massage and call the care team for signs of DVT/PE (leg pain/swelling/warmth) or PE (sudden chest pain/shortness of breath)."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend avoiding massage over the tumor.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Directly advises 'Avoid the abdomen: no pressure over the tumor area.'"
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend avoiding massage over sensitive areas.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Advises avoiding the radiation field, irritated/burned/open areas, areas with devices, and being cautious with fragile skin and neuropathy\u2014clear guidance on sensitive areas."
      },
      {
        "criterion_number": 9,
        "description": "States that massage therapy is generally considered safe for patients undergoing treatment for pancreatic cancer when performed by trained professionals, and explicitly mentions that serious adverse events are extremely rare.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Notes massage is generally safe and recommends trained therapists, but does not explicitly state that serious adverse events are extremely rare."
      },
      {
        "criterion_number": 10,
        "description": "States that evidence from randomized controlled trials or meta-analyses shows massage therapy can reduce pain, anxiety, and fatigue, and may improve quality of life in cancer patients, and explicitly mentions that the certainty of evidence is low and benefits are typically moderate.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not reference RCTs/meta-analyses, quality of evidence, or characterize benefits as moderate/with low certainty."
      },
      {
        "criterion_number": 11,
        "description": "Advises consulting the oncology team or healthcare provider before starting massage therapy, and mentions bleeding risk (e.g., low platelets) as a specific safety concern.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Recommends oncology approval and details platelet thresholds (<50,000 light only; <20,000 avoid) and cautions with blood thinners, fulfilling the bleeding risk requirement."
      },
      {
        "criterion_number": 12,
        "description": "Advises consulting the oncology team or healthcare provider before starting massage therapy, and mentions unstable bone lesions as a specific safety concern.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Advises oncology approval and specifically addresses bone metastases, recommending avoiding pressure/stretching over affected bones, which covers concern for unstable bone lesions."
      }
    ],
    "question_number": 152,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:33:09.668419",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe personalized medicine approaches in pancreatic cancer, including tumor genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly outlines precision medicine approaches and details tumor genetic testing (NGS, MSI/TMB, HER2, fusions, liquid biopsy) and how results guide treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that precision medicine, or personalized oncology, tailors cancer treatment based on a patient\u2019s unique tumor characteristics, such as genetic and molecular profiles, to improve effectiveness and reduce toxicity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that precision medicine can guide chemo choice and identify targeted/immunotherapy options; links treatment to tumor genetics/molecular profiling, implying improved effectiveness and personalization."
      },
      {
        "criterion_number": 3,
        "description": "The response should include somatic testing for patients with locally advanced pancreatic cancer who are candidates for systemic therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends comprehensive somatic tumor profiling 'ideally early' for all patients, which includes locally advanced candidates for systemic therapy."
      },
      {
        "criterion_number": 4,
        "description": "The response should include somatic testing for patients with metastatic pancreatic cancer who are candidates for systemic therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends broad tumor NGS (DNA/RNA) and related assays; metastatic setting addressed throughout treatment guidance."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that both germline and somatic testing are recommended for all patients with pancreatic cancer, as actionable alterations may be present even in the absence of family history.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States germline testing for all patients regardless of family history and recommends comprehensive tumor profiling (somatic)."
      },
      {
        "criterion_number": 6,
        "description": "The response should include germline testing for inherited pancreatic cancer syndromes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifies germline testing with key genes (BRCA1/2, PALB2, ATM, Lynch genes, etc.), consistent with inherited syndromes."
      },
      {
        "criterion_number": 7,
        "description": "The response should include germline testing is recommended for all patients with confirmed pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly recommends germline testing for all patients regardless of family history."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that mutations found by somatic testing can sometimes be targeted with medications.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Links somatic findings (e.g., NTRK, BRAF, HER2, KRAS G12C, MSI-H) to matched targeted or immunotherapies."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that based on genetic testing and molecular profiles, targeted therapies can be given.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple examples of targeted therapies guided by molecular results (PARP inhibitors, TRK inhibitors, HER2-directed therapy, BRAF inhibitors)."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that patients with certain germline mutations are candidates for targeted therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that germline BRCA1/2 (and PALB2) can guide use of platinum and PARP inhibitor maintenance (olaparib)."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that FDA-approved targeted therapies include PARP inhibitors (e.g., olaparib) for patients with germline BRCA1/2 mutations, typically as maintenance therapy following platinum-based chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically states olaparib as maintenance for metastatic PDAC with germline BRCA1/2 after response/stability on platinum."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that TRK inhibitors (larotrectinib, entrectinib) are indicated for NTRK fusion-positive tumors, regardless of histology.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions NTRK fusions actionable with larotrectinib or entrectinib and notes tumor-agnostic approvals."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that immune checkpoint inhibitors (pembrolizumab, dostarlimab) are approved for dMMR/MSI-H PDAC, a rare but important subset.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States MSI-H/dMMR PDAC is rare but pembrolizumab has tumor-agnostic approval and can be very effective."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that sotorasib is an emerging agent for KRAS G12C-mutated pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly references KRAS G12C inhibitors including sotorasib (and adagrasib) with evolving access and suggests clinical trials."
      },
      {
        "criterion_number": 15,
        "description": "The response should include that clinical trials may be testing drugs targeting certain mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes trials as key to precision medicine, listing basket studies and trials for KRAS, DDR combinations, HER2/NRG1, etc., and provides search resources."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages asking the care team specific questions, consulting an oncologist, and considering second opinions at high-volume centers."
      }
    ],
    "question_number": 153,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:33:39.068419",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that diarrhea is a common side effect from certain chemotherapy drugs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that diarrhea is common during pancreatic cancer care and specifically references chemotherapy-related causes (e.g., irinotecan with early/late diarrhea and targeted drugs like erlotinib)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that diarrhea can be managed with anti-motility agents such as loperamide.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Loperamide is explicitly recommended, with standard and high-dose strategies described. Diphenoxylate-atropine is also mentioned."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that dietary modifications include the elimination of lactose-containing products and high-osmolar supplements.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While diet advice is given, it does not specifically recommend eliminating lactose or high-osmolar supplements; yogurt is even suggested, which is lactose-containing."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that loperamide is given starting at 4 mg followed by 2 mg every 4 hours or after each unformed stool, not exceeding 16 mg per day.",
        "score_given": 2,
        "max_points": 2,
        "justification": "The standard dosing is correctly provided: 4 mg once, then 2 mg after each loose stool (max 16 mg/day)."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that diarrhea from chemotherapy can be managed by dose reduction.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises 'dose adjustments' for offending medications (including targeted anticancer drugs) and to discuss 'dose adjustments' for future chemotherapy cycles, which encompasses dose reduction."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that diarrhea from chemotherapy can be managed by schedule modification.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no explicit mention of modifying the chemotherapy schedule (e.g., delaying or changing frequency) as a management strategy."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that diarrhea from chemotherapy can be managed by switching to an alternate regimen.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Switching to an alternate chemotherapy regimen is not mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that diarrhea can be associated with pancreatic enzyme deficiency.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Pancreatic exocrine insufficiency is identified as a common cause of diarrhea with hallmark stool characteristics."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that diarrhea associated with pancreatic enzyme deficiency can be improved with pancreatic enzyme supplementation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly recommends pancreatic enzyme replacement therapy (e.g., pancrelipase/Creon) with meals and snacks to improve diarrhea."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that in patients with exocrine pancreatic insufficiency, pancreatic enzyme replacement therapy (PERT) should be initiated and titrated to symptom control, as this can significantly reduce steatorrhea and improve nutritional status.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises initiating PERT with starting doses, titrating based on stool response, and notes that this can dramatically improve diarrhea and nutrition."
      },
      {
        "criterion_number": 11,
        "description": "The response should discuss symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly emphasizes involving the oncology team early, provides red flags warranting urgent contact, and lists specific questions to discuss with the team."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that if diarrhea progresses to grade 3 or 4 or persists after 24\u201348 hours of loperamide, aggressive management is recommended.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises urgent care for \u22656 loose stools/day (grade 3) or diarrhea lasting >24 hours despite loperamide and states not to continue high-dose loperamide beyond 48 hours without medical supervision, implying escalation."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that aggressive management includes intravenous fluids for dehydration, octreotide, and empiric antibiotics if infection is suspected.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Octreotide is mentioned, but IV fluids are not, and antibiotics are suggested only if stool tests are positive (not empiric if suspected)."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that octreotide is initially given as 100\u2013150 \u03bcg subcutaneously three times daily, with escalation up to 500 \u03bcg if needed.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Octreotide is referenced without dosing or escalation details."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that stool studies and laboratory evaluation for infectious etiologies should be performed in severe cases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises stool testing for infection, especially if diarrhea is moderate/severe or persistent, and notes C. difficile risk after antibiotics/hospitalization."
      }
    ],
    "question_number": 154,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:34:22.747838",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing the treatment plan with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises: \"Ask the oncology team what to expect: treatment plan (surgery, chemo, radiation), cadence..., likely side effects... and what they recommend about working.\""
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend understanding the prognosis.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No direct mention of discussing prognosis, survival expectations, staging, or anticipated disease course."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the goals of treatment.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not instruct to clarify curative vs. palliative goals or overall goals of care; palliative care is mentioned as a resource but not in the context of discussing treatment goals."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend considering the impact of stopping work on health insurance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides detailed discussion of health insurance implications: FMLA continuation, COBRA, Marketplace, Medicaid, Medicare, and network/formulary checks. Also warns: \"Do not resign until you understand benefits.\""
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend considering the impact of stopping work on income.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses income protections (PTO, STD/LTD, state disability, SSDI/SSI) and provides budgeting and financial planning advice."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the expected physical effects of treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Advises asking about \"likely side effects, infection risk\" and reassessing after first treatment cycle with consideration of job demands."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the expected mental effects of treatment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While emotional support resources are listed, it does not recommend learning or discussing anticipated mental/cognitive effects of treatment."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend considering employer-sponsored medical leave.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Thoroughly covers FMLA, ADA accommodations, PTO, and disability policies; emphasizes applying for leave/disability before resigning."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly mentions at least two common symptoms of pancreatic cancer and states these can impair functioning or ability to work.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit listing of pancreatic cancer symptoms (e.g., pain, fatigue, weight loss, dietary issues) or their impact on work capacity."
      },
      {
        "criterion_number": 10,
        "description": "The response states that multiple factors should be systematically evaluated to support informed, patient-centered decision-making.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a structured \"practical checklist\" and a sequenced plan of next steps, indicating systematic evaluation prior to decisions."
      },
      {
        "criterion_number": 11,
        "description": "The response states that discussions should elicit or consider the patient\u2019s personal values, goals, and/or preferences, including quality of life versus life extension.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not explicitly mention eliciting personal values or weighing quality of life versus life extension."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly mentions that financial and practical considerations are critical in the decision to stop working.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Directly ties the decision to financial/practical factors with strong warnings and detailed sections: \"Do not resign until you understand benefits,\" plus extensive financial planning and practical supports."
      },
      {
        "criterion_number": 13,
        "description": "The response recommends referral to, or consultation with, financial counselors or social workers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends working with the hospital social worker and nonprofit navigators for disability applications and financial assistance."
      },
      {
        "criterion_number": 14,
        "description": "The response states that patients should be informed about disability benefits, workplace accommodations, and/or community support programs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers STD/LTD, SSDI/SSI, ADA accommodations, FMLA, caregiver leave, and community resources (PanCAN, CancerCare, Triage Cancer, CLRC)."
      }
    ],
    "question_number": 155,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:34:53.049811",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe tumor profiling as involving comprehensive molecular analysis of tumor tissue and often blood to identify genetic, transcriptomic, and proteomic alterations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines tumor profiling, includes tumor and blood (liquid biopsy), and details testing for DNA mutations/CNVs (genomic), RNA fusions (transcriptomic), and protein expression by IHC (proteomic), plus MSI/MMR and TMB."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a tumor biopsy can be used for tumor profiling.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states NGS on a tumor sample from a prior biopsy or surgery; new biopsy if needed."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that circulating tumor DNA can be used for tumor profiling.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States a blood \"liquid biopsy\" may be used if tissue is limited, indicating ctDNA-based profiling."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that tumor biopsies can be tested for mutations in the DNA.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes labs look for \"DNA mutations and copy-number changes\" in the tumor."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that tumor biopsies can be tested for mutations in the RNA.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States \"Gene fusions (often via RNA testing)\" are assessed."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that tumor biopsies can be tested for the presence of certain proteins.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions HER2 overexpression assessed by IHC/FISH and PD-L1 reporting, indicating protein testing."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that circulating tumor DNA can be tested for mutations in DNA.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Links liquid biopsy (blood) as an alternative to tissue NGS, implying ctDNA mutation testing even though \"ctDNA\" is not named explicitly."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that tumor profiling helps identify alterations that may be actionable for therapy selection or clinical trial enrollment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States profiling guides treatment and clinical trial options and lists actionable alterations and matched therapies; also notes trial matching if no actionable change."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that routine molecular tumor profiling is now feasible and recommended for all patients with pancreatic cancer, regardless of stage or surgical eligibility. Based on the NCCN Guidelines Version 2.2025, Clinical Presentation and Workup pathway for pancreatic adenocarcinoma, stating that patients with clinical suspicion of pancreatic cancer or evidence of dilated pancreatic/bile duct should undergo pancreatic protocol CT or MRI (abdomen) for evaluation. A multidisciplinary consultation is recommended after imaging. Workup includes chest and pelvis CT, endoscopic ultrasonography (EUS), MRI for indeterminate liver lesions, PET/CT or PET/MRI for high-risk features, and ERCP with stent placement if biliary obstruction is present. Laboratory evaluation should include liver function tests and baseline CA 19-9 after biliary drainage. If diagnosis is confirmed, perform genetic testing for inherited mutations. For metastatic disease, confirm with biopsy from a metastatic site, and perform molecular profiling of tumor tissue and complete staging with chest and pelvis CT. Depending on findings, categorize as resectable (PANC-2), borderline resectable (PANC-4), locally advanced (PANC-5), or metastatic disease (PANC-10). If no mass or diagnosis is confirmed, refer to a high-volume center for evaluation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not reference NCCN 2.2025 workup pathway or recommend universal routine molecular profiling across all stages; no imaging/workup details provided."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that approximately 20\u201328% of patients have actionable findings, and those who receive matched therapies based on tumor profiling have significantly improved progression-free and overall survival compared to those who do not.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No percentages or survival benefit data are provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that actionable alterations include BRCA1/2 mutations, NTRK, BRAF, FGFR2, RET, NRG1, and ALK fusions, and mismatch repair deficiency (dMMR/MSI-H).",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions BRCA1/2, NTRK, BRAF, RET, ALK, HER2, and MSI-H/dMMR but omits FGFR2 and NRG1 specifically."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Provides questions for the care team but does not explicitly recommend discussing with an oncologist."
      }
    ],
    "question_number": 156,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:35:24.180130",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the connection between chronic inflammation of the pancreas and the risk of pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response focuses on inflammation within established pancreatic cancer (tumor microenvironment, obstruction-related inflammation, systemic cytokines) but does not state that chronic pancreatic inflammation (e.g., chronic pancreatitis) increases the risk of developing pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that inflammation plays a central or significant role in pancreatic cancer pathogenesis, progression, or clinical outcomes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes that inflammation is tightly linked to pancreatic cancer and that the inflammatory tumor microenvironment fuels tumor growth and reduces therapy responsiveness. It also ties inflammation to clinical outcomes (pain, cachexia, clotting, treatment tolerance)."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that there is no treatment for targeting inflammation in pancreatic cancer per NCCN guidelines (version 2.2025).",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of NCCN guidelines v2.2025 or that there is no guideline-endorsed, inflammation-targeting treatment specific to pancreatic cancer. The response instead enumerates supportive measures and clinical trials without referencing this guideline stance."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that inflammation is implicated in many cancers and include symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response lists symptoms and systemic effects (fever, fatigue, weight loss, etc.), it does not state that inflammation is implicated broadly across many cancers. Because the criterion requires both elements, full credit cannot be awarded."
      },
      {
        "criterion_number": 5,
        "description": "The response should explicitly mention that strategies to manage inflammation in pancreatic cancer are being researched or investigated in clinical or translational research.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It includes a section titled \"Clinical trials targeting inflammation\" and notes multiple investigational approaches, inviting discussion of trial options with the care team."
      },
      {
        "criterion_number": 6,
        "description": "The response should explicitly mention that strategies involving cytokine signaling are being researched, investigated, or studied for managing inflammation in pancreatic cancer.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It specifically mentions drugs targeting IL-1 and IL-6 pathways, which are cytokine signaling targets, as areas under study."
      },
      {
        "criterion_number": 7,
        "description": "The response should explicitly recommend that the user discuss this case with an oncologist.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response repeatedly advises consultation with the oncology team (e.g., \"Always check with the oncology team first,\" \"ask the team whether she\u2019s a candidate\") and provides questions for her care team, satisfying the criterion."
      }
    ],
    "question_number": 157,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:35:42.636912",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes at least three specific benefits of art therapy for cancer patients, such as emotional expression, stress reduction, coping skills, mood improvement, self-esteem, social connection, or mindfulness/relaxation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response lists multiple concrete benefits: emotional support with improved anxiety, stress, mood, and quality of life; symptom relief including reduced perception of pain and fatigue and immediate relaxation benefits; coping and communication improvements including sleep and communication with family/care team; and caregiver stress reduction. These clearly exceed three specific benefits."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that art therapy is not an anti-cancer therapy, does not treat cancer itself, or is not a substitute for medical cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states, \u201cIt\u2019s not a cure and doesn\u2019t shrink tumors,\u201d and notes it is safe to try alongside medical care, clearly indicating it is not a substitute for cancer treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response provides the name \u201cAmerican Art Therapy Association\u201d and states or implies that this organization can be used to find a qualified art therapist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It names the American Art Therapy Association and directs the user to its \u201cFind a Therapist\u201d directory to locate an ATR-BC, satisfying the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response clearly recommends that the user discuss the use of art therapy with an oncologist or healthcare provider involved in the cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response advises, \u201cLet the oncology team know you\u2019re adding art therapy so everyone can coordinate,\u201d which is a clear recommendation to involve the care team."
      }
    ],
    "question_number": 158,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:35:54.752015",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The person should contact the insurance company to understand the reason for the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly instructs to ask the insurer why it was denied in plain language and to request the exact clinical criteria and policy documents."
      },
      {
        "criterion_number": 2,
        "description": "The person should file an appeal as an option to remedy the denial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly advises filing an expedited/urgent appeal and outlines multiple appeal levels including external review."
      },
      {
        "criterion_number": 3,
        "description": "The person should work with their oncology team to help with the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It directs the user to have the oncology team file an urgent appeal, conduct a peer-to-peer, and provide detailed clinical justification."
      },
      {
        "criterion_number": 4,
        "description": "The person should work with their oncology team to understand the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "By advising a peer-to-peer review, requesting clinical criteria, and having the oncologist align documentation with guidelines, it clearly involves the oncology team in interpreting and addressing the denial reasons."
      },
      {
        "criterion_number": 5,
        "description": "Patient assistance programs should be considered.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends manufacturer patient assistance programs, bridge programs, copay cards, and independent foundations."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly defines prior authorization as a process in which insurers require approval before a medication is covered.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not explicitly define prior authorization or describe it as insurer approval before coverage."
      },
      {
        "criterion_number": 7,
        "description": "The response states that prior authorization denials or delays are common in oncology care and mentions at least one impact.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes risk of harm from delays, it does not state that prior authorization denials/delays are common in oncology."
      },
      {
        "criterion_number": 8,
        "description": "The person should contact the oncologist to request a referral to a financial navigator or social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking the clinic for an oncology financial counselor or navigator and mentions the hospital\u2019s financial counselor/oncology social worker."
      },
      {
        "criterion_number": 9,
        "description": "The appeal process involves submitting a formal appeal with supporting evidence.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It provides a detailed appeal outline and specifies including guideline citations, compendia support, clinical details, and key studies."
      },
      {
        "criterion_number": 10,
        "description": "If appeals are unsuccessful, alternative access strategies should be pursued, such as patient assistance programs or manufacturer co-pay cards.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends alternative access strategies including patient assistance and copay support, and mentions bridge programs during appeals."
      },
      {
        "criterion_number": 11,
        "description": "The response names at least one patient advocacy organization that can help connect the user with resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists Patient Advocate Foundation, Triage Cancer, Pancreatic Cancer Action Network, and others with phone numbers."
      }
    ],
    "question_number": 159,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:36:19.769760",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple prompts to involve the care team: 'Call the team promptly...', 'let oncology know quickly', 'Don\u2019t start new prescription creams or antibiotics without checking with the oncology team', and 'Consider asking for a dermatology (oncodermatology) consult.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should describe common chemotherapy-related side effects, including dry skin.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists dry, itchy skin and numerous chemotherapy-related skin effects (maculopapular rash, acneiform rash, hand-foot syndrome, photosensitivity, nail/hair changes, mucositis)."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe management of dry skin, including using thick emollient creams.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends 'thick moisturizers/ointments (CeraVe, Vanicream, Aquaphor) twice daily' and adding urea creams."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe management of dry skin, including avoiding hot water.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises 'lukewarm showers' and to 'avoid... hot water.'"
      },
      {
        "criterion_number": 5,
        "description": "The response should describe management of dry skin, including avoiding scrubbing the skin.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly says to avoid 'harsh scrubs.'"
      },
      {
        "criterion_number": 6,
        "description": "The response should describe common chemotherapy-related side effects, including hand-foot syndrome associated with certain chemotherapy drugs like capecitabine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Has a section on 'Hand-foot syndrome (5-FU, capecitabine; can occur with FOLFIRINOX due to 5-FU)'."
      },
      {
        "criterion_number": 7,
        "description": "The response should include management of hand-foot syndrome, including the use of urea-based creams.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends 'moisturize twice daily with urea 20\u201340% cream.'"
      },
      {
        "criterion_number": 8,
        "description": "The response should include management of hand-foot syndrome, including the use of lanolin-based creams.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Lanolin-based creams are not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response should include management of hand-foot syndrome, including the use of supportive footwear.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises 'wear cushiony socks/shoes.'"
      },
      {
        "criterion_number": 10,
        "description": "The response should include management of hand-foot syndrome, including the use of gloves at night.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Gloves at night are not mentioned for hand-foot syndrome."
      },
      {
        "criterion_number": 11,
        "description": "The response should include management of hand-foot syndrome, including avoiding friction on affected areas.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States 'avoid friction/heat' and to reduce activity causing pressure."
      },
      {
        "criterion_number": 12,
        "description": "The response should include management of hand-foot syndrome, including dose reduction of chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes 'Report early\u2014dose adjustments often help' and that oncology may hold/adjust treatment."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe radiation dermatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes 'Radiation-related skin issues' and 'radiation-recall,' with features and triggers (e.g., gemcitabine)."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe management of radiation dermatitis, including the use of creams approved by the radiation team.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions topical steroids (mometasone/triamcinolone) but does not specify use of creams approved by the radiation oncology team."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe management of radiation dermatitis, including avoiding sun exposure.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While general sun protection is recommended, sun avoidance is not specifically tied to radiation dermatitis management."
      },
      {
        "criterion_number": 16,
        "description": "The response explicitly names at least one chemotherapy agent as a cause of skin changes, such as gemcitabine, FOLFIRINOX, or nab-paclitaxel.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Names multiple agents including gemcitabine, 5-FU, capecitabine, FOLFIRINOX, nab-paclitaxel/taxanes, irinotecan, erlotinib."
      },
      {
        "criterion_number": 17,
        "description": "The response lists at least four distinct manifestations of chemotherapy-related skin changes, with at least two from the specified list.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists xerosis/pruritus, maculopapular rash, acneiform rash, hand-foot syndrome, photosensitivity, nail changes, mucositis\u2014well over four."
      },
      {
        "criterion_number": 18,
        "description": "The response states that skin changes may also be due to other causes such as infection, other medications, or unrelated skin disorders/systemic diseases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes possible infection ('Rapidly spreading redness... or pus'), thrush for mouth changes, and cholestasis signs causing itch ('yellow eyes/skin or dark urine... could be bile flow issues')."
      },
      {
        "criterion_number": 19,
        "description": "The response states that prevention of skin problems is important and should begin at or before therapy initiation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes early, consistent care; 'Prevention from day 1 helps' for EGFR rash; preventive topical steroid during radiation; cryotherapy during bolus 5-FU to prevent sores."
      },
      {
        "criterion_number": 20,
        "description": "The response recommends using gentle, pH-balanced cleansers, regular moisturization, and broad-spectrum sun protection.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends 'gentle, fragrance-free products,' 'mild cleansers (Vanicream, Cetaphil),' thick moisturizers/ointments, and 'broad-spectrum SPF 30\u201350.'"
      },
      {
        "criterion_number": 21,
        "description": "The response mentions prophylactic cooling measures during taxane infusions for hand-foot syndrome, supported by guidelines or evidence.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions cool compresses for HFS and scalp cooling for hair loss, and oral cryotherapy for mucositis, but no prophylactic limb cooling during taxane infusions for HFS."
      },
      {
        "criterion_number": 22,
        "description": "The response states that correct identification of skin changes is important to ensure appropriate management and to avoid unnecessary discontinuation of effective cancer therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages dermatology input and mentions dose holds/adjustments, but does not explicitly state that correct identification prevents unnecessary discontinuation."
      },
      {
        "criterion_number": 23,
        "description": "The response recommends hydration with emollients, topical corticosteroids, antihistamines, and oatmeal baths for dry skin and itch.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Includes emollients, topical steroids, and antihistamines, but does not mention oatmeal baths."
      },
      {
        "criterion_number": 24,
        "description": "The response states that for acne-like rash, oral tetracyclines and topical steroids are effective treatments.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifies 'oral doxycycline or minocycline' with 'a mild steroid (hydrocortisone 2.5%)' for acneiform rash."
      },
      {
        "criterion_number": 25,
        "description": "The response states that for hand-foot syndrome, urea creams, topical steroids, and cooling procedures are beneficial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends urea 20\u201340% creams, high-potency topical steroids, and 'cool compresses' for HFS."
      },
      {
        "criterion_number": 26,
        "description": "The response states that mild immune-related rashes can be managed with topical corticosteroids, urea-containing creams, and antihistamines for pruritus.",
        "score_given": 0,
        "max_points": 3,
        "justification": "For immune-related rash, mentions topical steroids and antihistamines but not urea-containing creams."
      },
      {
        "criterion_number": 27,
        "description": "The response states that severe immune-related rashes can be managed with systemic corticosteroids and, if refractory, immunomodulators, and that therapy interruption may be necessary for severe reactions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes therapy hold and prednisone for severe cases, but does not mention immunomodulators for refractory toxicity."
      }
    ],
    "question_number": 160,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:37:14.582287",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the tumor microenvironment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear description of PDAC TME including dense fibrotic stroma, immunosuppressive immune infiltrates, abnormal vasculature/hypoxia, and metabolic/neural/microbial influences."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that the tumor microenvironment in pancreatic cancer critically influences both treatment options and outcomes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States the TME is a major reason PDAC is hard to treat, shapes treatment choices and trials, and notes failed TME-targeting approaches did not improve survival, indicating impact on outcomes."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that the pancreatic cancer tumor microenvironment has a dense desmoplastic stroma which can act as a physical barrier.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions dense fibrotic stroma (desmoplasia) with collagen/hyaluronan creating high pressure, compressing vessels, and limiting drug delivery."
      },
      {
        "criterion_number": 4,
        "description": "The response should include a description of stromal cells, including fibroblasts.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes cancer-associated fibroblasts as key producers of extracellular matrix components contributing to desmoplasia."
      },
      {
        "criterion_number": 5,
        "description": "The response should include a description of stromal cells, including pancreatic stellate cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Pancreatic stellate cells are not specifically mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response should include a description of immune cells within the tumor microenvironment of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Details immunosuppressive macrophages and myeloid cells and scarcity/exclusion of effector T cells."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer can be immunosuppressive.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Calls the TME immunosuppressive and explains T-cell exclusion and poor checkpoint inhibitor responses."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the tumor microenvironment architecture creates physical and biochemical barriers that limit drug delivery, promote immune evasion, and drive resistance to chemotherapy, targeted therapy, and immunotherapy.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Describes dense stroma limiting drug penetration (physical barrier), hypoxia reducing therapy effectiveness, and immune exclusion promoting immune evasion; notes TME-driven resistance to chemotherapy and immunotherapy."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "States the TME is a major reason PDAC resists drugs; details poor penetration and hypoxia reducing chemo effectiveness and immunotherapy resistance."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in metastasis.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Metastasis is not explicitly linked to the TME in the response."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in relapse.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Relapse/recurrence is not discussed in relation to the TME."
      },
      {
        "criterion_number": 12,
        "description": "The response should include that drugs targeting the tumor microenvironment in pancreatic cancer have not yet shown benefit to patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes hedgehog inhibitors and PEGPH20 failed to improve survival in phase III and sometimes worsened outcomes."
      },
      {
        "criterion_number": 13,
        "description": "The response should include that many studies are underway evaluating the role of tumor microenvironment-targeted therapies in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes clinical trials as the main avenue for TME-targeted strategies and lists multiple ongoing approaches."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that current and emerging treatment strategies increasingly focus on remodeling the tumor microenvironment to improve therapeutic efficacy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly advocates for stromal normalization/reprogramming (e.g., losartan, vitamin D analogs, FAK inhibitors) to improve perfusion and immune access."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that locoregional therapies such as radiation and ablation may also alter the tumor microenvironment, increasing antigen presentation and immune response.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States radiation can increase antigen release and inflame tumors, used in combination with PD-1 blockade; also discusses improving oxygenation affecting radiosensitivity."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a section titled 'Good questions to ask your oncologist' and advises considering care at a center with PDAC trials."
      }
    ],
    "question_number": 161,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:37:46.852077",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Pet therapy can offer emotional benefits for patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly lists emotional benefits such as lower anxiety, improved mood, and reduced loneliness."
      },
      {
        "criterion_number": 2,
        "description": "Pet therapy can offer psychological benefits for patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states psychological effects including decreased anxiety/distress and improved mood, which are clear psychological benefits."
      },
      {
        "criterion_number": 3,
        "description": "Treatment of cancer can cause immune suppression.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises avoiding visits during severe neutropenia and scheduling outside the expected post-chemotherapy nadir, indicating treatment-related immunosuppression."
      },
      {
        "criterion_number": 4,
        "description": "Pets can carry diseases that can harm immunosuppressed people.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It highlights infection risk and recommends certified, vaccinated animals and deworming, avoidance of raw diets, and avoiding higher-risk species, acknowledging zoonotic risk to immunosuppressed patients."
      },
      {
        "criterion_number": 5,
        "description": "Patients should avoid exposing open wounds to pets or animals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response instructs to keep animals away from wounds and dressings and to prevent pets from licking any devices/wounds."
      },
      {
        "criterion_number": 6,
        "description": "Patients should avoid exposing port sites to animals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifically says to keep animals away from ports/PICC lines and to cover devices with clothing or a clean barrier."
      },
      {
        "criterion_number": 7,
        "description": "Patients should discuss the safety of pet therapy with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It clearly advises coordinating with the oncology team first to assess safety based on blood counts and symptoms."
      },
      {
        "criterion_number": 8,
        "description": "Pet therapy visits are beneficial and generally safe for patients undergoing treatment for pancreatic cancer when conducted with certified therapy animals under appropriate infection control protocols.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states visits are beneficial and generally safe when done through certified therapy animal programs with infection control precautions."
      },
      {
        "criterion_number": 9,
        "description": "To reduce exposure to chemotherapy and radiation residues, patients should take precautions to limit the impacts on pets.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not address protecting pets from chemotherapy/radiation residues (e.g., handling bodily fluids post-treatment)."
      },
      {
        "criterion_number": 10,
        "description": "Immunocompromised patients with pancreatic cancer receiving chemotherapy or radiation therapy should practice good hand hygiene after handling pets, avoid contact with pet waste, and prevent pets from licking open wounds.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends hand hygiene before/after contact, avoiding pet waste handling or using gloves, and preventing pets from licking wounds."
      },
      {
        "criterion_number": 11,
        "description": "If patients are severely immunosuppressed, they should avoid contact with young animals, reptiles, or exotic pets.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response advises avoiding young puppies/kittens and reptiles/amphibians/rodents while immunosuppressed, aligning with guidance for severely immunosuppressed patients."
      }
    ],
    "question_number": 162,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:38:02.728843",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing financial concerns with a social worker associated with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly advises contacting the hospital social worker/patient navigator for gas/parking vouchers, shuttle services, hotel discounts, and assistance applying for aid; also includes a step to call the hospital\u2019s social worker."
      },
      {
        "criterion_number": 2,
        "description": "The response should include information for the American Cancer Society Road to Recovery program.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Names ACS Road To Recovery, describes free volunteer rides, and provides phone number and URL; also includes it in the step-by-step."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information on travel grants through national patient advocacy organizations, including the Pancreatic Cancer Action Network.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists PanCAN Patient Services with contact info and role in finding travel/lodging aid; also mentions other national orgs that offer grants (e.g., CancerCare, Lazarex)."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing financial concerns with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises contacting the hospital social worker/patient navigator, it does not explicitly recommend discussing financial concerns with the oncology team or oncologist."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend discussing financial concerns with a financial counselor associated with their oncology team.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No mention of a financial counselor or billing/financial services at the oncology clinic."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend discussing lodging assistance programs with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Advises asking the hospital social worker/patient navigator about hotel discounts and hospitality houses, i.e., lodging assistance via the oncology-associated team."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide information on travel grants through national patient advocacy organizations, including Cancer Care.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Specifically lists CancerCare with description of small transportation grants and contact info; includes additional relevant organizations."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that resources include hospital-based transportation programs.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Mentions hospital shuttle services, parking/gas vouchers, and partnerships with Uber/Lyft or volunteer drivers via hospital programs."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that resources include philanthropic or grant-funded travel assistance.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Lists multiple philanthropic/grant-funded options such as CancerCare grants, Lazarex reimbursement, Mercy Medical Angels, and Miracle Flights."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that telemedicine is increasingly used to reduce the need for travel, allowing for virtual visits, remote symptom monitoring, and tele-rehabilitation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of telemedicine or virtual care to reduce travel."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that telehealth appointments are generally as effective as in-person visits for many aspects of care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement comparing effectiveness of telehealth to in-person visits."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that telehealth offers benefits, including reduced travel burden, lower costs, decreased infection risk, and improved access to expertise.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not discuss benefits of telehealth."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that telehealth may be less suitable for initial diagnosis, physical examinations, or sensitive discussions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No caveats about when telehealth may be less suitable."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention limitations of telehealth, including challenges with physical examination, technology barriers, and occasional concerns about reduced personal connection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention telehealth limitations."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that the CDC recommends developing a personal travel health plan, ensuring adequate medication supply, and considering supplemental medical or evacuation insurance.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No CDC travel health planning recommendations are included."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No explicit recommendation to discuss with an oncologist."
      }
    ],
    "question_number": 163,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:38:27.659930",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapies together.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions dual checkpoint blockade (PD-1 plus CTLA-4), which is combining immunotherapies."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States PD-1/PD-L1 inhibitor plus chemotherapy (e.g., gemcitabine/nab-paclitaxel or FOLFIRINOX)."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with targeted therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes PD-1 combinations with MEK/RAS-pathway inhibitors and KRAS G12C inhibitors, which are targeted therapies."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with other new agents.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists combinations with CD40 agonists, CSF1R/CCR2/CCR5/CXCR4 inhibitors, FAK inhibitors, STING/TLR agonists, vaccines, and oncolytic viruses."
      },
      {
        "criterion_number": 5,
        "description": "The response should include the definition of immunotherapy per the NCI definition of cancer terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not provide an NCI-style definition of immunotherapy."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors are MSI high.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions PD-1 therapy in MSI-H disease but does not name pembrolizumab or its approval."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors are mismatch repair deficient.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions dMMR sensitivity to PD-1 therapy but does not state pembrolizumab approval."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors have a high tumor mutational burden.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Notes TMB-high can benefit from PD-1 therapy but does not name pembrolizumab or its TMB-H approval."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that other immunotherapies are investigational.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Describes many combinations as early-phase and cell therapies as highly experimental, indicating investigational status."
      },
      {
        "criterion_number": 10,
        "description": "The response should include information for clinicaltrial.gov for current trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides ClinicalTrials.gov and suggests useful filters."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend understanding what type of combination immunotherapy is being tested.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Advises asking about trial drugs used and why; outlines categories of combinations to understand the regimen type."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend understanding the evidence behind the combination immunotherapy in the trial.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Encourages asking about 'success seen so far,' which addresses evidence behind the regimen."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend understanding the potential side effects of the combination immunotherapy in the trial.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Details immune-related toxicities and advises discussing main risks and prompt reporting of symptoms."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe eligibility criteria for clinical trials, including the stage of disease.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifies stage/line of therapy as eligibility factors."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe eligibility criteria for clinical trials, including the site of disease.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not explicitly address site-of-disease eligibility (e.g., metastatic vs locally advanced or organ-specific sites)."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe eligibility criteria for clinical trials, including prior treatments.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes trials may specify first-line vs later-line treatment histories."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe eligibility criteria for clinical trials, including required testing.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions need for recent biopsy/fresh tissue and HLA typing for some cellular therapy trials."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that research trials explore whether a new medical strategy, treatment, or device is safe and effective for humans.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not explicitly state that trials test safety and effectiveness of new strategies in humans."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not state the essential role of trials in optimizing therapies."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that trials are divided into phases (phase I - phase IV).",
        "score_given": 0,
        "max_points": 8,
        "justification": "References 'phase' and 'early phase' but does not mention the full Phase I\u2013IV structure."
      },
      {
        "criterion_number": 21,
        "description": "The response should explain the different phases of clinical trials.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not explain what Phase I\u2013IV entail."
      },
      {
        "criterion_number": 22,
        "description": "The response should mention that current research on immunotherapy combinations for pancreatic cancer is focused on overcoming the immunosuppressive tumor microenvironment and enhancing antitumor immune responses.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Highlights the suppressive tumor microenvironment and strategies to recruit/activate T cells and reprogram the TME."
      },
      {
        "criterion_number": 23,
        "description": "The response should mention promising strategies include combining immunotherapy with chemotherapy, TME-modifying agents, and other immune stimulants.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Lists combinations with chemotherapy, TME-modifying agents (CD40, CSF1R/CCR2/5/CXCR4/FAK), and immune stimulants (STING/TLR agonists, vaccines, oncolytic viruses)."
      },
      {
        "criterion_number": 24,
        "description": "The response should mention that neoadjuvant immunotherapy combinations are being tested to prime the immune system before surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions adjuvant vaccine + immunotherapy but not neoadjuvant combinations before surgery."
      },
      {
        "criterion_number": 25,
        "description": "The response should mention that cancer vaccines are under investigation as an approach for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly references vaccines (including KRAS-targeted/personalized neoantigen) being studied in trials."
      },
      {
        "criterion_number": 26,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages discussing testing and trials with the oncologist and seeking referral/second opinion."
      }
    ],
    "question_number": 164,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:39:26.737266",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the current treatment plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises asking for a written treatment roadmap including chemo/radiation days, infusion length, pump disconnects, labs, scans, and rest weeks, demonstrating emphasis on understanding the plan."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing the treatment schedule with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It instructs to ask the oncology team for a written plan, request morning or afternoon slots, and ask if the schedule can flex around life events\u2014clear guidance to discuss scheduling with the team."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend open communication with the care team about work, family, and personal goals.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends aligning appointments with work/family rhythms, obtaining consent for caregivers to communicate, and poses key questions for the care team including support for work/school letters, indicating open communication about personal goals."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend open communication with work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises talking early with employers about flexibility, outlines options (remote work, compressed weeks, shifting hours), and suggests identifying a second-in-command and setting out-of-office plans."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding side effects of treatments.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It details common side effects (fatigue, nausea, infection risk, neuropathy, bowel changes) and emphasizes tracking symptoms, preventive antiemetic scheduling, and call-early thresholds."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the timing of side effects.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It specifies timing patterns (fatigue/nausea peaking days 1\u20134; infection risk days 7\u201310) and provides regimen-specific timing for FOLFIRINOX and gemcitabine/nab-paclitaxel."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend utilizing a support system, including talking with a social worker.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly recommends asking for an oncology social worker for help with scheduling, letters, financial assistance, transportation, and home services."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend utilizing a support system, including talking with a patient navigator.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It recommends engaging a nurse navigator (patient navigator) to assist with logistics and support."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that early referral to palliative care is recommended for symptom management, emotional support, and caregiver assistance, and is not synonymous with hospice.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises early palliative care and states it focuses on symptom relief, energy, mood, and caregiver support alongside active treatment, clarifying it is not the same as hospice."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that practical strategies for managing treatment schedules include leveraging telehealth, app-based, and telephone support to increase flexibility and reduce travel burden.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it mentions apps (Medisafe) and using the hospital portal and phone numbers, it does not explicitly recommend telehealth/virtual visits or explicitly link these tools to reducing travel burden and increasing flexibility."
      }
    ],
    "question_number": 165,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:39:50.449470",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention that treatment-related mouth problems, particularly oral mucositis, are common in patients with pancreatic cancer receiving chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that mouth problems (including sores) are common with chemotherapy and targeted/immunotherapy; discusses mucositis explicitly in pain control section."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing their mouth problems with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple prompts to involve the oncology team (\u201cOptions to discuss with his oncology team,\u201d \u201cWhen to call the oncology team urgently\u201d) and what to ask at next visit."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend maintaining good oral hygiene.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides detailed oral hygiene measures: brushing 2\u20133 times/day, flossing with precautions, frequent bland rinses, avoiding alcohol-containing mouthwashes."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that meeting with an oral medicine provider can be helpful.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not specifically recommend consultation with an oral medicine specialist or dentist for evaluation."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend staying hydrated.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises sipping water frequently and measures to keep the mouth moist."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend getting regular dental care.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Addresses denture care but does not recommend routine dental checkups or seeing a dentist."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that oral cryotherapy (holding ice chips in the mouth during and after administration of agents such as 5-fluorouracil) is effective for prevention of mucositis for select chemotherapy regimens.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically notes ice chips before and during bolus 5\u2011FU infusions to reduce mouth sores."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that benzydamine mouthwash is supported for prevention, especially in patients receiving radiotherapy or chemoradiotherapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Benzydamine mouthwash is not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that chlorhexidine mouthwash is not recommended for prevention in most adult cancer populations.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Chlorhexidine is not discussed; no statement that it is not recommended for prevention."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that bland mouth rinses (e.g., sodium bicarbonate or saline) are preferred for routine care and symptom management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends frequent bland rinses with baking soda/salt solution or plain saline."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that topical anesthetics and mixed medication mouthwashes may be used for pain control.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions viscous lidocaine, doxepin mouth rinse, morphine mouth rinse, and notes that \u201cmagic mouthwash\u201d combinations can help symptomatically."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that gabapentin may be considered for mucositis-related pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Gabapentin is not mentioned."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that topical and systemic antifungals are indicated for secondary candidiasis.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Identifies thrush and recommends topical antifungals (nystatin/clotrimazole) and oral fluconazole for more severe cases."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that antibiotics are reserved for documented secondary bacterial infections.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No guidance provided on antibiotics for secondary bacterial infections."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that management often involves over-the-counter pain relief such as acetaminophen or ibuprofen.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention OTC analgesics like acetaminophen or ibuprofen; only notes systemic pain medicines and cautions about NSAIDs with low platelets."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that multidisciplinary and supportive care is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes supportive care and team involvement (oncology team guidance, urgent contact triggers, and referral to a dietitian)."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that management could include dietary adjustments such as soft or liquid diets, small frequent meals, and nutritional support.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides detailed dietary adjustments (soft, moist, high-protein foods; cool foods; sauces; straws) and suggests dietitian referral."
      }
    ],
    "question_number": 166,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:40:21.476673",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define minimal residual disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines MRD as tiny amounts of cancer remaining after treatment that are too small for imaging, and explains detection via ctDNA."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that minimal residual disease testing in pancreatic cancer is investigational.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that MRD in pancreatic cancer is 'not yet standard of care' and is considered investigational with ongoing trials."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing minimal residual disease testing with an oncologist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Advises to 'Talk with her oncology team about goals' and other specifics regarding testing."
      },
      {
        "criterion_number": 5,
        "description": "The response should include that NCCN guidelines do not recommend minimal residual disease testing in pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions 'major guidelines' but does not specifically reference NCCN or explicitly state that NCCN does not recommend MRD testing."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that insurance may not cover minimal residual disease testing.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that 'Insurance coverage and cost vary; tests can be expensive without coverage,' indicating potential lack of coverage."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that postoperative ctDNA positivity is associated with a higher risk of early recurrence and worse survival in resected pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States that postoperative ctDNA positivity is linked to higher recurrence risk and earlier detection than imaging, but does not explicitly mention early recurrence or worse survival."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that serial minimal residual disease testing can provide dynamic risk stratification.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes serial testing to track response (falling vs rising levels) and periodic surveillance, which reflects dynamic risk stratification."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that minimal residual disease testing may identify patients who could benefit from intensified surveillance or additional therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that MRD positivity may prompt closer monitoring, earlier imaging, and discussion of clinical trials, implying intensified surveillance and potential additional therapy."
      }
    ],
    "question_number": 167,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:40:35.969494",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend asking the oncology team for spiritual care professionals.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response explicitly advises, \"Ask the oncology clinic or hospital operator for the chaplain/spiritual care department,\" and suggests requesting a referral to palliative care and asking the oncology social worker for referrals."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend reaching out to local places of worship.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It recommends contacting \"Your own faith community (clergy, lay visitors, congregational care teams).\""
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend reaching out to community support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions support groups multiple times, including through oncology social workers and organizations like Cancer Support Community and CancerCare, which provide support groups."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend national cancer support organizations, including the American Cancer Society.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists several national organizations and includes the American Cancer Society with contact information."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend national cancer support organizations, including Cancer Care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It specifically includes CancerCare with phone number and describes available services."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that spiritual counseling and support can be accessed through hospital-based chaplaincy services.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It instructs to ask for the hospital chaplain/spiritual care department and notes hospital chaplains serve people of any or no faith, typically at no cost."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that spiritual counseling and support can be accessed through interdisciplinary palliative care teams.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises requesting a referral to palliative care and states palliative teams routinely include chaplains and coordinate with the medical team."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that interventions such as prayer, mindfulness/meditation, and facilitated sessions with trained providers, including both individual and group formats, have demonstrated benefits for spiritual well-being, hope, and meaning in cancer care.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions prayer/meditation, counseling, and support groups, it does not state that these interventions have demonstrated (evidence-based) benefits for spiritual well-being, hope, and meaning."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that cancer.net and the Pancreatic Cancer Action Network (pancan.org) provide high-quality information and support services.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It includes the Pancreatic Cancer Action Network (PanCAN) with contact information but does not mention cancer.net."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it suggests coordination with the medical team and referrals through the clinic, it does not explicitly recommend discussing the case with the oncologist."
      }
    ],
    "question_number": 168,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:41:00.546501",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend learning about pancreatic cancer, including diagnosis.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It advises to \"Know the roadmap: diagnosis stage...\" and to clarify diagnosis details with the care team, encouraging understanding of the diagnosis."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend learning about pancreatic cancer, including staging.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explicitly references knowing the \"diagnosis stage\" and asks the user to share his stage to tailor advice."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend learning about pancreatic cancer, including treatment options.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It lists treatment modalities (surgery, chemotherapy, radiation) and supportive options (palliative care, celiac plexus block, biliary stents, enzyme replacement), clearly prompting discussion of treatment options."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend national patient support resources, including information for the Pancreatic Cancer Action Network.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes PanCAN with website and phone number, and also lists CancerCare, American Cancer Society, and Cancer Support Community."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend open communication within the couple and with the care team.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It emphasizes building a clear plan with the care team, keeping key contacts, maintaining a binder of questions, and suggests couple check-ins (e.g., \u201cWhat feels hardest today?\u201d)."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend building a support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises building a team for meals/rides/respite, using support groups, and working with a social worker and community resources."
      },
      {
        "criterion_number": 7,
        "description": "The response should explicitly state that significant lifestyle changes are common for both patients and spouses/partners after a pancreatic cancer diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It opens with \u201cPancreatic cancer brings a lot of change very quickly,\u201d addresses \u201cyou\u2019re both going through this,\u201d and later notes changing roles and intimacy shifts, indicating lifestyle changes affecting both partners."
      },
      {
        "criterion_number": 8,
        "description": "The response should explicitly mention at least two of the following: uncertainty about the future, role changes, emotional upheaval, or altered daily routines.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions changing roles and addresses emotional upheaval via depression/anxiety being common and treatable. It also suggests altered routines (planning the day around energy peaks), exceeding the minimum two items."
      },
      {
        "criterion_number": 9,
        "description": "The response should explicitly recommend early integration of supportive and/or palliative care for symptom management, psychosocial support, or advance care planning.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It states, \u201cAsk for early palliative care,\u201d explains its role in symptom and mood management, and notes it can be used alongside active treatment."
      },
      {
        "criterion_number": 10,
        "description": "The response should explicitly state that palliative and/or supportive care should be offered to all patients with pancreatic cancer, regardless of stage or prognosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it says palliative care is standard and can be used alongside active treatment, it does not explicitly state it should be offered to all patients regardless of stage or prognosis."
      },
      {
        "criterion_number": 11,
        "description": "The response should explicitly state that both dietary and exercise interventions are important for maintaining quality of life and optimizing outcomes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It provides dietary guidance and notes light movement can reduce fatigue, but does not explicitly state that both diet and exercise are important for maintaining quality of life and optimizing outcomes."
      },
      {
        "criterion_number": 12,
        "description": "The response should explicitly state that regular exercise and healthy lifestyle changes are associated with improved physical and psychological outcomes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions light movement reducing fatigue and addresses emotional health, it does not explicitly link regular exercise and healthy lifestyle changes to improved physical and psychological outcomes."
      },
      {
        "criterion_number": 13,
        "description": "The response should explicitly recommend discussing the case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It encourages working with the care team and seeking referrals, but does not explicitly recommend discussing the case with an oncologist."
      }
    ],
    "question_number": 169,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:41:30.424210",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe tumor heterogeneity, including diverse genetic, epigenetic, transcriptomic, and microenvironmental features both between patients (inter-tumoral) and within a single tumor (intra-tumoral).",
        "score_given": 0,
        "max_points": 8,
        "justification": "Inter- and intra-tumoral heterogeneity are described, with genetic, transcriptomic (classical vs basal-like), and microenvironmental elements mentioned. However, epigenetic heterogeneity is not explicitly addressed, so the full set of required dimensions is incomplete."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that tumor heterogeneity can include differences in genetic mutations within a tumor.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly states that different parts of the same tumor and different metastases can have different mutations and evolve under treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that tumor heterogeneity can include differences in genetic mutations between tumor sites.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that different metastases can harbor different mutations, satisfying inter-site genetic heterogeneity."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that tumor heterogeneity can include differences in cellular growth between cancer sites.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically mentions that one lesion may grow while others shrink, indicating differing growth dynamics across sites."
      },
      {
        "criterion_number": 5,
        "description": "The response should include that tumor heterogeneity can include differences in microenvironment between tumor sites.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Discusses PDAC\u2019s dense stroma and immune-suppressive microenvironment in general but does not state that the microenvironment differs between sites."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that tumor heterogeneity is a major driver of variable treatment response, therapy resistance, and clinical outcomes in pancreatic ductal adenocarcinoma.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly states that heterogeneity is a big reason treatment and outcomes vary and links it to resistance and evolving clones."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that tumor heterogeneity is thought to contribute to drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Notes emergence of resistant clones, survival of resistant cells after response, and stromal contributions to resistance."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that tumor heterogeneity is thought to contribute to the use of multiple chemotherapy agents.",
        "score_given": 6,
        "max_points": 6,
        "justification": "States, \u201cBecause of heterogeneity, two standard first-line options are used,\u201d and describes switching regimens at progression."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that phenotypic plasticity allows tumor cells to shift between subtypes, especially under therapeutic or microenvironmental stress, contributing to acquired resistance and disease progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions expression subtypes and clonal evolution but does not discuss subtype switching or phenotypic plasticity explicitly."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that tumor heterogeneity limits the effectiveness of one-size-fits-all approaches and underlies the need for molecular profiling and personalized treatment strategies.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends germline and tumor profiling, highlights rare targetable alterations, and frames choices as personalized due to heterogeneity."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend discussing genetic testing with the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises that everyone with PDAC should have germline testing and to ask the care team whether it has been done and about results."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that research efforts focus on integrating genomic, transcriptomic, and single-cell analyses to better classify tumors and guide therapy selection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions RNA subtype testing and clinical trials, but does not reference integrated genomic/transcriptomic approaches or single-cell analyses."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages asking the care team specific questions and suggests consultation at a high-volume pancreatic cancer center, which implies discussion with the oncology team."
      }
    ],
    "question_number": 170,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:41:56.471648",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include the definitions of different types of research studies, including randomized clinical trials and observational studies.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response lists multiple study types (treatment trials, supportive care, registries/biobanks), it does not define what a randomized clinical trial is nor explicitly define observational studies. No explanation of randomization or non-interventional/observational methodology is provided."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain that not all research studies are clinical trials, and some explore ancillary aspects of cancer care such as symptom control or mental health.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response clearly states options beyond treatment trials, including supportive care and quality-of-life studies addressing pain, appetite/weight, fatigue, depression/anxiety, palliative care, and caregiver support, demonstrating that not all research is a clinical trial."
      },
      {
        "criterion_number": 3,
        "description": "The response should include links and references to informational websites about clinical trials being held across the United States, such as the National Cancer Institute (NCI).",
        "score_given": 7,
        "max_points": 7,
        "justification": "It provides concrete resources and links: NCI trial search (cancer.gov), ClinicalTrials.gov, and PanCAN (pancan.org), plus phone numbers for NCI and PanCAN."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient ask their oncologist about locations where clinical trials are being held and consider a referral to institutions where trial participation is possible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises discussing with the oncologist which trials are open locally and asks about referral to nearby centers. It also mentions that many trials are at major academic centers and suggests telehealth triage/remote prescreening."
      },
      {
        "criterion_number": 8,
        "description": "The response should include definitions of phases 1, 2, and 3 clinical trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it references filtering by phase on ClinicalTrials.gov, it does not define what Phase 1, 2, or 3 trials entail."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that clinical trials are most commonly done at academic medicine institutions.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states that many pancreatic trials are only at major centers and lists several academic/NCI-designated institutions, satisfying the criterion."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that clinical trials may include an experimental treatment or placebo, and the efficacy may not be known as compared to standard of care treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes trials may add a new drug or test new approaches but does not explicitly mention the possibility of placebo arms or that efficacy versus standard of care may be unknown."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly mention clinical trials as a research opportunity.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clinical trials are explicitly and repeatedly mentioned as a research option across different disease settings and biomarker contexts."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly mention patient registries or biorepositories as opportunities for further studies.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly mentions observational registries and biobanks and cites specific examples such as Count Me In and PRECEDE, as well as local hospital biobanks."
      }
    ],
    "question_number": 171,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:42:23.449777",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe how cells that acquire mutations that can go on to form a cancer in our bodies can evade the immune system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly explains tumor immune evasion in pancreatic cancer: immune-cold tumors, low neoantigen burden, poor T-cell infiltration, dense stroma blocking entry/drug delivery, and immunosuppressive cells/signals (Tregs, MDSCs, TAMs, TGF-\u03b2)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the immune system\u2019s role in protecting the body from mutated cells that have oncogenic potential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that immunotherapy helps the immune system recognize and kill cancer cells and discusses T-cell responses to tumor antigens, implying physiologic immune surveillance against abnormal/mutated cells."
      },
      {
        "criterion_number": 3,
        "description": "The response should include a definition of immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a direct definition: immunotherapy helps the immune system recognize and kill cancer cells."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the mechanism of action of immunotherapies in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes mechanisms across modalities: checkpoint inhibitors (PD-1/PD-L1, CTLA-4), vaccines generating T-cell responses, CD40 agonists activating APCs, adoptive cell therapies (TCR/CAR-T), and microenvironment-modulating agents to 'heat up' tumors."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe features of pancreatic cancer that make this malignancy difficult to treat with immunotherapy.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Identifies key barriers specific to PDAC: immune-cold phenotype, low mutation/neoantigen load, desmoplastic stroma, paucity of intratumoral T cells, and immunosuppressive milieu."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that there is research being done on the role of the immune system in pancreatic cancer treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly highlights ongoing clinical trials and research combinations (chemo/radiation plus ICIs, CD40 agonists, vaccines, adoptive cells, microenvironment modulators) with mixed/ongoing results."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient speak with his/her oncologist about clinical trials that might utilize immunotherapy for pancreatic cancer, or consider a referral to a center that does clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises discussing clinical trials with the oncologist, suggests evaluation at NCI-designated/high-volume centers, and provides trial-finding resources."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that a limited number of pancreatic cancer cases have features that do make it respond to immunotherapy, such as MSI-H or mismatch repair deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that ~1% of PDACs are MSI-H/dMMR and can respond to PD-1 inhibitors; also mentions rare TMB-high cases."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that they should ask the oncologist if her mother\u2019s tumor has MSI-H or mismatch repair deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a specific question to ask the oncologist about MSI/dMMR testing (and TMB) and suggests doing it if not already performed."
      }
    ],
    "question_number": 172,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:42:41.232489",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must define caregiver burnout as physical, emotional, and mental exhaustion, and normalize it as a common experience among caregivers.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response normalizes burnout as common and lists signs (exhaustion, irritability, hopelessness, getting sick often), but it does not explicitly define caregiver burnout as physical, emotional, and mental exhaustion."
      },
      {
        "criterion_number": 2,
        "description": "The response must link to no-cost support services for caregivers, such as support groups or online groups of people with similar experiences.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists multiple no-cost or low-cost caregiver support services (e.g., CancerCare free counseling and support groups, Cancer Support Community helpline and groups, PanCAN, Caregiver Action Network, Family Caregiver Alliance) with contact information."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly mention insurance-covered caregiver assistance and advise inquiring with the insurance carrier about coverage.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes that hospice is covered by Medicare and many insurers, it does not explicitly advise contacting the insurance carrier to ask about caregiver assistance coverage."
      },
      {
        "criterion_number": 5,
        "description": "The response must provide resources for mental wellbeing, specifically mentioning therapists through Psychology Today\u2019s website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response provides mental health resources (e.g., CancerCare counseling, Crisis 988), but does not mention Psychology Today or therapists via that website."
      },
      {
        "criterion_number": 6,
        "description": "The response must describe the use of family members and friends to help with caretaking responsibilities.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly advises asking family/friends to take specific tasks (meals, rides, laundry) and suggests coordination tools."
      },
      {
        "criterion_number": 7,
        "description": "The response must recommend reaching out to the oncology team to inquire if social work resources are available to assist in determining if any in-home support or respite services are financially covered by the patient\u2019s insurance.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It recommends meeting the oncology social worker and navigator but does not explicitly tie this to determining whether in-home or respite services are covered by the patient\u2019s insurance."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention that Hospice services offer varying degrees of in-home support and caregiver support, if/when appropriate for their loved one.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Under a section titled 'Get respite and in-home help,' it mentions hospice bringing an interdisciplinary team and offering short-term inpatient respite, indicating in-home and caregiver support when appropriate."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that there are options for professional caregiver support to give a break to family members/loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses professional supports such as home health, non-medical home-care agencies, adult day programs, and hospice respite, which provide breaks for caregivers."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that palliative care involvement can help with optimizing symptom management which may help reduce caregiver burden.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends a referral to palliative care for symptom control and caregiver support at any stage."
      },
      {
        "criterion_number": 11,
        "description": "The response should state they should make sure to take time for self-care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes scheduling rest as essential care, taking breaks, setting boundaries, and monitoring burnout signs\u2014clear self-care guidance."
      }
    ],
    "question_number": 173,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:43:14.912053",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should explain what liquid biopsies are and how they are different from traditional biopsies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response defines a liquid biopsy as a blood test detecting tumor-related material (ctDNA, CTCs, exosomes) and contrasts it with tissue testing by noting it is minimally invasive, repeatable, and a practical alternative when tissue is limited, while guidelines still prefer tissue first."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that \u201cliquid biopsy\u201d involves taking a sample of blood to analyze either circulating tumor DNA or circulating tumor cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states liquid biopsy is a blood test and specifies ctDNA and CTCs as targets, and details that it involves a standard blood draw of 10\u201320 mL."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain the different uses of liquid biopsies in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It covers multiple uses: identifying targetable alterations when tissue is limited, monitoring treatment response with serial ctDNA, and post-surgery MRD surveillance."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention if liquid biopsy is FDA approved for any uses in pancreatic adenocarcinoma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While test names are provided (e.g., Guardant360, FoundationOne Liquid CDx), the response does not address FDA approval status in pancreatic adenocarcinoma specifically."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe that liquid biopsies are used as an adjunct to traditional cancer monitoring techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that many teams rely mainly on CA19-9 and imaging and that ctDNA monitoring is an added tool, and explicitly notes it does not replace imaging or clinic assessment."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that this is not sufficient to establish whether or not the cancer is responding to treatment and that it has to be used in addition to imaging tests.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that rising ctDNA may prompt earlier imaging and that doctors generally confirm with scans before changing therapy, emphasizing adjunctive use."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe advantages of liquid biopsy over traditional biopsy, but should state that liquid biopsy cannot be used to diagnose cancer at this time.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Advantages are described (minimally invasive, repeatable, captures heterogeneity), but it does not explicitly state that liquid biopsy cannot be used to diagnose cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe that liquid biopsies can provide information about the genetic mutations in a cancer which can impact treatment options.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It details detection of actionable mutations (e.g., BRCA1/2, MSI-high, NTRK, BRAF V600E, HER2, KRAS) and explicitly connects findings to therapy choices and clinical trials."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that the role of liquid biopsy in cancer care is being heavily studied.",
        "score_given": 11,
        "max_points": 11,
        "justification": "It characterizes MRD monitoring as promising but investigational, used mainly in clinical trials or specialized centers, and mentions ongoing study of MRD assays in pancreatic cancer."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that liquid biopsy meaningfulness is different across cancer types and sometimes among patients with the same cancers, as some tumors do not shed material as much as others.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes variability within pancreatic cancer (low shedding, small/responding tumors may be undetectable) but does not explicitly state differences across cancer types."
      },
      {
        "criterion_number": 14,
        "description": "The response should also state that the approach is not established as standard of care and would likely be offered in the context of a research study.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states MRD/recurrence monitoring is not yet standard in pancreatic cancer and is used mainly in clinical trials or specialized centers; it also frames ctDNA monitoring as an added tool rather than standard."
      }
    ],
    "question_number": 174,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:43:48.083317",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Emphasize managing treatment and disease-related side effects to preserve independence and quality of life",
        "score_given": 3,
        "max_points": 3,
        "justification": "Strong emphasis on symptom control to maintain function (palliative care, pain management, neuropathy, bowel changes, jaundice, fatigue, sleep, mood/cognition) and explicit framing as preserving independence."
      },
      {
        "criterion_number": 2,
        "description": "Describe expected side effects of pancreatic cancer treatment",
        "score_given": 3,
        "max_points": 3,
        "justification": "Identifies chemo-related neuropathy, nausea, taste changes, infection risk (fever threshold), diarrhea, constipation from opioids, steroid/chemo-related glucose fluctuations, fatigue, and need for dose adjustments."
      },
      {
        "criterion_number": 3,
        "description": "Describe common symptoms from pancreatic cancer",
        "score_given": 3,
        "max_points": 3,
        "justification": "Covers pain, jaundice/itching from biliary obstruction, weight loss, pancreatic exocrine insufficiency (greasy/floating stools, bloating), diabetes, fatigue, bowel changes, and clot risk."
      },
      {
        "criterion_number": 4,
        "description": "Suggest ways to use technology to help with everyday tasks in the home",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends wearable medical alerts, voice assistants, smart lights, doorbell/camera, pill organizers with alarms, smart dispensers, and shared digital calendars."
      },
      {
        "criterion_number": 5,
        "description": "Suggest home modifications to allow the patient to traverse and use their home independently",
        "score_given": 5,
        "max_points": 5,
        "justification": "Detailed home safety setup: remove tripping hazards, bright lighting, nightlights, dual handrails, grab bars, non-slip mats, shower chair, raised toilet seat, mobility aids, reacher/long-handled tools, perching stool; recommends OT home safety assessment."
      },
      {
        "criterion_number": 6,
        "description": "Emphasize maintaining autonomy and control for the patient",
        "score_given": 3,
        "max_points": 3,
        "justification": "Begins with defining what independence means to the patient, sets personal goals, and includes caregiver strategies like 'ask before helping' and 'supported independence.'"
      },
      {
        "criterion_number": 7,
        "description": "Recommendations to assist with ADLs during side effects",
        "score_given": 8,
        "max_points": 8,
        "justification": "Provides OT energy conservation (4 Ps), adaptive equipment (shower chair, grab bars, raised toilet, sock aid), mobility aids, med management, nutrition strategies, bowel plans, pain control, home health aides, and caregiver techniques."
      },
      {
        "criterion_number": 8,
        "description": "Emphasize importance of maintaining good mental health by patient and caregivers",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses anxiety/depression and 'chemo brain,' recommends counseling, peer groups, medications, structured routines and tools; includes caregiver respite and burnout prevention."
      },
      {
        "criterion_number": 9,
        "description": "Mention resources for in-home assistance such as paid caregivers or Hospice services",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests home health (nursing, PT/OT at home) and visiting aides for bathing/housekeeping; covers transportation and meal delivery resources. While hospice not explicitly named, paid in-home supports are clearly discussed."
      },
      {
        "criterion_number": 10,
        "description": "Suggest asking oncology team about social work support and/or insurance coverage for in-home caregiver",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly includes social worker/navigator on the care team for transport, finances, home help, and paperwork; later notes financial/legal assistance via social worker, implying help with coverage for services."
      },
      {
        "criterion_number": 12,
        "description": "State that physical independence can be promoted by maintaining strength with rehab and exercises",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends oncology rehab (PT/OT) and provides specific exercise guidance (walking, resistance bands, sit-to-stands, balance exercises) to prevent deconditioning and clots."
      },
      {
        "criterion_number": 13,
        "description": "State that assistance devices and equipment (e.g., shower chairs, grab bars) can help maintain independence",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists shower chair, handheld shower, grab bars, non-slip mats, raised toilet seat, reacher, sock aid, long-handled shoehorn, and mobility aids."
      },
      {
        "criterion_number": 14,
        "description": "State that emotional support including patient groups helps maintain independence",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages counseling and peer groups to address mood/cognition and support function; ties mental health to maintaining independence."
      }
    ],
    "question_number": 175,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:44:13.392124",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include a definition of genetic testing for heritable cancer syndromes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explains germline multigene panel testing using blood/saliva and defines single-site cascade testing for a known familial mutation, effectively describing what hereditary cancer genetic testing is."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that genetic testing for inherited mutations is recommended for all patients with pancreatic adenocarcinoma at diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that all patients with pancreatic adenocarcinoma should be offered germline testing regardless of age or family history and advises testing the father as soon as possible."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient discuss genetic testing for inherited cancer syndromes and molecular testing of tumor tissue with their oncologist and oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises asking the oncologist to order germline testing, it does not mention molecular testing of tumor tissue (somatic/tumor profiling)."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe why family members at risk of inheriting a genetic mutation should be aware if they have it.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that knowing one\u2019s carrier status guides surveillance/screening (e.g., pancreas screening at specific ages; childhood surveillance for STK11/TP53/PRSS1) and that a negative targeted test can return relatives to general-population screening."
      },
      {
        "criterion_number": 7,
        "description": "The response should list cancer syndromes and mutated genes that are associated with an increased risk of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists multiple relevant genes and syndromes (BRCA1/2, PALB2, ATM, CDKN2A, STK11/Peutz-Jeghers, Lynch genes, TP53/Li-Fraumeni, PRSS1, etc.)."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly mention that BRCA1 and BRCA2 testing can be considered, particularly if there are other first-degree relatives with malignancies such as breast or prostate cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although BRCA1/2 are listed among genes to test, the response does not explicitly connect BRCA1/2 testing to the presence of breast or prostate cancer in first-degree relatives."
      },
      {
        "criterion_number": 11,
        "description": "If a patient\u2019s genetic testing for inherited mutations returns positive for a pathogenic mutation or they have a strong family history for cancer (regardless of mutation status), they should be referred to a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends referral to a board-certified genetic counselor and discusses scenarios with strong family history and positive findings where a genetics professional would guide testing and surveillance."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that some family members of a patient with a positive pathogenic mutation may be at increased risk for certain cancers and should consider genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly recommends cascade single-site testing for first-degree (and then extended) relatives if a familial mutation is found and discusses gene-specific surveillance, implying increased risk for certain cancers."
      }
    ],
    "question_number": 176,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:44:39.724287",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the phenomenon known as \u201cchemo-brain,\u201d or cognitive issues experienced by individuals undergoing chemotherapy treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly describes 'Chemo-related cognitive impairment (\u201cchemo brain\u201d)' with typical domains affected (attention, processing speed, memory, word-finding)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that treatment-related cognitive changes are a known side effect of treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'treatment\u2011related cognitive changes' and details medication and chemotherapy effects as causes."
      },
      {
        "criterion_number": 3,
        "description": "The response should include information about impaired cognition related to chemotherapy treatment and how long it is expected to last once treatment is completed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes improvement during dose breaks and typically over 3\u201312 months after finishing therapy, with possibility of lingering symptoms."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the cognitive changes can be from the chemotherapy drugs or from the cancer itself.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Attributes causes to chemotherapy and to illness/cancer-related factors (e.g., cancer-related clotting leading to stroke, biliary stent infections, metabolic/nutritional issues due to pancreatic cancer)."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that some medications, such as opioids, used for symptom management can cause depressed cognition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically lists opioids (and benzodiazepines, anticholinergics, steroids) as contributors and recommends dose review."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that other etiologies of impaired cognition may also be present, such as organ dysfunction, age-related cognitive decline, poor nutritional status, or medication side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies metabolic derangements, anemia, thyroid issues, vitamin deficiencies, dehydration, liver dysfunction, poor nutrition, and medication effects."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that depression is related to cognitive impairment, especially in the elderly population.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends screening for depression/anxiety and notes both can resemble cognitive impairment."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some causes of cognitive impairment are reversible, while others are not.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States changes are 'often at least partly reversible' and that some toxicities are reversible if recognized quickly, while some symptoms may linger."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient or family member discuss cognitive impairment with the patient\u2019s oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a detailed section titled 'What to ask her oncology team to do next' with specific actions."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that symptoms can be managed with \u201ccognitive rehabilitation,\u201d which can include exercises such as puzzles and word games.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention 'cognitive rehabilitation' or examples like puzzles/word games."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that optimizing lifestyle changes, such as good sleep and exercise, can help manage symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends light daily exercise, optimizing sleep, hydration, regular meals, and pacing strategies."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that in some cases, the treatment team may consider prescribing a stimulant such as methylphenidate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of stimulants or methylphenidate."
      }
    ],
    "question_number": 177,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:44:59.156008",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe what cancer stem cells are.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines CSCs as a small sub\u2011group of tumor cells with stem-like traits that self-renew and regenerate diverse cell types."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the role that cancer stem cells play in tumorigenesis and metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that CSCs can regenerate the tumor (tumorigenesis) and seed recurrences and distant spread (metastasis)."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe what is known about cancer stem cells in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides PDAC-specific details: common CSC markers (CD44, CD24, EpCAM, CD133, ALDH, c-MET), stromal microenvironment features, resistance patterns, and trial landscape."
      },
      {
        "criterion_number": 5,
        "description": "The response should reference research on pancreatic cancer stem cells and include real citations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No primary literature citations or specific study references are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should clearly state what is known about how pancreatic cancer stem cells affect treatment efficacy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states CSC-mediated resistance to chemotherapy and radiation, contribution to relapse, and implications for current treatment choices and trial enrollment."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that cancer stem cells are a subpopulation of cancer cells within a tumor that possess the ability to self-renew and differentiate into various cell types, and the concept of persistence must be clearly mentioned.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States CSCs are a small sub\u2011group with self\u2011renewal and ability to regenerate diverse cell types, and clearly conveys persistence via survival under stress, survival after chemo/radiation, and seeding recurrences."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that cancer stem cells are more resistant to conventional therapies like chemotherapy and radiation, and mention at least two mechanisms such as quiescence, efflux pumps, DNA repair, or microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states CSC resistance to chemo and radiation; provides multiple mechanisms: slow division (quiescence), drug efflux pumps, enhanced DNA repair, apoptosis resistance, and protective microenvironment."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that there are currently no standard of care treatments that directly target cancer stem cells, but it is an active area of research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states there is no approved test or standard drug targeting CSCs in PDAC and describes ongoing active research and clinical trials."
      }
    ],
    "question_number": 178,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:45:23.592973",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe different types of support groups such as in-person, virtual, and telephone.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists formats: in-person hospital/community groups, live virtual (Zoom/telehealth), telephone groups, moderated online forums/social media, and one-on-one peer mentoring."
      },
      {
        "criterion_number": 2,
        "description": "The response should list resources with website links that provide free or insurance-covered pancreatic cancer support group information such as PanCAN, NCI, and NCCN.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Multiple organizations are named (PanCAN, Cancer Support Community, CancerCare, ACS, etc.) but no website links are provided, and NCI/NCCN are not mentioned."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient and/or family inquire with the oncology team about support group resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises asking the oncology social worker or palliative care team at local hospitals/centers for pancreas-specific or GI cancer groups."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the importance of maintaining mental health support for patients and caregivers affected by pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights benefits (easing isolation, coping) and includes emotional well-being topics (anxiety/depression, mindfulness), emphasizing mental health support for patients and caregivers."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention websites for people to find support groups local to their home.",
        "score_given": 0,
        "max_points": 3,
        "justification": "References organizations and hotlines but does not mention specific websites or web-based locators for local groups."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention ways in which support groups for people affected by cancer can be helpful.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes multiple benefits: easing isolation, answering practical questions, coping, communication skills, symptom management, practical and emotional support."
      },
      {
        "criterion_number": 7,
        "description": "The response should normalize the use of support groups for people affected by cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Uses normalizing language (\u201cMany people find\u2026\u201d) and reassures it\u2019s okay to try and switch groups."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that people can use support groups for different stages of cancer, and that mental health challenges can be faced even during the survivorship period.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Mentions groups by stage including survivorship, but does not explicitly state that mental health challenges can occur during survivorship."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize that support groups can help people affected by cancer feel less isolated or alone.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly states that the right support group eases isolation."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that faith-based support groups exist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly mentions faith- or culture-specific groups."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that support groups are not a substitute for seeking mental health services if you are suffering from depression, and should describe what depression is.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not state that support groups are not a substitute for professional care nor describe depression."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention other avenues for support including palliative medicine and Hospice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions palliative care teams and palliative-care\u2013focused groups, but does not mention Hospice."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that virtual options include Facebook groups and PanCAN virtual support groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions live virtual groups and social media in general, but does not explicitly mention Facebook groups or PanCAN virtual support groups."
      }
    ],
    "question_number": 179,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:45:50.884875",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 2,
        "description": "The response must explicitly describe how malignant cells evade the body\u2019s immune system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly notes that pancreatic tumors are 'immune cold' with few T cells and many suppressive immune cells, explaining immune evasion and why checkpoint inhibitors often fail unless MSI-high/dMMR."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly describe the mechanisms of action for chemotherapy, immunotherapy, and radiation in killing cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it lists drug classes and resistance mechanisms, it does not explicitly explain how chemotherapy kills cells (beyond hints), how immunotherapy works (e.g., unleashing T-cell responses), or how radiation kills via DNA damage; thus MOA for all three modalities is not explicitly described."
      },
      {
        "criterion_number": 4,
        "description": "The response must thoroughly cover multiple mechanisms of treatment resistance, including genetic mutations, tumor heterogeneity, drug efflux, alterations in drug targets, epigenetic changes, adaptive responses, and the tumor microenvironment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It covers tumor heterogeneity (clonal selection), adaptive responses (backup pathways, metabolism, DNA repair), microenvironment (dense stroma, hypoxia), drug efflux (ABC transporters), target alterations (microtubule changes), and genetic factors (BRCA/PALB2). However, it does not mention epigenetic changes; because the criterion requires inclusion of all listed areas, full credit cannot be awarded."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly mention cancer stem cells and connect them to specific resistance mechanisms such as drug efflux pumps, enhanced DNA repair, or immune evasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cancer stem cells are not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that surviving resistant cells can repopulate the tumor after most cells are killed by treatment.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It clearly states that treatment kills sensitive cells and 'those survivors then grow and become the dominant cancer (clonal selection),' which explicitly describes repopulation by resistant cells."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly describe that with every treatment, a selective pressure is applied to cancer cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response explicitly invokes 'clonal selection' and uses the herbicide analogy, describing how treatment exposure selects for resistant clones, which conveys selective pressure."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that this topic is being widely researched and cite at least one source from the literature.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it mentions ongoing efforts and clinical trials, it neither states that the topic is widely researched nor cites any literature sources."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly defines treatment resistance as the phenomenon where cancer cells over time no longer respond to therapies.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It defines primary (intrinsic) and acquired resistance, explicitly stating that cancer may respond for a while and then progress as resistant cells take over, which matches the required definition."
      }
    ],
    "question_number": 180,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:46:13.976930",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must describe specific biomarkers for pancreatic cancer, explicitly mentioning both CA 19-9 and CEA.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response lists numerous specific biomarkers and explicitly includes both CA 19-9 and CEA, with appropriate context for their use."
      },
      {
        "criterion_number": 2,
        "description": "The response must explain what circulating tumor DNA (ctDNA) is and how it is considered a cancer biomarker in some malignancies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "ctDNA is not mentioned or explained."
      },
      {
        "criterion_number": 3,
        "description": "The response must summarize how ctDNA enters the bloodstream and is detected through blood tests.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of ctDNA biology or blood-based detection mechanisms is provided."
      },
      {
        "criterion_number": 4,
        "description": "The response must include ways that ctDNA detection can enhance existing modalities for cancer monitoring, including detection of new and potentially targetable mutations in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of ctDNA\u2019s role in monitoring or identifying emergent targetable mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response must include at least one link to existing scientific literature regarding ctDNA use in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No citations or links are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response must suggest that the patient discuss pancreatic cancer biomarker testing with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises to ask for both germline testing and comprehensive tumor profiling, effectively prompting discussion with the care team."
      },
      {
        "criterion_number": 7,
        "description": "The response must define biomarkers for cancer in general terms, including at least one example of a measurable indicator (e.g., proteins, genes, or mutations).",
        "score_given": 0,
        "max_points": 10,
        "justification": "While many biomarkers are listed, there is no general definition of what a biomarker is."
      },
      {
        "criterion_number": 8,
        "description": "The response must describe how biomarkers are used in pancreatic cancer care and explicitly state that they are an adjunct to traditional imaging and biopsy interventions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Uses of biomarkers are described, but it does not explicitly state they are an adjunct to imaging/biopsy."
      },
      {
        "criterion_number": 9,
        "description": "The response must discuss that biomarker reliability varies between individuals with cancer and are not always interpretable, including a specific example of variability.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes CA 19-9 is not reliable in everyone (5\u201310% do not produce it) and can rise with bile duct blockage, illustrating variability and interpretive limits."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that biomarkers can have false positives and false negatives.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It implies potential false positives with CA 19-9 but does not explicitly state the concepts of false positives and false negatives."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that BRCA and HRD genes are key biomarkers as they can predict response to platinum chemotherapy and PARP inhibitors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly explains BRCA1/2 and PALB2 (HR-related) predicting platinum sensitivity and potential PARP inhibitor use."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that MSI/MMR is an important biomarker as it can identify the small percentage of patients that may respond to immunotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states MSI-high/dMMR tumors may respond to immunotherapy and notes this is uncommon but important to find."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that testing can be done on a blood sample or from tumor tissue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It specifies germline testing via blood/saliva and tumor profiling via tissue NGS, and mentions blood-based NGS if tissue is scarce."
      }
    ],
    "question_number": 181,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:46:40.779663",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must describe at least two management strategies for osteopenia and osteoporosis, such as bisphosphonates, denosumab, calcium, or vitamin D.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response includes multiple strategies: calcium (1000\u20131200 mg/day), vitamin D3 (800\u20132000 IU/day), bisphosphonates (alendronate, risedronate, IV zoledronic acid), denosumab every 6 months, and lifestyle interventions. This exceeds the requirement of two strategies."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly describe at least two types of bone and bone density problems that can arise during cancer treatment, such as osteopenia, osteoporosis, or bone metastases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response discusses bone loss/osteoporosis, bone metastases, fractures (including vertebral compression fractures), and hypercalcemia. This fulfills the requirement of at least two types."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly mention bone metastases and at least two treatment options, such as systemic therapy, observation, radiation, or surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Bone metastases are explicitly addressed. At least two treatment options are provided: palliative radiation and surgical/procedural options (orthopedic consultation for fractures, vertebroplasty/kyphoplasty). Bone-modifying agents are also mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that bone metastases can be painful and/or asymptomatic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response links bone metastases with pain by noting bone-modifying agents reduce 'pain events' and that palliative radiation is effective for 'focal painful sites.' This satisfies the 'can be painful' component."
      },
      {
        "criterion_number": 5,
        "description": "The response must mention the frequency or rarity of pancreatic cancer metastasizing to the bone.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement is made about how common or rare bone metastases are in pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response must define or describe osteopenia and osteoporosis.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While osteoporosis is mentioned, there is no definition or description (e.g., low bone density/T-score thresholds). Osteopenia is not explicitly named or defined."
      },
      {
        "criterion_number": 7,
        "description": "The response must identify at least one risk factor for osteopenia and osteoporosis and explain how these conditions are tested, such as with a DEXA scan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple risk factors are listed (steroids, chemotherapy, inactivity, malnutrition, vitamin D deficiency, PPI use). Testing with DEXA scan is explicitly recommended at baseline and every 12\u201324 months."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention granulocyte colony stimulating factor and its potential side effect of temporary bone pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Granulocyte colony-stimulating factor (G-CSF) and its association with transient bone pain are not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response must emphasize that pain related to cancer or cancer-treatment is taken seriously and should be discussed with the patient\u2019s oncology team.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Although pain control strategies and emergencies are discussed, there is no explicit instruction to report pain to or discuss it with the oncology team, nor an explicit emphasis that such pain is taken seriously."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention that palliative medicine is a specialty for managing symptoms related to medical diagnoses and treatments, and that the patient can request a referral to this specialty if available.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Palliative radiation is mentioned, but there is no mention of the palliative medicine specialty or advising a referral to it."
      }
    ],
    "question_number": 182,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:47:10.293559",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define epigenetics.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines epigenetics as chemical tags on DNA or packaging proteins that control gene expression without altering DNA sequence, and lists key mechanisms (DNA methylation, histone modifications, chromatin remodeling, non-coding RNAs)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how epigenetic changes can happen in normal cells, including gene silencing, activation, and DNA methylation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains that epigenetics turn genes on or off (silencing/activation), names DNA methylation explicitly, and notes influences such as aging and inflammation, indicating how epigenetic changes arise, not solely in cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how epigenetic changes impact the cell\u2019s function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links epigenetic changes to altered gene expression that affects cell identity, aggressiveness, EMT, immune evasion, adaptation to hypoxia/nutrients, and drug tolerance, all direct impacts on cellular function."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of epigenetic changes in cancer cells.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It details epigenetic roles in initiating and fueling cancer, cooperating with mutations (KRAS, TP53, etc.), defining PDAC subtypes, promoting invasion/metastasis, drug resistance, and immune evasion."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that epigenetic changes can lead to inactivation of silencing tumor-suppressor genes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that epigenetic silencing can switch off tumor-suppressor genes and gives the example of promoter hypermethylation turning off tumor-suppressor promoters."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that epigenetic changes can lead to activation of oncogenes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes that epigenetic changes can \"turn on growth programs\" in cancer, which is equivalent to activating oncogenic pathways."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that epigenetic changes can contribute to changes in the behavior of the tumor, such as increased propensity to spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states epigenetic programs enable EMT, invasion, and metastasis, demonstrating altered tumor behavior and increased propensity to spread."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that epigenetic changes can impact treatment response.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that chromatin changes can induce drug-tolerant states leading to resistance and relapse, and discusses how reversing epigenetic silencing might restore drug sensitivity (investigational)."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that targeting epigenetic changes in pancreatic cancer is an experimental topic that is being actively researched.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states there is no established standard epigenetic therapy in PDAC, but it is an active research area with multiple epigenetic drugs in clinical trials and provides specific classes (DNMT, HDAC, BET, EZH2, etc.)."
      }
    ],
    "question_number": 183,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:47:27.070578",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend considering accredited agencies with a good reputation.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Explicitly advises choosing agencies that are licensed, Medicare\u2011certified, and accredited (Joint Commission, CHAP, ACHC) and to check ratings on Medicare Care Compare."
      },
      {
        "criterion_number": 2,
        "description": "Recommend agencies that provide a broad range of services for evolving needs.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Details multiple service lines (skilled home health, non\u2011medical care, palliative, hospice) and emphasizes capabilities across pain, drains, nutrition, blood sugars, PT/OT, social work, and rapid escalation/transition to palliative or hospice."
      },
      {
        "criterion_number": 3,
        "description": "Recommend inquiring with oncology team about social work support to find covered home health care.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Directs the reader to ask the oncology clinic navigator or social worker to send referrals and to assist with comparing agencies and coverage."
      },
      {
        "criterion_number": 4,
        "description": "State that there is a broad range of in-home care types and that the family should consider their needed tasks.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly outlines multiple in\u2011home care types (skilled home health, non\u2011medical care, palliative, hospice) and prompts preparation of a needs/goals summary, implying consideration of specific tasks."
      },
      {
        "criterion_number": 5,
        "description": "Summarize common assistance types (e.g., cooking, cleaning, home upkeep, shopping).",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists non\u2011medical supports such as help with bathing, dressing, meals, errands, and companionship; these encompass common household and daily living assistance (meals/cooking, errands/shopping)."
      },
      {
        "criterion_number": 6,
        "description": "Provide links to websites where patients can learn more about types of care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Names resources (Medicare Care Compare, PanCAN, ACS, CancerCare) but does not include actual hyperlinks/URLs."
      },
      {
        "criterion_number": 7,
        "description": "Mention Hospice as in-home care for prognosis of 6 months or less.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly describes hospice at home for ~6\u2011month prognosis with focus on comfort and included services."
      },
      {
        "criterion_number": 8,
        "description": "State that home health includes skilled nursing and in-home therapies (PT/OT).",
        "score_given": 3,
        "max_points": 3,
        "justification": "Defines home health (skilled) as including RN and PT/OT along with other disciplines."
      },
      {
        "criterion_number": 9,
        "description": "Explicitly seek agencies with oncology experience/oncology-trained staff.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises looking for strong oncology/palliative experience and specific oncology-related capabilities (pain, chemo safety, ports, biliary drains)."
      }
    ],
    "question_number": 184,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:47:49.403945",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define angiogenesis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines angiogenesis as new blood vessel growth stimulated by tumors to supply oxygen and nutrients."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the role of angiogenesis in solid tumors.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that many cancers rely on angiogenesis and that blocking it can slow growth and augment other treatments, capturing its general role in solid tumors."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of angiogenesis in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Accurately contrasts PDAC (hypovascular, desmoplastic stroma, hypoxia, poor drug delivery) with pNETs (hypervascular and more angiogenesis-dependent)."
      },
      {
        "criterion_number": 4,
        "description": "The response should discuss how angiogenesis is a target for cancer treatment in some cancers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes that anti-angiogenic therapy can help in many cancers and specifies targeted options effective in pNETs (sunitinib, everolimus), demonstrating angiogenesis as a treatment target."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that anti-angiogenesis drugs are not used routinely in pancreatic cancer as they have not been shown to significantly improve outcomes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that anti-angiogenic drugs have not improved survival in PDAC, are not standard, and cites examples (bevacizumab, aflibercept, ramucirumab, VEGF TKIs) that failed to show benefit."
      },
      {
        "criterion_number": 6,
        "description": "The response should link to randomized control trials studying the effect of anti-angiogenic therapies in pancreatic cancer, with summaries.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions that large trials were negative and lists agents but provides no specific trial names, links, or concise randomized trial summaries."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss treatment options with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages discussion with the oncology team, provides specific questions to ask, and invites sharing details to tailor guidance."
      }
    ],
    "question_number": 185,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:48:01.163532",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that liver function is routinely monitored during treatment using labs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states baseline and regular (every 1\u20133 weeks) monitoring with liver blood tests (AST/ALT, ALP, GGT, bilirubin, albumin, INR) during therapy."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe ways in which pancreatic cancer and pancreatic cancer treatment can affect the liver.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers bile duct obstruction from tumor, liver metastases, chemotherapy hepatotoxicity, immunotherapy hepatitis, radiation injury, TPN/antibiotic-related injury."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that changes in liver function labs will often be investigated further with imaging studies.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes imaging when indicated (ultrasound, CT/MRI, MRCP) and ERCP to evaluate or place stents when abnormalities occur."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe ways in which liver injury can be treated, such as dose reduction in systemic treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes holding chemotherapy for abnormalities, dose reduction, switching agents, and regimen-specific management (irinotecan, oxaliplatin, 5-FU), plus supportive care."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe ways in which liver injury can be treated, such as local therapy to tumors in the liver.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions liver metastases but only states systemic therapy and symptom control; does not discuss local liver-directed therapies (e.g., ablation, SBRT, embolization)."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe ways in which liver injury can be treated, such as biliary stenting.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides detailed management of biliary obstruction with ERCP and stenting, percutaneous drains if needed, monitoring and exchange of stents."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe ways in which liver injury can be treated, such as elimination of offending medications or supplements.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises reviewing and stopping/changing offending drugs (antibiotics/antifungals, TPN) and warns that herbals/supplements can injure the liver, urging disclosure of all products."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe ways in which liver injury can be treated, such as treatment of infection.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends urgent antibiotics and biliary drainage for cholangitis and notes treatment of viral hepatitis/infections as causes."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that in rare cases, biopsy of liver tissue is needed to understand the cause of liver injury.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention liver biopsy as a diagnostic step."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that many different medications and supplements can cause liver toxicity, and the patient should discuss all medications and supplements they take while undergoing cancer treatment to ensure no interactions.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly states multiple drug classes and supplements can cause hepatotoxicity and instructs bringing all medications/supplements to the team; also recommends reviewing for interactions."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe red flag symptoms for liver injury.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists urgent symptoms: fever/chills, RUQ pain, jaundice/dark urine, severe itching, confusion/somnolence, severe N/V, bleeding, melena, ascites/shortness of breath."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend the patient discuss any new or worrisome symptoms with a member of their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a 'When to call urgently' section and a 'Questions to discuss with the care team,' effectively advising communication with the oncology team about new or concerning symptoms."
      },
      {
        "criterion_number": 13,
        "description": "The response should emphasize the importance of exercise, nutrition, and sleep in mitigating treatment-related toxicities and side effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Addresses nutrition and hydration but does not emphasize exercise or sleep; criterion not fully met."
      }
    ],
    "question_number": 186,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:48:34.769146",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should discuss what tumor dormancy is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines tumor dormancy and describes three forms (cellular/quiescence, angiogenic, immune-mediated), emphasizing cells are alive but not actively dividing."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the implications of tumor cells that can enter dormancy, such as disease recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that dormant cells can persist after therapy in PDAC and contribute to recurrence despite clear scans; discusses rationale for adjuvant/maintenance therapy."
      },
      {
        "criterion_number": 3,
        "description": "The response should outline that there is ongoing study on the subject of tumor dormancy, though it is not fully understood at this time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States evidence is still developing with much from lab/animal studies and mentions ongoing clinical trials testing dormancy-targeting strategies."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention that dormancy can occur due to microenvironmental factors such as changes in the tumor microenvironment, lack of nutrients, or the presence of certain immune cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Attributes dormancy to surrounding tissue changes (inflammation, scarring, new blood vessels), immune environment, and angiogenic dormancy (blood supply limitation), all microenvironmental factors."
      },
      {
        "criterion_number": 5,
        "description": "The response must state that dormant cells are often less susceptible to chemotherapy than rapidly dividing cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes dormant cells are harder to kill because most treatments work best on dividing cells."
      },
      {
        "criterion_number": 6,
        "description": "The response should reference evidence from the scientific literature that discusses tumor dormancy in pancreatic cancer, and only references with a PubMed identification number (PMID) should be included.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No scientific literature references or PMIDs are provided; only general resources (NCI, PanCAN, clinicaltrials.gov) are mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should indicate whether or not it is possible to detect dormant cancer cells in the body in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States imaging usually cannot detect dormant cells; discusses CA19-9 limitations and emerging ctDNA/MRD assays in PDAC, indicating detection is challenging and not standard."
      }
    ],
    "question_number": 187,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:48:48.549557",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe what an advance directive is and why people create them.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains that advance directives ensure a loved one's wishes are known and honored, and details components (living will, health care proxy, POLST) and their purpose when the patient cannot speak for themselves."
      },
      {
        "criterion_number": 2,
        "description": "Recommend asking the oncology team if there are resources to assist in creating advance directives (e.g., social work).",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises meeting with the care team and specifically to ask oncology or palliative care to complete a POLST and document code status/goals. While it doesn\u2019t explicitly name social work, it clearly directs engagement with the oncology team for assistance and provides resource tools (PREPARE, Five Wishes, The Conversation Project)."
      },
      {
        "criterion_number": 3,
        "description": "Direct the patient to consider acceptable medical treatments in emergencies or incapacity (CPR, dialysis, artificial nutrition, IV fluids, antibiotics) as part of a living will.",
        "score_given": 10,
        "max_points": 10,
        "justification": "A comprehensive list is provided: CPR/DNR, intubation/ventilation, ICU care, vasopressors, shocks, dialysis, artificial nutrition/hydration (feeding tube, TPN), IV fluids, antibiotics, and more, explicitly tied to the living will/advance directive."
      },
      {
        "criterion_number": 4,
        "description": "Recommend electing a durable power of attorney for healthcare.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The 'Health care proxy/medical power of attorney' section instructs naming a primary decision-maker and backup with contact information and HIPAA release."
      },
      {
        "criterion_number": 5,
        "description": "State that the patient should complete a POLST with their oncologist or other practitioner and have it in the home in an easy-to-see location.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains POLST/MOLST is a medical order completed with a clinician and instructs to ask oncology or palliative care to complete it. It also advises keeping a copy on the fridge for EMS, fulfilling the easy-to-see home location."
      },
      {
        "criterion_number": 6,
        "description": "State that advance directives should include a DNR order if desired.",
        "score_given": 10,
        "max_points": 10,
        "justification": "DNR is explicitly discussed under resuscitation preferences and as part of POLST content; it also advises ensuring matching clinician orders (e.g., DNR in the chart) and mentions DNR bracelets."
      },
      {
        "criterion_number": 7,
        "description": "Encourage completing advance directives as soon as possible, even if cancer is in remission or cured.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it recommends reviewing and updating regularly, it does not explicitly encourage completing directives as soon as possible or regardless of remission/cure status."
      },
      {
        "criterion_number": 8,
        "description": "Explain logistics of completing an advance directive and recommend turning in a copy to the oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It covers state-specific forms, witness/notary requirements, meeting with the care team, and advises giving copies to the primary doctor/oncologist and uploading to the patient portal."
      },
      {
        "criterion_number": 9,
        "description": "Emphasize to pancreatic cancer patients the importance of future planning due to the disease\u2019s aggressive nature and difficulty to cure.",
        "score_given": 5,
        "max_points": 5,
        "justification": "A dedicated section addresses 'Issues commonly relevant in pancreatic cancer' and highlights specific future-planning considerations, underscoring the need for proactive planning in this disease context."
      }
    ],
    "question_number": 188,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:49:15.754957",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define what targeted therapy is in oncologic treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines targeted therapy as drugs that focus on specific genetic changes/biomarkers in the cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain what combination targeted therapy is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that combination targeted therapy uses two or more targeted drugs together or with another treatment to enhance effect and delay resistance."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe what kinds of targeted therapy options exist in pancreatic cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists multiple targetable alterations and therapies relevant to pancreatic cancer (PARP inhibitors for BRCA/PALB2, HER2 combinations, BRAF/MEK, TRK inhibitors for NTRK fusions, RET inhibitors, KRAS inhibitors in trials, immunotherapy for MSI-H/TMB-high)."
      },
      {
        "criterion_number": 4,
        "description": "The response should illustrate why more than one targeted medication might be used at the same time to treat cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides reasons for combining drugs, including dual pathway blockade and preventing resistance, with concrete examples (BRAF+MEK, HER2 antibody + TKI)."
      },
      {
        "criterion_number": 5,
        "description": "The response should explain why the patient\u2019s tumor tissue needs to undergo molecular testing to understand what targeted therapies are indicated.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes comprehensive molecular profiling (NGS) and germline testing to identify actionable alterations guiding therapy."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain that some targeted therapies may not work on the patient\u2019s tumor due to lack of targetable mutations.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that only a minority of pancreatic cancers have clearly targetable alterations and that targeted therapies may not be options for all."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain that targeted therapies do not always work in pancreatic cancer due to tumor heterogeneity.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not explicitly attribute variable efficacy to tumor heterogeneity; discusses resistance and rarity of targets but not heterogeneity as the reason."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe that targeted therapies are sometimes used at the same time as traditional chemotherapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that targeted drugs are sometimes added to chemotherapy, though less common outside trials in pancreatic cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient discuss this further with their oncologist as targeted therapies are individualized to each patient\u2019s cancer, and not all targeted therapies are treatment options for all patients with pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages discussion with the oncology team, provides specific questions, and emphasizes individualized decisions based on molecular results."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention KRAS inhibitors as a current area of research in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions KRAS G12C inhibitors and ongoing clinical trials for KRAS G12D/G12V/G12R-targeted drugs and combinations."
      },
      {
        "criterion_number": 11,
        "description": "The response must mention PARP inhibitors are used in pancreatic cancer patients with BRCA1/2 mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically references PARP inhibitor maintenance (e.g., olaparib) for BRCA1/2 or PALB2-associated pancreatic cancers."
      }
    ],
    "question_number": 189,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:49:36.968042",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define metastasis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response lists sites of spread but does not define metastasis as the spread of cancer cells to distant organs/tissues."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how cancer metastasizes, such as hematologic spread and lymphatic spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explanation of mechanisms (hematogenous, lymphatic, or peritoneal seeding). It mentions vessel and lymph node involvement but not as mechanisms of metastatic dissemination."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how pancreatic cancer metastasizes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes patterns specific to pancreatic cancer: direct invasion of adjacent organs, involvement of major vessels and regional lymph nodes, and typical distant sites."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly state that pancreatic cancer typically spreads locally first, involving surrounding lymph nodes, organs, and blood vessels.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although local and regional spread is described, the response does not explicitly state that local spread typically occurs first."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that metastatic spread of the pancreatic cancer can be influenced by the location of the primary tumor, for example whether it is located at the pancreatic head or the tail.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes spleen invasion is more common with tail tumors, but does not state that metastatic spread patterns are influenced by primary tumor location (head vs tail)."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly state that the liver is usually the first location for metastases.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It says the liver is the most frequent site but does not explicitly state it is usually the first site of metastasis."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly state that pancreatic cancer can metastasize to the peritoneum or lining of the abdominal cavity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly lists the peritoneum/omentum as a common site and mentions ascites."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that pancreatic cancer can spread to the lungs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lungs are explicitly listed as a common distant site."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that pancreatic cancer can spread to at least one of the following less common sites: bones, brain, or adrenal gland.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists bone, adrenal glands, and brain as less common sites."
      },
      {
        "criterion_number": 11,
        "description": "The response should explain what proportion of pancreatic cancers are metastatic at diagnosis and why.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No proportions or reasons provided regarding metastatic disease at diagnosis."
      },
      {
        "criterion_number": 12,
        "description": "The response should discuss that pancreatic cancer commonly has already metastasized at the time of diagnosis because it often is asymptomatic at an early stage and only becomes symptomatic, prompting diagnostic investigation, once it has spread beyond its original site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of asymptomatic early course leading to late/metastatic diagnosis."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that treatment options exist for all stages of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Treatment options for all stages are not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that options for treatment modalities, for example surgery or chemotherapy, depend on the stage of the cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement linking treatment modality choices to cancer stage."
      }
    ],
    "question_number": 190,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:50:09.356017",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe how pancreatic cancer chemotherapy treatment can cause injury to the kidneys.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Clearly explains drug-related kidney injury with specific examples (gemcitabine TMA, immune-related nephritis from checkpoint inhibitors, dehydration from irinotecan/5-FU/capecitabine, contrast) and how these lead to AKI."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly mention that platinum drugs (e.g., cisplatin, oxaliplatin) can directly injure the kidney.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Mentions oxaliplatin with kidney injury (albeit uncommon) and discusses switching away from cisplatin to carboplatin, indicating recognition of platinum-associated nephrotoxicity."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how other pancreatic cancer treatments, such as surgery or radiation, can cause injury to the kidneys.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address renal effects of surgery or radiation therapy."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that urinary tract infection should be ruled out, as some cancer treatments can put patients at increased risk for infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions infections (notably biliary infections/cholangitis) but does not specifically mention urinary tract infection as a cause to rule out."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe that patients undergoing systemic treatment for pancreatic cancer should have their kidney function monitored frequently to evaluate for toxicity.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends labs before each cycle and during symptoms with specific tests (creatinine/eGFR, BUN, electrolytes, urinalysis) and tracking vitals/urine output."
      },
      {
        "criterion_number": 7,
        "description": "The response must clearly state that the first step is to identify the offending agent and reduce or hold the drug.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States 'First step: figure out the cause' and advises holding/adjusting nephrotoxins and chemotherapy; also provides examples (holding ICIs for nephritis, stopping gemcitabine in TMA)."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is monitored and managed, such as serial lab tests of renal function to understand if it is improving over time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details serial monitoring with labs, urine studies, vitals, and imaging if needed, and involvement of nephrology when severe/unclear."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as dose reduction of systemic treatment, particularly the offending drugs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifies dose adjustments (e.g., capecitabine dose reduction by eGFR, oxaliplatin adjustments) and switching away from cisplatin when necessary."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as administration of intravenous fluids or other medications to support the kidneys.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends IV fluids for AKI/dehydration, electrolyte repletion, antibiotics for infection, corticosteroids for immune nephritis, and careful contrast hydration."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly mention that IV fluids can be used to provide hydration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states 'IV fluids for AKI/dehydration' and IV fluids if needed with irinotecan-related diarrhea."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as thorough evaluation of other medications or supplements a patient is taking to ensure there are no harmful interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a detailed medication review (chemo, antibiotics, PPIs, NSAIDs, herbal supplements) and lists substances to avoid unless approved."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly mention that alleviating obstruction (e.g., via stenting or nephrostomy) can help recover renal function.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Notes obstruction as a potential cause and suggests ultrasound to assess, but does not explicitly state that relieving urinary obstruction (e.g., stent/nephrostomy) aids renal recovery."
      },
      {
        "criterion_number": 14,
        "description": "The response must explicitly state that dehydration and obstruction (e.g., biliary or urinary) can lead to kidney injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists volume depletion (dehydration) as a cause of AKI and lists obstruction among causes in the initial differential for kidney problems."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient consult with their oncology team and oncology pharmacist prior to starting new medications or supplements while undergoing pancreatic cancer treatment to avoid harmful interactions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises avoiding certain substances unless approved and suggests care-team questions, but does not explicitly recommend consultation with an oncology pharmacist before starting new medications/supplements."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that sometimes dialysis may be indicated if there is a severe kidney injury related to cancer treatment.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Provides a dedicated section on dialysis indications and notes it may be temporary for severe cases, including TMA."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend staying well hydrated and with adequate nutrition intake while undergoing pancreatic cancer treatment to preserve energy and organ functions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages regular fluids/oral rehydration, and emphasizes adequate calories/protein with dietitian support."
      }
    ],
    "question_number": 191,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:50:58.714268",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the role of genetic mutations in cancer.",
        "score_given": 9,
        "max_points": 9,
        "justification": "Clearly explains trunk vs. branch mutations and lists specific genetic alterations (KRAS, CDKN2A, TP53, SMAD4), as well as types of DNA changes (point mutations, copy-number changes, structural rearrangements, chromothripsis, whole-genome doubling) and how they drive tumor behavior."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how cancer treatment applies selective pressure on cancer cells, allowing those that harbor certain characteristics that confer resistance to therapy a survival advantage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that treatment imposes strong selection; resistant cells often pre-exist and expand under therapy, describing selective pressure and survival advantage."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain that after certain treatments, tumor cells susceptible to that treatment will have died while those resistant to the treatment survive, making the residual cancer fundamentally different from the original cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that chemotherapy shrinks sensitive clones while sparing pre-existing resistant ones, which then expand and cause relapse, indicating a changed residual tumor composition."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how genetic mutations can cause cancer cells to resist certain treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that resistance can emerge through new mutations during treatment or pre-existing resistant clones, directly linking mutations to resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the heterogeneous cellular make-up of pancreatic cancer at baseline.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes intra-tumor heterogeneity (patchwork of lineages, trunk/branch mutations) and PDAC\u2019s complex microenvironment (fibrotic stroma, cancer-associated fibroblasts, sparse T cells), reflecting baseline heterogeneity."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the mesenchymal-epithelial transition, including triggers for this phenomenon.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions cellular state changes, it does not specifically discuss epithelial\u2013mesenchymal transition (EMT) or mesenchymal\u2013epithelial transition (MET) or their triggers."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe methods for evaluating tumor evolution over time, including circulating tumor DNA and/or traditional biopsy of the primary tumor or metastatic lesion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends molecular profiling, repeat profiling at progression, and liquid biopsy (ctDNA) to track evolution; also suggests new/ repeat tissue biopsy to detect resistance mechanisms."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that tumor evolution is when the cancer changes and adapts over time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly characterizes cancer as dynamic and evolving via selection and adaptation (\u201cDarwinian evolution inside the body,\u201d \u201cCancer is not static. It\u2019s a moving target\u201d)."
      }
    ],
    "question_number": 192,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:51:18.326304",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define complementary therapies, including supportive and integrative therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response implies that complementary therapies are used alongside standard care (e.g., 'used safely alongside pancreatic cancer treatment') and mentions Integrative Medicine programs, but it does not actually define 'complementary therapy' nor explicitly define 'supportive care' or 'integrative therapy.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should define aromatherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It equates aromatherapy with essential oils ('Aromatherapy (essential oils)') and describes routes of use (inhalation, topical), which constitutes a functional definition."
      },
      {
        "criterion_number": 3,
        "description": "Mention that ingested or applied substances can cause reactions and it may be difficult to distinguish whether a reaction is from the complementary therapy or the cancer treatment; therefore, use with caution.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it warns about skin reactions, photosensitivity, airway irritation, and advises caution, it does not explicitly state that reactions may be difficult to distinguish from cancer treatment side effects."
      },
      {
        "criterion_number": 4,
        "description": "Inform patients that complementary therapies do not treat cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly warns against any therapy claiming to 'cure cancer' and emphasizes using these modalities for symptom support, implying they do not treat the cancer itself."
      },
      {
        "criterion_number": 5,
        "description": "Inform patients that some complementary therapies may help with symptoms related to their cancer diagnosis, such as stress or insomnia.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It notes benefits for anxiety, sleep, coping, nausea, pain, and neuropathy (e.g., 'Mind-body... safe and effective for anxiety, sleep, and coping')."
      },
      {
        "criterion_number": 6,
        "description": "Recommend the patient inquire with their oncology team if there are practitioners of complementary therapies that they trust, or can place a referral to.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises asking if the center has an Integrative Medicine/Integrative Oncology program and to use oncology-trained, licensed practitioners, which fulfills the recommendation to seek trusted referrals through the care team."
      },
      {
        "criterion_number": 7,
        "description": "Provide website links to informational pages from cancer societies such as NCI or PanCAN.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No links to cancer society resources (e.g., NCI, PanCAN) are provided."
      },
      {
        "criterion_number": 8,
        "description": "Strongly recommend discussing any complementary therapies under consideration with the oncology team to ensure no harmful interactions with cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly urges coordination with the oncology team to avoid interactions, to share a complete list with the oncology team and pharmacist, and to inform the care team of usage, which is a strong recommendation."
      },
      {
        "criterion_number": 9,
        "description": "Explicitly state that aromatherapy is safest when used through inhalation and that oils must be appropriately prepared.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states 'Inhalation is usually the safest route' and specifies proper dilution for topical use (0.5\u20131% in a carrier oil) with patch testing, meeting both requirements."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly state that essential oils on the skin should be used with caution due to the risk of worsening skin irritation from chemotherapy or radiation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises that topical use should be rare and very diluted, to avoid application near radiation fields, and notes 'Chemo can already make skin more sensitive,' explicitly supporting caution due to chemotherapy and radiation-related skin sensitivity."
      }
    ],
    "question_number": 193,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:51:45.975897",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define metabolism in humans.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response explains metabolism functionally as how cells use nutrients for energy and building blocks, e.g., \"Cancer cells change how they use nutrients to fuel rapid growth\" and details nutrient use and recycling. This effectively defines metabolism in a human/cellular context."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the Warburg Effect.",
        "score_given": 9,
        "max_points": 9,
        "justification": "It explicitly states that cancer cells \"use lots of glucose and make lactate even when oxygen is present (the 'Warburg effect').\" This is a correct and concise description of the Warburg effect."
      },
      {
        "criterion_number": 3,
        "description": "The response should include information about glucose, amino acid, and lipid metabolism in cancer cells, specifically in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response discusses high glucose use and lactate export, dependence on amino acids (glutamine) and alanine from stellate cells, and lipid utilization/synthesis, specifically in pancreatic cancer. All three nutrient classes are addressed."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that changes in metabolism can alter sensitivity to cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states the tumor\u2019s altered metabolism and dense stroma can \"limit drug delivery and create resistance\" and that the metabolically harsh microenvironment impairs immunotherapy efficacy, directly linking metabolism to treatment sensitivity."
      },
      {
        "criterion_number": 5,
        "description": "The response should not recommend specific diets for the management of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "No specific named therapeutic diet is recommended to treat cancer. Dietary guidance is general supportive care (e.g., small frequent high-protein meals) and explicitly cautions against restrictive diets; it does not promote a specific diet to manage cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should not indicate that restrictive diets, such as the ketogenic diet or intermittent fasting, should be started by patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states ketogenic/very low-carb diets have not shown benefit and are not recommended outside clinical trials, and advises avoiding restrictive diets. It does not suggest initiating ketogenic diets or intermittent fasting."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss diet with their oncologist and request a referral to a nutritionist if they are interested in learning more.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends early referral to an oncology dietitian and suggests discussing supplements and diet with the oncology team. The \"Practical steps\" explicitly include meeting with an oncology dietitian."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that there is not any current evidence for dietary interventions to alter the metabolism of the cancer and improve treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states ketogenic/very low-carb diets have not shown survival benefit in pancreatic cancer and are not recommended outside trials, and does not present any dietary approach as improving treatment. This communicates the lack of evidence for dietary interventions to alter tumor metabolism and improve outcomes."
      }
    ],
    "question_number": 194,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:52:12.545337",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should list causes of eye problems related to cancer and/or cancer treatment, including chemotherapy-induced optic neuropathy, immunotherapy-related inflammation, bleeding, cataracts, dry eye, metastatic disease to the brain or eye, and infections.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While the response lists several treatment-related causes (e.g., immunotherapy-related uveitis/optic nerve inflammation, bleeding such as subconjunctival hemorrhage, dry eye, infections, and vascular events), it does not mention chemotherapy-induced optic neuropathy, cataracts, or metastatic disease to the brain or eye. Therefore it does not include all required examples."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly state that chemotherapy can lead to eye dryness and irritations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response notes chemotherapy-related irritation (e.g., gemcitabine causing irritation/conjunctivitis; 5-FU causing burning/watery eyes) but does not explicitly state that chemotherapy can cause dry eyes. The criterion requires an explicit statement including dryness."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly state that the use of steroids can lead to an increase in cataracts or glaucoma.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response says steroids can raise eye pressure and cause central serous chorioretinopathy, but does not explicitly state increased risk of cataracts or glaucoma."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly state that immunosuppressed patients are more likely to have infections in their eyes.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although infection risk is mentioned (e.g., contact lens wearers, shingles), the response does not explicitly link increased eye infection risk to being immunosuppressed."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the patient\u2019s eye symptoms may not be related to cancer or cancer treatment, and they should seek out an eye exam by a qualified practitioner.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Non\u2013cancer-treatment causes are listed (e.g., high/fluctuating blood sugar), implying symptoms may be unrelated. The response also advises urgent/same-day ophthalmology for certain symptoms and to ask the oncology team about same-day ophthalmology, satisfying the recommendation for an eye exam."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend that the patient document characteristics of their symptoms, such as severity and date of onset.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends sharing detailed characteristics, including exact symptoms, when they started, laterality, triggers, and associated features. This satisfies documenting onset and characteristics."
      },
      {
        "criterion_number": 7,
        "description": "The response should list \u201cred flag\u201d eye symptoms that should prompt immediate presentation to medical care, such as vision loss or severe pain.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides a comprehensive list of urgent symptoms (e.g., sudden vision loss, curtain over vision, flashes/floaters, painful red eye with decreased vision, severe headache with eye pain, new double vision, unequal pupils, neurologic deficits, infusion-related vision changes, shingles near eye, chemical exposure)."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly state that any eye symptoms should be discussed with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly instructs to loop in the oncology team promptly and to call the oncology nurse line to report eye symptoms."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient possibly request a referral to an ophthalmologist, based on reported symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises asking the oncology team if they want same-day ophthalmology and calls for urgent ophthalmology in specific scenarios, effectively recommending referral based on symptoms."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that eye drops can be used to mitigate symptoms of dry eyes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends preservative-free artificial tears 4\u20136 times/day and lubricating gel/ointment at night for gritty symptoms, which directly addresses using eye drops to mitigate dryness."
      }
    ],
    "question_number": 195,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:52:52.216036",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define neoantigens in cancer as proteins expressed on the surface of cancer cells, used by the immune system to differentiate cancer from healthy tissue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines neoantigens as mutation-derived peptide fragments presented on the cell surface by HLA molecules and recognized by T cells, enabling immune distinction between tumor and normal cells."
      },
      {
        "criterion_number": 2,
        "description": "Mention ongoing research involving neoantigens in cancer, including cancer vaccines, immunotherapy, and CAR-T trials.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response discusses neoantigen research such as personalized and shared vaccines, checkpoint inhibitors, and TCR/TIL therapies, but it does not mention CAR-T trials. Because the criterion specifies inclusion of CAR-T, full credit cannot be awarded."
      },
      {
        "criterion_number": 3,
        "description": "State that there are no FDA-approved treatments targeting neoantigens at this time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly characterizes neoantigen approaches as experimental and available only in clinical trials and not standard care, which conveys that there are no FDA-approved neoantigen-targeting treatments."
      },
      {
        "criterion_number": 4,
        "description": "Recommend that the patient discuss the role of neoantigens in their cancer care with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking the care team about appropriateness of neoantigen-based trials and provides specific questions for the next visit, directly encouraging discussion with the oncology team."
      },
      {
        "criterion_number": 5,
        "description": "Recommend considering referral to be considered for clinical trials for pancreatic cancer treatment in their area.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends asking the oncologist for referral to centers running neoantigen vaccine or T-cell therapy studies and provides resources for finding trials, meeting the criterion."
      }
    ],
    "question_number": 196,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:53:18.015352",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must define autophagy, including its normal role in cellular turnover, specifically mentioning degradation and recycling of cellular components, and maintaining cellular homeostasis by removing damaged organelles and protein aggregates.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines autophagy as a recycling system delivering components to lysosomes for breakdown and reuse; mentions maintaining health/homeostasis and explicitly notes removal of damaged mitochondria and proteins."
      },
      {
        "criterion_number": 2,
        "description": "The response must describe the dual role of autophagy in cancer, including both tumor suppression and promotion, with context on how these roles change during cancer progression.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicit 'double-edged sword' explanation: tumor-suppressive early and tumor-promoting in established cancers; includes therapy-induced autophagy contributing to resistance."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that autophagy can be protective against cancer by removing damaged or dysregulated proteins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States autophagy removes damaged proteins and organelles and that adequate autophagy suppresses tumors early; links to prevention of toxic buildup and DNA damage, implying protective effect via clearance."
      },
      {
        "criterion_number": 4,
        "description": "The response must describe the role of autophagy in pancreatic adenocarcinoma, specifically addressing its upregulation and contribution to cancer cell survival and treatment resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes PDAC has unusually high autophagy and depends on it for metabolism, stress tolerance, immune evasion, and treatment resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that cancerous cells can utilize autophagy to promote survival, growth, and therapy resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States established tumors hijack autophagy to survive harsh conditions, grow, spread, and resist therapy."
      },
      {
        "criterion_number": 6,
        "description": "The response must explain if the autophagy process can be targeted with cancer treatment, providing at least one reference with a PMID if available.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Explains targeting strategies (e.g., HCQ, ULK1/2, VPS34 inhibitors) but provides no literature references or PMIDs."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that blocking autophagy has been explored as an area of research but there are no current standard of care treatments targeting autophagy in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly states autophagy inhibition is under active research and that, outside clinical trials, it is not standard of care in PDAC."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention specific drugs targeting autophagy, reference existing evidence in the scientific literature, and clearly state if any treatment strategy is FDA approved.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions specific drugs (e.g., hydroxychloroquine) and targets but does not cite scientific literature with references and does not clearly state FDA approval status for autophagy-targeting strategies in PDAC."
      },
      {
        "criterion_number": 10,
        "description": "The response must reference at least one scientific literature source with a PubMed identification number (PMID).",
        "score_given": 0,
        "max_points": 3,
        "justification": "No PMIDs or specific literature citations are provided."
      }
    ],
    "question_number": 197,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:53:43.016846",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the different types of support groups that exist for cancer patients and family members of cancer patients.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly distinguishes patient vs. caregiver groups; mentions pancreatic-specific and advanced cancer groups; discusses professionally facilitated groups, closed vs. drop-in structures, online/telephone groups, and online communities as complements."
      },
      {
        "criterion_number": 3,
        "description": "The response should address whether there is evidence that a telehealth support group is inferior to an in-person support group.",
        "score_given": 6,
        "max_points": 6,
        "justification": "States that telehealth groups are about as effective as in-person groups and notes comparable outcomes in distress, anxiety/depression, QoL, perceived support, satisfaction, and therapeutic alliance; acknowledges some may prefer in-person."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide references and sources for evidence regarding the effectiveness of telehealth versus in-person support groups.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No specific studies, citations, or links provided; only general statements about research."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that in-person and telehealth groups each have their advantages and disadvantages and either may be as effective based on an individual\u2019s needs and preferences.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly outlines pros and cons of each modality and emphasizes individual fit; suggests hybrid approach for those with access to both."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that telehealth groups can be more accessible and convenient.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes better attendance due to no travel, usefulness when travel is tiring or symptoms fluctuate, and positions telehealth as a convenient option."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some may feel that in-person groups will lead to better emotional connection.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Directly states some people feel more connected in person and explains fewer nonverbal cues and lack of informal interactions online."
      },
      {
        "criterion_number": 9,
        "description": "The response should include a way for the patient or family member to input their location to generate a list of local support group resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Invites the user to share whether the support is for patient or caregiver, their location/time zone, and preferences to provide tailored group options."
      },
      {
        "criterion_number": 10,
        "description": "The response should list organizations to contact that might be able to provide support resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple organizations: PanCAN, Cancer Support Community/Gilda\u2019s Club, CancerCare, and mentions hospital-based resources and reputable online communities."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient ask their oncology team for assistance in finding support groups.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends contacting the cancer center\u2019s oncology social worker to access disease-specific groups, which constitutes asking the oncology team."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe that increased stress is normal when dealing with a cancer diagnosis and treatment, or as a family member of a cancer patient.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Expresses empathy and acknowledges difficulty but does not explicitly state that increased stress is normal or expected."
      }
    ],
    "question_number": 198,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:54:14.231040",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention the effect of caffeine on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises to avoid caffeine after late morning and notes it fragments sleep."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention the effect of alcohol on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises to avoid alcohol in the evening and notes it fragments sleep."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the effect of illegal drugs on sleep.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of illegal/illicit drugs (e.g., cocaine, methamphetamine) and their effects on sleep; cannabis was mentioned but not framed as illegal drugs or their specific sleep effects."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe strategies to improve sleep that are evidence-based.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes evidence-based measures: CBT-I with stimulus control, consistent wake time, morning light exposure, nap limitation, sleep environment optimization, wind-down routine, and addressing medical contributors (pain, reflux, pruritus, sleep apnea)."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide references for evidence-based sleep improvement interventions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations, guidelines, or references provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should include insights into things in everyday life that may be interfering with a patient\u2019s ability to sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses screens/blue light, late heavy meals, evening fluids, naps, caffeine, alcohol, room temperature/light/noise\u2014common everyday factors that impair sleep."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide insights into how cancer-related symptoms can interfere with sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details multiple cancer/treatment-related disruptors: pain, steroid-induced insomnia, nausea/GERD, cholestatic pruritus, neuropathy/restless legs, nocturia (including steroid/diabetes causes), sleep apnea, and anxiety."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of appropriate management of cancer-related or cancer-treatment related symptoms to prevent interference in everyday life, including sleep.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Strong emphasis on working with the care team to optimize pain regimens, adjust steroid timing/dose, manage reflux, treat jaundice/itching (e.g., stenting, cholestyramine), evaluate sleep apnea, and address mood\u2014clearly linking management to better sleep."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe common symptoms that people with pancreatic cancer might experience.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions common pancreatic cancer symptoms/complications such as pain, jaundice with itching, nausea/reflux, and weight loss."
      },
      {
        "criterion_number": 10,
        "description": "The response should direct the patient to discuss any symptoms of cancer or cancer treatment with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Repeatedly instructs to ask/discuss with the care team and includes a clear list of when to call the team urgently."
      },
      {
        "criterion_number": 11,
        "description": "The response should emphasize the importance of mental health and the impact of stress on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses mood/anxiety and recommends psycho-oncology, counseling, or palliative care to improve coping and sleep."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that sleep hygiene is an important first step.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Provides many sleep hygiene tips but does not explicitly state that 'sleep hygiene is an important first step.'"
      },
      {
        "criterion_number": 13,
        "description": "The response must mention a consistent relaxing bedtime routine starting 30 to 60 minutes before bedtime.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends a 45\u201360 minute wind-down with relaxing activities before bed."
      },
      {
        "criterion_number": 14,
        "description": "The response must clearly state that stimulant use, such as nicotine, should be avoided in the afternoon and evenings.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Advises limiting caffeine but does not mention nicotine or broadly advise avoiding stimulants in the afternoon/evening."
      },
      {
        "criterion_number": 15,
        "description": "The response must explicitly recommend optimizing the sleep environment by keeping the room dark, cool, and quiet.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends keeping the bedroom cool, dark, and quiet and suggests eye mask, earplugs, or white noise."
      },
      {
        "criterion_number": 16,
        "description": "The response must mention that supportive therapies, such as melatonin or other sleep aids, can be considered if deemed safe by the medical team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests melatonin and other sleep medications framed as 'to discuss with his clinician,' emphasizing safety and coordination with the care team."
      }
    ],
    "question_number": 199,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:55:18.467220",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer-related cachexia.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines cachexia as a syndrome of ongoing skeletal muscle loss driven by tumor-related inflammation and metabolic changes, with functional impact (weakness, fatigue, reduced treatment tolerance)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how cachexia occurs in patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains mechanisms specific to pancreatic cancer: tumor-driven inflammation, pancreatic exocrine insufficiency causing malabsorption, biliary/gastric outlet obstruction, treatment side effects reducing intake, and diabetes/insulin impairment worsening muscle loss."
      },
      {
        "criterion_number": 3,
        "description": "The response should delineate cancer cachexia from regular weight loss.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides a dedicated section contrasting causes, metabolic state (hypercatabolism), body composition (preferential muscle loss), reversibility, and diagnostic clues versus simple undernutrition."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that cachexia can occur independently of dietary changes.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States weight and muscle can drop despite adequate intake and that inflammatory signals increase energy use and breakdown \"even if calories are provided,\" showing independence from dietary intake alone."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that cachexia involves muscle loss.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly describes cachexia as ongoing loss of skeletal muscle and highlights sarcopenia."
      },
      {
        "criterion_number": 6,
        "description": "The response should include information about prognosis in patients experiencing cancer cachexia.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions reduced treatment tolerance but does not explicitly discuss prognosis or survival implications associated with cachexia."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide evidence-based recommendations to patients experiencing cancer cachexia.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Offers multi-pronged, evidence-informed strategies: referral to oncology dietitian/palliative care/PT/OT, pancreatic enzyme replacement, antiemetics, bowel regimen, pain optimization, nutrition strategies, activity, and medications (megestrol, short-course steroids, mirtazapine, prokinetics), plus monitoring."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss their concerns about cancer cachexia with their oncology team and/or a nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly advises asking for a cachexia plan with referrals to an oncology dietitian and palliative care and to share monitoring with the care team."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that cachexia is difficult to manage.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes cachexia cannot be fully reversed by nutrition alone and requires combined approaches, implying and effectively stating management difficulty."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that cachexia can be mitigated by nutritional support, medications, and physical therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends nutrition strategies and oral supplements, medications (appetite stimulants, mirtazapine, prokinetics), and activity/PT/OT to maintain function."
      }
    ],
    "question_number": 200,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:55:47.071190",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe EMT as a transformation where epithelial cells acquire mesenchymal characteristics.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains epithelial cells switching to a more mesenchymal state\u2014looser, flexible, and motile\u2014using accurate descriptions and analogies."
      },
      {
        "criterion_number": 2,
        "description": "Mention EMT as a key feature of cancer progression, contributing to tumor progression, invasion, metastasis, and therapy resistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly links EMT to spread (metastasis) and reduced sensitivity to chemotherapy; discusses EMT\u2019s role in cancer behavior and resistance."
      },
      {
        "criterion_number": 3,
        "description": "Define epithelial cells as those forming the lining of glands, organs, and body surfaces, including the pancreas, and describe their tight connections and specific functions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes epithelial cells as tightly attached and lining organs, but does not explicitly mention glands, body surfaces, the pancreas, or specific functions beyond being organized and stationary."
      },
      {
        "criterion_number": 4,
        "description": "Define mesenchymal cells as those that can move, change shape, and are found in connective tissue, supporting organs and glands.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes mesenchymal-state cells are looser, flexible, and able to move, but does not state they are found in connective tissue or that they support organs and glands."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly state that EMT enables cancer cells to migrate to distant sites, leading to metastasis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly states EMT helps cells detach, move through tissue and blood, and seed new sites (metastasis), with mention of MET at secondary sites."
      },
      {
        "criterion_number": 6,
        "description": "Mention that EMT is an area of current research and explicitly state that there are no treatments aimed at this process yet.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States EMT is largely a research concept and mentions clinical trials targeting EMT-related signals are not standard yet, but does not explicitly state that there are no treatments aimed at EMT."
      },
      {
        "criterion_number": 8,
        "description": "State that plasticity is a key factor in treatment resistance in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes EMT as dynamic/partial and links this in-between state to drug resistance within the pancreatic cancer context, conveying the role of plasticity in resistance."
      }
    ],
    "question_number": 201,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:56:20.266968",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define the microbiome as the microorganisms that live in the body and play roles in digestion, immune function, metabolism, and inflammation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response defines the microbiome as bacteria, fungi, and viruses living in the body, but it does not explicitly state the broad roles of digestion, metabolism, and inflammation in the definition. Immune effects are discussed, but a full definition covering all listed roles is not provided."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that the microbiome is associated with cancer, specifically pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response repeatedly links the microbiome to pancreatic ductal adenocarcinoma (PDAC), including tumor colonization, risk associations, prognosis, and progression."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how the microbiome is thought to affect pancreatic cancer treatment, including its influence on the efficacy of immunotherapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Treatment effects are detailed: bacterial inactivation of gemcitabine, antibiotics\u2019 potential impact, and the microbiome\u2019s role in shaping the immune microenvironment. It notes PDAC\u2019s poor response to immunotherapy and discusses microbiome influence on immunotherapy based on evidence from other cancers."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how the microbiome can influence how the body metabolizes chemotherapy drugs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clear examples are provided: Gammaproteobacteria inactivating gemcitabine via cytidine deaminase and gut microbial enzymes affecting irinotecan toxicity."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that modulating the microbiome to improve cancer outcomes is an active area of research with limited evidence and no standard of care options to date.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response explicitly states that microbiome-directed therapies are investigational, results are preliminary, and there is no standard-of-care microbiome intervention for PDAC."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention the various roles the microbiome is postulated to play in the human body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses roles including immune modulation, drug metabolism/tolerability, infection risk (e.g., stents, surgery), and connections to oral health and nutrition, satisfying the requirement to mention various roles."
      },
      {
        "criterion_number": 7,
        "description": "The response should summarize the scientific research with references (PMID if available).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Key studies are summarized with journal citations (Cell 2019; Science 2017; Cancer Discovery 2018; Nature 2019). While PMIDs are not listed, references and summaries are present."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe standard of care treatments for pancreatic cancer, including chemotherapy and immunotherapy, and mention that appropriate treatment selection depends on the stage of cancer and fitness of the patient.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Chemotherapy regimens (gemcitabine, FOLFIRINOX) and limited use of immunotherapy (MSI-H/dMMR) are mentioned, and surgery is referenced, but the response does not explicitly state that treatment selection depends on stage and patient fitness."
      },
      {
        "criterion_number": 9,
        "description": "The response should suggest that the patient discuss whether there are ways to support a healthy microbiome with a nutritionist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends dietary approaches and explicitly suggests asking for a referral to an oncology dietitian to support microbiome and nutrition."
      }
    ],
    "question_number": 202,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:56:53.185766",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that mood changes are very common with the diagnosis of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that mood and personality changes are common in pancreatic cancer and provides prevalence context (30\u201350%), conveying high frequency."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing treatment-related mood changes with the oncology team to ensure they are provided with available local resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises telling the oncology or palliative care team promptly, keeping a symptom diary, and asking clinicians about resources and referrals."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend a referral to a mental health provider familiar with cancer patients and cancer care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends psycho-oncology counseling and referrals to psycho-oncology, indicating mental health care specialized in cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe counseling as an intervention that may help alleviate mood issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions psycho-oncology counseling, cognitive behavioral therapy, and other non-medication supports."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe medications, such as antidepressants, as an intervention that may help alleviate mood issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists SSRIs/SNRIs, mirtazapine, duloxetine, and other psychotropics as treatment options."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe support group participation as an intervention that may help alleviate mood issues.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Recommends support groups for patients and caregivers as part of non-medication supports."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide supportive language about mood changes during cancer treatment and attempt to normalize this phenomenon.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Opens with empathy, states mood changes are common and treatable, and reassures the reader they are not alone."
      },
      {
        "criterion_number": 8,
        "description": "The response should reference studies that quantify patients with cancer that suffer from mood changes after diagnosis and/or during treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides quantified prevalence (30\u201350% with clinically significant depression), indicating study-based estimates."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe different interventions that may help alleviate mood issues, such as psychiatric evaluation, exercise, nutrition, and cancer-related symptom control.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers screening, medication review, symptom control (pain, nausea, sleep, constipation), blood sugar management, light activity, sleep hygiene, balanced nutrition, counseling, and psychiatric medications."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that patients with suicidal thoughts consider presentation to medical care urgently or emergently.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly instructs to call local emergency services and provides the US 988 Suicide & Crisis Lifeline for immediate risk of self-harm."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the role of palliative medicine in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises contacting the palliative care team; describes their role in screening, addressing reversible contributors, and symptom management."
      },
      {
        "criterion_number": 12,
        "description": "The response should list common side effects of both pancreatic cancer and pancreatic cancer treatment, and suggest that feeling poorly can impact one\u2019s mood.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists pain, fatigue, poor sleep, nausea, weight loss, malabsorption, neuropathy, and medication side effects; links these symptoms to worsened mood."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that some patients benefit from a mental health standpoint by having their affairs in order, as this can provide some peace of mind in the face of a serious illness.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention advance care planning or organizing personal affairs for peace of mind."
      },
      {
        "criterion_number": 14,
        "description": "The response should list online resources for support for patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides Pancreatic Cancer Action Network (PanCAN) and American Cancer Society as resources."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that mindfulness and relaxation techniques can be considered.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends mindfulness/relaxation and breathing techniques as supportive interventions."
      }
    ],
    "question_number": 203,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:57:23.770369",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define tumor suppressor genes and their function in the human body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines tumor suppressor genes as the body's 'brakes' on cell growth and explains core functions (DNA repair, cell-cycle arrest, apoptosis)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how defects in tumor suppressor genes can lead to cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that loss of tumor suppressor function removes growth brakes, promotes unchecked proliferation, genomic instability, and resistance to cell death; also contextualizes with oncogene activation and PDAC progression."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how tumor suppressor genes gain defects or mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details the two-hit hypothesis (germline or somatic first hit and subsequent second hit) and mechanisms including mutations, deletions, promoter methylation, and loss of heterozygosity; mentions haploinsufficiency."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that there are genetic syndromes inherited in families that affect tumor suppressor genes, leaving affected individuals at higher risk of developing cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "References hereditary syndromes and germline risk genes (e.g., STK11/Peutz-Jeghers, BRCA1/2, PALB2, ATM, Lynch) and recommends germline testing and family counseling."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention tumor suppressor genes that are thought to play a role in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists key PDAC tumor suppressors (CDKN2A, TP53, SMAD4) and others relevant to pancreatic cancer biology (BRCA1/2, PALB2, ATM, PTEN, ARID1A, RNF43, STK11)."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that this is an active area of research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that directly fixing tumor suppressors is not usually possible yet and mentions clinical trials targeting downstream pathways, indicating ongoing research activity."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss whether there are clinical trials available in their area with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages discussion with the care team about whether results suggest benefit from a clinical trial and lists it among 'Good questions to ask the care team.'"
      }
    ],
    "question_number": 204,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:57:48.422418",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 2,
        "description": "Recommend discussing mental health counseling with the oncology team to connect with local resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises, \u201cAsk your oncology clinic for referrals to their oncology social worker and palliative care team,\u201d which directly recommends engaging the oncology team for local resources."
      },
      {
        "criterion_number": 3,
        "description": "Introduce palliative medicine as a specialty for managing symptoms or end-of-life care for pancreatic cancer patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Palliative care is clearly introduced as an interdisciplinary team focused on symptom relief, emotional support, and goals-of-care, with a specific note that early palliative care is recommended for pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "List at least three types of mental health care providers, including their credentials and any limitations in practice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple provider types are listed with credentials and scope: Oncology social worker (LCSW), Psycho-oncologist/health psychologist (licensed psychologist/therapist), Psychiatrist (for medications), Marriage and Family Therapist (LMFT), Chaplain/pastoral counselor, and Hospice/bereavement counselor. The roles/limitations are delineated (e.g., psychiatrists for meds; LMFT for couples/family; chaplains for spiritual concerns)."
      },
      {
        "criterion_number": 5,
        "description": "Mention at least one modality for delivery of mental health counseling, such as in-person or telehealth.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Telehealth is explicitly mentioned (\u201cPractical availability (telehealth, scheduling)\u201d and directory filters include \u201ctelehealth\u201d)."
      },
      {
        "criterion_number": 6,
        "description": "Explicitly state that choosing the best provider is individualized and cannot be recommended online.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response notes that the \u201cright\u201d counselor depends on goals (individualized), it does not explicitly state that a best provider cannot be recommended online."
      },
      {
        "criterion_number": 7,
        "description": "Mention providers affiliated with religious denominations or faith-based counseling options.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response includes \u201cChaplain or pastoral counselor\u201d and advises looking for a board-certified chaplain, meeting the faith-based provider requirement."
      },
      {
        "criterion_number": 8,
        "description": "Mention mental health resources available for family members and caregivers of cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly addresses caregivers and families (caregiver stress, family/couples work, LMFT for family strain) and lists resources like Cancer Support Community/Gilda\u2019s Club and hospice/bereavement services for families."
      },
      {
        "criterion_number": 9,
        "description": "Recommend seeking counseling proactively, not waiting for a crisis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The guidance to \u201cstart with an oncology social worker or palliative care team\u201d and the recommendation for early palliative care for pancreatic cancer clearly encourage a proactive approach."
      },
      {
        "criterion_number": 10,
        "description": "Recommend at least one additional way to improve overall wellbeing, such as nutrition, exercise, sleep, or symptom control.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response emphasizes symptom control via palliative care and notes therapy for sleep and anxiety/depression, which are additional ways to improve wellbeing beyond counseling type selection."
      },
      {
        "criterion_number": 11,
        "description": "State that a licensed clinical social worker would be a good resource to utilize for advice and to be connected to further resources such as financial or caregiver support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly highlights an Oncology social worker (LCSW) as a great first stop, noting help with care navigation, financial/legal resources, and family meetings."
      }
    ],
    "question_number": 205,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:58:33.799071",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define what DNA damage repair pathways are in the human body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines DDR as cellular systems that constantly repair DNA damage and notes tumors may lose parts of these systems."
      },
      {
        "criterion_number": 2,
        "description": "The response should list examples of genes implicated in DNA repair pathways in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides multiple relevant genes/pathways: BRCA1/2, PALB2, RAD51, Fanconi genes, ATM\u2013ATR\u2013CHK1/2, and MMR genes (MLH1, MSH2, MSH6, PMS2)."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain treatments in pancreatic cancer that are indicated for mutations in certain DNA repair pathway mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains platinum sensitivity for HRR defects, PARP inhibitor maintenance for germline BRCA1/2, immunotherapy for MSI-H/dMMR, and mentions DDR-targeted trials and radiation sensitivity."
      },
      {
        "criterion_number": 4,
        "description": "The response should list DNA pathway repair targeted therapies in pancreatic cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists PARP inhibitors (olaparib) and investigational DDR-targeted agents (ATR, WEE1, CHK1, DNA-PK inhibitors)."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe how mutations in DNA damage repair pathways affect chemotherapy effectiveness.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States HRR defects (e.g., BRCA/PALB2) increase sensitivity to platinum chemotherapy and notes potential increased radiation sensitivity."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe how mutations in these pathways are detected in tumors, which is through genetic testing of tumor tissue from a biopsy or through a blood test.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends germline testing for all patients (blood/saliva) and tumor molecular profiling (NGS) on tumor tissue, detailing what to assess (MMR/MSI, TMB, HRR genes)."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide references to scientific literature with PMID for any of the FDA-approved treatments listed in rubric 4.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No PMIDs or literature references are provided for FDA-approved treatments (e.g., olaparib maintenance)."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss tumor genetic testing with their oncologist to understand if they are a candidate for any DNA damage repair pathway mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises discussing completion of germline testing and tumor profiling with the oncology team."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend the patient inquire about clinical trials in their local area that might be evaluating new drugs that target DNA damage repair pathways, or inquire about a referral to a local institution that might have general clinical trials for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages asking about clinical trials for ATR/WEE1/CHK1/PARP combinations and other DDR-targeted approaches."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that around 5-10 percent of pancreatic cancers have these mutations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "States ~10% germline and 15\u201325% overall DDR defects, but does not state the specified 5\u201310% figure."
      }
    ],
    "question_number": 206,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:59:12.443135",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must clearly define inflammation using terms such as \u201cimmune response,\u201d \u201ctissue injury,\u201d or \u201cprotective mechanism.\u201d",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions that some inflammation comes from the body's immune response but does not clearly define inflammation as an immune response to tissue injury or infection, nor does it frame it as a protective mechanism."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly distinguish between acute and chronic inflammation, mentioning characteristics like \u201cshort-term\u201d vs. \u201clong-term\u201d or \u201crapid onset\u201d vs. \u201cpersistent.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit distinction between acute and chronic inflammation is made; terms like short-term/long-term or rapid/persistent are not used."
      },
      {
        "criterion_number": 3,
        "description": "The response must describe at least two medical strategies for managing inflammation, such as \u201ctargeted therapies,\u201d \u201cimmunotherapies,\u201d \u201csteroids,\u201d or \u201cpain management.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple strategies are provided: chemotherapy/targeted/immunotherapy, NSAIDs, corticosteroids, pain management, anticoagulation, and management of biliary obstruction/infection."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that there is no formal, evidence-based strategy to quantify and target inflammation in cancer patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes monitoring markers (CRP, albumin, NLR) and that routine anti-inflammatory drugs are not standard, it does not explicitly state that there is no formal, evidence-based strategy to quantify and target inflammation."
      },
      {
        "criterion_number": 5,
        "description": "The response must state that treating the cancer itself, such as through \u201csurgery\u201d or \u201cradiation,\u201d is postulated to improve cancer-related inflammation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that the most effective way to reduce cancer-driven inflammation is to treat the cancer and lists surgery, chemotherapy, and radiation."
      },
      {
        "criterion_number": 6,
        "description": "The response must mention chronic pancreatitis or chronic pancreatic injury as a factor in cancer formation and provide at least one scientific reference with a PMID.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chronic pancreatitis is not discussed as a risk factor for cancer formation, and no scientific references or PMIDs are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response must recommend at least two lifestyle interventions to decrease inflammation, such as \u201cplant-based diet,\u201d \u201cexercise,\u201d \u201chydration,\u201d or \u201cgood quality sleep.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends sleep, stress management, and light regular activity/physical therapy; also notes vaccinations to reduce infection-driven inflammation. These constitute at least two lifestyle measures relevant to reducing inflammatory burden."
      },
      {
        "criterion_number": 8,
        "description": "The response must recommend against nicotine and alcohol use and reference their role in promoting inflammation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It advises no smoking and limiting alcohol but does not explicitly tie nicotine or alcohol to promoting inflammation."
      },
      {
        "criterion_number": 9,
        "description": "The response must recommend that the patient report any symptoms to their oncology team for symptom management.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Provides a clear list of urgent symptoms and instructs when to call the care team, directly advising communication with the oncology team."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that chronic inflammation promotes tumor growth. Synonyms for \u201cpromotes\u201d include \u201csupports,\u201d \u201caids,\u201d or \u201cfacilitates.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that inflammatory components within the tumor microenvironment \u201ccan help tumors grow, spread, and resist therapy,\u201d which conveys that inflammation promotes tumor growth."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that inflammatory signaling pathways are overactivated in cancer, using terms like \u201coveractivated,\u201d \u201cupregulated,\u201d or \u201cenhanced.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions pathways (NF-\u03baB/STAT3), it does not explicitly describe them as overactivated, upregulated, or enhanced in cancer."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that the immune system can be activated to recognize and attack cancer, using terms like \u201cempower,\u201d \u201cstimulate,\u201d or \u201cleverage.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions immunotherapy for MSI-H/dMMR tumors but does not explicitly state that these approaches activate or stimulate the immune system to attack cancer."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly state that anti-inflammatory drugs are not used as a primary treatment for pancreatic cancer. Synonyms for \u201cprimary\u201d include \u201cmain\u201d or \u201cfirst-line.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that routine use of anti-inflammatory drugs (COX-2 inhibitors, cytokine blockers, JAK inhibitors) is not standard outside trials, implying they are not first-line therapy."
      },
      {
        "criterion_number": 14,
        "description": "The response must explicitly state that NSAIDs and steroids are prescribed to manage symptoms associated with cancer, using terms like \u201csymptom management,\u201d \u201csymptom control,\u201d or \u201calleviate symptoms.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists NSAIDs for pain and short courses of corticosteroids for appetite, energy, pain flares, and nausea under \u201cMedications that help with inflammatory symptoms,\u201d indicating use for symptom control."
      }
    ],
    "question_number": 207,
    "source": "gpt-5",
    "graded_at": "2025-11-01T18:59:53.985807",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention using a pill organizer with compartments for different times of the day and days of the week.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions preparing \"pillboxes\" and describes smart dispensers and blister packs organized by time of day, indicating use of compartmentalized organizers."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention using a medication management application, with examples such as Medisafe, MyTherapy, or CareZone.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Names specific apps: Medisafe, MyTherapy, and Apple Health Medications, with features described."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention setting alarms or reminders on digital devices to alert when it\u2019s time to take medication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes app-based \"reminders\" and \"alerts\" (Medisafe, Apple Health) and smart dispensers that \"remind\" users."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention creating a physical chart or digital document listing all medications, dosages, and times.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends a master medication list (drug, dose, timing, purpose) kept in print and digital formats; also suggests a weekly Medication Administration Record."
      },
      {
        "criterion_number": 5,
        "description": "The response should direct the patient to discuss options for medication management with their oncology team and/or pharmacy team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises asking the oncology nurse for a chemo-cycle calendar and consulting the pharmacy for multi-dose blister packs; encourages bringing med lists to appointments for review."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend exploring medication delivery services and bubble packs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends pharmacy multi-dose blister packs and services like Amazon Pharmacy\u2019s PillPack, plus automatic refills and delivery."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient have a loved one help with their medication management.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes caregiver involvement: Medisafe \u201cMedfriend\u201d, sharing Apple Health data, using MAR for handoffs, and assigning roles among caregivers."
      },
      {
        "criterion_number": 8,
        "description": "The response should empathize about the medication burden in patients undergoing cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Opens with empathy and acknowledges complex, changing medication schedules in pancreatic cancer care."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention meeting with a pharmacist or provider to complete a medication reconciliation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises bringing the updated med list to every appointment and to reconcile after hospital discharges, implying medication reconciliation with the care team."
      }
    ],
    "question_number": 208,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:00:28.534296",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define oncogenes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines proto-oncogenes and explains that when they are altered to be constitutively active, they become oncogenes that drive inappropriate growth and survival."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe that oncogenes can undergo mutation, which might put the individual at risk for developing cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that proto-oncogenes can be altered (mutated) and become oncogenes that provide persistent growth signals contributing to cancer development."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how oncogenes mutate.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Enumerates mechanisms: point mutations, gene amplification, chromosomal rearrangements, and regulatory/epigenetic changes."
      },
      {
        "criterion_number": 5,
        "description": "The response should reference which mutated oncogenes are implicated in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names KRAS (with common variants and frequency) as the dominant oncogene in PDAC and mentions other oncogenic alterations (MYC amplification, NTRK fusions, BRAF V600E, HER2 amplification)."
      },
      {
        "criterion_number": 6,
        "description": "The response should state whether there are FDA-approved treatments available for pancreatic cancers with mutated oncogenes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions KRAS G12C inhibitors are approved in other cancers and notes rare targetable alterations but does not explicitly state whether FDA-approved, tissue-agnostic therapies (e.g., NTRK inhibitors) are available for pancreatic cancer; no clear yes/no statement specific to pancreatic cancer approvals."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that patients with pancreatic cancer undergo tumor genetic testing either with biopsy of primary tumor or blood test.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends comprehensive molecular testing of the tumor and sometimes blood, specifying detection of KRAS variants and rare actionable oncogenes."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that patients inquire with their oncology team if there are clinical trial opportunities available to them, or a local institution.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes clinical trials exist and that testing can open doors to trials, but does not explicitly recommend that the patient ask their oncology team or local institution about clinical trial opportunities."
      }
    ],
    "question_number": 209,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:01:00.892876",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe that treatment sequencing in pancreatic cancer is determined by the stage of the cancer and the intent of the treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states sequencing is tailored to stage (resectable, borderline, locally advanced, metastatic) and notes goals differ by intent (chance of cure in earlier stages vs living longer/feeling better in advanced stages)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe that sometimes pancreatic cancer management requires different modalities of treatments, such as chemotherapy and surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes multimodality care including surgery, chemotherapy, radiation, targeted therapy, immunotherapy, and stenting."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe that in pancreatic tumors thought to be surgically resectable, patients often undergo chemotherapy prior to surgery to shrink the tumor and kill any micrometastases for the best possible surgical outcome.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains neoadjuvant chemotherapy as an alternative path for clearly resectable disease and the usual path for borderline resectable, with rationale to treat micrometastatic disease early and increase R0 resection rates."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that surgery rarely plays a role in advanced pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it outlines systemic therapy for metastatic disease and notes only selected conversion surgery in locally advanced cases, it does not explicitly state that surgery rarely plays a role in advanced disease."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe what treatment sequencing in pancreatic cancer is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines that sequencing is the order of therapies and provides stage-specific sequences (surgery then adjuvant, neoadjuvant then surgery, systemic therapy first, etc.)."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain the goal of treatment sequencing in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States goals clearly: improve chance of cure in earlier stages and prolong life/quality of life in advanced stages; also details goals like achieving R0 resection and treating micrometastatic disease."
      },
      {
        "criterion_number": 7,
        "description": "The response should state risks involved if cancer treatment is not appropriately sequenced.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that during neoadjuvant therapy a tumor may progress and surgery becomes impossible; emphasizes timely initiation of adjuvant therapy, implying risk if delayed."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient request a multidisciplinary conference to discuss their pancreatic cancer management recommendations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends review at a multidisciplinary tumor board/high-volume center to impact outcomes and sequencing decisions."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe what a tumor board (or multidisciplinary conference) is for discussions on management of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions tumor board review but does not describe what a tumor board is or who participates."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain that the oncology care team needs to gather information to make informed recommendations on pancreatic cancer treatment, such as imaging studies, tumor biomarkers, and possibly tumor genetic testing.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists needed information including stage/resectability, CA 19-9, biliary stent, performance status, and explicitly mentions germline testing and tumor molecular profiling."
      },
      {
        "criterion_number": 11,
        "description": "The response should emphasize that treatment sequencing is individualized to the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States sequencing is tailored to stage, health, molecular findings, and other factors; emphasizes individualized decisions at centers and invites details to tailor a plan."
      },
      {
        "criterion_number": 12,
        "description": "The response should define the following terms: neoadjuvant, adjuvant, perioperative.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Uses the terms but does not provide definitions for neoadjuvant, adjuvant, or perioperative."
      }
    ],
    "question_number": 210,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:01:28.913753",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define hypoxia as a low oxygen state often seen in tumors because the tumor outgrows its blood supply.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines tumor hypoxia as areas with low oxygen and explains it is common in PDAC due to poor blood supply and stromal compression of vessels, aligning with the concept of outgrowing/insufficient vascular supply."
      },
      {
        "criterion_number": 2,
        "description": "Describe why cancer cells that exist in a hypoxic environment are difficult to treat.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains multiple reasons: reduced drug delivery, radiation resistance, more aggressive biology, and suppression of anti-tumor immune responses, directly addressing why hypoxia makes treatment difficult."
      },
      {
        "criterion_number": 3,
        "description": "Describe how hypoxic environments affect cancer\u2019s response to treatment.",
        "score_given": 9,
        "max_points": 9,
        "justification": "The response details effects on chemotherapy (delivery limitations), radiation (reduced effectiveness, use of SBRT/adaptive RT, radiosensitizers), and immunotherapy (limited benefit in typical PDAC), fully addressing treatment response implications."
      },
      {
        "criterion_number": 4,
        "description": "State that radiation therapy becomes less effective in hypoxic conditions because oxygen plays a role in radiation-induced DNA damage.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states oxygen makes radiation work better and that low oxygen can make cells 2\u20133 times harder to kill, capturing the oxygen effect on radioresponse consistent with the oxygen-fixation mechanism."
      },
      {
        "criterion_number": 5,
        "description": "Describe the mechanism of action of VEGF inhibitors and their postulated role in the treatment of hypoxic tumors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "VEGF inhibitors are not mentioned; no discussion of anti-angiogenesis, vessel normalization via VEGF blockade, or their hypothesized role in addressing hypoxia."
      },
      {
        "criterion_number": 6,
        "description": "Explain whether there is evidence-based information about hyperbaric oxygen therapy in hypoxic tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states hyperbaric oxygen is investigational/center-specific and not standard of care, indicating lack of established evidence-based benefit."
      },
      {
        "criterion_number": 7,
        "description": "Describe how hypoxic environments affect the immune system\u2019s ability to access cancer cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response notes that hypoxia suppresses anti-tumor immune responses, addressing impaired immune activity within hypoxic tumors."
      },
      {
        "criterion_number": 8,
        "description": "Recommend discussing whether there are clinical trials focusing on tumor cell hypoxic environments available in their area.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly advises asking about clinical trials, including those targeting hypoxia/stroma or improving drug delivery."
      },
      {
        "criterion_number": 9,
        "description": "State that hypoxia can make the tumor more aggressive and promote metastasis (spread).",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it says hypoxia drives more aggressive behavior, it does not explicitly state that it promotes metastasis or spread."
      }
    ],
    "question_number": 211,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:02:02.216107",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Document questions/concerns in advance of appointments",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises bringing an agenda with the top 3 questions and handing it to the team at the start of the visit."
      },
      {
        "criterion_number": 2,
        "description": "Encourage clarification and question-asking during appointments",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages plain-language explanations, use of teach-back, and directly seeking clarification (e.g., \u201cDid I get that right?\u201d)."
      },
      {
        "criterion_number": 3,
        "description": "Recommend requesting a language interpreter if preferred",
        "score_given": 10,
        "max_points": 10,
        "justification": "States: \u201cRequest a professional medical interpreter if English isn\u2019t preferred.\u201d"
      },
      {
        "criterion_number": 4,
        "description": "Recommend bringing a loved one and taking notes/recording",
        "score_given": 110,
        "max_points": 110,
        "justification": "Advises bringing a second person to appointments and taking notes or recording (with permission)."
      },
      {
        "criterion_number": 5,
        "description": "Recommend using online patient portals for messages",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically recommends using the patient portal for non-urgent issues and provides SBAR structure for messages."
      },
      {
        "criterion_number": 6,
        "description": "Recommend inquiring about best contacts/channels and establishing a point person",
        "score_given": 7,
        "max_points": 7,
        "justification": "Suggests asking for a single point person (e.g., oncologist or nurse navigator) and clarifying contact channels and response times."
      },
      {
        "criterion_number": 7,
        "description": "Provide a list of online resources for patients/families",
        "score_given": 0,
        "max_points": 5,
        "justification": "No external online resources or links (e.g., PanCAN, NCI) are provided."
      },
      {
        "criterion_number": 8,
        "description": "Recommend additional points of contact (advocates, social work, nurses, palliative care)",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends nurse navigator/care coordinator, palliative care, social work, practice manager, and patient relations/ombudsman."
      },
      {
        "criterion_number": 9,
        "description": "Emphasize importance of feeling supported during the cancer journey",
        "score_given": 5,
        "max_points": 5,
        "justification": "Opens with empathy, includes a dedicated 'Caregiver support' section, and suggests support groups and resources to promote feeling supported."
      },
      {
        "criterion_number": 10,
        "description": "Inform patients they can ask for a written summary after visits",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises to ask for written instructions and visit summaries after appointments; also suggests a one-page written care plan."
      },
      {
        "criterion_number": 12,
        "description": "State that patient navigators can assist with coordination/communication",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends asking for a nurse navigator or care coordinator to improve coordination and communication."
      }
    ],
    "question_number": 212,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:02:35.273524",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer cell plasticity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines plasticity as the ability of cancer cells to switch identities/behaviors without new DNA mutations, via reversible changes in gene expression, metabolism, and cell\u2013cell interactions; provides PDAC-specific states (epithelial/classical vs mesenchymal/basal-like)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how cancer cell plasticity makes cancer cells more difficult to treat.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains multiple mechanisms by which plasticity hinders treatment: emergence of drug-tolerant persister cells, adaptive pathway rewiring, EMT-driven resistance, immune evasion, and microenvironmental support (CAF signals, hypoxia), as well as changing therapeutic targets over time."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the epithelial-mesenchymal transition in pancreatic cancer.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Describes EMT as a plastic state shift in PDAC from epithelial/classical toward mesenchymal/basal-like (squamous) with increased invasiveness and drug resistance; explicitly notes EMT\u2019s role in aggressiveness."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role plasticity plays in the metastatic potential of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that EMT enables cells to travel and seed metastases, linking plasticity directly to increased metastatic potential."
      },
      {
        "criterion_number": 5,
        "description": "The response should define and describe cancer cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "While not using the exact term 'dormancy,' it accurately describes drug-tolerant persister cells that survive by temporarily slowing growth and later regrow\u2014capturing the concept of dormancy/quiescence after therapy."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe how cancer cell plasticity can contribute to cancer cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links plasticity to the emergence of persister cells with altered metabolism (e.g., OXPHOS, autophagy) and slowed proliferation under treatment pressure\u2014i.e., plasticity enabling entry into a drug-tolerant dormant-like state."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe how cancer cell plasticity allows cancer cells to evade the immune system, making immunotherapy relatively ineffective.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes plastic changes that reduce antigen presentation and increase PD-L1, contributing to immune evasion and explaining PDAC\u2019s limited response to immunotherapy except in MSI-H/dMMR cases."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention ways that cancer-directed therapy can be used to attempt to overcome cancer cell plasticity, such as treatment sequencing and medication combinations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides concrete strategies: combination therapy upfront, maintenance or timed switching, organoid testing, liquid biopsy monitoring; lists combination approaches (KRAS-pathway, autophagy, EMT/TGF-beta/AXL, epigenetic, OXPHOS, CAF reprogramming) aimed at constraining plasticity and resistance."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that therapeutic strategies to target plasticity is an active area of research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that many ongoing clinical trials aim to block plasticity or persister biology and provides examples, emphasizing that results are mixed and research is active."
      }
    ],
    "question_number": 213,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:02:57.378410",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define mechanical forces in relation to cancer cells, explicitly mentioning \u201cphysical forces\u201d or \u201cpressure.\u201d",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines and exemplifies mechanical forces, explicitly mentioning compressive forces and interstitial fluid pressure, as well as pushing/pulling and vessel squeezing."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the effect of different mechanical forces on cancer growth and proliferation, including the activation of pathways or signaling pathways.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Details multiple forces (stiffness, solid stress, interstitial pressure, shear) and links them to growth, survival, invasion, and resistance via pathways including integrins, FAK/Src, Rho/ROCK, YAP/TAZ, PI3K/AKT, and TGF-\u03b2."
      },
      {
        "criterion_number": 3,
        "description": "The response should define desmoplastic stroma, which is often seen in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines desmoplasia as CAF/stellate cell-driven collagen and hyaluronan deposition leading to dense, stiff matrix."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the pancreatic cancer tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes PDAC TME as highly fibrotic with abundant CAFs, collagen, hyaluronan, high pressure, compressed/abnormal vessels, and immune exclusion."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention future research directions as it pertains to desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions multiple investigational strategies (VDR agonists, FAK inhibitors, TGF-\u03b2, ROCK, LOX, integrins) and ongoing trials."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain if there are FDA approved therapies that act on the desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes that pegvorhyaluronidase failed phase 3 and that most approaches are experimental or not standard, but does not explicitly state whether any FDA-approved stromal-targeting therapies for PDAC exist."
      },
      {
        "criterion_number": 8,
        "description": "The response must state that in pancreatic cancer, the stroma is very dense and stiff, leading to high interstitial pressure and reduced oxygen and nutrient delivery.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states PDAC is unusually fibrotic and stiff with high interstitial pressure and reduced blood flow causing hypoxia (reduced oxygen delivery); reduced nutrient delivery is reasonably implied by reduced blood flow."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that the dense stroma can impede treatment delivery and induce hypoxia, explicitly mentioning \u201chypoxia\u201d and \u201ctreatment resistance.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly mentions hypoxia, impeded drug delivery, and a \u201ctreatment-resistant state\u201d with resistance to chemotherapy, radiotherapy, and targeted agents."
      },
      {
        "criterion_number": 10,
        "description": "The response must state that the dense stroma can impede immune cells from reaching the tumor, explicitly mentioning \u201cimmune evasion\u201d or \u201creduced efficacy of immunotherapy.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "States immune evasion with barriers to T-cell entry and describes PDAC as immune-excluded; also discusses strategies that may enhance immunotherapy."
      }
    ],
    "question_number": 214,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:03:58.021154",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend discussing the primary medical team responsible for tracking referrals and oncologic care; usually the medical oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises identifying a clear 'quarterback' and notes this is usually the medical oncologist, directly addressing who leads and tracks overall care."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly state that a clinician is designated as the main provider responsible for care coordination and continuity.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly calls for a single written care plan and a designated 'quarterback' who leads overall care, fulfilling the requirement."
      },
      {
        "criterion_number": 3,
        "description": "Describe the potential medical teams involved in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists a multidisciplinary pancreas clinic team (medical oncology, surgical oncology, radiation oncology, gastroenterology, interventional radiology, palliative care, nutrition, genetics), and mentions primary care/endocrinology for diabetes, satisfying this criterion."
      },
      {
        "criterion_number": 4,
        "description": "Recommend keeping a comprehensive log of test results and progress notes to provide to providers if needed.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it recommends a digital 'records kit' and keeping imaging, it does not explicitly instruct keeping a comprehensive log of test results and progress notes to share if records are not received."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly recommend creating a centralized document listing all providers, their roles, and test results, to bring to appointments.",
        "score_given": 0,
        "max_points": 6,
        "justification": "It recommends a one-page medical summary with key contacts and identifies role responsibilities, but does not explicitly include test results within that centralized document to bring to visits."
      },
      {
        "criterion_number": 6,
        "description": "Recommend having a loved one accompany the patient to appointments, preferably the same person, and take notes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit recommendation to bring a loved one to appointments for note-taking or continuity."
      },
      {
        "criterion_number": 7,
        "description": "Recommend using online patient portals to ask questions and contact the oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions using the same patient portal to share information but does not explicitly recommend using portals to ask questions or contact the oncology team."
      },
      {
        "criterion_number": 8,
        "description": "Describe professionals who can help with care coordination (e.g., nurse case managers, social workers).",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends a nurse navigator for coordination and includes social workers, palliative care, financial counselors, and patient organization navigators, adequately covering coordination helpers."
      }
    ],
    "question_number": 215,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:04:35.560210",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define senescence in cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines senescence as a durable cell-cycle arrest where cells remain metabolically active but stop dividing; presents it as a stress response placing damaged cells into a long-term non-proliferative state."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how senescence can lead to secretion of inflammatory molecules (senescence-associated secretory phenotype) which can alter the microenvironment to make it more amenable to tumor progression.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains SASP and details that it can foster inflammation, fibrosis, drug resistance, metastasis, and support survival/spread of nearby cancer cells, explicitly linking to a tumor-promoting microenvironment."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe senescence-associated secretory phenotype factors.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists SASP components including cytokines (IL-6/IL-8), growth factors, and proteases."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of senescence in normal cells.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While general features are described, the response does not explicitly discuss senescence\u2019s roles in normal physiology (e.g., tumor suppression barrier, wound healing, embryogenesis, aging) in non-cancer contexts."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe ways in which cancer cells evade senescence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes PDAC commonly has KRAS mutations and alterations in p53 and p16 (CDKN2A) that affect senescence pathways, implying evasion via disruption of key tumor suppressor pathways."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain how some cancer therapies induce senescence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that chemotherapy and radiation can induce therapy-induced senescence and lists examples (FOLFIRINOX components, gemcitabine/nab-paclitaxel), noting scans may show stable disease due to senescence rather than cell death."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain what senolytics are, and describe if there are any FDA approved in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines senolytics as agents that kill senescent cells, provides example (navitoclax) and clearly states these approaches are not standard of care in PDAC, indicating no FDA-approved senolytics for pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that this is an active area of research in the scientific community.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple mentions of ongoing trials, investigational combinations, and strategies under study indicate active research."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that senescence is caused by cellular stressors such as DNA damage or activation of tumor suppressor genes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it labels senescence a stress response and mentions therapy-induced senescence, it does not explicitly attribute it to DNA damage or activation of tumor suppressors (e.g., p53/p16) as causative mechanisms."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that senescence can be a positive factor as it stops tumor growth.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly states senescence is helpful by arresting tumor growth and notes potential immediate tumor growth arrest as a benefit."
      }
    ],
    "question_number": 216,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:05:12.427361",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define exosomes as vesicles that cells can release into their surroundings.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines exosomes as tiny membrane packages released by almost all cells, indicating they are extracellular vesicles shed into the surroundings."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe what exosomes contain, such as proteins, lipids, and RNA.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states exosomes carry proteins, fats (lipids), and genetic material like microRNAs, directly addressing contents."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of exosomes in cancer cells, including cell-cell communication.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It states cancer cells release many exosomes that act as a communication network, reprogramming the tumor microenvironment and distant organs."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of exosomes in tumor promotion.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It details how exosomes promote proliferation, invasion, angiogenesis, stromal remodeling, metabolic support, and chemoresistance, all contributing to tumor promotion."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the role of exosomes in immune evasion.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explains that exosomes suppress immunity by carrying PD-L1 and specific microRNAs to weaken T-cell responses and by reprogramming immune cells such as macrophages."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the role of exosomes in drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly states that exosomes drive therapy resistance and, in PDAC, deliver miR-21 and miR-155 that reduce gemcitabine activation and enhance survival pathways."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe the emerging or experimental role of exosomes as tumor biomarkers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes that exosomes circulate in blood and their contents are being studied as biomarkers (e.g., KRAS mutations, glypican-1), with mixed results and not yet standard of care."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe how exosomes travel in the body.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It specifies that exosomes circulate in blood and influence distant organs, indicating systemic transport via circulation."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain how exosomes are thought to facilitate metastases in cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It describes pre-metastatic niche formation, including liver priming with immune activation, fibronectin deposition, and cell recruitment that favor metastasis."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe if there are any FDA approved treatments that are associated with cancer exosomes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly states there are no approved drugs that block exosome release or uptake and that therapeutic uses are in early-phase trials."
      }
    ],
    "question_number": 217,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:05:38.067888",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define advance directive and living will, and recommend completion/updates at end of life",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response recommends completing an advance directive/living will and describes living will preferences (life support, tube feeding, ICU), but it does not define what an advance directive is. The criterion requires definitions of both."
      },
      {
        "criterion_number": 2,
        "description": "Recommend a palliative medicine consultation to consider transitioning focus to comfort",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends a referral to palliative care now for symptom relief and planning, even if still doing treatment."
      },
      {
        "criterion_number": 3,
        "description": "Describe Hospice and include that prognosis <6 months is eligibility criterion",
        "score_given": 0,
        "max_points": 10,
        "justification": "Hospice is described (services, triggers), but it does not state the explicit eligibility of a prognosis of 6 months or less."
      },
      {
        "criterion_number": 4,
        "description": "Describe different categories of tasks to address near end of life",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers medical/symptom management, legal/financial, equipment/home supports, work/caregiving, end-of-life preferences, digital/practical, after-death tasks, and caregiver/grief support\u2014clear categorical guidance."
      },
      {
        "criterion_number": 5,
        "description": "Define what a medical durable power of attorney is",
        "score_given": 10,
        "max_points": 10,
        "justification": "It identifies a healthcare proxy/medical power of attorney as the chosen medical decision-maker, effectively defining the role."
      },
      {
        "criterion_number": 6,
        "description": "Describe steps to elect a medical durable power of attorney",
        "score_given": 0,
        "max_points": 7,
        "justification": "It advises choosing a medical decision-maker and completing documents but does not describe the steps (e.g., completing the specific form, required witnesses/notarization, distributing copies) to formally elect one."
      },
      {
        "criterion_number": 7,
        "description": "Define a POLST and recommend filling it out and displaying it at home",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains POLST/MOLST translates wishes into medical orders and recommends keeping it on the fridge for EMS\u2014both a definition and display recommendation."
      },
      {
        "criterion_number": 8,
        "description": "Ensure the patient\u2019s healthcare teams have a copy of the POLST",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it recommends keeping POLST on the fridge for EMS, it does not advise ensuring all healthcare providers have a copy."
      },
      {
        "criterion_number": 9,
        "description": "State that Hospice benefits vary across insurance plans and to understand specific benefits",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions coverage by Medicare/most insurers but does not state that benefits vary by plan or advise confirming specific benefits."
      },
      {
        "criterion_number": 10,
        "description": "Include that Hospice services support both patient and family/caregivers",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly lists hospice services including respite for caregivers and social work/spiritual care, indicating support for family/caregivers."
      },
      {
        "criterion_number": 11,
        "description": "Recommend electing a financial durable power of attorney",
        "score_given": 10,
        "max_points": 10,
        "justification": "Under legal and financial planning, it explicitly recommends a durable financial power of attorney."
      },
      {
        "criterion_number": 12,
        "description": "Recommend considering funeral arrangements and communicating to loved ones",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises identifying funeral/cremation/burial preferences, budget, and pre-arrangements, and provides conversation prompts for the family\u2014implying communication of these preferences."
      },
      {
        "criterion_number": 13,
        "description": "Recommend planning for religious/spiritual rituals around death",
        "score_given": 5,
        "max_points": 5,
        "justification": "It prompts discussing spiritual needs and spiritual/cultural rituals as part of end-of-life preferences and mentions chaplaincy."
      },
      {
        "criterion_number": 14,
        "description": "Describe importance of open communication with decision makers to ensure wishes are respected",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages clarifying goals, choosing a medical decision-maker, and provides detailed conversation prompts for the family\u2014facilitating communication to honor wishes."
      },
      {
        "criterion_number": 16,
        "description": "State that end-of-life planning is individualized and should follow the patient\u2019s wishes",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes tailoring to the person\u2019s priorities and preferences (e.g., what matters most, preferred place of care, specific rituals), and offers to customize based on the individual situation."
      }
    ],
    "question_number": 218,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:06:35.298873",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer cell dormancy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines dormancy and its forms: cellular (quiescent, non-dividing cells that can later \u2018wake up\u2019), micrometastatic/angiogenic (growth balanced by death due to limited blood supply), and immune-mediated (immune system keeps cells in check)."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how long a cancer cell can remain dormant in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States dormancy can persist for years to decades in some cancers and notes PDAC typically recurs within 1\u20132 years but late recurrences (5+ years) do occur."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain why it is advantageous for cancer cells to be able to enter a dormant state.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly explain the advantage to cancer cells (e.g., survival under stress, evasion of therapy/immune attack)."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe scenarios in which a cancer cell may be prompted to enter dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes conditions associated with entering/maintaining dormancy: limited blood supply (angiogenic constraints), immune surveillance, and signals from the local microenvironment/ECM."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe what is known about cancer cell dormancy in pancreatic cancer, preferably with references to the scientific literature with PMID.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides PDAC-specific context: most recurrences within 1\u20132 years, evidence of dormant disseminated tumor cells, and occurrence of late recurrences (5+ years). No PMIDs provided, but the description is accurate and substantive."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that dormancy can occur because of microenvironmental or genetic factors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly attributes dormancy to microenvironmental factors such as inflammation, tissue remodeling, angiogenesis, extracellular matrix signals, and immune surveillance."
      },
      {
        "criterion_number": 8,
        "description": "The dormant cells will often be less susceptible to chemotherapy than rapidly dividing cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that dormant cells are less susceptible to chemotherapy or link quiescence to reduced chemo effectiveness."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that these dormant cells can lead to disease recurrence after treatments as they can reactivate after a long period of time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States dormant cells can \u2018wake up\u2019 and cites late recurrences (years to decades), implying post-treatment reactivation leading to recurrence."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that dormancy is an active area of research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes dormancy triggers are an active area of research and mentions ongoing clinical trials exploring related strategies."
      }
    ],
    "question_number": 219,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:07:29.350785",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define mechanical stress as physical forces and pressures exerted on and within a tumor mass, arising from tumor growth, interactions with surrounding tissues, and the tumor\u2019s microenvironment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines mechanical stress via solid stress, matrix stiffness, interstitial fluid pressure, and shear stress, and links these forces to tumor growth and surrounding tissue interactions."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how mechanical stress on tumor cells impacts their ability to grow and metastasize.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains promotion of invasion and metastasis, EMT, stemness, and pro-survival signaling (YAP/TAZ, FAK/Src, Rho/ROCK, TGF-\u03b2), and selection for aggressive phenotypes under hypoxia."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the relationship between mechanical stress in tumors and hypoxia.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States vessel compression and high interstitial pressure lead to poor perfusion and hypoxia, with hyaluronan contributing to pressure and vessel collapse."
      },
      {
        "criterion_number": 4,
        "description": "The response should explain that mechanical stress on tumor tissue is implicated in treatment resistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes drug delivery barriers from compressed vessels/IFP and hypoxia-related resistance to radiation and chemotherapy."
      },
      {
        "criterion_number": 5,
        "description": "The response should define the tumor microenvironment.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Characterizes the tumor microenvironment by describing CAFs, dense ECM (collagen, hyaluronan), immune cell exclusion, and vascular/pressure features, effectively defining its components and roles."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe sources of mechanical stress in tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Enumerates solid stress from growth and stroma, matrix stiffness, interstitial fluid pressure, and shear stress as sources."
      },
      {
        "criterion_number": 7,
        "description": "The response should inform the patient that effects of mechanical stress on tumor tissue are not fully elucidated and are an area of active scientific research.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Highlights multiple investigational strategies, ongoing trials, and evolving insights (e.g., stromal depletion backfiring), indicating active research and incomplete understanding."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention the effect of mechanical stress on the tumor in angiogenesis, invasion, metastasis, and promotion of tumor cell survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Covers invasion, metastasis, and survival signaling but does not explicitly address angiogenesis or how mechanics modulate it."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that pancreatic cancer is characterized by a very dense and stiff stroma, leading to high interstitial pressure and reduced oxygen and nutrient delivery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes PDAC\u2019s dense, stiff, fibrotic stroma; hyaluronan-driven high pressure; vessel compression with hypoxia; and states tumors are \u201cstarved,\u201d implying reduced nutrient delivery."
      },
      {
        "criterion_number": 11,
        "description": "The response must state that the dense stroma can impede immune cells from reaching the tumor, aiding immune evasion and reducing the efficacy of immunotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States the dense, stiff matrix physically excludes T cells and promotes immunosuppressive cells, blunting immune responses; also discusses combining stroma-targeting with immunotherapy, implying impact on immunotherapy efficacy."
      }
    ],
    "question_number": 220,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:08:22.460313",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define tumor organoids as a miniature 3D model of the patient\u2019s tumor grown in a lab from the patient\u2019s own cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines organoids as 3D 'mini-tumors' grown from a patient\u2019s own cancer cells, preserving tumor features."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how tumor organoids are used for testing cancer medications to determine the most effective one.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states researchers expose patient-derived organoids to various chemotherapies/targeted agents to see what kills them best and notes correlation with patient responses."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain that the use of tumor organoids is experimental and not available at all cancer centers, and that there are no large randomized clinical trials for tumor organoids.",
        "score_given": 0,
        "max_points": 10,
        "justification": "States organoid testing is mostly at academic centers, within research, and not standard of care (experimental/limited availability), but does not explicitly state that there are no large randomized clinical trials."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe how tumor organoids are grown.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes derivation from biopsy/surgery, embedding in a gel-like matrix, feeding with growth factors, and self-organization into 3D structures."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain how tumor organoids are different than cultured cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Directly contrasts organoids with traditional 2D cell lines, noting greater preservation of tumor complexity and differences from PDX models."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe how tumor organoids are used to tailor treatments to the patient from which they are derived.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses functional precision oncology using the patient's organoids to inform therapy choices, including timelines and clinical integration considerations."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe advantages of using patient-derived organoids for research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes advantages such as better modeling of tumor biology than 2D cells, being faster/cheaper than PDX, potential predictive value, and utility for biobanking/biomarker discovery."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe limitations of using patient-derived organoids for research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Identifies limitations including lack of full immune/vascular/stromal context, variable success rates and timelines, and uncertain translation to patient outcomes."
      }
    ],
    "question_number": 221,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:08:57.966135",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend that the patient choose a medical decision maker, or medical durable power of attorney.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises clarifying decision-making authority and completing an advance directive/health care proxy, identifying the legal surrogate, and documenting the primary contact, which fulfills selecting a medical decision maker."
      },
      {
        "criterion_number": 2,
        "description": "Recommend that the patient and next of kin request assistance from social work from their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends involving the oncology social worker for mediation and support and lists oncology social worker/patient navigator as resources, meeting the criterion."
      },
      {
        "criterion_number": 3,
        "description": "Inform about the role of palliative medicine in cancer care for goals of care and documentation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises a referral to palliative care, describes roles in symptom relief, goals-of-care support, family meetings, and includes documentation steps (e.g., POLST/MOLST, chart notes)."
      },
      {
        "criterion_number": 4,
        "description": "Recommend designating a primary family member to attend appointments and relay information.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It instructs to choose one point person for the care team and another for updating extended family, and to identify the primary contact for clinicians."
      },
      {
        "criterion_number": 5,
        "description": "Recommend establishing a meeting schedule for regular updates to the greater family.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests a communication plan and a point person to update family, it does not explicitly recommend setting a recurring meeting schedule for regular updates."
      },
      {
        "criterion_number": 7,
        "description": "State that the priority should be the patient\u2019s wishes and she should be as involved as possible.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly states, \u201cThe patient\u2019s values come first,\u201d and emphasizes following her informed choices if she has capacity, and substituted judgment otherwise."
      },
      {
        "criterion_number": 8,
        "description": "Recommend holding family meetings with the healthcare team so family can hear directly from the physician.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises requesting a dedicated family meeting with the oncologist (and team) and outlines topics to cover, fulfilling this criterion."
      },
      {
        "criterion_number": 9,
        "description": "Emphasize the importance of clear communication between family members.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly emphasizes structured communication: appointing a point person, using a shared document/group chat, employing communication techniques (I statements, reflecting), and separating facts from values."
      }
    ],
    "question_number": 222,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:09:30.232276",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define circadian rhythms as the body\u2019s natural 24-hour internal clock regulated by the brain and influenced by external cues, including hormone regulation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response describes a 24-hour cellular clock and time-of-day variation in physiological processes but does not state regulation by the brain (SCN), influence of external cues (e.g., light), or hormone regulation."
      },
      {
        "criterion_number": 2,
        "description": "Describe chronotherapy as timing cancer treatments to align with circadian rhythms for better efficacy and fewer side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Chronotherapy is explicitly defined as giving treatments at certain times to affect effectiveness and side effects."
      },
      {
        "criterion_number": 3,
        "description": "Explain how circadian disruption is thought to promote pancreatic cancer growth, including references to literature or reputable sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explanation of how circadian disruption promotes pancreatic cancer growth is provided, and no sources are cited."
      },
      {
        "criterion_number": 4,
        "description": "Recommend ways to promote normal circadian rhythms: consistent sleep, regular meals, natural light exposure, avoiding screens/blue light at night.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides actionable recommendations including fixed wake time, morning daylight exposure, regular meal times, and limiting screens/bright light before bed."
      },
      {
        "criterion_number": 5,
        "description": "Explain the effect of poor or interrupted sleep on circadian rhythms and overall health, noting potential to promote cancer progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response suggests sleep hygiene but does not explain how poor sleep disrupts circadian rhythms or its potential impact on health/cancer progression."
      },
      {
        "criterion_number": 6,
        "description": "Explain the effect of poor or inadequate diet on circadian rhythms, mentioning that irregular eating can disrupt circadian rhythms and that maintaining regular meal times is important.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it recommends regular meal times and avoiding large late-night meals, it does not explicitly state that irregular eating disrupts circadian rhythms."
      },
      {
        "criterion_number": 7,
        "description": "Provide general sleep hygiene recommendations including consistent sleep duration, avoiding screens/blue light at night, and exposure to natural light during the day.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Includes avoiding screens before bed and morning daylight exposure but does not mention maintaining consistent sleep duration; rubric requires inclusion of all listed elements."
      },
      {
        "criterion_number": 8,
        "description": "Recommend consulting a nutritionist familiar with nutritional challenges in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No recommendation to consult a nutritionist is provided."
      },
      {
        "criterion_number": 9,
        "description": "Recommend inquiring about clinical trials on circadian rhythms in pancreatic cancer, mentioning resources like ClinicalTrials.gov.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response suggests asking the oncology team about trials but does not mention ClinicalTrials.gov or similar resources."
      },
      {
        "criterion_number": 11,
        "description": "Clearly state that there is no current high-quality data supporting timed treatment in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It says high-quality clinical evidence is limited and guidelines do not mandate timing, but does not clearly state that there is no high-quality data supporting timed treatment in pancreatic cancer."
      }
    ],
    "question_number": 223,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:10:28.894164",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define mitochondria.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a functional definition: 'Mitochondria make ATP (energy) and supply ingredients for DNA, fats, and proteins via the TCA cycle,' which adequately defines mitochondria by role."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the roles of mitochondria in normal cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains multiple normal roles: energy production (ATP), biosynthetic precursors (TCA cycle), redox control (ROS creation/management), and regulation of intrinsic apoptosis."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain what is known about how the role of mitochondria in cancer cells differs from that of normal cells.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Details cancer-specific differences: PDAC metabolic flexibility using glycolysis and OXPHOS; upregulation of anti-apoptotic BCL-2 family members; dependence on autophagy/mitophagy; microenvironment-driven metabolite sharing; shift to high OXPHOS after chemotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the increased metabolic demands on cancer cells and why this happens.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that cancer cells have increased metabolic demands due to rapid proliferation and stress; focuses more on metabolic flexibility and nutrient scarcity rather than the reason for increased demand."
      },
      {
        "criterion_number": 5,
        "description": "The response should explain the Warburg effect.",
        "score_given": 0,
        "max_points": 8,
        "justification": "The Warburg effect is not mentioned or explained (no description of aerobic glycolysis with lactate production despite oxygen availability)."
      },
      {
        "criterion_number": 6,
        "description": "The response should define apoptosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Apoptosis is referenced but not defined as programmed cell death."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain the role of mitochondria in apoptosis in normal cells, and explain how this can be altered in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that the intrinsic apoptosis pathway is controlled at mitochondria by BCL-2 family proteins and that PDAC upregulates anti-apoptotic members (BCL-XL, MCL-1), conferring resistance."
      },
      {
        "criterion_number": 8,
        "description": "The response should define reactive oxygen species and how they are created with regard to the role that mitochondria play.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions ROS creation/management but does not define ROS or explain their generation (e.g., electron transport chain leakage producing superoxide)."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how ROS can damage surrounding cells, and the subsequent cellular signaling pathways that are stimulated as a result.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of ROS-mediated damage to surrounding cells or specific downstream signaling pathways (e.g., DNA damage responses, NF-\u03baB, HIF-1\u03b1)."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe that as a facilitator of cellular energy, mitochondria are a potential treatment target.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly describes mitochondria-focused strategies (autophagy inhibitors, OXPHOS inhibitors, apoptosis targeting) and links them to mitochondrial energy/metabolism."
      },
      {
        "criterion_number": 11,
        "description": "The response should define glutamine and how this substance is used in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies glutamine as an amino acid and explains cancer usage: 'PDAC rewires glutamine use to support redox balance and mitochondria'; mentions glutaminase inhibitors."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that cancer treatment targeting mitochondrial functions are experimental and not part of FDA-approved treatment regimens at this time.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Explicitly states most mitochondria-targeted drugs are experimental/investigational and that standard chemotherapy remains the backbone."
      }
    ],
    "question_number": 224,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:11:33.739900",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend discussing insurance coverage issues with the oncology team administering the experimental treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises working with the treating oncologist and study team on coverage-related actions (e.g., oncologist submitting prior authorization and letter of medical necessity; asking the study team for a Coverage Analysis; asking the oncologist to request Expanded Access), which directly involves discussing insurance and coverage with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "Mention that financial assistance programs are available for some experimental drugs and explicitly state that this varies from drug to drug, requiring inquiry.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions manufacturer assistance programs and that companies often provide drugs under Expanded Access, it does not explicitly state that assistance for experimental drugs varies by drug and requires asking/inquiry."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly mention that travel to and from the trial center is often not covered.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response lists travel/lodging assistance programs but does not explicitly state that travel costs to trial centers are often not covered by insurance."
      },
      {
        "criterion_number": 5,
        "description": "Describe what \u201ccompassionate use\u201d is and recommend asking the oncology team about this.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines expanded access/compassionate use and recommends asking the oncologist to request Expanded Access when no suitable trial fits and off-label is denied."
      },
      {
        "criterion_number": 6,
        "description": "Recommend discussing concerns with the cancer center\u2019s financial team and/or patient advocacy office.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises working with a financial counselor at the treating hospital and provides multiple advocacy resources for navigation and appeals support."
      },
      {
        "criterion_number": 7,
        "description": "Recommend becoming familiar with the insurance policy to understand what is or is not covered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly advises confirming coverage with the plan, checking network/referrals, obtaining prior authorizations, and requesting plan document/SPD sections cited in denials\u2014encouraging familiarity with policy details."
      },
      {
        "criterion_number": 8,
        "description": "Inform the patient that they have the right to appeal any decision made by the insurance company.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It outlines internal appeals (including expedited), peer-to-peer review, and binding external independent review, clearly indicating the right to appeal denials."
      },
      {
        "criterion_number": 9,
        "description": "Recommend seeking out patient advocacy groups online to learn how other patients navigated the same issues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it lists advocacy organizations and navigation hotlines, it does not explicitly recommend using online patient advocacy groups to learn from other patients\u2019 experiences."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly state that insurance usually only covers standard of care treatments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses coverage of routine care in trials and circumstances for off-label coverage but does not explicitly state that insurance usually only covers standard-of-care treatments."
      },
      {
        "criterion_number": 11,
        "description": "Indicate that clinical trials typically cover the experimental treatment itself, while insurance covers standard-of-care components such as imaging.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that sponsors usually provide the investigational drug/device and research tests, while insurance covers routine patient costs (e.g., visits, labs, imaging), and advises obtaining a Coverage Analysis."
      }
    ],
    "question_number": 225,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:12:19.740964",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define ferroptosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines ferroptosis as a regulated cell death distinct from apoptosis, driven by lipid peroxidation leading to membrane failure, with antioxidant defenses (GPX4/glutathione, FSP1/CoQ10) preventing it."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the role of iron in ferroptosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states ferroptosis is iron-dependent and discusses iron-driven lipid damage and iron chelators as protection."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of ferroptosis in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Addresses PDAC-specific vulnerabilities (cystine uptake via system Xc-, KRAS/redox/lipid metabolism), tumor microenvironment factors, and interactions with radiation, chemotherapy, and immune responses."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that there are currently drugs under investigation with the aim to induce ferroptosis in pancreatic cancer cells but there are no current available established treatments that target ferroptosis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States there are no FDA-approved ferroptosis-inducing anticancer drugs, mentions early-phase trials and investigational strategies (system Xc- blockade, GPX4 inhibitors), and notes pancreatic-specific trials are limited."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide references in the scientific literature about ferroptosis and link PMID if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or PMIDs are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe why ferroptosis occurs.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explains it occurs when antioxidant defenses (GPX4/glutathione, FSP1/CoQ10) are blocked or overwhelmed, allowing lipid peroxides to accumulate and cause membrane failure."
      },
      {
        "criterion_number": 7,
        "description": "The response should define apoptosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines apoptosis as programmed cell death and contrasts it with ferroptosis."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe the difference between apoptosis and ferroptosis.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes ferroptosis is distinct from apoptosis and describes ferroptosis\u2019s iron-dependent lipid peroxidation mechanism, implicitly contrasting mechanisms."
      }
    ],
    "question_number": 226,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:12:46.695765",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly links stiffness, pressure, and ECM architecture to increased invasiveness and stepwise metastatic processes."
      },
      {
        "criterion_number": 2,
        "description": "The response includes descriptions of the mechanical properties of tissue: elasticity, viscosity, density, and compression.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Addresses elasticity (stiffness) and compression/pressure; mentions 'dense' stroma but does not explicitly discuss viscosity. Since not all specified properties are described, full credit cannot be awarded."
      },
      {
        "criterion_number": 3,
        "description": "The response describes compression of surrounding tissue by the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains solid stress raising interstitial pressure and compressing blood vessels, impairing perfusion."
      },
      {
        "criterion_number": 4,
        "description": "The response defines desmoplastic stroma and its role in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes the dense, scar-like ECM rich in collagen and hyaluronan produced by CAFs/stellate cells, noting its role in stiffness and treatment resistance\u2014i.e., desmoplasia."
      },
      {
        "criterion_number": 5,
        "description": "The response describes ways by which cancer metastasizes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers local invasion, intravasation, survival in circulation under shear stress, extravasation, and colonization, including guidance along aligned fibers."
      },
      {
        "criterion_number": 6,
        "description": "The response describes epithelial-to-mesenchymal transition and what environmental factors trigger this transition in pancreatic cells and pancreatic cancer cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that stiff ECM activates mechanosignaling (YAP/TAZ, FAK) that promotes EMT, linking environment to EMT induction."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how pancreatic cells interact with desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains CAF/stellate-cell-derived ECM (collagen, hyaluronan) creating stiffness; cancer cells sense it via integrins/FAK/YAP and migrate along aligned fibers."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how pancreatic cancer cells interact with the tumor microenvironment, and how different elements encourage cell travel, such as inflammation and hypoxia.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details hypoxia from vessel compression, immune exclusion, ECM alignment as tracks, pressure-driven intravasation, and how these TME features facilitate migration and spread."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the effect of DNA mutations, such as KRAS, on a pancreatic cancer cell\u2019s potential to travel outside of the primary site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of KRAS or other driver mutations and their roles in motility or metastasis."
      },
      {
        "criterion_number": 10,
        "description": "The response explains other methods for the spread of pancreatic cancer besides invasion into solid tissue, such as hematologic spread, lymphatic spread, and perineural invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions intravasation into blood and lymph, survival in circulation, extravasation, and perineural invasion."
      },
      {
        "criterion_number": 11,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links stiffness/pressure to poor perfusion and drug delivery; discusses normalization strategies (losartan, PEGPH20 experience), and implications for chemo, radiation, and immunotherapy."
      },
      {
        "criterion_number": 12,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No formal citations or references to specific journal articles are provided."
      }
    ],
    "question_number": 227,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:13:52.439004",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends contacting the patient\u2019s healthcare team or oncology team about patient advocacy opportunities within their organization.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly suggests engagement within the healthcare organization, e.g., joining Patient and Family Advisory Councils (PFACs) at the cancer center and the hospital\u2019s PFAC, palliative care advisory group, or navigation program advisory board, and working with the cancer center\u2014effectively directing contact with the oncology institution for advocacy roles."
      },
      {
        "criterion_number": 2,
        "description": "The response offers examples of patient advocacy groups and provides contact information or a website for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While many groups include websites (e.g., PanCAN, Lustgarten, Hirshberg, Let\u2019s Win, PCORI, Research Advocacy Network, ACS CAN, Imerman Angels, Cancer Support Community, Smart Patients), several cited groups or programs lack URLs/contact info (e.g., Gilda\u2019s Club, Inspire pancreatic forums, ASCO/AACR/ESMO conferences, FDA Patient Representative Program, NIH/NCI committees, DOD CDMRP, state coalitions). Because not all examples include contact info, full credit cannot be awarded under binary scoring."
      },
      {
        "criterion_number": 3,
        "description": "The response defines patient advocacy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit definition of patient advocacy is provided; the response lists activities and avenues but does not define the term."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of patient advocacy work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response gives numerous concrete examples: policy/legislative action, grant reviewing, peer mentoring and navigation, awareness/media, fundraising, hospital PFAC/IRB participation, disparities initiatives, and regulatory engagement."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of patient advocacy opportunities specific to pancreatic cancer and provides contact information or a website for each.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists multiple pancreatic cancer\u2013specific organizations with URLs (PanCAN, Lustgarten, Hirshberg Foundation, Let\u2019s Win, World Pancreatic Cancer Coalition, Pancreatic Cancer UK) and describes specific opportunities within each."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends joining pancreatic cancer support groups, either online or in-person, to learn about advocacy opportunities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends joining and participating in support settings: PanCAN Survivor & Caregiver networks, Cancer Support Community/Gilda\u2019s Club, Smart Patients (pancreatic-cancer community), and Inspire pancreatic forums, and even suggests joining an online community as a starting action."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions at least three different areas of advocacy for pancreatic cancer patients, such as direct patient support, support groups, funding for cancer research, awareness of clinical trials, or political lobbying.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It covers numerous areas: direct peer support/mentoring, support groups, fundraising events, research advocacy (grant review, NCI committees), clinical trial awareness (PanCAN Clinical Trial Finder, Let\u2019s Win), policy/legislative lobbying (PanCAN Advocacy, ACS CAN), awareness/media campaigns, and systems change at hospitals."
      }
    ],
    "question_number": 228,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:15:20.933290",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains normal cellular metabolism in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly describes that normal cells with oxygen use mitochondria to fully burn glucose for lots of ATP and contrasts energy versus building block needs in accessible language."
      },
      {
        "criterion_number": 2,
        "description": "The response outlines the differences between normal cellular metabolism and cancer cell metabolism.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It systematically contrasts tumor versus normal metabolism across multiple axes (Warburg effect, mitochondrial use, glutamine reliance, macropinocytosis, autophagy, lipid metabolism, PPP, hypoxia adaptation)."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the Warburg effect.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly names and explains the Warburg effect and why it benefits tumors."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of how cancer cell metabolism affects its clinical behavior.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Gives concrete clinical links: FDG-PET imaging, microenvironment acidification aiding invasion and immune evasion, lactate shuttling, cachexia, and microenvironmental fuel sharing."
      },
      {
        "criterion_number": 5,
        "description": "The response gives examples of targeting the differences in cancer cell metabolism as a means of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions therapeutic strategies under study targeting glycolysis, glutamine metabolism, autophagy, mitochondrial respiration, and lipid synthesis."
      },
      {
        "criterion_number": 6,
        "description": "The response provides published scientific journal articles as evidence for its claims and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Lists general resources (NCI, PanCAN) and vaguely references reviews, with only one loosely titled review mentioned and no specific citations or PMIDs tied to claims."
      },
      {
        "criterion_number": 7,
        "description": "The response should define glycolysis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Uses the term glycolysis but does not provide a definition (e.g., breakdown of glucose to pyruvate with small ATP yield)."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe how cancer cells use glutamine, and how this is different than normal cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that tumors use glutamine as a major carbon/nitrogen source and that PDAC relies on a non-standard glutamine pathway to generate NADPH, indicating a difference from normal cells."
      },
      {
        "criterion_number": 9,
        "description": "The response should define lactic acid and describe how excess lactic acid can be produced by cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes lactate production and export but does not define lactic acid/lactate explicitly or detail its biochemical identity."
      },
      {
        "criterion_number": 10,
        "description": "The response should not recommend specific diets for management of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "No specific diet recommendations are made."
      },
      {
        "criterion_number": 11,
        "description": "The response should not reference specific diets unless it provides PMID to studies that examine the effect of diet on pancreatic cancer, and the response should provide a summary of the findings.",
        "score_given": 5,
        "max_points": 5,
        "justification": "No specific diets are referenced; thus, the condition is satisfied."
      },
      {
        "criterion_number": 12,
        "description": "The response should not indicate that restrictive diets, such as ketogenic diet or intermittent fasting, should be started by patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Does not suggest starting any restrictive diets."
      },
      {
        "criterion_number": 13,
        "description": "The response should clearly state if treatments are experimental or if they are evidence-based and/or FDA approved.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly notes that metabolic therapies are in clinical trials and not standard for pancreatic cancer."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient discuss diet with their oncologist and request a referral to a nutritionist if they are interested in learning more.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Suggests asking the care team about nutrition but does not explicitly recommend discussing diet with the oncologist or requesting referral to a nutritionist/dietitian."
      }
    ],
    "question_number": 229,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:16:20.885019",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises: 'Tell the oncology team early if numbness... are worsening,' 'Discuss with oncology/PCP' for duloxetine, and 'Ask the oncologist for referrals.'"
      },
      {
        "criterion_number": 2,
        "description": "The response states peripheral neuropathy is a common side effect of certain chemotherapy agents used to treat pancreatic cancer, including oxaliplatin.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States 'CIPN is common with pancreatic cancer regimens such as FOLFIRINOX (oxaliplatin) and gemcitabine + nab-paclitaxel.'"
      },
      {
        "criterion_number": 3,
        "description": "The response should define chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Uses the term 'CIPN' but does not explicitly define it as nerve damage from chemotherapy to peripheral nerves."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of symptoms of peripheral neuropathy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists numbness, tingling, pain, cold sensitivity, weakness/foot drop, trouble gripping, dizziness; provides multiple symptom examples."
      },
      {
        "criterion_number": 5,
        "description": "The response provides examples of how peripheral neuropathy symptoms may affect a patient\u2019s function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes effects on balance/falls, gait, dexterity (buttons, cooking), need for assistive devices, and task modification for safety."
      },
      {
        "criterion_number": 6,
        "description": "The response states some patients may see an improvement in symptoms when the causative medication is stopped.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes 'Some CIPN improves after chemotherapy ends' and discusses dose adjustments/treatment breaks/switching drugs."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe that some patients have diminishment of chemotherapy-induced peripheral neuropathy over time, but sometimes it is permanent.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions gradual improvement after chemotherapy ends but does not state that symptoms can be permanent."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends physical therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Strongly recommends PT with detailed interventions, home exercise program, and assistive device evaluation."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends occupational therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends OT with hand function, desensitization, adaptive equipment, and task modification strategies."
      },
      {
        "criterion_number": 10,
        "description": "The response states medication may help with some symptoms of peripheral neuropathy and provides examples like gabapentin, pregabalin, and duloxetine.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Identifies duloxetine as first-line; also lists gabapentin/pregabalin, venlafaxine, TCAs, topical lidocaine, and capsaicin."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the grading system oncologists use to quantify the severity of chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention CTCAE or any formal grading system; only references 'moderate-to-severe symptoms.'"
      },
      {
        "criterion_number": 12,
        "description": "The response should describe ways that patients with peripheral neuropathy can adapt to their environment to prevent adverse events.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides extensive home safety strategies: remove trip hazards, nightlights, grab bars, railings, non-slip mats, shower chair, assistive devices."
      },
      {
        "criterion_number": 13,
        "description": "The response should inform patients of the importance of protecting body parts that are experiencing neuropathy, such as appropriately sized and firm shoes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises well-fitting, closed-toe, non-slip shoes; avoid barefoot; daily foot checks; test water temperature; avoid heating pads on numb areas."
      },
      {
        "criterion_number": 14,
        "description": "The response should encourage patients to participate in activities that promote general wellness such as exercise, balanced nutrition with an emphasis on plant-based foods, good sleep hygiene, and adequate hydration.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Encourages exercise and mentions sleep support indirectly, but does not encourage balanced nutrition (plant-based) or hydration; no explicit sleep hygiene guidance."
      }
    ],
    "question_number": 230,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:17:03.076461",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what liquid-liquid phase separation is in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clear, accessible explanation using the 'oil droplets in vinaigrette' analogy; describes droplet-like, membraneless compartments that form, fuse, and dissolve, and their basic purpose."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how liquid-liquid phase separation relates to cancer cell biology.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Connects LLPS to cancer hallmarks: amplified growth signaling (RAS/RAF), transcriptional condensates at super-enhancers, DNA repair condensates, stress granules in therapy resistance, tumor suppressor disruption (p53), and epigenetic condensates (HP1)."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the role of liquid-liquid phase separation in normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States normal roles such as organizing signaling, gene regulation, DNA repair, and stress responses; references PARP-mediated repair condensates and stress granules as physiological processes."
      },
      {
        "criterion_number": 4,
        "description": "The response describes the role of liquid-liquid phase separation in pancreatic cancer and specific ways it can be affected.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides PDAC-specific links: KRAS-driven signaling clusters, YAP/TAZ condensates in stiff stroma, BRCA/PALB2-deficient tumors and PARP context, stress granules contributing to chemoresistance in PDAC, and frequent TP53 mutations affecting condensates."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the link between common mutations seen in pancreatic cancer and dysregulated liquid-liquid phase separation, including references to the scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it links KRAS, TP53, BRCA/PALB2, and YAP/TAZ to condensate biology, it provides no citations or references to published scientific literature."
      },
      {
        "criterion_number": 6,
        "description": "The response explains that this is an active area of scientific research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes that most 'condensate-aware' treatments are in trials and lists multiple emerging trial-stage approaches, conveying active ongoing research."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that there are no FDA-approved treatments that target liquid-liquid phase separation at this time.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not state that no FDA-approved LLPS-targeting therapies exist; instead describes PARP inhibitors as a 'condensate-related' therapy without clarifying they do not directly target LLPS."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends that the patient consider inquiring about liquid-liquid phase separation in pancreatic cancer with their oncology team and ask about local clinical trial availability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages discussion with the oncology team and consideration of clinical trials but does not specifically recommend asking about LLPS or LLPS-focused trials."
      },
      {
        "criterion_number": 9,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or references to published journal articles are provided."
      }
    ],
    "question_number": 231,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:17:44.461537",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states the tumor is very stiff and discusses stiffness repeatedly, including its biological effects."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects dense stroma, high pressure, and solid stress to poor drug penetration, reduced chemo effectiveness, radiation resistance due to hypoxia, and limited immunotherapy efficacy."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions blood flow and hypoxia as potentially having effects on treatment effectiveness.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes vessel compression leading to poor perfusion and hypoxia, and explains how hypoxia diminishes radiation sensitivity; also notes perfusion\u2019s impact on drug delivery."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No formal citations or specific journal references are provided, despite mentioning trials and agents."
      },
      {
        "criterion_number": 5,
        "description": "The response defines mechanical properties of tissues, including at least two of the following: interstitial fluid pressure, solid stress, or fibrotic structure.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines all three: interstitial fluid pressure (from hyaluronan and poor lymphatics), solid stress (matrix and cell contraction collapsing vessels), and fibrotic structure (collagen/hyaluronan-rich stroma)."
      },
      {
        "criterion_number": 6,
        "description": "The response describes compression of surrounding tissue by the tumor, specifically mentioning blood vessels or lymphatics.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that solid stress squeezes and collapses blood vessels and notes poor lymphatic drainage."
      },
      {
        "criterion_number": 7,
        "description": "The response defines desmoplastic stroma and describes its role in pancreatic cancer, including its composition.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes the fibrotic stroma produced by CAFs with collagen and hyaluronan, and explains its roles in stiffness, barrier to immune cells, and therapy resistance."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how pancreatic cancer remodels the extracellular matrix to promote a tumor-friendly environment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains ECM remodeling by fibroblasts (collagen, hyaluronan) and how stiffness-driven signaling (YAP/TAZ, FAK) supports invasion, survival, and immunosuppression."
      },
      {
        "criterion_number": 9,
        "description": "The response states that research on the effects of mechanical properties of tissue on treatment delivery is active and ongoing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes multiple ongoing studies and trials (e.g., losartan combinations, vitamin D analogs, FAK/ROCK/integrin inhibitors) and frames the field as moving toward normalization strategies."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends that the patient inquire about experimental treatments or clinical trials with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly advises asking about eligibility for trials targeting stroma, vessel normalization, and mechanosignaling and provides discussion points for the oncology team."
      }
    ],
    "question_number": 232,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:18:11.330366",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends having a plan for emergencies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a clear emergency plan: specific red flags (fever, uncontrolled pain, vomiting, confusion, bleeding, chest pain, etc.) and preparation steps (emergency packet with diagnoses/med list/contacts, lockbox code for EMTs, preferred hospital)."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker or patient care navigator.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends asking the oncology clinic for a nurse navigator or social worker and later advises talking to an oncology social worker about insurance and resources."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends utilizing telemedicine when available and appropriate.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises joining oncology visits by video/speakerphone, obtaining portal proxy access, adding caregivers to telehealth invites, scheduling remote video check-ins, and considering virtual second opinions."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends engaging family and friends for assistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends identifying a local point person (relative/friend/neighbor), using a shared calendar for task sign-ups, and leveraging a core team via group communications."
      },
      {
        "criterion_number": 5,
        "description": "The response states the patient\u2019s healthcare team may have resources to help patients at home and lighten caregivers\u2019 load.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It highlights nurse navigators/social workers coordinating home services and transportation, palliative care for symptom support, home health nursing when eligible, and hospice services supplying equipment, meds, and 24/7 support."
      },
      {
        "criterion_number": 6,
        "description": "The response provides data on caregiver burnout and cites its sources from published scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it addresses caregiver wellbeing, it does not provide any prevalence data or risk statistics, nor does it cite published scientific literature."
      },
      {
        "criterion_number": 7,
        "description": "The response offers examples of signs and symptoms of caregiver burnout.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It advises boundaries, support groups, routines, and respite but does not list concrete burnout symptoms such as exhaustion, sleep disturbance, irritability, anxiety/depression, or withdrawal."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions assisted living, home health aides, and respite homes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions home health nursing and private aides, and suggests planning respite, but does not mention assisted living or respite homes specifically."
      },
      {
        "criterion_number": 9,
        "description": "The response offers resources for cancer patients and their caregivers and provides contact information or websites.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It lists PanCAN, CancerCare, American Cancer Society, and Area Agency on Aging, but does not include contact information or website URLs."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of regular and comprehensive communication with the patient to ensure they feel well supported.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes routine communication through scheduled video calls, morning/evening texts, and debrief calls after appointments, supporting consistent connection and support."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend shared apps or other technological tools to share information between the patient and distant caregivers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends specific tools: Lotsa Helping Hands, ianacare, Google Calendar/Sheets, CaringBridge, WhatsApp, Medisafe, and patient portals like MyChart."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend ways that caregivers can provide support from afar.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It provides multiple remote strategies: join appointments by phone/video, monitor a shared symptom log and weights, manage meds and refills, arrange transportation and home services, set up home safety, coordinate calendars, and prepare an emergency packet."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient look into their insurance to understand if they have a benefit for paid caregiving.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It suggests speaking with a social worker about insurance coverage and benefits in general but does not explicitly advise checking insurance for paid caregiving or home care benefits."
      },
      {
        "criterion_number": 14,
        "description": "The response should provide online resources for patients with pancreatic cancer to learn more about local caregiving opportunities.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it names organizations (PanCAN, ACS, Area Agency on Aging), it does not provide online resources or links specifically to find local caregiving opportunities."
      }
    ],
    "question_number": 233,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:18:47.222418",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cell competition for oxygen and nutrients within a tumor in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly describes competition for scarce nutrients and oxygen, hypoxia, acidity, and how faster growers or hypoxia\u2011adapted cells outcompete others, using accessible language and examples."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses how cell competition may lead to clonal evolution of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains selection dynamics (frequency\u2011dependent selection, ecological games) and how interactions/pressures shape which clones expand, directly addressing clonal evolution."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses how clonal evolution in cancer can lead to drug resistance and progression of disease.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states therapy as a selective pressure that removes sensitive clones and allows resistant clones to expand; mentions communal resistance and shifting dynamics after treatment."
      },
      {
        "criterion_number": 4,
        "description": "The response describes cancer cell competition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple mechanisms of competition (resources, space/mechanics, immune evasion) and contrasts with cooperation, thoroughly describing competition."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the origin of cancer, from a single mutated cell that proliferates over time.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it discusses multiple clones and tumor ecosystems, it does not describe the single\u2011cell mutated origin or initial clonal expansion."
      },
      {
        "criterion_number": 6,
        "description": "The response describes that sometimes the interests of different subpopulations of cancer cells oppose each other, and how.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes direct competition for nutrients/space and mechanical crowding where 'winners' force 'losers' into apoptosis/quiescence; describes producer vs free\u2011rider conflict, illustrating opposed interests."
      },
      {
        "criterion_number": 7,
        "description": "The response describes that sometimes the interests of different subpopulations of cancer cells are aligned and their effect benefits all of the cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes cooperative behaviors such as public goods, leader\u2013follower invasion, metabolic cross\u2011feeding, communal drug resistance, and shared immunosuppressive niches that benefit multiple clones."
      },
      {
        "criterion_number": 8,
        "description": "The response explains ways pancreatic cancer cells differ and how they compete with each other.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides PDAC\u2011specific differences (desmoplastic stroma, CAF heterogeneity, metabolic scavenging via autophagy/macropinocytosis, alternative fuels) and explains competition under nutrient scarcity and immunosuppression."
      }
    ],
    "question_number": 234,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:19:08.943022",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states PDAC tumors are very stiff due to dense stroma and references stiffness-sensing pathways."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Connects stiffness and solid stress to poor perfusion, drug delivery barriers, hypoxia-driven resistance, mechanotransduction signaling, efflux pumps, and immune exclusion affecting chemo and immunotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions blood flow and hypoxia as potentially having effects on treatment effectiveness.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes compressed blood vessels reduce blood flow; hypoxia activates HIF-1\u03b1 and survival programs that reduce drug sensitivity."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or specific journal articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While EMT is mentioned, the response does not explicitly link tissue mechanics to invasion or metastasis (spread)."
      },
      {
        "criterion_number": 6,
        "description": "The response includes descriptions of the mechanical properties of tissue: stiffness, elasticity, viscosity, density, and compression.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Covers stiffness, solid stress/pressure, and compression, and mentions 'dense' stroma, but does not describe elasticity or viscosity; not all specified properties are addressed."
      },
      {
        "criterion_number": 7,
        "description": "The response describes compression of surrounding tissue by the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that the stiff matrix and growing cells compress blood vessels, increasing pressure."
      },
      {
        "criterion_number": 8,
        "description": "The response defines desmoplastic stroma and its role in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Defines dense scar-like stroma composed of collagen and hyaluronan produced by cancer-associated fibroblasts/stellate cells and links it to stiffness and treatment resistance."
      },
      {
        "criterion_number": 9,
        "description": "The response explains what the tumor microenvironment is.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes components (stroma, fibroblasts, ECM, immune context) and their functional impact on perfusion, signaling, and immune exclusion."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how pancreatic cancer is able to remodel its surrounding extracellular matrix to promote a tumor-friendly environment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains CAF/stellate cell-driven ECM deposition, activation of mechanotransduction pathways, and immune exclusion that create a pro-tumor microenvironment."
      },
      {
        "criterion_number": 11,
        "description": "The response explains that research on the effects of mechanical properties of tissue on treatment delivery is active and ongoing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Highlights multiple investigational strategies (FAK inhibitors, ARBs, vitamin D analogs, CXCR4 inhibitors, ROCK/integrin/YAP-TEAD inhibitors, sonoporation, nanoparticles) and ongoing trials."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends that the patient inquire about experimental treatments or clinical trials in their area with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly advises asking about clinical trials and discussing ARBs or other stroma-modulating approaches with the oncology team."
      }
    ],
    "question_number": 235,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:19:34.356787",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains proteostasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines proteostasis clearly as keeping proteins made, folded, moved, and removed properly, using plain language and relatable analogies (e.g., 'garbage disposals')."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how proteostasis may be altered in cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains cancer-specific proteotoxic stress and the heightened dependency of pancreatic cancer on autophagy, UPR, chaperones, and proteasome under harsh tumor conditions."
      },
      {
        "criterion_number": 3,
        "description": "The response provides examples of cancer treatments that target proteostasis in cancer cells and explains their mechanism of action in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Gives multiple concrete examples (hydroxychloroquine, ULK1/2, PIKfyve, VPS34 inhibitors, proteasome, p97/VCP, neddylation, HSP inhibitors, PERK/IRE1 agents) and explains mechanisms simply (e.g., blocking lysosomal recycling, intensifying ER stress)."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly prompts discussion with the oncologist and provides a practical list of targeted questions to ask."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the role of proteostasis in normal cells, including protein synthesis, protein folding, protein trafficking, and protein degradation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers all four roles (making, folding, moving, degrading) and names the key systems (chaperones, UPR, proteasome, lysosome/autophagy)."
      },
      {
        "criterion_number": 6,
        "description": "The response explains different steps and phases of proteostasis, which could be potential targets for cancer treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Breaks down targetable phases: autophagy/lysosome, proteasome/ERAD (p97), chaperones, and UPR/ISR pathways, linking each to therapeutic strategies."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions whether there are any FDA-approved therapies for pancreatic cancer that target proteostasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that proteostasis-targeting therapies are mostly in clinical trials and not standard for pancreatic cancer, implying there are no FDA-approved proteostasis-targeted therapies specifically for pancreatic cancer."
      }
    ],
    "question_number": 236,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:20:00.570717",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Repeatedly encourages engaging the oncology team: provides specific questions for the next visit, asks the oncologist for best/most likely/worst case, suggests asking if it\u2019s safe to pause 48\u201372 hours, and to share goals with the team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a Palliative Care team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends early palliative care referral and includes a script asking palliative care to join the team."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups and online resources for cancer patients and their families.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists PanCAN Patient Services, Cancer Support Community (support groups, counseling), Prepare for Your Care, and Ottawa Personal Decision Guide."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends breaking up decisions into smaller portions and creating pros and cons lists to organize thoughts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests shrinking choices, using best/most likely/worst case framing, time-limited trials, reversible vs. irreversible decisions, and offers to help draft a pros/cons sheet."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing goals of care with the patient to help with decision making.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a goals-clarification section (longevity, function, comfort), instructs to rank top 3 and share with the team."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a patient care navigator or social worker.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention a patient care navigator or social worker; resources listed do not explicitly direct to these roles."
      },
      {
        "criterion_number": 7,
        "description": "The response provides data on caregiver burnout and cites its sources from published scientific literature.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No data or citations provided; only general advice and signs of burnout."
      },
      {
        "criterion_number": 8,
        "description": "The response offers examples of signs and symptoms of caregiver burnout.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists red flags such as persistent hopelessness, irritability, sleep completely off, and feeling unsafe."
      },
      {
        "criterion_number": 9,
        "description": "The response should attempt to normalize treatment decision fatigue for patients undergoing cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly states that decision fatigue is a very normal response."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of maintaining mental health while undergoing cancer treatments, for both the patient and their loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Stresses caregiver self-care, respite, and psycho-oncology/counseling referral; highlights palliative care support for mood and caregiver strain."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that patients lean on their support network for assistance in making medical decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages appointing a family point person, dividing roles (medical, logistics, home, communication), and seeking help from others."
      },
      {
        "criterion_number": 12,
        "description": "The response should suggest that the patient request more frequent appointments with their oncology team for ongoing conversations and to answer questions that arise.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides questions for the next visit and suggests short decision pauses but does not recommend more frequent appointments."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that documentation of thoughts can be helpful to reflect upon when it comes time to make a medical decision.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends a one-page summary to bring to every visit and references decision aids; offers to help create a pros/cons sheet."
      }
    ],
    "question_number": 237,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:20:33.236358",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a step-by-step explanation (break away, intravasation, survival, extravasation, colonization) using accessible language (e.g., 'glue' between cells) with minimal jargon and clarifications."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes local invasion, direct extension into nearby organs, lymphatic spread, hematogenous spread, peritoneal seeding, and perineural invasion."
      },
      {
        "criterion_number": 3,
        "description": "The response describes lymphatic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states entry into lymphatic vessels, notes that lymphatics are 'leakier,' and that lymph nodes can catch cells."
      },
      {
        "criterion_number": 4,
        "description": "The response describes hematologic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains blood-borne spread and highlights portal venous drainage from the pancreas to the liver as the common first site."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically names EMT and explains its role in making cells more mobile and invasive."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions how different treatment modalities are or are not helpful once cancer has metastasized.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Discusses roles of systemic chemotherapy (e.g., FOLFIRINOX, gemcitabine/nab-paclitaxel) for escaped cells, targeted/immune therapies for select subgroups, radiation for local/regional disease, surgery when feasible, and supportive care\u2014contextualized in interrupting metastasis."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides a list of questions for the care team and invites sharing details to tailor advice for the next appointment."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers loss of adhesion, EMT, matrix degradation by MMPs, platelet cloaking, immune evasion, adhesion molecules in extravasation, exosomes/pre-metastatic niche, and signaling pathways (e.g., CXCR4/CCR2)."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes bloodstream stress encountered by circulating cells but does not describe metastasis initiation as a response to cellular stress (e.g., hypoxia, nutrient stress) driving dissemination."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions the healthcare team uses advanced imaging like CT, MRI, and PET/CT to identify places the cancer has spread to.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States CT or MRI of chest/abdomen/pelvis and sometimes PET, in the context of monitoring spread."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe perineural invasion and describe how cancer can spread this way.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that pancreatic cancers often travel along nerves (perineural invasion) and lists perineural spread among main routes."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe how cancer cells lodge in tissues distant from their original site.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details extravasation (adhesion to vessel walls, squeezing through) and colonization via pre-metastatic niche formation and dormancy."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe that pancreatic cancer is often diagnosed at advanced stages, when it has already spread outside of the original site.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not explicitly state that pancreatic cancer is frequently diagnosed at advanced/metastatic stages."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain the most common sites that cancer cells spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies liver as the most common initial site via portal vein, and mentions lungs, bones, and peritoneum."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe patterns of spread in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers portal venous spread to liver, peritoneal seeding, perineural invasion, dense stroma influences, and early liver involvement."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe characteristics of cancers that have higher predilection for spreading.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes features promoting spread such as EMT, loss of adhesion, protease activity, KRAS-driven biology, inflammatory microenvironment, and stromal context enabling motility."
      }
    ],
    "question_number": 238,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:21:08.765262",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines cancer stem cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines CSCs as a small subpopulation that survives treatment and can regenerate the tumor, driving recurrence and metastasis."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the role of cancer stem cells in cancer biology using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains in accessible language that CSCs resist therapy, can 'lie low,' regenerate tumors, and contribute to metastasis, with minimal jargon and a plain-language summary."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the role cancer stem cells may play in cancer recurrence.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly connects CSC survival to tumor regrowth and states this is a key reason for recurrence after initial response."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Repeatedly references stiffness, fibrosis, and a stiffer-than-normal pancreatic environment affecting tumor cells."
      },
      {
        "criterion_number": 5,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes how aligned collagen and confined spaces guide invasion and how EMT-like plasticity fosters metastatic potential."
      },
      {
        "criterion_number": 6,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links high interstitial pressure, poor perfusion, and hypoxia to reduced drug delivery and chemoradiation resistance."
      },
      {
        "criterion_number": 7,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific journal citations or references were provided."
      },
      {
        "criterion_number": 8,
        "description": "The response defines tumor microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Effectively characterizes the tumor microenvironment as the dense, scar-like stroma composed of fibroblasts, ECM (collagen, hyaluronan), and abnormal vasculature that shapes tumor behavior."
      },
      {
        "criterion_number": 9,
        "description": "The response describes mechanical cues as they pertain to solid tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Enumerates stiffness/fibrosis, pressure/poor perfusion, shear/compression, and matrix architecture/topography as relevant mechanical cues."
      },
      {
        "criterion_number": 10,
        "description": "The response delineates between other types of environmental inputs that cells experience and mechanical forces, such as chemical or hormonal cues.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Differentiates mechanical inputs ('cues from the matrix') from other inputs like inflammation, indicating CSC states shift with both mechanical and non-mechanical signals."
      },
      {
        "criterion_number": 11,
        "description": "The response describes that pancreatic cancer promotes desmoplasia in its microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States PDAC has an extreme desmoplastic reaction driven by fibroblasts and stellate cells producing collagen and hyaluronan."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how mechanical forces in the tumor microenvironment influence the behavior of cancer stem cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Connects stiffness-driven integrin/FAK/SRC/ROCK and YAP/TAZ signaling to increased CSC markers, EMT-like plasticity, survival, chemoresistance, and protective niches."
      },
      {
        "criterion_number": 13,
        "description": "The response links scientific literature with PMID on the subject, if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No PMIDs or explicit literature citations are provided."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how mechanical forces in the tumor microenvironment affect disease recurrence and metastatic potential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly links mechanical cues to CSC-mediated relapse and notes aligned fibers and EMT-like changes that facilitate invasion and metastasis."
      },
      {
        "criterion_number": 15,
        "description": "The response mentions how mechanical cues affect tumor cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes CSCs can 'lie low' in protective niches shaped by matrix architecture and adverse perfusion, implying dormancy influenced by mechanics."
      },
      {
        "criterion_number": 16,
        "description": "The response mentions that the desmoplastic tumor microenvironment in pancreatic cancer is actively being researched.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Highlights ongoing research and clinical trials targeting stroma, mechanosignaling (FAK/integrins/YAP), and stromal normalization strategies."
      }
    ],
    "question_number": 239,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:21:40.676465",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises using the care team as the primary information source and outlines specific steps for appointments (prepare top 3 questions, ask best/worst/most likely, take notes, teach-back), clearly encouraging discussion with the healthcare team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends asking the oncology clinic for referrals to an oncology social worker, psycho-oncology/therapy, and palliative care."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically mentions support groups (Gilda\u2019s Club/Red Door Community) and suggests a caregiver group to reduce isolation."
      },
      {
        "criterion_number": 4,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages building a support team, designating a point person, coordinating help via tools (CaringBridge, Lotsa Helping Hands, Meal Train), and asking for concrete help."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of stress relief strategies.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides multiple practical strategies: grounding (5-4-3-2-1), box breathing, worry window, helpful self-talk, gentle routine, movement, sleep hygiene, micro-joys, and cope-ahead plans."
      },
      {
        "criterion_number": 6,
        "description": "The response offers examples of organizations that offer support for cancer patients and their families and provides contact information or a website.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists several reputable organizations with phone numbers/websites: PanCAN, CancerCare (website provided), Cancer Support Community, American Cancer Society, Family Caregiver Alliance, and Gilda\u2019s Club."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends prioritizing self-care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes sleep regularity, movement, routines, boundaries (e.g., no medical reading after 8 p.m.), and scheduling daily micro-joys."
      },
      {
        "criterion_number": 8,
        "description": "The response should normalize the range of emotions felt after a loved one receives a serious cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Validates uncertainty and exhaustion; explicitly states it\u2019s normal to cycle between grief and normal life and reassures that one doesn\u2019t have to be brave all the time."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of maintaining mental health during times of strife.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Highlights psycho-oncology/therapy (CBT, ACT, mindfulness), offers coping skills, and includes crisis resources (988) for mental health emergencies."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of maintaining healthy lifestyle habits to support wellbeing during times of stress, such as a cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends daily movement (walking, stretching, yoga) and prioritizing regular sleep/wake times, along with gentle daily routines."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend organization of thoughts and questions to discuss with the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises writing top 3 questions before appointments, asking structured questions during, taking notes or recording, and using teach-back after visits."
      },
      {
        "criterion_number": 12,
        "description": "The response should emphasize the importance of understanding the diagnosis to the patient and suggest ways to educate themselves.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages using the care team or a trusted site as the primary information source and recommends strategies (teach-back, structured questions) to ensure understanding."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention the importance of getting one\u2019s affairs in order upon receiving a cancer diagnosis, as this can provide some peace of mind about the future.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Legacy/meaning-making projects are discussed, but there is no mention of legal/financial planning, advance directives, or getting affairs in order."
      },
      {
        "criterion_number": 14,
        "description": "The response should emphasize the importance of avoiding isolation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages support groups and a caregiver group, notes that sharing with those who understand reduces isolation, and promotes reaching out for concrete help."
      }
    ],
    "question_number": 240,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:22:12.274256",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what phase separation is using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines phase separation with accessible analogies (oil droplets in vinegar), explains membrane-less droplets, and describes them as on-demand work hubs in simple language."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how phase separation relates to cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly connects condensates to multiple cancer hallmarks (growth signaling, stress survival, DNA repair, metabolism, immune evasion, invasion/metastasis) with concrete examples."
      },
      {
        "criterion_number": 3,
        "description": "The response defines biomolecular condensates.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Defines biomolecular condensates as membrane-less protein/RNA droplets that concentrate or exclude molecules and form/dissolve dynamically."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how phase separation affects drug resistance in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that stress granules promote survival under chemo/radiation and correlate with resistance; discusses strategies to weaken stress granules to improve therapy."
      },
      {
        "criterion_number": 5,
        "description": "The response describes how phase separation affects gene manipulation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses gene regulation via super-enhancer condensates (BRD4/MED1) that amplify oncogene transcription, effectively covering how condensates modulate gene activity."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the role that phase separation plays in the tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links condensates to responses to microenvironmental stress (hypoxia, nutrient deprivation) and immune sensing (cGAS), and notes PDAC survival in low-oxygen, low-nutrient conditions."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the effect that phase separation has on cellular metabolism and survival.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that glycolytic/mTOR enzymes can phase separate to rewire metabolism; describes stress granules enhancing survival under harsh conditions and therapy."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that phase separation is the topic of ongoing research at this time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that condensate-targeting drugs are early-stage and references ongoing clinical trials and exploratory combination strategies."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the role of phase separation in the facilitation of invasion and metastasis of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions condensates organizing actin/focal adhesions and EMT programs that promote movement and tissue invasion."
      },
      {
        "criterion_number": 10,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or specific journal references are provided to support the claims."
      }
    ],
    "question_number": 241,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:22:29.272454",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains how cells 'feel' forces at the surface, membrane, cytoskeleton, and nucleus, and describes key sensors (integrins, ion channels, cadherins, cilium) using accessible language and concrete examples."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a straightforward description of downstream responses (gene expression via YAP/TAZ and MRTF, cytoskeletal remodeling, ECM remodeling, changes in cell fate and function), in clear, non-technical terms."
      },
      {
        "criterion_number": 3,
        "description": "The response outlines how these processes may be altered in pancreatic cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details PDAC-specific alterations: stiff, pressurized stroma; activation of integrin/FAK/Src, Rho\u2013ROCK, YAP/TAZ; roles of CAFs, hyaluronan, LOX; immune exclusion and vessel compression."
      },
      {
        "criterion_number": 4,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No explicit citations or references to published scientific journal articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "Define mechanotransduction as the process by which cells convert mechanical stimuli into biochemical signals.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Directly defines mechanotransduction as converting physical forces into biochemical signals that change cell behavior."
      },
      {
        "criterion_number": 6,
        "description": "Include the relevance of mechanotransduction in normal physiology and disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses relevance in normal physiology (differentiation, immune cell activation, primary cilium signaling) and in disease, especially PDAC desmoplasia and therapy resistance."
      },
      {
        "criterion_number": 7,
        "description": "Describe at least two types of mechanical forces acting on tissues, such as stretch, pressure, stiffness, compression, tension, shear stress, or hydrostatic pressure.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists multiple force types: stiffness, stretch/tension, compression (solid stress), fluid pressure and flow with shear, and tissue deformation."
      },
      {
        "criterion_number": 8,
        "description": "Explain how mechanical forces in tumors and/or the surrounding tissues differ from normal tissue, specifically mentioning the creation of a stiff and dense extracellular matrix (ECM).",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states PDAC has a dense, fibrotic stroma rich in collagen and hyaluronan that makes tissue much stiffer than normal, with elevated solid stress and fluid pressure."
      },
      {
        "criterion_number": 9,
        "description": "Describe at least two ways cells detect mechanical forces, including structures like ion channels, integrins, cell surface receptors, or the cytoskeleton.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes several detection mechanisms: integrins/focal adhesions, cadherins, mechanosensitive ion channels (Piezo/TRP), primary cilium, GPCRs/caveolae, cytoskeleton, and nucleus."
      },
      {
        "criterion_number": 10,
        "description": "Describe how pancreatic cancer cells respond to mechanical forces in their environment, particularly focusing on stiffness or desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that stiff ECM and compression activate integrin/FAK/Src, Rho\u2013ROCK, YAP/TAZ, and mechanosensitive channels, promoting proliferation, EMT, invasion, therapy resistance, and metabolic changes."
      },
      {
        "criterion_number": 11,
        "description": "Define desmoplastic stroma as a key feature of pancreatic cancer characterized by excessive fibrous tissue formation around the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines PDAC desmoplasia as dense, fibrotic stroma around the tumor rich in collagen and hyaluronan, identifying it as a key feature."
      }
    ],
    "question_number": 242,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:22:53.987778",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends meeting with a Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends early palliative care involvement for symptom relief and support."
      },
      {
        "criterion_number": 2,
        "description": "The response explains Advanced Care Planning and how it impacts a patient\u2019s clinical course.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes clarifying values/goals, revisiting after scans/treatment decisions, hospice timing, and how POLST/advance directives guide medical decisions."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions code status.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions POLST/MOLST as medical orders about resuscitation and treatments, which encompasses code status."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions an advanced directive or living will.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically lists advance directive/living will under health care decisions."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions financial planning and recommends discussing this with a professional with experience in this.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises will/trust, beneficiaries, POAs, and explicitly suggests considering an attorney; includes legal resource organizations."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a social worker or counselor.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends counseling via CancerCare (free counseling, groups); encourages support for caregiver needs via palliative care."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions the importance of a strong support system during cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages letting others help with meals, rides, childcare, household tasks; references caregiver support from palliative care."
      },
      {
        "criterion_number": 8,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or websites.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists PanCAN with website and phone, GetPalliativeCare.org, and other resource organizations."
      },
      {
        "criterion_number": 9,
        "description": "The response should instruct patients to create a POLST with their healthcare provider, and post this in a visible place in their home.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions POLST/MOLST but does not instruct creating it with the provider nor posting it at home."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the patient elect a healthcare durable power of attorney.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends a healthcare proxy and durable powers of attorney (finances and health)."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient ensure their financial affairs are in order.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises will/trust, beneficiaries, POWs, account lists, TOD/POD designations; checklist reinforces these actions."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient elect a financial durable power of attorney.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically includes durable powers of attorney for finances."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient complete a will and designate beneficiaries on life insurance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends creating/updating a will and updating beneficiary designations, including life insurance."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient consider reaching out to friends and loved ones in order to connect and spend time together.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages letters, voice/video messages, weekly story chats, and accepting help\u2014promoting meaningful connection."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient consider how to reconcile their affairs in the financial, legal, and social realms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers legal/financial basics, digital legacy, work/business transitions, and personal legacy activities."
      },
      {
        "criterion_number": 16,
        "description": "The response should provide online references and links to resources regarding legacy planning.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides online resources such as PanCAN (pancan.org), GetPalliativeCare.org, Five Wishes, StoryCorps, and BeRemembered for legacy planning."
      },
      {
        "criterion_number": 17,
        "description": "The response should suggest the patient inquire about assistance with some of these aspects of legacy planning with their oncology team, to understand if there are resources available.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not specifically advise asking the oncology team about assistance or available resources for legacy planning."
      }
    ],
    "question_number": 243,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:23:33.543078",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses clear, plain-language analogies (e.g., 'zippers' for cadherins and 'Velcro' for integrins), defines ECM as the surrounding scaffold, and explains focal adhesions and signaling in an accessible way."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how cell adhesion processes are changed in cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details multiple cancer-associated changes: reduced E-cadherin/cadherin switch, proteolytic cleavage of cadherins, EMT activation, integrin activation/recycling dynamics, invadopodia formation, and anoikis resistance."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions cadherins (E-cadherin) and integrins in several sections and explains their roles."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions changes to cell adhesion in pancreatic cancer specifically.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides a PDAC-specific section covering dense stroma, specific integrins (\u03b15\u03b21, \u03b1v\u03b25/\u03b26, \u03b16\u03b24), CD44\u2013hyaluronan interactions, altered tight junction/desmosome proteins, collective invasion, perineural invasion, and liver metastasis interactions."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published scientific journal articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains ECM as the surrounding scaffold and lists components (collagen, laminin, fibronectin, hyaluronan) and the basement membrane in context of adhesion and invasion."
      },
      {
        "criterion_number": 7,
        "description": "The response explains epithelial-mesenchymal transition (EMT).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes EMT as a program that reduces epithelial adhesion and increases mobility, names key drivers (Snail/Slug/Twist, TGF-\u03b2), and notes partial EMT."
      },
      {
        "criterion_number": 8,
        "description": "The response explains how EMT facilitates cancer cell spread.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Links EMT to loosening cell\u2013cell adhesion, increased motility, invasion, and metastasis; also notes collective migration with partial EMT and clinical relevance to spread."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the components of cell adhesion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers cell\u2013cell adhesion (cadherins, catenins, tight junctions, desmosomes) and cell\u2013ECM adhesion (integrins, focal adhesions, associated proteins like talin, kindlin, FAK, Src, paxillin, vinculin)."
      },
      {
        "criterion_number": 10,
        "description": "The response describes the components of cell detachment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains detachment via proteolytic cleavage of cadherins (MMPs, ADAMs), integrin turnover and recycling, rear-release via calpain, invadopodia-mediated matrix degradation, and anoikis evasion."
      },
      {
        "criterion_number": 11,
        "description": "The response includes different enzymes implicated in cell adhesion and detachment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions MMPs (MMP14/MT1-MMP, MMP2/9), ADAMs, cathepsins, and calpain in the context of adhesion modulation and ECM degradation."
      },
      {
        "criterion_number": 12,
        "description": "The response describes factors in the tumor microenvironment that promote or facilitate tumor cell detachment and migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses dense fibrotic PDAC stroma, hyaluronan-rich environment, cancer-associated fibroblasts, endothelial interactions (selectins, ICAM/VCAM), platelet cloaking, chemokines/growth factors at metastatic sites, and perineural invasion."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions if there are any FDA-approved treatments that target cancer cell detachment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States that FAK/integrin-targeting approaches are in trials and not standard of care, but does not explicitly address FDA approval status of detachment-targeting therapies."
      }
    ],
    "question_number": 244,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:23:55.135347",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises asking the oncologist for best/worst/most likely scenarios and lists specific questions to bring to the next appointment."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Promotes open dialogue using 'I hope\u2026 and I worry\u2026', suggests family meetings, and encourages eliciting the patient's hopes and worries."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends early palliative care involvement, discusses hospice, and references counseling resources (CancerCare)."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Centers on values and goals ('what matters'), clarifies acceptable trade-offs, and includes advance care planning and parallel plans."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions CancerCare offering free counseling/support groups and encourages use of such resources."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists organizations (PanCAN, CancerCare, Get Palliative Care, etc.) but does not provide URLs or contact information."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages counseling/support groups, highlights caregiver mental health (burnout, anxiety, depression) and seeking support, and integrates palliative care for psychosocial support."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly states it is normal to feel pulled between hope and realism."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses quality-of-life trade-offs (side effects, hospital days, clinic visits), stop rules (ER visits, time in bed), and maximizing comfort and connection."
      },
      {
        "criterion_number": 10,
        "description": "The response should provide online resources for pancreatic cancer information and support groups for the patient to consider reaching out to a community about their struggles.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides online-accessible resources (PanCAN, CancerCare, Get Palliative Care, The Conversation Project, Prepare for Your Care) suitable for information and support."
      }
    ],
    "question_number": 245,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:24:13.257116",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what condensates are using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes condensates as tiny, droplet-like, membrane-less compartments and uses analogies like 'pop-up workstations,' making the concept understandable to lay readers."
      },
      {
        "criterion_number": 2,
        "description": "The response defines biomolecular condensates as membrane-less organelles containing proteins, RNA, and other molecules.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States they are membrane-less compartments that gather proteins and RNAs, and gives examples (nucleolus, stress granules, P-bodies), satisfying the definition."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how condensates relate to cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains multiple cancer-relevant roles: amplifying growth signals (RAS/MAPK), enhancing transcription at super-enhancers, promoting stress survival, aiding DNA repair, and metabolic rewiring."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how biomolecular condensates become deregulated in cancer cells, including at least one mechanism of deregulation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides mechanisms of altered regulation, e.g., oncogenic signaling (RTK\u2192RAS/MAPK) forming clustered signaling condensates, super-enhancer condensates driving survival genes, and stress-induced granules that favor tumor survival."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published journal articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response references at least one scientific literature source regarding biomolecular condensates, including a PMID.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No scientific literature references or PMIDs are included."
      },
      {
        "criterion_number": 7,
        "description": "The response defines liquid-liquid phase separation (LLPS) as the process by which condensates form.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although weak, reversible interactions are mentioned, LLPS is not named or defined."
      },
      {
        "criterion_number": 8,
        "description": "The response explains the role of biomolecular condensates in normal cells, including at least one function such as gene regulation or stress response.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes concentrating molecules to speed reactions, switching genes on/off in bursts, sequestering factors, and coordinating stress responses in normal physiology."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the protein YAP/TAZ and its role in biomolecular condensates in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions YAP/TAZ forming nuclear condensates at super-enhancers that drive survival and proliferation genes."
      },
      {
        "criterion_number": 10,
        "description": "The response lists at least two ways that biomolecular condensates encourage cancer cell growth, proliferation, or migration.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists several mechanisms: amplifying growth signals, boosting transcription of survival/proliferation genes, enabling stress tolerance, aiding DNA repair, and metabolic rewiring\u2014well beyond the minimum of two."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that the study of biomolecular condensates and their role in cancer is an area of active scientific research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that therapeutic strategies are mostly in trials or preclinical and that the concept is shaping ongoing trial design, indicating active research."
      },
      {
        "criterion_number": 12,
        "description": "The response states whether there are FDA-approved therapies that target biomolecular condensates in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that most approaches are in trials/preclinical and 'doesn\u2019t change today\u2019s standard care,' implying there are no FDA-approved condensate-targeted therapies."
      }
    ],
    "question_number": 246,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:24:36.071223",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Tissue stiffness is explicitly mentioned multiple times and framed as central to PDAC biology."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links stiffness to invasion and metastasis via collagen alignment, enhanced adhesion, EMT, and mechanotransduction pathways."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains poor perfusion, high interstitial pressure, impaired drug delivery, and stiffness-driven drug resistance, as well as implications for immunotherapy access."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No specific journal articles or formal citations are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Desmoplasia is defined as a wound-healing response with CAFs/stellate cells depositing and crosslinking ECM (collagen, hyaluronan) leading to rigidity."
      },
      {
        "criterion_number": 6,
        "description": "The response explains how and why pancreatic cancer promotes the formation of desmoplastic stroma around itself.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains tumor-driven activation of stromal cells, ECM deposition, crosslinking, hyaluronan-induced swelling, and TGF-\u03b2 activation amplifying fibrosis."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the process of cell adhesion in normal tissue.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While integrins and adhesion signaling are mentioned, normal tissue cell adhesion is not explicitly described."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how increased stiffness in tumors and the tumor microenvironment influences cell adhesion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that stiff ECM clusters integrins, strengthens adhesions, activates FAK/Src and Rho/ROCK signaling, and enhances motility and invasion."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the effect of tissue stiffness on angiogenesis and drug resistance.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Drug resistance is discussed, but angiogenesis is not explicitly mentioned; the text focuses on vessel compression and hypoperfusion rather than angiogenic responses."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how the development of desmoplastic stroma around pancreatic cancer tumors is a protective factor.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes that complete stromal ablation can worsen disease in mice, implying some stromal elements restrain tumor growth."
      },
      {
        "criterion_number": 11,
        "description": "The response explains whether there are FDA-approved treatments that target tissue stiffness in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It discusses investigational approaches (e.g., FAK/ROCK inhibitors, LOX inhibitors) and negative trials but does not explicitly state the FDA approval status for stiffness-targeting therapies in PDAC."
      },
      {
        "criterion_number": 12,
        "description": "The response defines mechanotransduction.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mechanotransduction is effectively defined via description of mechanical cues (stiff ECM) triggering integrin clustering and downstream signaling (FAK/Src, YAP/TAZ)."
      },
      {
        "criterion_number": 13,
        "description": "The response suggests that the patient discuss the role of clinical trials in their cancer care with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends discussing local clinical trials targeting stroma/mechanics with the care team and offers help finding trials."
      }
    ],
    "question_number": 247,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:24:55.488215",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly emphasizes clear communication, such as recommending regular family meetings or using communication tools.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends a family meeting (Step 1), a communication plan (Step 4), predictable update rhythm, conflict rules, and tools like shared calendars, care apps, shared folders, plus weekly huddles (Step 11)."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing care coordination with the patient\u2019s healthcare team or medical providers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Designates a clinical point person to talk with the medical team, mentions HIPAA releases, preparation for appointments, post-visit summaries, emergencies to call care team, and suggests family meeting with the oncology team."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends discussing care coordination with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises early palliative care, meeting with a cancer center social worker, involving faith/community support, and requesting mediation via a social worker."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly emphasizes the importance of a strong support system, such as building a caregiver network or ensuring emotional support.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Builds a multi-person caregiver network with defined roles, includes emotional/spiritual support, community support (meal trains, volunteers), and respite/backup planning."
      },
      {
        "criterion_number": 5,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Lists organizations (e.g., PanCAN, CancerCare, CSC/Gilda\u2019s Club, Family Caregiver Alliance) but does not include contact information or website URLs."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly recommends participating in a support group for cancer patients and their families.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends teen support groups and lists organizations offering support groups (Cancer Support Community/Gilda\u2019s Club, CancerCare)."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends educating the family on the patient\u2019s diagnosis and treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages sharing information per patient consent, summarizing appointments for the family, keeping care plan/med list accessible, and using PanCAN for treatment information."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that one family member is designated as a communication person, and perhaps accompany the patient to their medical appointments and take notes.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Designates a Care Captain and backup; assigns one clinical point person; instructs that one person takes notes during visits and another may join by phone/video."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the communication person to develop a strategy to deliver information to the multi-generational family members.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Outlines a structured communication strategy with predictable update rhythm (nightly texts/weekly emails), funneling questions through the point person, and tailoring roles/updates by generation."
      },
      {
        "criterion_number": 10,
        "description": "The response should reinforce the importance of boundaries for the pancreatic cancer patient while they undergo treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes patient consent for what is shared, who is involved, and setting boundaries on tasks people can/can\u2019t do\u2014protecting the patient\u2019s preferences and limits."
      },
      {
        "criterion_number": 11,
        "description": "The response should suggest that the patient inquire with their oncology team if there are resources available for group support or for cultural mediation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it lists support resources and suggests mediation via a social worker, it does not explicitly advise asking the oncology team about group support or cultural mediation resources."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient or loved ones identify care needs, such as cleaning or food prep, and assign roles to family members according to their strengths.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a detailed needs map (medical, daily living, practical, emotional, financial) and assigns roles matched to capacity across generations with a task roster."
      },
      {
        "criterion_number": 13,
        "description": "The response should encourage the patient to focus on their own wellbeing and mental health.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes emotional/spiritual support, counseling, early palliative care, and symptom management\u2014all supporting the patient\u2019s wellbeing and mental health."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend online resources for pancreatic cancer information as well as support services that the patient and family members can access to answer questions, etc.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends multiple online-accessible resources (e.g., PanCAN Patient Services, CancerCare, Family Caregiver Alliance, AARP Care Guides, NeedyMeds) for information and support."
      }
    ],
    "question_number": 248,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:25:23.615061",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains epithelial-mesenchymal transition and how this affects a cell\u2019s ability to migrate.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions EMT and explains it switches on motility genes and turns off adhesion genes, linking EMT to increased motility."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes local invasion and entry into blood vessels and lymphatics; also notes perineural spread. Clearly includes direct, lymphatic, and hematogenous pathways."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers loss of adhesion (E-cadherin), cytoskeletal changes, invadopodia and proteases (MMPs/cathepsins), chemotaxis, anoikis resistance, hypoxia/HIF-1\u03b1, acidity, and stromal/immune interactions."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes harsh conditions like hypoxia and metabolic acidosis that activate invasion pathways and emphasizes stress responses (autophagy) aiding survival during detachment."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions the healthcare team uses advanced imaging like CT, MRI, and PET/CT to identify places the cancer has spread to.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of CT, MRI, PET/CT, or imaging modalities used to stage or detect metastases."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions how different treatment modalities are or are not helpful once cancer has metastasized.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions standard treatments generally but does not discuss their roles specifically in metastatic disease (e.g., systemic therapy vs. surgery/radiation limits after metastasis)."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Offers to help interpret reports but does not explicitly recommend discussing with the patient\u2019s own healthcare team."
      },
      {
        "criterion_number": 8,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear, patient-friendly description of invasion and spread using accessible language and concrete examples."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how a cancer cell develops, including DNA mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes genetic and epigenetic changes (KRAS activation; loss of TP53, CDKN2A, SMAD4) that drive invasive programs, addressing mutation-driven development."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe tumor suppressor genes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Lists genes lost in PDAC (TP53, CDKN2A, SMAD4) but does not describe what tumor suppressor genes are or their function."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe oncogenes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions KRAS activation but does not define oncogenes or explain their role in promoting growth/invasion."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe cell adhesion, and how this process can be altered in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains loss/alteration of adhesion proteins like E-cadherin that normally keep cells attached, detailing how this change facilitates invasion."
      },
      {
        "criterion_number": 13,
        "description": "The response should explain the phenomenon of loss of cell-cell adhesion in cancer cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Directly describes loss of cell-cell adhesion ('letting go of neighbors') with E-cadherin example."
      },
      {
        "criterion_number": 14,
        "description": "The response should define tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines tumor microenvironment as the normal cells and matrix around the tumor and discusses its role in invasion."
      },
      {
        "criterion_number": 15,
        "description": "The response should explain how cancer cells can use enzymes to change the tumor microenvironment to their advantage.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details invadopodia and release of proteases (MMPs, cathepsins) to digest ECM/basement membrane; also notes acidification activating matrix-digesting enzymes."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe other ways cancer cells can interact with the tumor microenvironment to promote migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes recruitment/reprogramming of fibroblasts and immune cells, ECM remodeling/stiffness, chemokine gradients, and immune evasion facilitating migration."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe any unique ways pancreatic cancer cells are thought to metastasize.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights dense desmoplastic stroma, matrix stiffness/pressure, frequent perineural invasion, and tendency for early dissemination\u2014features distinctive to PDAC."
      },
      {
        "criterion_number": 18,
        "description": "The response should recommend websites that help explain different aspects of pancreatic cancer and provide resources for pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No websites or external resources are recommended."
      }
    ],
    "question_number": 249,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:25:51.928197",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response discusses the normal flow of fluid from blood vessels to the extracellular space to the lymphatic system and blood vessels using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly outlines blood flow (perfusion), interstitial fluid flow, and lymphatic drainage in plain language and indicates lymphatics remove fluid from tissues, conveying the normal pathway from blood to tissue to lymph."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how fluids move in normal tissue to perform tasks such as nutrient and oxygen delivery, and to manage waste products.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that blood flow delivers oxygen (and drugs) and that lymphatic drainage removes fluid from tissues, covering nutrient/oxygen delivery and waste/fluid clearance in normal physiology."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses changes to fluid flow that may occur in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes PDAC-specific alterations: dense stroma, abnormal/compressed vessels, high interstitial fluid pressure, poor lymphatic drainage, and outward interstitial flow at the tumor edge."
      },
      {
        "criterion_number": 4,
        "description": "The response describes abnormalities seen in tumors with fluid management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies leaky and collapsed vessels, elevated interstitial pressure, and impaired lymphatic drainage\u2014key abnormalities in tumor fluid management."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses the implications of altered fluid flow on cancer treatment, including reduced drug delivery or immune cell penetration into the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains reduced perfusion limiting drug supply, loss of convective transport hindering large-drug penetration, diffusion limitations for small drugs, and immune exclusion due to vessel compression/IFP."
      },
      {
        "criterion_number": 6,
        "description": "The response describes how fluid flow affects cancer behavior.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Links poor flow to hypoxia/acidosis, flow-guided invasion along chemokine gradients, and immune exclusion, all influencing aggressive tumor behavior."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how low flow to tumor tissue stimulates further cancer cell growth and development.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that hypoxia and acidosis from poor blood flow select for more invasive, treatment-resistant cells, promoting malignant progression."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions how altered cellular biology and extracellular structures can impact cancer behavior.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses dense collagen/hyaluronan matrix, solid stress, and stromal/ECM-targeting agents (e.g., FAK, TGF-\u03b2) and how these features influence perfusion, immunity, and invasion."
      },
      {
        "criterion_number": 9,
        "description": "The response provides published scientific journal articles as evidence of its claims and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No specific journal citations or references are provided; trials are mentioned without formal citations."
      },
      {
        "criterion_number": 10,
        "description": "The response describes different fluids that exist in a tumor and its environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly identifies blood, interstitial fluid, and lymph; also mentions chemokines/growth factors carried by interstitial flow."
      },
      {
        "criterion_number": 11,
        "description": "The response describes the tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes stroma (collagen, hyaluronan), abnormal vasculature, immune exclusion, mechanical stresses\u2014key components of the tumor microenvironment."
      },
      {
        "criterion_number": 12,
        "description": "The response describes attributes of tumors and the surrounding tissue that disrupt the normal function of fluids.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Attributes include dense/desmoplastic stroma, solid stress compressing vessels, leaky vasculature, and poor lymphatic drainage, all disrupting fluid dynamics."
      },
      {
        "criterion_number": 13,
        "description": "The response defines desmoplastic stroma and how pancreatic cancer encourages the development of this.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While dense stroma is described, the term 'desmoplastic stroma' is not defined and there is no explanation of how PDAC drives its development."
      },
      {
        "criterion_number": 14,
        "description": "The response defines interstitial fluid pressure.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains IFP conceptually as elevated pressure inside the tumor due to leaky vessels, poor lymph drainage, and matrix swelling\u2014a clear practical definition."
      },
      {
        "criterion_number": 15,
        "description": "The response explains how increased interstitial fluid pressure impacts drug delivery, including uneven distribution of exposure in the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States high IFP collapses pressure gradients, shutting down convection for large drugs; notes poor perfusion creates undertreated pockets\u2014uneven intratumoral exposure."
      },
      {
        "criterion_number": 16,
        "description": "The response explains that poor fluid flow in tumor tissue is an active area of scientific research at this time.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions multiple ongoing clinical and preclinical strategies (vessel/stroma normalization, ultrasound, hyperthermia, exercise) and trials, indicating active research."
      }
    ],
    "question_number": 250,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:26:20.482510",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing dignity-preserving approaches with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response advises discussing dignity with clinicians in general and offers scripts for visits, but it does not explicitly direct the reader to discuss dignity-preserving approaches with the oncologist specifically."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing dignity-preserving approaches with a Palliative Care specialist.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly recommends an early palliative care consult for symptom control, stress support, communication, and planning, applicable at any disease stage."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly mentions Advance Care Planning and includes either Advance Directives or Living Wills.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advance care planning is addressed with explicit mention of advance directives (e.g., Five Wishes), medical power of attorney, and POLST/MOLST."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends establishing the patient\u2019s goals of care, including understanding and documenting the patient\u2019s preferences and involving them in decision-making.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It encourages eliciting values and goals, discussing trade-offs, involving the patient in choices, and documenting preferences in a shareable dignity plan."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends support groups for cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of support groups is included."
      },
      {
        "criterion_number": 6,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific organizations, websites, or contact information are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should attempt to normalize feelings of loss of control for cancer patients at the time of diagnosis and/or during cancer treatment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While empathetic, it does not explicitly normalize feelings of loss of control or state that such feelings are common."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe components of personal dignity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It thoroughly covers components of dignity: autonomy, respect, communication, privacy/modesty, symptom control, roles/identity, legacy/meaning, environment, and cultural/spiritual needs."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the patient, family, and friends of the patient, and oncology care team to respect the patient\u2019s bodily autonomy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly promotes bodily autonomy: asking permission before touch, allowing declination of interventions, addressing the patient first, and preserving modesty; it also advises family not to 'take over.'"
      },
      {
        "criterion_number": 10,
        "description": "The response should encourage the patient to prioritize management of side effects and symptoms of cancer or cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It urges prompt control of specific symptoms common in pancreatic cancer and advises creating action plans for symptom flares."
      },
      {
        "criterion_number": 11,
        "description": "The response should encourage the patient to communicate any side effects or symptoms of cancer or cancer treatment to their oncology care team to ensure they are being offered management solutions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It instructs to ask about plans for symptom flares and thresholds for calling, and to bring questions to visits, which encourages contacting the care team regarding symptoms."
      },
      {
        "criterion_number": 12,
        "description": "The response should encourage the patient and family to have open and ongoing communication about the patient\u2019s wishes for medical care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It promotes sharing values and goals with the team, clarifying who to involve in decisions and updates, and using a dignity plan to communicate preferences."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient and loved ones promote independence and normalcy in the patient\u2019s life as much as possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends preserving roles, avoiding unnecessary takeover, and using OT/PT to maintain function and daily routines, supporting independence and normalcy."
      },
      {
        "criterion_number": 14,
        "description": "The response should encourage the patient to always remember that anything that happens to their body with regard to cancer treatment is their choice.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states to involve him in decisions, allow him to decline unwanted interventions, and to ask permission before touching, reinforcing bodily choice."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient disclose any feelings of overwhelm or loss of autonomy with their oncology team and inquire about resources for support.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it suggests oncology social work/psycho-oncology for emotional support, it does not explicitly direct the patient to disclose feelings of overwhelm or loss of autonomy to the oncology team."
      },
      {
        "criterion_number": 16,
        "description": "The response should emphasize the importance of prevention of caregiver burnout.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It addresses caregiver dignity and burnout prevention with practical steps: accepting help, respite, safe transfer training, boundaries, and considering home-based support."
      }
    ],
    "question_number": 251,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:26:56.575705",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains how cells respond to mechanical stress, including processes like ECM remodeling, increased contractility, and effects on proliferation, invasion, metastasis, and drug resistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes actomyosin-driven contractility, traction, ECM remodeling by CAFs (collagen alignment, LOX crosslinking, HA production), activation of mechanotransducers (FAK/Src, YAP/TAZ), and resulting impacts on invasion, proliferation, survival, and therapy resistance."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly relates tissue properties, such as stiffness and fibrous stroma, to their potential effect on cancer spread, including invasiveness and metastasis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links stiff, fibrotic stroma and aligned collagen to enhanced invasion and guidance (e.g., tracks, perineural invasion) and describes stiffness-induced signaling that promotes aggressive behavior."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly relates tissue properties to their potential consequences for treatment effectiveness and resistance, including drug penetration and resistance mechanisms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains how solid stress and HA-driven pressure compress vessels, reducing perfusion and drug delivery, causing hypoxia and therapy resistance; discusses stroma-normalizing strategies aiming to improve penetration."
      },
      {
        "criterion_number": 4,
        "description": "The response explains how cells sense mechanical stress, including mechanosensing mechanisms like mechanoreceptors, integrins, or mechanotransduction pathways.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mechanosensing is addressed via integrins and downstream FAK/Src and YAP/TAZ pathways; mentions mechanical activation of latent TGF-beta from ECM."
      },
      {
        "criterion_number": 5,
        "description": "The response provides specific citations from published scientific journal articles as evidence for its statements.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides specific journal article titles and venues (Nature Reviews Cancer; Annual Review article by Jain\u2019s group; review on PDAC desmoplasia), which qualify as citations to peer-reviewed literature."
      },
      {
        "criterion_number": 6,
        "description": "The response must explain normal cell contractility, including the role of the actomyosin complex in generating mechanical forces for movement.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that cells generate internal tension through actomyosin and transmit traction via integrins; links actomyosin to migration modes and contractility."
      },
      {
        "criterion_number": 7,
        "description": "The response must define actin, including its role in cellular structure and function.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Actin is referenced implicitly within 'actomyosin' but not defined as a cytoskeletal filament or its structural/functional roles."
      },
      {
        "criterion_number": 8,
        "description": "The response must define myosin, including its function in cell contractility.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Myosin is mentioned (e.g., myosin II inhibitors) and implied as a motor, but no explicit definition of myosin\u2019s function in contractility is provided."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly describe the tumor microenvironment, including its components and characteristics.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes PDAC TME components (CAFs, collagen, HA, immune cells, vessels), characteristics (desmoplasia, stiffness, pressure), and their interactions."
      },
      {
        "criterion_number": 10,
        "description": "The response must define the extracellular matrix, including its composition and function.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Identifies ECM components (collagen, HA) and functions (mechanical stiffness, storage/activation of growth factors, creation of tracks), satisfying composition and function."
      },
      {
        "criterion_number": 11,
        "description": "The response must define mechanobiology, including its relevance to cancer progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While mechanobiology concepts are thoroughly discussed, there is no explicit definition of 'mechanobiology' as a field and its scope."
      },
      {
        "criterion_number": 12,
        "description": "The response must explain epithelial-mesenchymal transition (EMT), including its occurrence in pancreatic cancer cells and its impact on cancer spread.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Migration modes are discussed (mesenchymal vs. amoeboid), but EMT itself is not defined or linked to PDAC or its role in dissemination."
      }
    ],
    "question_number": 252,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:27:26.732974",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines the extracellular matrix and explains its role in normal cellular biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines ECM as tissue scaffolding composed of proteins and sugars (collagen, fibronectin, hyaluronan) and notes it is built/remodeled by nearby cells, indicating its structural role in normal biology."
      },
      {
        "criterion_number": 2,
        "description": "The response contrasts the role of the extracellular matrix in cancer cell biology with normal cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Contrasts normal scaffolding with cancer-associated changes (desmoplasia, stiffness, signaling via integrins/FAK/PI3K/YAP, immune exclusion), highlighting distinct functions in cancer versus normal tissue."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses the potential consequences of an altered extracellular matrix for cancer treatment effectiveness and resistance, including examples like decreased drug and immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains vessel compression leading to poor drug delivery and hypoxia, immune exclusion limiting T-cell penetration, and references investigational strategies to improve delivery; explicitly links ECM to treatment resistance."
      },
      {
        "criterion_number": 4,
        "description": "The response discusses the potential consequences of an altered extracellular matrix on cancer cell biology, including examples like angiogenesis and metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes ECM-aligned collagen acting as tracks for invasion, entry into blood/lymph (metastasis), pro-survival signaling, and hypoxia-driven aggressiveness; adequately covers consequences on cancer biology."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to specific published journal articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the different components of the extracellular matrix in normal tissue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists key ECM components (collagen, fibronectin, hyaluronan) and characterizes ECM as proteins and sugars, satisfying the requirement."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how the extracellular matrix changes in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details desmoplasia with dense, scar-like matrix, high pressure, stiffness, increased hyaluronan, and predominance of stroma over cancer cells in PDAC."
      },
      {
        "criterion_number": 8,
        "description": "The response explains how the changes in the extracellular matrix in pancreatic cancer promote cancer growth and facilitate movement of cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains integrin-mediated signaling (FAK/Src, PI3K, YAP/TAZ) promoting survival and invasiveness, and describes aligned collagen guiding invasion and spread."
      },
      {
        "criterion_number": 9,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines desmoplasia as an extremely dense, scar-like stroma; sufficient for defining desmoplastic stroma."
      },
      {
        "criterion_number": 10,
        "description": "The response defines tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions the tumor microenvironment but does not explicitly define it."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how desmoplastic stroma causes hypoxia in the tumor microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifies that dense collagen/hyaluronan increase pressure and compress blood vessels, limiting blood flow and causing hypoxia."
      },
      {
        "criterion_number": 12,
        "description": "The response describes how hypoxia in the tumor microenvironment causes inflammation, and how this promotes cancer growth.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While hypoxia is mentioned, the link to inflammation and its pro-tumor effects is not described."
      },
      {
        "criterion_number": 13,
        "description": "The response describes how the desmoplastic stroma in the pancreatic cancer microenvironment contributes to treatment resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses poor drug penetration, T-cell exclusion reducing immunotherapy efficacy, and stiffness driving treatment-resistant states."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how the desmoplastic stroma in the pancreatic cancer microenvironment can cause symptoms and complications due to mechanical forces on the surrounding structures, specifically mentioning the effect on blood vessels.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains mechanical compression of blood vessels due to high interstitial pressure; while symptoms are not detailed, the required vessel effect and mechanical complication are clearly described."
      }
    ],
    "question_number": 253,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:28:01.526365",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing relationship challenges or support strategies with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises: 'Ask the oncology team about sexual health side effects...' and 'Schedule regular family meetings ... with oncology ... to align on goals, symptoms, and roles,' which directly recommends discussing relationship-related issues and strategies with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing relationship challenges with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends 'Schedule regular family meetings ... with ... palliative care or a social worker' and explains early palliative care benefits, fulfilling the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends joining a support group for cancer patients or their families.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states: 'Reach out to a counselor, oncology social worker, or a caregiver group early' and lists Gilda\u2019s Club/Cancer Support Community offering local support groups, which is an explicit support-group recommendation."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly emphasizes the importance of self-care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "A full 'Protecting your own capacity (caregiver)' section highlights micro-rest, burnout signs, counseling, respite, and maintaining one personal activity, clearly emphasizing self-care."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly emphasizes the importance of having a support system during cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages building an 'inner circle,' using update hubs, being specific in asks for help, and accepting help from those who show up\u2014clearly underscoring the need for a support system."
      },
      {
        "criterion_number": 6,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists PanCAN (877-272-6226), CancerCare (800-813-HOPE), ACS (800-227-2345), Family Caregiver Alliance (caregiver.org), and Gilda\u2019s Club/Cancer Support Community, meeting the requirement for named resources with contact details."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that loved ones of a patient with pancreatic cancer seek education about the disease and common symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests asking the care team questions and mentions side effects and palliative care focus, it does not explicitly recommend that loved ones seek education about pancreatic cancer and its common symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage open communication between the patients and their loved ones.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises a check-in script ('Do you want solutions, company, or a distraction?'), setting 'cancer-free time' and weekly 'hard talk,' sharing hopes and worries, and age-appropriate honesty with children\u2014clear encouragement of open communication."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the patient to seek support from their loved ones.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It provides scripts for asking for help, encourages accepting help from those who show up, and suggests using support networks for tasks and visits\u2014explicitly encouraging seeking support."
      },
      {
        "criterion_number": 10,
        "description": "The response should attempt to normalize the stress that patients feel after receiving a pancreatic cancer diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It begins by normalizing strain ('It\u2019s common for relationships to feel strained or to shift during cancer') and notes that children\u2019s big feelings may show as behavior, which normalizes stress responses."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend against behaviors that might isolate the patient after a serious medical diagnosis.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it promotes connection and provides communication tools, it does not explicitly advise against isolating behaviors or warn against withdrawal after diagnosis."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient prioritize symptom control to feel as normal as possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends early palliative care focusing on comfort, energy, pain, appetite, and sleep, noting this often improves day-to-day life\u2014i.e., prioritizing symptom control."
      },
      {
        "criterion_number": 13,
        "description": "The response should indicate that some people may not feel comfortable discussing a serious cancer diagnosis with a friend or loved one, and that this can be a normal response.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It acknowledges variability: 'Some people will step up; others may fade. Accept help from the ones who show up and release expectations,' which normalizes that some may avoid engagement."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient observe which people in their social circle want to be supportive, and to lean on these people.",
        "score_given": 0,
        "max_points": 0,
        "justification": "Although the response advises accepting help from those who show up, this criterion carries 0 maximum points; no points can be awarded."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient continue to reach out to friends and loved ones, and try to participate in the same activities they previously did, to maintain relationships.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It suggests specific familiar activities (morning coffee, 10-minute walks, watching a show together), maintaining routines for kids, and provides scripts to reach out for help, satisfying the criterion."
      },
      {
        "criterion_number": 16,
        "description": "The response should suggest that the patient consider creating boundaries with people, including how to handle unsolicited advice.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It has a 'Boundaries' section and provides scripts for unsolicited advice ('We\u2019re following the medical team\u2019s plan'), visiting rules, and redirecting conversations."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend that the patient consider activities where they can be fully present with the people they are with, for the best quality interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends short, predictable, connection-focused activities and 'cancer-free time,' plus meaning-making projects (photos, voice notes, gratitude journal), promoting fully present interactions."
      }
    ],
    "question_number": 254,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:28:39.378527",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains how cancer cells detect mechanical characteristics of their environment.",
        "score_given": 0,
        "max_points": 0,
        "justification": "Although the response thoroughly explains detection mechanisms (integrins, cadherins, ion channels, cytoskeleton, nucleus), this criterion has a maximum of 0 points per the rubric."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how cancer cells respond to mechanical characteristics of their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It details immediate responses (Ca2+ influx, FAK/Src, Rho GTPases, cytoskeletal reorganization) and longer-term adaptations (YAP/TAZ, MRTF/SRF transcriptional programs, EMT, durotaxis, ECM remodeling, immune modulation, metabolic shifts)."
      },
      {
        "criterion_number": 3,
        "description": "The response outlines how mechanosensing processes may be altered in pancreatic cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "PDAC-specific alterations are clearly described: extreme desmoplastic stiffness and pressure, abundant collagen/hyaluronan, CAF activation and feedback loops, hyperactive FAK/Src, Rho/ROCK, YAP/TAZ, integrins, CD44-hyaluronan, TRPV4/Piezo signaling, and cooperation with oncogenic KRAS with clinical consequences (invasion, therapy resistance, immune exclusion)."
      },
      {
        "criterion_number": 4,
        "description": "The response defines mechanosensing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that cancer cells \"feel\" physical properties and convert mechanical cues into biochemical signals (mechanotransduction), providing a clear, lay definition of mechanosensing."
      },
      {
        "criterion_number": 5,
        "description": "The response describes mechanosensing in normal cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple general (non-cancer-specific) mechanisms are described\u2014integrin/focal adhesion signaling, cadherin-based junctions, actomyosin contractility, mechanosensitive channels (Piezo/TRPV4), caveolae, primary cilium/glycocalyx, and nuclear mechanosensing\u2014applicable to normal cells."
      },
      {
        "criterion_number": 6,
        "description": "The response defines desmoplastic stroma and describes its development in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It defines desmoplasia as dense fibrotic stroma rich in collagen and hyaluronan and explains development via CAF activation, ECM deposition and crosslinking (e.g., LOX), increased stiffness/pressure, and vessel compression that impairs perfusion and drug delivery."
      },
      {
        "criterion_number": 7,
        "description": "The response describes integrins, cytoskeleton, ion channels, and membrane sensors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Integrins/focal adhesions (talin, vinculin, FAK/Src), actin\u2013myosin contractility (Rho/ROCK), mechanosensitive channels (Piezo1/2, TRPV4), and membrane sensors (caveolae, glycocalyx; CD44/syndecans; primary cilium) are all accurately described."
      },
      {
        "criterion_number": 8,
        "description": "The response explains the YAP/TAZ pathway and its role in the development of desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that stiffness drives YAP/TAZ nuclear localization to promote growth and ECM remodeling and specifically notes that stiffness activates CAFs through YAP/TAZ, which in turn deposit ECM and stiffen the stroma, with mention of TEAD inhibitors under investigation."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions if there are FDA-approved therapies that target the cancer cells\u2019 ability to mechanosense.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It lists investigational targets (FAK, ROCK, integrins, LOX, YAP/TEAD) and notes mixed trial results but does not explicitly state whether any FDA-approved therapies exist; therefore, the criterion is not met."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how cancer cells migrate in response to cues from mechanical forces in their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It describes durotaxis (migration toward stiffness), contact guidance along aligned fibers, confinement-driven migration, and switching between mesenchymal and amoeboid modes regulated by contractility."
      },
      {
        "criterion_number": 11,
        "description": "The response defines epithelial-mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is mentioned but not defined (e.g., loss of epithelial polarity/adhesion and acquisition of mesenchymal migratory traits), so no credit."
      },
      {
        "criterion_number": 12,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No specific journal citations are provided; only suggested search terms are given."
      }
    ],
    "question_number": 255,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:29:05.147958",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the normal flow of fluid from blood vessels to the extracellular space to the lymphatic system, including nutrient and oxygen delivery and waste management.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response focuses on tumor-associated pressures and barriers but does not describe normal physiology of fluid flow, nutrient/oxygen delivery, or lymphatic waste removal."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how fluid flow becomes compromised in tumors, including increased intratumoral pressure due to abnormal blood vessels, poor lymphatic drainage, and dense stroma.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly attributes elevated interstitial fluid pressure to leaky vessels, poor lymphatic drainage, and hyaluronan-rich matrix, and discusses solid stress from dense fibrotic stroma (collagen, activated fibroblasts)."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses the implications of altered fluid flow on cancer treatment, specifically mentioning reduced drug delivery and immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains vessel compression reducing perfusion and drug delivery, impaired transvascular transport, and explicitly notes limited immune cell infiltration and reduced immunotherapy efficacy."
      },
      {
        "criterion_number": 4,
        "description": "The response explains how increased interstitial fluid pressure impacts drug delivery, including uneven distribution of exposure in the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It details flattened pressure gradients impairing transvascular movement and notes outward interstitial flow at tumor margins that keeps larger drugs at the rim rather than the core, indicating uneven intratumoral distribution."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses the impact of altered fluid flow on radiation therapy due to hypoxia.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It connects vessel compression to hypoxia and states that radiation can be less effective in hypoxic tumors."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions the impact of altered cellular biology and extracellular structures on cancer behavior, including tumor growth, metastasis, and resistance to therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions hypoxia altering tumor cell behavior and drug response (resistance), it does not address tumor growth or metastasis; the criterion requires inclusion of these aspects."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how low flow to tumor tissue stimulates further cancer cell growth and development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit discussion of low flow driving or stimulating further tumor growth/development was provided."
      },
      {
        "criterion_number": 8,
        "description": "The response defines desmoplastic stroma and how pancreatic cancer encourages its development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It references dense, fibrotic stroma and activated fibroblasts but does not define desmoplasia or explain how PDAC promotes its development (e.g., stellate cell activation, signaling pathways)."
      },
      {
        "criterion_number": 9,
        "description": "The response defines interstitial fluid pressure.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It defines interstitial fluid pressure as fluid pressure in the tumor's spaces and explains why it rises."
      },
      {
        "criterion_number": 10,
        "description": "The response describes ways that increased pressure from interrupted fluid dynamics and desmoplastic stroma can cause compression on surrounding structures, leading to blockages and symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions compression of blood vessels but does not extend to surrounding organ/duct compression, blockages (e.g., biliary/duodenal), or associated symptoms."
      },
      {
        "criterion_number": 11,
        "description": "The response provides specific published scientific journal articles as evidence of its claims, with proper citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to specific published journal articles are provided."
      },
      {
        "criterion_number": 12,
        "description": "The response explains that poor fluid flow in tumor tissue is an active area of scientific research at this time.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes ongoing trials and investigational approaches (e.g., stroma-modifying agents, vessel modulation, focused ultrasound), indicating this is an active research area."
      }
    ],
    "question_number": 256,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:29:30.005025",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends clear communication with the family regarding how everyone is dealing with the patient\u2019s cancer diagnosis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides a detailed communication plan (central update channel, what to share, visiting rules), a template message to set tone/boundaries, encourages a neutral family meeting, and suggests using \u201cI\u201d statements\u2014clearly promoting open, structured communication."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises engaging the clinic\u2019s social worker, oncology navigator, and palliative care team; recommends family meetings facilitated by the clinic team, directly involving the healthcare team in communication/support."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends an oncology social worker/navigator, early palliative care, and chaplain/spiritual support; suggests involving these professionals to facilitate family meetings and coping."
      },
      {
        "criterion_number": 4,
        "description": "The response emphasizes the importance of self-care and healthy boundaries.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strong emphasis on caregiver respite, sleep, breaks, daily coping practices, limiting doom-scrolling, setting visiting rules, and a script to set boundaries. Also includes the \u201ccomfort in, dump out\u201d guideline to protect inner circle members."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of a strong support system for patients with cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages building a coordinated support network through a point person, care calendar, defined roles, and participation in support groups\u2014clearly emphasizing strong support systems."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations that support cancer patients and their families and includes contact information or websites.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists PanCAN (website and phone), CancerCare (website), Cancer Support Community/Gilda\u2019s Club (website), American Cancer Society (phone), The Dougy Center (website), and The Conversation Project (website)."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends participating in a support group for cancer patients and their families.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically recommends support groups, noting separate groups for patients and caregivers as invaluable, and provides organizations that host such groups."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends educating the family on the patient\u2019s diagnosis and treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises deciding what details to share, using a centralized update channel, offering age-appropriate explanations to children (including that doctors are treating it), and involving palliative care\u2014collectively encouraging family education about the diagnosis and care."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage that family members provide emotional support to each other.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Promotes mutual support via the \u201ccomfort in, dump out\u201d model, weekly check-ins for caregivers, acknowledging different coping styles, and family meetings to reduce conflict."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend pursuit of professional mental health counseling for family members of a patient with pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends psycho-oncology therapists/counselors and family therapists; includes crisis resources (988/911) and criteria for when to seek urgent help."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend resources that patients and families of patients with pancreatic cancer can access for information about the disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides PanCAN and American Cancer Society, among others, which offer comprehensive disease information and guidance."
      },
      {
        "criterion_number": 12,
        "description": "The response should list sources and/or websites for support groups for patients with pancreatic cancer and their family members.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists Cancer Support Community/Gilda\u2019s Club and CancerCare (with websites), and PanCAN peer connections, all known for support groups."
      },
      {
        "criterion_number": 13,
        "description": "The response should encourage family members to provide assistance and support to their loved ones affected by pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Offers a comprehensive practical help plan (meal trains, rides, childcare, errands, respite coverage), assigns roles including age-appropriate tasks for children, and provides tools to organize assistance."
      }
    ],
    "question_number": 257,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:30:06.594160",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The answer outlines the steps of metastasis (invading tissue, entering/leaving vessels, traveling in blood/lymph, colonizing new sites) using accessible explanations (e.g., squeezing through tight spaces, slipping between endothelial cells) and defines technical terms in simpler language."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly mentions direct invasion into surrounding tissue, intravasation/extravasation through blood and lymph vessels, and survival of circulating tumor cells in the bloodstream."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mechanisms such as actomyosin contractility (Rho/ROCK\u2013myosin II), invadopodia and MMPs, integrins/focal adhesions, nuclear deformability (lamin A/C, chromatin compaction), YAP/TAZ mechanosignaling, and EMT are described."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "EMT and \"partial EMT\" are explicitly named and linked to increased motility and mechanical plasticity."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although mechanical and shear stresses encountered during dissemination are discussed, the response does not frame metastasis as being triggered by cellular stress (e.g., hypoxia, therapy-induced stress) nor explicitly state metastasis occurs as a response to stress."
      },
      {
        "criterion_number": 6,
        "description": "The response explains cancer cell deformability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Deformability is clearly defined as a cell\u2019s ability to change shape and squeeze through tight spaces, governed by the cytoskeleton, adhesion, and nuclear stiffness, with detailed examples of how deformation occurs."
      },
      {
        "criterion_number": 7,
        "description": "The response defines extracellular matrix and cytoskeleton.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The cytoskeleton is described as the cell\u2019s skeleton (actin, microtubules, intermediate filaments), and the ECM is described as a mesh of collagen and other fibers surrounding tumors, effectively defining both."
      },
      {
        "criterion_number": 8,
        "description": "The response explains cell adhesion processes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Adhesion is addressed through discussion of integrins and focal adhesions, how strongly a cell sticks to surroundings, and how cells pass between endothelial cells."
      },
      {
        "criterion_number": 9,
        "description": "The response describes how cell deformity changes in cancer cells as compared to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains that cancer cells can become more deformable via reduced lamin A/C and looser chromatin, increased vimentin with EMT, and altered actomyosin activity, contrasting with stiffer, less plastic states."
      },
      {
        "criterion_number": 10,
        "description": "The response describes the impact of enhanced deformability of cancer cells on their ability to metastasize.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Enhanced deformability is linked to success at multiple steps: invasion through small ECM pores, intravasation/extravasation, transit through capillaries under shear, and adaptation to new tissue mechanics."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how cancer cells with increased ability to deform survive stresses that normal cells would not.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that more deformable circulating tumor cells can pass narrow capillaries and withstand fluid shear stress, whereas stiffer cells become trapped or damaged, indicating survival under conditions that would harm less deformable cells."
      },
      {
        "criterion_number": 12,
        "description": "The response describes desmoplastic stroma in the pancreatic cancer tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly describes PDAC\u2019s dense, fibrotic stroma (desmoplasia) rich in hyaluronic acid and collagen, produced by cancer-associated fibroblasts, and its effects (raised pressure, vessel compression, tiny pores)."
      },
      {
        "criterion_number": 13,
        "description": "The response explains how increased deformability capabilities are necessary for cells to travel within the desmoplastic stroma of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states that to invade the dense PDAC stroma, cancer cells either remodel the matrix or become more deformable, directly linking deformability to movement through desmoplastic tissue."
      }
    ],
    "question_number": 258,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:30:38.653492",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the normal physiological flow of fluid from blood vessels to the extracellular space and lymphatic system in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response focuses on tumor-specific interstitial flow and poor lymphatic drainage but does not describe normal physiology (capillary filtration into the interstitial space with return via lymphatics) in layman\u2019s terms."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses changes to fluid flow in pancreatic cancer, such as increased intratumoral pressure, and how these changes differ from normal tissue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states that PDAC has dense, fibrotic stroma that compresses blood vessels, lowers perfusion, increases interstitial pressure, and alters flows due to leaky vessels and blocked lymphatics\u2014contrasting with normal tissue."
      },
      {
        "criterion_number": 3,
        "description": "The response addresses how altered fluid flow impacts cancer treatment, including drug delivery and immune cell penetration into tumors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that high interstitial fluid pressure and outward flow reduce drug convection into tumors and discusses how vascular abnormalities affect delivery. It also mentions effects on immune cell trafficking and that exercise may improve immune infiltration."
      },
      {
        "criterion_number": 4,
        "description": "The response discusses the potential impacts of altered fluid flow on cancer behavior, including metastasis, proliferation, migration, and invasion.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It covers flow-directed migration, EMT-like changes, invadopodia formation, platelet shielding, CTC clusters, microvascular niches for metastasis, and activation of YAP/TAZ linked to proliferation."
      },
      {
        "criterion_number": 5,
        "description": "The response provides at least one citation from a published scientific journal article as evidence for its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No journal citations are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response defines shear stress.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Shear stress is explicitly defined as the frictional force from fluid moving over a cell."
      },
      {
        "criterion_number": 7,
        "description": "The response describes what sources of shear stress exist in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists multiple sources: blood flow in vessels, interstitial flow, ductal fluid (relevant to PDAC), and body cavity fluids (ascites)."
      },
      {
        "criterion_number": 8,
        "description": "The response defines mechanobiology.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it describes mechanosensing pathways and structures, it does not define mechanobiology as a field."
      },
      {
        "criterion_number": 9,
        "description": "The response explains that cancer cells can encounter shear stress forces in the tumor, in the bloodstream, and in lymph channels.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It explicitly covers shear in the tumor (interstitial) and bloodstream, but does not state that cancer cells experience shear in lymph channels."
      },
      {
        "criterion_number": 10,
        "description": "The response describes desmoplastic stroma and how this forms in pancreatic cancer\u2019s tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It identifies PDAC as desmoplastic and fibrotic but does not describe how this stroma forms (e.g., activation of pancreatic stellate cells/CAFs, ECM deposition processes)."
      },
      {
        "criterion_number": 11,
        "description": "The response explains the effect that the desmoplastic stroma has on fluid flow in and around a pancreatic cancer tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that stiff, fibrotic stroma compresses vessels, lowers perfusion, raises interstitial fluid pressure, and drives outward interstitial flow due to leaky vessels and blocked lymphatics."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how increased shear stress encourages cancer cells to proliferate and metastasize.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links fluid shear to EMT-like changes, invasion, platelet-mediated survival and extravasation, and activation of YAP/TAZ associated with proliferation and metastatic competence."
      },
      {
        "criterion_number": 13,
        "description": "The response describes how shear stresses on cancer cells impact drug resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that shear increases antioxidant defenses and DNA damage responses, promoting therapy resistance, and notes that ductal shear can increase drug resistance and that YAP/TAZ activation is linked to chemoresistance."
      }
    ],
    "question_number": 259,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:31:07.998762",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly encourages asking detailed questions \"in appointments\" and suggests a second opinion at a high\u2011volume pancreatic cancer center, indicating discussion with the oncology team/oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises appointing a family point person, holding short family check\u2011ins, and using group updates to reduce burden\u2014clear recommendations for open communication among patient and caregivers."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends early palliative care referral and consulting an oncology social worker, therapist, and chaplain."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It prompts defining what matters, non\u2011negotiables, and trade\u2011offs; advises advance directives and care preferences, clearly aligning decisions with goals of care."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly suggests support groups for patients and caregivers and lists CancerCare, which offers free counseling and groups."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists multiple organizations and includes specific websites: GetPalliativeCare.org, ClinicalTrials.gov, and PrepareForYourCare.org."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It highlights coping, recommends therapist/chaplain support, counseling and support groups (CancerCare), and strategies to protect energy and seek respite\u2014emphasizing mental health support."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It normalizes the experience by stating \"Many families in your situation\" and framing a \"both\u2013and\" stance as common and helpful."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It addresses quality\u2011of\u2011life considerations through trade\u2011offs (side effects, hospital time vs. time at home), symptom control, comfort, energy management, and planning aligned with personal priorities."
      },
      {
        "criterion_number": 10,
        "description": "The response should provide online resources for pancreatic cancer information and support groups for the patient to consider reaching out to a community about their struggles.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides online resources (PanCAN, CancerCare, ACS, GetPalliativeCare.org, ClinicalTrials.gov) including groups (CancerCare) and patient services (PanCAN) for information and community support."
      }
    ],
    "question_number": 260,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:31:33.779044",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains that cells grip the ECM via integrins that act as mechanosensors, describes focal adhesions, talin unfolding, and downstream sensing pathways in accessible language (e.g., 'grip,' 'scaffold')."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes how forces alter proliferation/survival (YAP/TAZ, FAK/Src), migration, matrix remodeling, immune modulation, and therapy resistance, with plain-language explanations of consequences."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links stiffness and fiber alignment to invasion/metastasis (e.g., durotaxis, contact guidance), and notes PDAC\u2019s stiff stroma promoting spread."
      },
      {
        "criterion_number": 4,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains how stiff, dense tissue compresses vessels, reducing perfusion and drug delivery, and how force-driven signaling contributes to resistance; includes PDAC-specific context."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No specific journal citations or references are provided; only general search terms are suggested."
      },
      {
        "criterion_number": 6,
        "description": "The response defines traction forces that exist in normal cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines traction forces as cells pushing/pulling via actomyosin through integrins and focal adhesions; provides typical force and stress scales, describing general (normal) cell behavior."
      },
      {
        "criterion_number": 7,
        "description": "The response defines the extracellular matrix.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Defines ECM as the scaffold around cells and later lists components such as collagen and hyaluronan."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how traction forces are changed in cancer cells, as opposed to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that stiff ECM increases traction via RhoA/ROCK and YAP/TAZ, notes high contractility in CAFs, and describes a vicious cycle of increased traction and ECM stiffening in cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response describes how increased traction forces from pancreatic cancer cells on their environment promote cancer cell proliferation and migration.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Connects strong traction and stiffness to upregulated growth signaling and migration mechanics; explicitly ties PDAC traction/stiffness to growth and spread."
      },
      {
        "criterion_number": 10,
        "description": "The response describes changes in the pancreatic cancer environment that are prompted by traction forces from the cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains traction-driven collagen alignment/compaction, ECM production/crosslinking (LOX), and vessel compression (solid stress) within PDAC."
      },
      {
        "criterion_number": 11,
        "description": "The response defines mechanotransduction.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although mechanosensing pathways are described, the term 'mechanotransduction' is not explicitly defined."
      },
      {
        "criterion_number": 12,
        "description": "The response defines desmoplastic stroma in pancreatic cancer\u2019s tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes PDAC desmoplasia as abundant, stiff stroma rich in collagen and hyaluronan with contractile CAFs, effectively defining the desmoplastic stroma."
      },
      {
        "criterion_number": 13,
        "description": "The response describes the effect of desmoplastic stroma on cancer cell\u2019s ability to metastasize.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links stiff, aligned ECM to invasion paths and metastasis and notes immune barriers that facilitate spread in PDAC."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how traction forces in cancer cells contribute to drug resistance in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Attributes reduced drug delivery to solid stress from traction and outlines force-driven signaling (integrin/FAK, YAP/TAZ) that reduces treatment sensitivity in PDAC."
      }
    ],
    "question_number": 261,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:32:02.315940",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The answer links viscosity, stiffness, and matrix architecture to invasion and migration (e.g., aligned collagen tracks, mechanical confinement forcing invasive strategies, interstitial flow shaping gradients), directly relating tissue properties to cancer spread."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly connects dense, viscous ECM and high interstitial pressure to reduced drug delivery, hypoxia, immune exclusion, and discusses therapy regimens and stroma-targeting approaches affecting treatment efficacy."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions reduced blood flow and hypoxia as potential consequences of tissue thickness which may have effects on treatment effectiveness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that swelling from hyaluronan raises pressures and compresses vessels, causing poor blood flow and hypoxia; it also notes thicker stroma increases diffusion distance leading to more hypoxia and drug resistance."
      },
      {
        "criterion_number": 4,
        "description": "Define viscosity and explain its role in normal cells, including the term \u201cviscosity\u201d and its function in cellular environments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Viscosity is clearly defined (\u201cresistant to flow or deformation\u201d); the response explains tissues are viscoelastic and that cells sense mechanical cues in their environment, addressing viscosity\u2019s functional role in cellular/tissue contexts."
      },
      {
        "criterion_number": 5,
        "description": "Describe changes in viscosity within the pancreatic cancer microenvironment, mentioning \u201cviscosity\u201d and specific alterations in cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions a viscous, gel-like ECM in PDAC, driven by hyaluronan and collagen, increased interstitial pressure, and how this alters transport and cell behavior\u2014meeting the requirement."
      },
      {
        "criterion_number": 6,
        "description": "Define the tumor microenvironment, using the term \u201ctumor microenvironment\u201d and describing its components.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While components (ECM, stroma, vessels, immune cells) are discussed, the specific term \u201ctumor microenvironment\u201d is not used and no explicit definition is provided."
      },
      {
        "criterion_number": 7,
        "description": "Define desmoplastic stroma and explain its formation in pancreatic cancer, using the term \u201cdesmoplastic stroma\u201d and describing its development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response describes dense, scar-like stroma and fibrosis in PDAC but never uses the term \u201cdesmoplastic stroma,\u201d nor explicitly explains its formation using that term."
      },
      {
        "criterion_number": 8,
        "description": "Describe the influence of desmoplasia on cancer cells, mentioning \u201cdesmoplasia\u201d and its effects on proliferation, migration, or invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Effects of the fibrotic stroma on migration/invasion are discussed, but the term \u201cdesmoplasia\u201d is not used, which is required by the rubric."
      },
      {
        "criterion_number": 9,
        "description": "Describe how desmoplasia limits oxygen delivery to tumor tissue, attributing reduced oxygen delivery specifically to \u201cdesmoplasia.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "Reduced perfusion and hypoxia are attributed to hyaluronan-induced pressure and dense stroma, but the term \u201cdesmoplasia\u201d is not used to attribute this effect."
      },
      {
        "criterion_number": 10,
        "description": "Explain how hypoxia affects cancer cell behavior, describing hypoxia\u2019s role in selecting aggressive, therapy-resistant cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response links hypoxia to increased drug resistance and discusses how the microenvironment promotes invasive, treatment-resistant behavior, satisfying the requirement to connect hypoxia with therapy resistance."
      },
      {
        "criterion_number": 11,
        "description": "Describe how desmoplasia limits tumor access by the immune system, mentioning \u201cdesmoplasia\u201d and its impact on immune cell infiltration.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It states that thick, viscous stroma excludes T cells, but does not specifically mention \u201cdesmoplasia,\u201d as required."
      },
      {
        "criterion_number": 12,
        "description": "Explain how desmoplasia causes drug resistance in pancreatic cancer, connecting \u201cdesmoplasia\u201d to reduced treatment efficacy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Drug resistance is linked to dense stroma and high pressure, but the specific term \u201cdesmoplasia\u201d is not used in this context."
      },
      {
        "criterion_number": 13,
        "description": "Explain how desmoplastic stroma selects for aggressive tumor cell behavior, linking \u201cdesmoplastic stroma\u201d to increased migratory behavior.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although invasive behavior is discussed, the response does not use the term \u201cdesmoplastic stroma,\u201d which is explicitly required by this criterion."
      },
      {
        "criterion_number": 14,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to published scientific journal articles are provided."
      }
    ],
    "question_number": 262,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:32:36.183893",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends including palliative care, a social worker, and chaplain/spiritual care (e.g., 'Include oncology, palliative care, a social worker, interpreter' and 'Key resources to request - Palliative care... Oncology social worker... Chaplain/spiritual care')."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends respectful and open communication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes respectful, open communication throughout: 'Ask, don\u2019t assume,' 'Ask\u2013Tell\u2013Ask,' 'layered communication,' and structured family meetings to share perspectives and goals."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions cultural mediators.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States 'Use professional interpreters or cultural mediators' explicitly."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends that the patient and family members communicate their important cultural beliefs to their oncology team for better understanding.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises discussing and sharing cultural and spiritual practices with the team ('Ask about traditional remedies or practices; share them with the team'; 'Discuss beliefs around pain, suffering, and feeding') and provides scripts to communicate preferences to the clinical team."
      },
      {
        "criterion_number": 5,
        "description": "The response strongly recommends that a medical interpreter is present for all medical appointments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strongly endorses professional interpreters ('Avoid using family/friends as interpreters,' 'Ask for an in-person or video medical interpreter') and includes interpreters in key meetings, implying use for clinical encounters."
      },
      {
        "criterion_number": 6,
        "description": "The response suggests that the patient request more time for their appointments, especially if a medical interpreter is needed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not advise requesting extended appointment times."
      },
      {
        "criterion_number": 7,
        "description": "The response suggests the patient and/or family inquire about services a patient advocacy office could provide.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of a patient advocacy office or inquiring about its services."
      },
      {
        "criterion_number": 8,
        "description": "The response encourages the patient to communicate their preferences around medical decision-making with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directs to clarify decision-making and information preferences, and to document and share them with the team; provides scripts for communicating these preferences."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends online resources for both patients and medical teams to learn about particular cultural norms around medical care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resources or websites are recommended."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends medical teams to complete thorough documentation on patient preferences surrounding communication and medical decision-making.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Multiple explicit recommendations to document preferences and legal designations ('Document their preferences in the chart,' 'Confirm and document health-care proxy,' 'Summarize ... decision-making structure, disclosure preferences, goals, and limits')."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends organizations that support cancer patients and their families and includes contact information or a website for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not list specific organizations or provide contact information/websites."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends setting boundaries.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages defining and documenting limits of care ('no ICU, okay with short hospitalization') and provides scripts to uphold the patient\u2019s disclosure and decision-making preferences, effectively setting boundaries with family and clinicians."
      }
    ],
    "question_number": 263,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:32:59.648908",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response repeatedly discusses stiffness of both cells and the extracellular matrix (ECM), fibrosis, desmoplasia, and measurement of stiffness (e.g., elastography)."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It links stiffness and softness to invasion/metastasis mechanisms, including durotaxis, aligned collagen tracks, deformability aiding passage through confined spaces, and organ mechanical niches influencing colonization."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that stiff, dense stroma compresses vessels, raises interstitial pressure, limits drug delivery, and activates mechanosignaling that contributes to therapy resistance; it also mentions attempts to normalize stroma (e.g., hyaluronan, FAK targeting)."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No specific journal articles or citations are provided; the response is explanatory without references."
      },
      {
        "criterion_number": 5,
        "description": "The response explains cancer cell deformability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines deformability (softer cells), discusses how malignant cells increase deformability, highlights nuclear constraints (lamins) as the bottleneck, and notes trade-offs between too stiff vs. too soft nuclei."
      },
      {
        "criterion_number": 6,
        "description": "The response defines extracellular matrix and cytoskeleton.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The ECM is briefly defined as the tumor's surroundings, but the cytoskeleton is not defined; therefore, full requirement not met."
      },
      {
        "criterion_number": 7,
        "description": "The response explains cell adhesion processes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although integrins and FAK are mentioned as mechanosensors, the response does not explain adhesion processes (e.g., focal adhesion formation/turnover or cell\u2013cell vs. cell\u2013matrix adhesion)."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how cell deformity changes in cancer cells as compared to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states that many malignant cells are softer/more deformable than normal epithelial cells, including pancreatic cancer cells, contrasting with the firm tumor bulk."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the impact of enhanced deformability of cancer cells on their ability to metastasize.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It connects increased deformability to squeezing through tight spaces, traversing small pores/capillaries, surviving blood shear stress, and migrating along stiffer ECM tracks, all facilitating metastasis."
      },
      {
        "criterion_number": 10,
        "description": "The response explains ways that cancer cells migrate from the primary tumor, including hematologic and lymphatic spread, perineural invasion, and direct invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It references invasion and hematogenous spread (blood) but does not address lymphatic spread or perineural invasion; requirement not fully met."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how cancer cells with increased ability to deform survive stresses that normal cells would not.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that more deformable tumor cells better survive shear forces in blood and pass through tiny capillaries\u2014mechanical stresses that would impede less deformable (normal) cells."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how increased deformability capabilities are necessary for cells to travel within the desmoplastic stroma of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It highlights PDAC\u2019s stiff, desmoplastic stroma and states that pancreatic cancer cells are more deformable, aiding invasion through the firm tumor microenvironment."
      }
    ],
    "question_number": 264,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:33:21.997397",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes how physical space restriction affects cancer cells, mentioning at least two effects such as \u201cenhanced migration,\u201d \u201cnuclear deformation,\u201d or \u201cadaptation.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly describes multiple effects of confinement, including faster/more directed migration, nuclear deformation/rupture with DNA damage, dormancy/stemness shifts, and altered therapy response."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how confinement enhances migration and invasion, using terms like \u201camoeboid migration,\u201d \u201cincreased speed,\u201d or \u201cmetastasis.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains increased speed and directionality in narrow tracks, mode switching to bleb-based/amoeboid migration, protease use, and notes links to metastasis and perineural invasion."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how confinement can promote genetic mutations, mentioning \u201cnuclear deformation,\u201d \u201cDNA damage,\u201d or \u201cgenomic instability.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that squeezing causes nuclear envelope rupture and DNA damage, with repeated events increasing mutations and potential aggressiveness."
      },
      {
        "criterion_number": 4,
        "description": "The response explains how confinement enhances cancer cells\u2019 ability to survive and adapt to stress, using terms like \u201cupregulate survival signals,\u201d \u201cresistant to therapies,\u201d or \u201cmechanical stress.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes dormancy, shifts to invasive/stem-like states via mechanosensitive pathways, selection under hypoxia/acidosis, and reduced sensitivity to therapies due to compression and altered mechanics."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms, including at least one analogy or example that avoids jargon.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with the lay concept that cells 'feel' physical spaces and uses accessible analogies such as 'tracks like rails' to convey mechanosensing context; avoids heavy jargon in these explanations."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms, including at least one analogy or example that avoids jargon.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses accessible language like 'squeeze through,' 'narrow tracks,' and explains responses (migration mode switching, nuclear squeezing) with concrete examples relevant to pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response provides at least one specific citation from a published scientific journal article as evidence for its statements.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No specific journal citations or references are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly relates tissue properties to their potential effect on cancer spread, including at least one specific example or mechanism.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links aligned collagen tracks and dense stroma to guided, confined migration and perineural invasion, providing mechanisms."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly relates tissue properties to their potential consequences for treatment effectiveness and resistance, including at least one specific example or mechanism.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains how dense stroma increases interstitial pressure, impedes drug penetration and immune access, and mentions decompression strategies (hyaluronan targeting, losartan, vessel normalization) affecting delivery."
      },
      {
        "criterion_number": 10,
        "description": "The response defines confinement in the context of cancer cells, using terms like \u201cphysical restriction,\u201d \u201ctumor microenvironment,\u201d or \u201cnarrow spaces.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly defines confinement with examples: geometric crowding, narrow gaps, compression, and one-dimensional tracks within the tumor microenvironment."
      },
      {
        "criterion_number": 11,
        "description": "The response defines desmoplastic stroma in pancreatic cancer, using terms like \u201cdense,\u201d \u201cfibrous,\u201d \u201cscar-like tissue,\u201d or \u201cstiff extracellular matrix,\u201d and describes its formation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes PDAC as highly fibrotic/desmoplastic with abundant collagen and hyaluronan; notes the role of cancer-associated fibroblasts in stiffening tissue and creating tracks, addressing formation."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly connects desmoplastic stroma to the confinement of cancer cells, explaining how it creates physical restriction.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly states that abundant collagen/hyaluronan and tiny pore spaces in PDAC create extreme confinement and high solid stress."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions the role of hypoxia in pancreatic cancer and describes why pancreatic tumors are in a hypoxic environment, using terms like \u201clow-oxygen\u201d or \u201cdense stroma.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes that tumor crowding and solid stress reduce blood flow, causing hypoxia and acidosis in PDAC\u2019s dense stroma."
      },
      {
        "criterion_number": 14,
        "description": "The response states that understanding confinement is an area of active scientific research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly states this remains an active area of research."
      }
    ],
    "question_number": 265,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:33:50.202841",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends flexibility in plans and modifications to allow the father to participate in family traditions.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides extensive adaptations: plan around energy, shorten events, micro\u2011rituals, delegate, adapt roles, build plan B/C, virtual options\u2014all enabling flexible participation."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends consulting palliative care and the oncology team for symptom control, and mentions a social worker and chaplain for ritual design and family dynamics."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the importance of a strong support system during cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Emphasizes lining up support, delegating tasks, involving team members, and using support groups, underscoring a robust support system."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions PanCAN and local cancer support groups but does not include any contact information or website URLs."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends open communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Promotes collaborative planning via a worksheet to complete together and encourages discussing preferences and roles with the father."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly recommends PanCAN and local cancer support groups for practical and emotional support."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient prioritize management of cancer or cancer-treatment related side effects to feel as \u201cnormal\u201d as possible to be present for himself and his family.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises pre\u2011medicating for pain/nausea, optimizing enzymes, adjusting antacids, consulting the team for symptom control around key dates, and packing a comfort kit\u2014all focused on maximizing well\u2011being for participation."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the family members consider documentation of the family traditional events with their father, as a way to reminisce and honor his presence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests legacy projects (recipe book, audio/video stories, letters), shared photo albums, recording toasts/songs, and labeling photo albums\u2014clear documentation strategies."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the family members to be thoughtful about ways their father can feel included in family events.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides specific low\u2011effort roles, environmental adjustments, and inclusion strategies tailored to comfort and participation."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest that the family seek their father\u2019s input on what meaningful events and activities he desires to participate in.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages offering choices, letting him pick a special role, and using a planning worksheet that includes 'Dad\u2019s chosen role(s),' directly seeking his input."
      }
    ],
    "question_number": 266,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:34:12.312743",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms, using accessible language and avoiding jargon, including the concept of cancer cells moving from the primary tumor to other parts of the body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses plain-language framing (e.g., 'hitch a ride') and clearly describes movement via blood/lymph/cavity fluids and steps like arrest and exit from vessels. While some terms (integrins, extravasation) appear, they are contextualized. The idea of cells leaving the original site and establishing elsewhere is conveyed."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, explicitly mentioning direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Blood and lymph spread are discussed in detail, but 'direct invasion' from the primary tumor into adjacent tissues is not explicitly stated as a route of spread. Invasion of mesothelium/endothelium is described, but not contiguous local invasion from the primary tumor."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses at least two cellular mechanisms by which cancer spreads in the body, such as amoeboid, mesenchymal, or collective migration, enzyme production, or environmental signals.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers amoeboid/bleb-based motility, actin\u2013myosin contraction, adhesion via selectins/integrins, enzyme-assisted transendothelial migration, and chemokine-triggered adhesion\u2014meeting the requirement for multiple mechanisms."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly mentions epithelial to mesenchymal transition (EMT) by name.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response clarifies that cancer cells do not swim, explicitly stating they lack the cellular machinery (e.g., flagella or cilia) to do so.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that most cancer cells don\u2019t 'swim' like bacteria or sperm and explicitly notes they lack cilia/flagella."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe ways cancer cells migrate, including in solid tissues and through a fluid-filled environment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes migration through blood/lymph and peritoneal/pleural fluids, and also movement when confined or near surfaces, extravasation, and invasion into underlying tissue\u2014covering both fluid and solid/structured environments."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain hematologic spread and lymphatic metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains carriage in blood and lymph, platelet cloaking, rolling/adhesion, and extravasation. Lymph is explicitly referenced alongside blood in the section heading and mechanisms."
      },
      {
        "criterion_number": 8,
        "description": "The response should explain amoeboid motility that some cancer cells can perform to actively travel through fluid.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly describes amoeboid/bleb-based motility enabling movement near surfaces or in confined spaces in fluid contexts."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain membrane fluctuations and how some cancer cells can do this to actively travel through fluid.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions rapid cycles of membrane blebs and whole-cell contractions generating forward motion\u2014i.e., membrane fluctuation-based propulsion."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain chemical gradients and provide examples, and should define chemotaxis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chemokines are mentioned as triggers, but chemotaxis is not defined, chemical gradients are not explained, and no examples of gradients are provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe passive movements of cancer cells in fluid-filled environments.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly covers passive carriage by blood/lymph flow, margination toward vessel walls, and floating of spheroids in cavity fluids."
      },
      {
        "criterion_number": 12,
        "description": "The response should provide links to the scientific literature that discusses ways cancer cells can move through fluid substances, with PMIDs if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or PMIDs are provided."
      },
      {
        "criterion_number": 13,
        "description": "The response should define desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma is not defined; stromal cells and extracellular matrix are mentioned but without defining the characteristic dense fibrotic stroma of PDAC."
      },
      {
        "criterion_number": 14,
        "description": "The response should summarize ways pancreatic cancer cells migrate in their solid tissue environment.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No PDAC-specific summary of migration within the solid pancreatic tumor microenvironment is provided."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe the most common way that pancreatic cancer cells are thought to spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state the most common routes of PDAC spread (e.g., hematogenous spread to liver via portal circulation, peritoneal dissemination) as 'most common.'"
      }
    ],
    "question_number": 267,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:34:39.138431",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines surface tension.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly defines cellular/tissue 'surface tension' as the energy cost to create/deform the cell surface, arising from actomyosin contractility and adhesion; also relates to Laplace law."
      },
      {
        "criterion_number": 2,
        "description": "The response defines interfacial forces.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that cancer cells feel/generate forces at boundaries where cells meet other cells, ECM, or fluids, and explains their functional impact."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the influence of surface tension on pancreatic cancer cells, specifically mentioning cell detachment, migration, or tumor spheroid formation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details spheroid compaction/pressure, invasion-as-wetting, migration mode switching, and resistance to detachment; ties these to PDAC contexts."
      },
      {
        "criterion_number": 4,
        "description": "The response describes the role of interfacial forces during cancer cell metastasis, specifically mentioning cell detachment, migration, or invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses invasion fronts, leader cells, cell\u2013ECM vs cell\u2013cell balance, survival in blood/peritoneal fluid under shear, and platelet/fibrin coating."
      },
      {
        "criterion_number": 5,
        "description": "The response states interfacial tissue planes typically serve as barriers for cancer spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that interfacial tissue planes are typical barriers; instead discusses mesothelial clearance by PDAC clusters without framing planes as barriers."
      },
      {
        "criterion_number": 6,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Uses technical mechanobiology language without a simple, layperson-level explanation of metastasis (breaking away, traveling, and forming new tumors)."
      },
      {
        "criterion_number": 7,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions direct invasion and hematogenous/peritoneal spread, but does not mention the lymphatic route."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers mechanotransduction (FAK/Src, RhoA/ROCK, YAP/TAZ), adhesion reprogramming (cadherins, integrins), leader cells, and migration mode switching."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly references 'EMT-like changes' in the context of mechanotransduction."
      },
      {
        "criterion_number": 10,
        "description": "The response describes cell-to-cell adhesion, specifically in the context of tumor spheroid formation and the balance with surface tension.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains cadherin-mediated cohesion and how it sets spheroid compactness/surface tension, and balances against cell\u2013ECM adhesion in wetting/invasion."
      },
      {
        "criterion_number": 11,
        "description": "The response describes at least two mechanical cues in the tumor microenvironment, such as stiffness or surface tension, and how cancer cells sense these signals.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies stiffness, solid stress, interstitial fluid pressure, fiber alignment, and surface tension; explains sensing via integrins/cadherins activating FAK/Src, RhoA/ROCK, YAP/TAZ."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions desmoplastic stroma and its relevance to pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly discusses PDAC\u2019s dense, fibrotic desmoplastic stroma and its effects on mechanics, invasion, perfusion, and therapy delivery."
      },
      {
        "criterion_number": 13,
        "description": "The response defines the extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes the ECM as a fiber-rich matrix composed of collagen and hyaluronan produced by CAFs, effectively conveying what ECM is."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how normal cells and cancer cells interact with the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Focuses on cancer cell interactions (integrins, traction, wetting) without contrasting with normal cell\u2013ECM interactions."
      }
    ],
    "question_number": 268,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:34:57.893379",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing uncertainty or care planning with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises to 'Ask the medical team' specific prognosis and planning questions and notes palliative care joining 'alongside oncology,' directing discussion of expectations and care planning with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends early palliative care and suggests talking to an oncology social worker, therapist, and faith leader."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends caregiver support groups and cites CancerCare\u2019s free counseling and caregiver support groups."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends establishing the patient\u2019s goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes a 'Two-track approach' (hope and plan), 'Discuss wishes gently' (what matters most, preferences for care), and suggests advance directives/Five Wishes\u2014clear goals-of-care planning."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It encourages discussing wishes gently (day-to-day priorities, care preferences) and building a support circle, promoting open communication."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists PanCAN, CancerCare, American Cancer Society, Family Caregiver Alliance, The Conversation Project, and Five Wishes."
      },
      {
        "criterion_number": 7,
        "description": "The response should attempt to normalize the challenge of living with long-term uncertainty.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opening statements validate the difficulty, noting that most people feel this way and that they\u2019re not alone."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend attempting to preserve normal routines in the home as much as possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends 'simple anchor routines' such as morning check-ins, daily walks, tea together, and a bedtime wind-down."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of quality of life when facing a serious diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes quality of life explicitly via early palliative care and focusing on comfort, connection, small joys, and values-based living."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest ways to maintain good quality of life for patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It offers concrete strategies: symptom management questions, grounding techniques, values-based daily acts, memory-making, routines, and support utilization."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that patients and family members learn about the disease to understand expected outcomes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking the medical team what to expect in coming weeks to months, signs treatment is helping, and when to call\u2014promoting understanding of prognosis and disease course."
      }
    ],
    "question_number": 269,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:35:19.183573",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly describes how cells leave the primary tumor, move along structures, enter vessels or nerves, and seed distant sites in accessible language."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions direct invasion along nerves and entry via vessels, but does not explicitly discuss spread through the lymphatic system; therefore does not include all required routes."
      },
      {
        "criterion_number": 3,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses clear analogies (grappling hooks, on\u2013off grip) and explains dynamic adhesions and signaling (integrins, FAK, Src) in accessible language."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Integrins are discussed extensively, but cadherins are not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response contrasts the biology of cancer cell adhesion with normal cell adhesion using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Describes cancer cell adhesion mechanisms but does not explicitly contrast them with normal cell adhesion behaviors."
      },
      {
        "criterion_number": 6,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No specific peer-reviewed articles, journals, or citations are provided; only generic resource suggestions are given."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions changes to cell adhesion in pancreatic cancer specifically.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Discusses PDAC stroma, CAFs, and guidance cues, but does not explicitly describe PDAC-specific changes in cell adhesion molecules or adhesion behavior (e.g., E-cadherin loss, integrin switching)."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe cell-to-cell adhesion and include definitions of integrins, collagen, and fibronectin.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address cell-to-cell adhesion or cadherins; defines integrins in lay terms and mentions collagen, but fibronectin is not mentioned or defined."
      },
      {
        "criterion_number": 9,
        "description": "The response should define extracellular matrix.",
        "score_given": 7,
        "max_points": 7,
        "justification": "ECM is described as the surrounding material that cells latch onto, with examples (collagen, laminin, hyaluronan), which constitutes an adequate lay definition."
      },
      {
        "criterion_number": 10,
        "description": "The response should define actin and myosin, and describe how these proteins act to deform cells to assist in traction and movement.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions an actin\u2013myosin system and its role in protrusion and contraction, but does not define actin and myosin individually."
      },
      {
        "criterion_number": 11,
        "description": "The response should define chemotaxis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines chemotaxis in context as movement along gradients of soluble signals."
      },
      {
        "criterion_number": 12,
        "description": "The response should define amoeboid migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a clear lay definition: rounder cells that squeeze and bleb through gaps with less proteolysis."
      },
      {
        "criterion_number": 13,
        "description": "The response should desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes desmoplastic/fibrous stroma as abundant collagen/hyaluronan around PDAC tumors; uses term desmoplasia with explanatory phrasing."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe how pancreatic cancer forms desmoplastic stroma in its environment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that cancer-associated fibroblasts produce and align collagen and hyaluronan, creating the dense stroma around PDAC."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe how pancreatic cells interact with desmoplastic stroma.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Details how PDAC cells use aligned fibers as tracks, follow CAFs, respond to stiffness, and use basement membranes to move and invade."
      },
      {
        "criterion_number": 16,
        "description": "The response should define tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions the tumor microenvironment but does not provide an explicit definition."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe how pancreatic cancer cells interact with the tumor microenvironment, and how different elements encourage cell travel, such as inflammation and hypoxia.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses interactions with stroma, CAFs, pressure, and hypoxia as drivers of directed movement; adequately addresses how the microenvironment promotes migration."
      },
      {
        "criterion_number": 18,
        "description": "The response should describe the effect of DNA mutations, such as KRAS, on a pancreatic cancer cell\u2019s potential to travel outside of the primary site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of KRAS or other genetic mutations and their impact on invasion or metastasis."
      }
    ],
    "question_number": 270,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:36:00.371393",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes how normal tissue structure is disrupted in solid cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly explains disruption: basement membrane breach, dense stroma, solid stress collapsing vessels, abnormal vessel geometry, acinar-to-ductal metaplasia changing architecture, and immune exclusion all illustrate disruption of normal tissue structure."
      },
      {
        "criterion_number": 2,
        "description": "The response describes that cancer cells proliferate in an unchecked fashion, disrupting the architecture of their environment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions proliferation cues (e.g., YAP/TAZ, cells at edges proliferate), it does not explicitly state unchecked/out-of-control proliferation or link it directly to architectural disruption."
      },
      {
        "criterion_number": 3,
        "description": "The response defines geometry in biology and medicine, and with regards to human cells and their surrounding structures.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a dedicated definition section outlining scales (nano to organ) and features (stiffness, fiber alignment, pore size, curvature, confinement), directly framing what 'geometry' means in tissues."
      },
      {
        "criterion_number": 4,
        "description": "The response describes that normal cells exist in a neat, orderly, and structured space within their respective tissues.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes cells embedded in an organized 3-D landscape of ducts, fibers, and vessels, references basement membranes and well-packed/flat areas, conveying orderly normal tissue architecture."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the components of normal tissue architecture, such as collagen and extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions collagen (including collagen I), extracellular matrix, hyaluronan, basement membrane, nerves, vessels\u2014key components of tissue architecture."
      },
      {
        "criterion_number": 6,
        "description": "The response describes desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details PDAC desmoplasia: 70\u201390% stroma, cancer-associated fibroblasts/stellate cells, stiffness, collagen alignment, hyaluronan content, and resulting pressures."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the effect of desmoplastic stroma on pancreatic cell proclivity to migrate and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States collagen alignment provides 'rails' guiding invasion, stiffness amplifies traction, and perineural/perivascular 'corridors' facilitate spread\u2014linking stroma to migration/spread."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the role of blood vessels in drug delivery, and how this can be impacted by pancreatic tumors and desmoplastic stroma.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains vessel compression from solid stress, hypovascular and heterogeneous perfusion in PDAC, and discusses 'normalizing' vasculature to improve drug delivery (e.g., hyaluronidase, FAK/LOX targeting)."
      },
      {
        "criterion_number": 9,
        "description": "The response clearly explains cancer metastasis in layman\u2019s terms, avoiding jargon and providing accessible explanations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While generally accessible, it includes significant jargon (YAP/TAZ, \u03b2-catenin) and does not plainly describe the full metastasis process (cells breaking away, entering lymph/blood, forming distant tumors) in lay terms."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly mentions all three main routes of cancer spread: direct invasion, lymphatic spread, and hematogenous spread.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions direct invasion and spread along nerves/vessels, but does not explicitly state lymphatic spread or hematogenous (blood-borne) spread."
      },
      {
        "criterion_number": 11,
        "description": "The response discusses at least two cellular mechanisms by which cancer spreads, such as changes in cell shape, loss of adhesion, or influence of the microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Discusses microenvironmental guidance (aligned fibers), stiffness/crosslinking increasing traction, confinement-dependent migration mode switching and nuclear squeezing\u2014covering multiple mechanisms."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly mentions epithelial to mesenchymal transition (EMT) by name or describes the process.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned by name, nor is the canonical process described explicitly."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions cancer metastasis as a response to cell stress, including stress-induced mechanisms.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions 'confinement stress' and 'solid stress' causing DNA damage and hypoxia selecting for aggressive clones, but does not explicitly connect stress to metastasis as a response."
      }
    ],
    "question_number": 271,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:36:21.660257",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends respectful and honest communication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response centers the mother\u2019s wishes, advises asking what to share and with whom, and provides clear, empathetic scripts for honest communication while maintaining privacy."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends maintaining personal boundaries.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It offers explicit boundary-setting strategies and copy/paste scripts (e.g., declining intrusive questions, visit rules), plus assigning a gatekeeper to protect boundaries."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends pancreatic cancer\u2013specific and general cancer caregiver support groups, including PanCAN, Cancer Support Community, and hospital-based caregiver groups."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it names organizations (PanCAN, Cancer Support Community), it does not include any phone numbers, email addresses, or website URLs."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes building a support network (circles of sharing, designated roles, practical/emotional help, and a \u201csecond circle\u201d so the caregiver isn\u2019t alone)."
      },
      {
        "criterion_number": 6,
        "description": "The response should inform the patient and family members that medical records are subject to HIPAA laws, which prevent divulgence of medical information unless a patient has specifically consented to this.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly references HIPAA, recommends HIPAA releases to name who can receive information, and suggests no-information status and code word/PIN, clearly conveying that disclosure requires consent."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient inform their oncology care team of their wishes to keep their diagnosis confidential.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises asking the hospital/clinic to set no-information status or a code/PIN and to use HIPAA releases, which directly implies communicating confidentiality wishes to the care team."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient and family members be careful and thoughtful with social media posting to maintain her confidentiality.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes specific social media rules: deciding what can be posted, suggesting a single approved post, and asking others not to tag or share updates."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient and/or family members seek a balance; it is OK to be selective with sharing her diagnostic information however isolation for patients and/or caregivers can accelerate burnout.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it promotes selective sharing and encourages seeking support, it does not explicitly warn that isolation can accelerate caregiver or patient burnout, which is a required element of this criterion."
      }
    ],
    "question_number": 272,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:36:48.020405",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms, avoiding jargon and providing context for a lay audience.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clear, accessible explanations with context for why squeezing matters; uses analogies and minimizes jargon while defining key ideas."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly mentions and explains the three main routes of cancer spread: direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions leaving the tumor (direct invasion) and entering and exiting blood and lymph vessels, and explains crossing vessel walls by squeezing between endothelial cells."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses at least three cellular mechanisms by which cancer spreads.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers cytoskeletal push pull, protease mediated ECM degradation via invadopodia, nuclear deformability, hydraulic volume changes via water and ion flux, guidance along pre made tracks, and mode switching."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly mentions epithelial-to-mesenchymal transition (EMT) and explains its relevance to cancer cell migration and invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly mention epithelial to mesenchymal transition; only references mesenchymal migration without defining EMT."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Notes mechanical and DNA stress but does not state that metastasis occurs as a response to cell stress."
      },
      {
        "criterion_number": 6,
        "description": "The response should define the extracellular matrix.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions matrix and stroma but does not define extracellular matrix as the network outside cells providing structural and biochemical support."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe the different components of the extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies components such as collagen and hyaluronan and references the basement membrane context, satisfying discussion of different ECM components."
      },
      {
        "criterion_number": 8,
        "description": "The response should define desmoplastic stroma and describe how this is formed in the pancreatic cancer environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes dense fibrotic stroma but does not use or define the term desmoplastic stroma nor explain how it is formed in PDAC."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how cancer cells are able to deform their shapes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains shape change via actomyosin contractility, blebbing, water and ion driven volume changes, and nuclear deformation."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain the cellular cytoskeleton and its main component parts, such as actin and myosin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes actin filaments building a front and myosin motors squeezing to drive the cell, aligning with cytoskeletal roles."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe amoeboid movement in cells and include a description of filopodia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Amoeboid movement and blebbing are described, but filopodia are not mentioned or described."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe mesenchymal movement in cancer cells and provide examples of enzymes used by cancer cells in this phenomenon.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mesenchymal migration is described as elongated and enzyme dependent, with examples such as matrix metalloproteinases deployed at invadopodia."
      },
      {
        "criterion_number": 13,
        "description": "The response should provide links to any scientific literature it references, including PMID.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or PMIDs are provided."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain how cells can use ion gradients to prompt movement.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains water and ion flux through aquaporins and ion pumps that shrink the rear and swell the front, driving movement."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe the importance of pancreatic cancer cells\u2019 ability to deform or squeeze in the desmoplastic stromal environment for survival and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that the dense fibrotic PDAC environment makes squeezing strategies crucial for invasion and spread."
      },
      {
        "criterion_number": 16,
        "description": "The response should include information about how the nucleus is thought to be deformable in cancer cell migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details nuclear softening via lamins and chromatin changes, cytoskeletal pulling and squeezing, and transient nuclear envelope ruptures with repair."
      }
    ],
    "question_number": 273,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:37:17.273877",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines topology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly frames topology as how tissues are connected and structured, and later as graphs/connectivity and alignment of networks (cells, ECM, vessels, ducts, nerves)."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes direct invasion via weakened junctions, ECM-guided invasion, duct/basement membrane disruption; lymphatic spread at invasive edge and nodal spread; and blood spread via vessel entry/exit and vascular topology."
      },
      {
        "criterion_number": 3,
        "description": "The response states that in cancer care, topology may relate to the organization of tissues, blood vessels, or lymphatics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly ties topology to organization of tissues, ECM, blood and lymphatic vessels and how this influences cancer behavior and treatment."
      },
      {
        "criterion_number": 4,
        "description": "The response states the anatomic organization of cancer may impact the cancer\u2019s stage or likelihood to respond to certain treatments like surgery or radiation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links topology to treatment response and resectability, noting strategies to remodel stroma to improve perfusion and that imaging/pathology features can predict response; explicitly mentions improved resectability in subsets."
      },
      {
        "criterion_number": 5,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Uses accessible analogies (highways, roadblocks, one-way streets) to explain how connected pathways enable cells to move, enter/exit vessels, and disseminate, making the concept understandable to lay readers."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions downregulation of E-cadherin, collective migration with leader\u2013follower dynamics, unjamming transitions, contact guidance along aligned collagen, protease-carved microtracks, and tumor\u2013nerve signaling."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe tissue networks and their component parts.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes networks comprising cells, ECM fibers, blood vessels, lymphatics, ducts, and nerves, and how their connectivity and structure interact."
      },
      {
        "criterion_number": 8,
        "description": "The response should define the extracellular matrix and describe its component parts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines ECM as a fiber network and names components such as collagens and hyaluronan; also discusses crosslinking and porosity."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe the desmoplastic stroma that pancreatic cancer encourages to grow in its environment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically highlights PDAC\u2019s dense desmoplastic stroma driven by cancer-associated fibroblasts and hyaluronan."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe how abnormal tissue, such as desmoplastic stroma, increases in density of tissue network structures and encourages cancer growth and spread.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains that dense, crosslinked ECM increases stiffness and solid stress, compresses vessels, blocks drug/immune access, and creates aligned migration paths facilitating spread."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the roles of blood and lymph vessels in cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details vessel density/branching/tortuosity affecting intravasation/extravasation; PDAC vessel compression; and lymphatic absence intratumorally with enrichment at invasive edge shaping nodal spread."
      },
      {
        "criterion_number": 12,
        "description": "The response should explain how disrupted tissue architecture can encourage cancer growth and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes disruption of epithelial junctions and basement membranes, topological defects leading to extrusion/invasion, and reorganized ECM that forms invasion tracks, all promoting growth/spread."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe cell-to-cell adhesions in normal cells, and how cancer cells can disrupt these adhesions making them more able to migrate.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes normal tight junctions and E-cadherin-mediated adhesion and how tumors downregulate E-cadherin and undergo unjamming to enable migration, including collective migration."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe how mechanical properties of tissue can stimulate tumor growth and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that stiffness, crosslinking, and solid stress raise interstitial pressure, compress vessels causing hypoxia and poor perfusion, which in turn affects growth, invasion, and therapy response."
      }
    ],
    "question_number": 274,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:37:42.588148",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response references the 'care team' and 'oncology clinic' generally but does not explicitly recommend discussing communication or planning with the patient's oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises asking for a child life specialist, social worker, and a therapist; mentions counseling and faith/community support; and discusses palliative care and hospice involvement."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends honest and open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It strongly emphasizes honesty, open dialogue, and alignment among adults, with scripts encouraging transparency and ongoing questions, fulfilling the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends tailoring the discussion to the age of the children.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It provides explicit, developmentally appropriate scripts for preschoolers, school-age children, and teens."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references CancerCare for Kids with online groups and the Cancer Support Community helpline, implying support group resources."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Multiple organizations are listed (PanCAN, CancerCare, Cancer Support Community, Dougy Center, NACG), but no websites, phone numbers, or contact details are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It discusses planning for different possibilities, focusing on comfort if treatments stop working, and engaging palliative/hospice care\u2014core elements of goals-of-care discussions."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It highlights mental health needs for children and adults, offers coping tools, lists red flags warranting professional help, and recommends counseling and community supports."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While empathic, it does not explicitly normalize the conflict between optimism and honesty."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references quality of life and details treatment impacts (fatigue, hair loss, appetite changes), and discusses comfort-focused care."
      },
      {
        "criterion_number": 11,
        "description": "The response should suggest that the patient and/or family members leverage support systems.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages engaging school personnel, friends, community, family logistics supports, and formal psychosocial resources."
      }
    ],
    "question_number": 275,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:38:11.745358",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes metastatic routes for pancreatic cancer, including local solid tissue invasion, hematologic spread, lymphatic spread, or perineural invasion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions perineural invasion in PDAC; discusses clusters entering blood and lymph (CTC clusters) and their survival; describes local invasion through ECM remodeling and along ducts, vessels, and nerve sheaths."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses cell-to-cell adhesions in both normal cells and cancer cells, highlighting differences.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains adherens junctions/desmosomes maintaining cohesion (\u201cseatbelts\u201d) and contrasts cancer\u2019s partial EMT loosening of junctions while retaining enough adhesion to move together, highlighting differences from intact adhesions in normal epithelia."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names integrins (e.g., \u03b15\u03b21, \u03b1v\u03b26) and cadherins (E-cadherin, P-cadherin) explicitly."
      },
      {
        "criterion_number": 4,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses clear analogies (seatbelts, tug\u2011of\u2011war team, rails), defines concepts like collective migration, and explains entry into blood/lymph and advantages of clusters in accessible language."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Details integrin\u2011mediated traction, actomyosin contractility, protease\u2011driven ECM degradation (MMPs, invadopodia), chemotaxis/durotaxis/haptotaxis, contact guidance, and CAF\u2011mediated path creation."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions partial EMT multiple times as a state enabling collective invasion."
      },
      {
        "criterion_number": 7,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains adherens junctions/desmosomes as \u201cseatbelts\u201d that keep groups cohesive and how tension and junctional mechanics coordinate pushing/pulling, in accessible language."
      },
      {
        "criterion_number": 8,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Cites peer\u2011reviewed review articles (Friedl & Mayor; Cheung & Ewald in Nature Reviews Cancer) and references reviews on PDAC stroma/perineural invasion."
      },
      {
        "criterion_number": 9,
        "description": "The response explains the concept of \u201cleader cells\u201d and implies the presence of \u201cfollower cells\u201d in a group of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines leader cells sensing cues and steering via Rac/Rho/Cdc42/PI3K, with followers transmitting forces and maintaining integrity."
      },
      {
        "criterion_number": 10,
        "description": "The response describes amoeboid movement in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States cancer cells can switch to a rounded \u201camoeboid\u201d squeezing mode when encountering barriers."
      },
      {
        "criterion_number": 11,
        "description": "The response describes mesenchymal migration in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes protease\u2011dependent mesenchymal movement with integrin adhesion, protrusions (lamellipodia/filopodia), and MMP\u2011mediated path\u2011clearing."
      },
      {
        "criterion_number": 12,
        "description": "The response defines the extracellular matrix.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Identifies ECM as the substrate cells grip via integrins and describes its composition in PDAC (collagen, hyaluronan) and mechanical properties (stiffness)."
      },
      {
        "criterion_number": 13,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes PDAC\u2019s stroma as dense, scar\u2011like, fibrotic, and stiff ECM produced by CAFs\u2014i.e., desmoplasia."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how pancreatic cancer cells interact with desmoplastic stroma to encourage cancer cell growth and migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that stiffness and collagen alignment guide strands (durotaxis/contact guidance); CAFs remodel ECM to create tracks; immune cells supply proteases and protection, facilitating invasion."
      },
      {
        "criterion_number": 15,
        "description": "The response explains how \u201cleader cells\u201d influence a clump of traveling cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States leaders sense environment, extend protrusions, set direction via signaling pathways, and transmit forces that coordinate group movement."
      },
      {
        "criterion_number": 16,
        "description": "The response defines at least one other protein involved in cell-to-cell adhesions.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions desmosomal proteins (desmogleins/desmocollins) and gap junction protein connexin\u201143 as mediators of cell\u2013cell adhesion/communication beyond cadherins."
      },
      {
        "criterion_number": 17,
        "description": "The response describes how cells communicate with each other, such as through chemical signals or enzymes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes communication via gap junctions, calcium waves, paracrine factors (EGF, TGF\u2011\u03b2, Notch), and mechanical feedback; also mentions protease signaling effects."
      }
    ],
    "question_number": 276,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:38:44.033410",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines curvature.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly defines curvature as the geometry of surfaces cells interact with (convex/concave ducts and vessels, radius of collagen fibers, shape of pores/tunnels, curved surfaces of clusters/organoids)."
      },
      {
        "criterion_number": 2,
        "description": "The response states that in cancer care, curvature may relate to the organization of tissues, blood vessels, or lymphatics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly links curvature to ducts, blood and lymphatic vessels, ECM fiber organization, and perivascular tracks, relating it to tissue and vascular organization."
      },
      {
        "criterion_number": 3,
        "description": "The response states the anatomic organization of cancer may impact the cancer\u2019s stage or likelihood to respond to certain treatments like surgery or radiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions prognostic correlations and emerging diagnostics, it does not state that anatomic organization affects stage or response to surgery or radiation."
      },
      {
        "criterion_number": 4,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Discussion uses technical language (e.g., curvotaxis, MT1-MMP, cGAS\u2013STING) and does not provide a layperson-friendly explanation of metastasis."
      },
      {
        "criterion_number": 5,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers direct invasion (\u201ccollective invasion,\u201d matrix degradation), lymphatic and blood spread (\u201ccurved blood and lymphatic vessels,\u201d docking and escape into circulation)."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes integrins/focal adhesions, FAK, RhoA/ROCK, BAR-domain proteins, MT1-MMP localization, YAP/TAZ activation, nuclear deformation/rupture, and cGAS\u2013STING signaling."
      },
      {
        "criterion_number": 7,
        "description": "The response should define the extracellular matrix.",
        "score_given": 0,
        "max_points": 10,
        "justification": "References ECM composition and properties (collagen fibers, stiffness, alignment) but does not explicitly define ECM as the non-cellular scaffold of proteins and polysaccharides surrounding cells."
      },
      {
        "criterion_number": 8,
        "description": "The response should define epithelial-to-mesenchymal transition (EMT).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions \u201cEMT-like traits\u201d but does not define EMT or describe the epithelial-to-mesenchymal phenotypic change."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain cancer cell migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains alignment and persistent migration along curved/cylindrical tracks (curvotaxis), and how curvature guides movement and invasion."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe the effect of mechanical forces on cell signaling.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details mechanotransduction: curvature affects membrane tension, actin, adhesions; YAP/TAZ nuclear localization modulates proliferation, survival, EMT-like traits."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe how varying levels of positive or negative curvature at the cellular level influence EMT and cancer cell migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Differentiates convex (tension, increased proliferation, nuclear YAP/TAZ) versus concave (compression, reduced YAP/TAZ, extrusion) and ties curvature to EMT-like programs via YAP/TAZ and to migration persistence on high curvature tracks."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe the effect of mechanical forces of tissues on cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes tissue-level stresses from curved ducts/organoids, dense fibrotic stroma, solid stress, and how these influence proliferation, extrusion, invasion, and signaling."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Characterizes PDAC stroma as dense, fibrotic with aligned, curved collagen fibers and narrow pores\u2014hallmarks of desmoplasia in PDAC."
      },
      {
        "criterion_number": 14,
        "description": "The response should include that cellular curvature acts as both a signal and constraint in cancer cell progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Shows curvature as a signal (altered membrane tension, adhesions, YAP/TAZ) and as a constraint (curved, narrow pores causing confinement, nuclear deformation/rupture) that shapes progression."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe cancer cell membrane tension, and what occurs when this force is too high.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions coupling to membrane tension but does not state specific consequences of excessively high membrane tension (e.g., impaired endocytosis/protrusion or membrane rupture)."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe how high cell surface membrane tension, such as from curvature, can hinder movement of the cytoskeleton.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not explicitly state that high membrane tension hinders cytoskeletal polymerization or protrusive activity; focuses on remodeling rather than inhibition."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe the effects of mechanical tension at the level of tissue and organs, particularly if imbalanced, on the spread of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects PDAC\u2019s abnormal mechanical environment (dense stroma, solid stress, curved/tense microenvironment) to enhanced invasion and dissemination, and mentions strategies to normalize these forces."
      },
      {
        "criterion_number": 18,
        "description": "The response should define paracrine signaling and explain its role in pancreatic cancer cell communication.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Paracrine signaling is not defined nor is its role in PDAC communication discussed."
      }
    ],
    "question_number": 277,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:39:17.261965",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing plans for celebrations with the patient\u2019s healthcare or oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises, \"Ask the care team about timing around treatment, fatigue, and infection risk\" and to coordinate with hospital staff about visitor policies, directly involving the oncology/healthcare team in planning."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends involving \"Oncology social workers\" and mentions counseling as support; although palliative care is not named, the inclusion of social workers and counseling meets the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends using \"support groups\" via oncology social workers and patient organizations, presenting them as a resource."
      },
      {
        "criterion_number": 4,
        "description": "The response offers examples of organizations that support cancer patients and their families and provides contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No specific organizations (e.g., PanCAN, ACS) or contact information/websites are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The overarching focus is minimizing stress and maximizing comfort and meaning (e.g., small, manageable events; comfort-first; meaningful micro-rituals), clearly emphasizing quality of life."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends creating a \"care team\" for logistics (rides, meals, tech) and using a shared calendar/app, directly promoting a strong support network."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of controlling symptoms related to pancreatic cancer or its treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It addresses symptom control considerations: planning around treatment/fatigue, infection risk mitigation, comfort measures (seating, rest space), gentle foods, and nausea aids (water/ginger/ice chips), and advises consulting the care team."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that caregivers take measures to prevent burnout.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests a coordinator and care team to reduce burden, it does not explicitly recommend caregiver self-care or specific measures to prevent caregiver burnout."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that loved ones plan small, meaningful gatherings with the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly recommends small, short, quieter gatherings and offers a \"milestone menu\" of small, meaningful options."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of flexibility when planning events with a patient with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes flexibility through energy mapping, short windows, an A/B plan, and the ability to cancel without guilt; guests are warned plans may change day-of."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that planners of celebrations consider incorporating time for rest and keep gatherings small and simple.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests brief events (30\u201390 minutes), a quiet room to rest, fewer people, and simpler settings, explicitly meeting both elements."
      },
      {
        "criterion_number": 12,
        "description": "The response should suggest that a professional therapist or counselor can help maintain mental health in patients experiencing pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes counseling support via oncology social workers and patient organizations, implying engagement with professional counselors for mental health."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that patients and/or family members take care of any legal and/or medical paperwork as soon as possible.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of legal/medical paperwork, advance directives, or early planning is included."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain that there will likely be a decline in overall health of the patient over time, and expectation management should be discussed by the patient and their oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not discuss disease trajectory, likely decline, or expectation management with the oncology team."
      }
    ],
    "question_number": 278,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:39:44.626106",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response clearly explains how changes in tissue density and architecture (cell jamming) influence cancer cell movement, tumor aggressiveness, and metastasis.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The answer clearly links tissue density/architecture to cell movement (jammed cores vs unjammed rims, pressure-driven escape) and hints at invasiveness, but it does not explicitly connect these changes to tumor aggressiveness and metastasis (distant spread). Therefore it does not fully satisfy all components of the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response defines and explains cancer cell jamming.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear definition using a crowd analogy and explains jamming as a solid-like state with constrained motion in tissues."
      },
      {
        "criterion_number": 3,
        "description": "The response defines and describes cancer cells that are in an unjammed state.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly describes unjammed as fluid-like with cells/groups rearranging and flowing, including collective movement."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how cancer cells become unjammed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists mechanisms promoting unjamming: reduced adhesion, increased traction/contractility, ECM alignment creating tracks, space created by division/death, chemical/mechanical cues; notes unjamming without full EMT."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the intrinsic properties of cells that contribute to jamming and unjamming of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses intrinsic factors such as cell\u2013cell adhesion/junctions and cellular contractility/traction affecting jamming and unjamming."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the extrinsic properties of cells that contribute to jamming and unjamming of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers extrinsic factors: ECM density, pore size, fiber alignment, friction/confinement, tissue pressure, and external chemical/mechanical cues."
      },
      {
        "criterion_number": 7,
        "description": "The response explains how unjamming of cancer cells contributes to cancer spread and migration of cancer cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that unjamming enables collective invasion and movement along paths of least resistance (ducts, nerves, vessels, aligned collagen), facilitating spread."
      },
      {
        "criterion_number": 8,
        "description": "The response explains methods of cancer cell movement.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes single-cell vs collective migration, pressure-driven escape, and movement along anatomical/ECM tracks."
      },
      {
        "criterion_number": 9,
        "description": "The response explains how jamming occurs in normal cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not explicitly discuss jamming in normal (non-cancer) tissues or physiologic contexts."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly discusses changes to tissue architecture specific to pancreatic cancer, such as desmoplastic reaction, fibrosis, or stromal remodeling.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details PDAC\u2019s dense fibrotic stroma, collagen and hyaluronan, raised pressure, vessel collapse, and stromal remodeling by CAFs aligning collagen; mentions perineural invasion."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly discusses the implications of altered tissue architecture on cancer treatment, specifically mentioning reduced drug delivery or immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that high stromal density/pressure collapses vessels and affects drug penetration; discusses stroma-targeting strategies and their mixed results. While immune penetration is not mentioned, reduced drug delivery is explicitly addressed."
      },
      {
        "criterion_number": 12,
        "description": "The response includes citations from published scientific journal articles to support its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references are provided."
      }
    ],
    "question_number": 279,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:40:14.798962",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly mentions both tissue stiffness and fibrosis in the context of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions \"Mechanical stiffness gradients\" affecting cell behavior and, in PDAC, \"hypoperfused, fibrotic regions\" and \"dense stroma.\" These references link stiffness and fibrosis directly to pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly discusses intercellular communication between pancreatic cancer cells and stromal cells, such as fibroblasts or pancreatic stellate cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It details paracrine signaling: tumor cell Hedgehog and TGF-\u03b2 acting on stroma; CAFs secreting CXCL12 and IL-6; and CAF subtype spatial organization (myCAFs, iCAFs, apCAFs) shaping cell positions."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly connects specific tissue properties, such as stiffness or fibrosis, to the process of cancer spread, including invasion or metastasis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that CAF-aligned collagen creates \"tracks\" that guide collective migration and invasion and that stiffness gradients orient cells via mechanosensors (YAP/TAZ), directly linking tissue properties to invasion."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly relates specific tissue properties, such as stiffness or fibrosis, to treatment response or resistance in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that dense, aligned stroma and high interstitial pressure in PDAC hinder drug and immune cell entry, and discusses stroma-modulating strategies to improve delivery and T-cell infiltration."
      },
      {
        "criterion_number": 5,
        "description": "The response provides at least one citation from a published scientific journal article to support its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to scientific journal articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response must describe the concept of pattern formation in cellular structures, including at least two biological processes contributing to these patterns.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines pattern formation as organized structures emerging from local rules and lists multiple contributing processes: nutrient/oxygen gradients, angiogenesis and flow, stromal self-organization, epithelial polarity rules, clonal evolution, reaction\u2013diffusion signaling, collective migration, immune organization, nerve interactions, and metabolic patterning."
      },
      {
        "criterion_number": 7,
        "description": "The response must provide at least two commonly recognizable examples of biological pattern formation, such as embryonic development or tissue architecture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It offers recognizable examples: duct/gland-like architecture and core\u2013rim (hypoxic/necrotic core with proliferative rim) patterns, as well as immune-excluded rings around tumor islets."
      },
      {
        "criterion_number": 8,
        "description": "The response must describe how organized structures develop in tumors, mentioning at least two mechanisms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes multiple mechanisms: diffusion-limited nutrient/oxygen gradients, abnormal angiogenesis and flow, CAF-driven ECM alignment, reaction\u2013diffusion signaling, and collective migration patterns."
      },
      {
        "criterion_number": 9,
        "description": "The response must explain how DNA mutations in cancer cells can change their behavior, linking these changes to pattern formation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It discusses clonal evolution: \"As mutations accumulate, subclones expand locally, creating a mosaic of 'patches' with different behaviors,\" linking genetic changes to spatial patterning via ecological niches."
      },
      {
        "criterion_number": 10,
        "description": "The response must describe how cancer cells promote angiogenesis, including the secretion of signals for new blood vessel growth.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it states tumors induce angiogenesis and vessels are irregular/leaky, it does not explicitly mention secretion of pro-angiogenic signals (e.g., VEGF) by cancer cells."
      },
      {
        "criterion_number": 11,
        "description": "The response must explain how cancer cells interact with tissues in their environment, including interactions with the extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes interactions with ECM: CAF-deposited aligned collagen guiding migration, stiffness-driven mechanosensing (YAP/TAZ), movement along aligned collagen, and perineural invasion."
      },
      {
        "criterion_number": 12,
        "description": "The response must define and describe the extracellular matrix, including its composition or function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes ECM composition (collagen, hyaluronan) and functions (increasing solid stress and interstitial pressure; alignment forming tracks that orient migration and growth). While not labeled as a formal definition, composition and function are clearly conveyed."
      },
      {
        "criterion_number": 13,
        "description": "The response must define and describe desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions dense/fibrotic stroma and uses the term \"desmoplasia\" in passing, it does not explicitly define or describe desmoplastic stroma as the fibroinflammatory, ECM-rich reaction characteristic of PDAC."
      },
      {
        "criterion_number": 14,
        "description": "The response must explain the influence of the tumor microenvironment on tumor cell pattern formation, including at least one component.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains how CAF subtypes, ECM alignment, and chemokine-mediated immune exclusion shape spatial organization and tumor islets, directly linking microenvironmental components to pattern formation."
      },
      {
        "criterion_number": 15,
        "description": "The response must describe evolutionary pressures on cancer cells and the acquisition of DNA mutations, including at least one selective advantage.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It addresses evolutionary pressures via niches (perivascular vs hypoxic) that select for different phenotypes (fast growth vs stress tolerance) and links this to subclonal expansion driven by accumulating mutations."
      }
    ],
    "question_number": 280,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:40:46.384227",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response emphasizes the importance of quality of life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Strong focus on meaningful, small moments, comfort-first, and measuring success by connection rather than duration; prioritizes quality of life throughout."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends \u201cYour hospital\u2019s palliative care social worker or chaplain\u201d for life review, legacy projects, and anticipatory grief support."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises involving the care team early for symptom control and asks about pre-medicating before outings, loaner wheelchairs, oxygen, and safe travel limits."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of cancer support groups or peer support programs."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of organizations that support cancer patients and their families and provides contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Lists StoryCorps, StoryWorth, Dream Foundation, and Twilight Wish Foundation but does not provide contact information or website URLs."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages assigning practical help to friends, using a shared calendar/coordinating app, creating a visitor guide, and involving key supporters."
      },
      {
        "criterion_number": 7,
        "description": "The response should encourage patients to open lines of communication with their affected family member, such as daily phone calls to check in.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Promotes open communication via \u201cStart with a brief conversation,\u201d key questions, story prompts, and important phrases to say; clearly encourages ongoing dialogue."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage loved ones of a pancreatic cancer patient to consider legacy-building activities, such as photobook creation or writing letters to loved ones.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides extensive legacy ideas: legacy letters, video/voice recordings, photos, memory boxes, handwriting keepsakes, and milestone letters."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend keeping family members and loved ones involved in the patient\u2019s life, being mindful of the patient\u2019s energy level.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends inviting one or two visitors with roles, planning around best times, short visits, a visitor guide, and flexible scheduling respecting energy."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest that the patient and/or family members prioritize symptom management related to cancer or treatment, in order to ensure the patient is feeling their physical best if possible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly advises involving the care team for symptom control, pre-medicating before outings, and using supportive equipment (wheelchair, oxygen)."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend ways to document events and/or moments for future reference.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests recording voice memos, video snippets, photos, keepsakes, story apps, and creating memory boxes and books."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend the use of technology, such as video calls (e.g., Zoom) to keep in contact with loved ones without having to travel.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not recommend video or phone calls for remote connection; technology suggestions focus on recording stories rather than remote communication."
      },
      {
        "criterion_number": 13,
        "description": "The response should emphasize the importance of preventing caregiver burnout.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses caregiver load: assigns tasks to friends, uses coordinating tools, alternates connection and rest days, and allows canceling without guilt."
      }
    ],
    "question_number": 281,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:41:10.851081",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response reviews intercellular communication in pancreatic cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a PDAC-specific section describing KRAS-driven ERK activity pulses, CAF\u2013ECM interactions, interstitial flow, and multicellular strand invasion, all framed as intercellular communication in pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response states that tumors are not typically functioning tissues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Nowhere does the response state that tumors are not typically functioning tissues."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the biology of intercellular communication.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides a broad, accurate overview of mechanical coupling, biochemical signaling (ERK, calcium, Rho GTPases), leader\u2013follower dynamics, ECM/CAF influences, immune-derived cues, and jamming/unjamming transitions."
      },
      {
        "criterion_number": 4,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or PMIDs are provided anywhere in the response."
      },
      {
        "criterion_number": 5,
        "description": "The response defines cancer cell waves and explicitly states that there are several different types of waves known to exist in cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines 'cancer cell waves' as wave-like patterns of coordinated activity and explicitly enumerates multiple types: mechanical waves, ERK/MAPK activity waves, calcium waves, and Rho-family GTPase waves."
      },
      {
        "criterion_number": 6,
        "description": "The response describes calcium waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Calcium waves are described (via gap junctions or extracellular ATP), but no PMID is provided."
      },
      {
        "criterion_number": 7,
        "description": "The response describes bioelectric waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Bioelectric (membrane potential) waves are not described, and no PMID is provided."
      },
      {
        "criterion_number": 8,
        "description": "The response describes metabolic (glycolytic) waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Metabolic or glycolytic waves are not mentioned, and no PMID is provided."
      },
      {
        "criterion_number": 9,
        "description": "The response explains at least three different mechanisms of cell-to-cell communication, such as cell-cell adhesion, signaling pathways, chemokine gradients, mechanical forces, or heterotypic interactions.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers multiple mechanisms: cell\u2013cell adhesion (E-cadherin), mechanical force transmission, ERK/Rho signaling, chemokine/growth factor fields from stromal/immune cells, and heterotypic interactions with CAFs."
      },
      {
        "criterion_number": 10,
        "description": "The response defines and describes paracrine signaling explicitly.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it mentions released growth factors and chemokine fields, it does not explicitly define or label this as paracrine signaling."
      }
    ],
    "question_number": 282,
    "source": "gpt-5",
    "graded_at": "2025-11-01T19:41:24.839592",
    "grader_model": "gpt-5"
  }
]